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ABSTRACT 
Background - Women who inherit the BRCA1/2 gene have up to an 85% lifetime 
chance of developing breast cancer and a 63% chance of developing ovarian 
Cancer.  Since the publication and update of the UK Nice National Guidelines 
(2015) for women with a strong family history and Angelina Jolie, the famous 
American actress declared her status and her surgery, many more women are 
seeking testing in order to undergo bilateral risk-reducing mastectomy and 
oophorectomy. Very little is known about the longer-term effect on the woman 
her partner and her relatives following diagnosis and bilateral mastectomy from 
a qualitative research perspective. 
 
Aim - The aim of this study, therefore, was to explore, interpret and develop an 
understanding of the experiences of women and their relatives living with the 
BRCA gene who elect to have bilateral risk-reducing mastectomy in an attempt 
to improve clinical practice by providing a new horizon of understanding. 
 
Methods - An interpretive hermeneutic phenomenological study was conducted 
guided by the philosophy of Gadamer (2004) with its emphasis on a fused 
horizon of understanding with eight BRCA positive women, five of their husbands 
and five of their relatives. This study is a prospective study that took place in a 
large teaching hospital in Wales. 
 
Findings - This study provides a new fused horizon of understanding of what it 
means to be a BRCA Positive woman and a relative living with the BRCA gene 
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who elect to undergo bilateral mastectomy as a risk-reducing modality. A 
hermeneutic text of interpretation exposed three main horizons (Gadamer, 
2004). ‘The price of survival’, which includes the journey of the overall desire to 
survive, not just prevent cancer. ‘The altered child’s trajectory’ which involves the 
transference of the fear of cancer onto (for) children and future generations and 
‘disembodied, a separation from self’ which includes the effects of surgery on 
sexuality, femininity and identity. These horizons unite the experiences of the 
women and her relatives resulting in a new fused horizon of understanding, 
‘being disembodied’. These findings add knowledge and understanding for 
clinicians, researchers and policy makers working in the field of breast care with 
many implications for practice.  
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OVERVIEW OF THE THESIS 
This section provides a summary of the seven chapters within this thesis.  
 
Chapter One – Setting the Scene and Laying the Foundations 
This chapter sets the context of the study and provides the background 
information in relation to the prevention of breast cancer and the decision to elect 
to have bilateral risk-reducing mastectomy. It includes information on the BRCA 
gene mutations 1 and 2, the risk, the family, health care providers, 
decision-making including breast reconstruction.  In addition, a short 
autobiography of the researcher and the motivation for the study is offered in 
Appendix One. The terms BRCA mutation, gene mutation, mutation positive or 
mutation carriers are used interchangeably.  
  
Chapter Two - The Current Horizon of Understanding (Gadamer, 2004) 
This chapter provides an overview of the current literature reviewed, what 
Gadamer (2004) calls, ‘the current horizon of understanding’1. Thus the 
pre-understandings and prejudices formed from that literature, are highlighted 
and my research questions emerged. 
 
Chapter Three – Methodology and Methods 
This chapter presents my epistemological and ontological position, my 
methodology and methods of conducting the research including the decision and 
                                            
1 Knowledge attained from the literature review and before this study was conducted. 
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advantages of utilising a qualitative approach; this is reflected upon throughout 
the study. Examples of my reflections are provided in Appendix 6. 
 
Chapter Four - The Probands’ Experiences  
This chapter presents the analysis and findings of the text generated from the 
eight probands2 who were interviewed pre-surgery, at six and twelve months 
post-surgery and a subsample of four probands at eighteen months. It provides 
the three horizons3 of understanding that developed from the data and which 
unite the experiences of the women, their husbands and their family.  
 
Chapter Five - The Husbands’ Experiences 
This chapter presents the analysis and findings of the text generated from the 
five husbands who were interviewed pre-surgery and at twelve months 
post-surgery. Three horizons of understanding developed from the data and are 
exposed.  
 
Chapter Six - The Family Members 
This chapter presents the analysis and findings of the texts generated from the 
five family members (one mother, two fathers, one sister and one brother) which 
contributes to understanding the phenomena of living with the BRCA gene and 
the surgery from the family’s perspective.  Thus, three horizons of understanding 
                                            
2 Women tested and who have the BRCA mutation. 
3 A ‘horizon’ is the range of vision that includes everything that can been seen from a particular vantage point. 
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are exposed from interpreting the parts, in this study (husbands and family) and 
the whole (probands) and which unite the experiences.  
  
Chapter Seven - The Expanded Horizon of Understanding 
This chapter revisits the pre-understandings and prejudices4 highlighted at the 
start of the study and puts forward an expanded horizon of understanding as a 
result of engaging in the hermeneutic experience (gaining a deep understanding 
of what it means to be a woman with a BRCA mutation who elects to remove 
both of her breasts), by viewing the parts (the husbands’ and the families’ 
experiences) in terms of the whole (the probands’ experiences) and engaging in 
the hermeneutic circle5 of understanding. A discussion of the findings and 
conclusion are offered together with the implications for practice. 
 
 
 
                                            
4 Prejudice refers to the productive pre-understandings that enlighten future understanding of the phenomenon, 
gleaned from experience and the current literature. 
5 The hermeneutic circle is the back and forth movement between partial understanding and the more complete whole. 
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CHAPTER ONE – Breast Cancer, Genetic Risk and BRCA 
Mutations 1 and 2  
This chapter provides the background and context of the study: the BRCA 
mutation 1 and 2 and the decision to elect to have preventative breast surgery. 
It provides information about the genetics of breast cancer risk for individuals 
and the implications for their wider family. It presents an overview of the many 
factors involved in the prevention of breast cancer and the decision to elect 
risk-reducing mastectomy (RRM) including the role of health care 
professionals, laying down the foundations for the chapters that follow. To 
enable greater understanding of RRM as a preventative intervention and to 
put the study into context, breast cancer and its treatments are also 
considered. 
 
1.1 Introduction 
The focus of this study is on understanding the experiences of women who 
have inherited a mutation in either of the two breast cancer susceptibility gene 
mutations (BRCA1 and BRCA2) and who have elected to have bilateral 
risk-reducing mastectomy (RRM), which involves the complete removal of both 
breasts, and the impact on their families. This is the first qualitative study to my 
knowledge that focusses specifically on BRCA positive women and the 
decision to have risk–reducing mastectomy that includes exploring the 
experiences of their partners and family members. The desire to conduct the 
study was born of nursing practice and a lifelong career caring for individuals 
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with breast cancer and their families, witnessing the devastation of diagnosis, 
treatment and death. It also resulted from seeing an increasing number of 
young women attending services and deciding to undertake bilateral 
risk-reducing mastectomy with no studies to date detailing the specific 
experiences and informational needs of younger women undergoing RRM 
(Glassey et al., 2016). Yet currently, breast care teams do not fully understand 
the effects of this surgery on these women or the wider impacts on their 
relationships with their family, especially their partners. The overall goal of this 
study is to inform a clinical service that meets the needs of BRCA positive 
women and their families by understanding their experience. 
 
1.1.1 Implications of the BRCA Mutation for Individuals and Their 
Families 
Although women with the BRCA mutation do not have cancer, they have up to 
an 85% lifetime risk of developing breast cancer and up to a 60% lifetime risk 
of developing ovarian cancer (Barcenas et al., 2006; Chen and Parmigiani, 
2007). The identification of a mutation means that they have to face many life 
changing, difficult decisions, including the decision to reduce this risk by 
removing their healthy breasts and ovaries, which carries benefits but also 
risks (Howard et al., 2009).  Although accepting cultural differences in the 
perception of body image and decision making, many women in the western 
world are provided with the option to consider surgery to remove both of their 
breasts and believe it is the only option to prevent cancer and the debilitating 
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treatment that it involves (Metcalfe et al., 2005b; Brandberg et al., 2008; 
Lostumbo et al., 2010). In the systematic review by Howard et al., (2009), 
forty-three published articles were reviewed identifying three main factors that 
influence high risk women’s decisions about surgery.  These include medical 
factors, for example, being BRCA positive, psychological factors including the 
increased anxiety following the death of relatives to breast cancer and social 
factors which involve their perceived obligations to the family, all of which 
cannot be viewed as independent or in isolation. How these factors affect 
women and their family in their everyday lives and how they influence 
decisions about genetic testing and preventative treatment, however, is less 
understood. 
 
1.1.2 The Decision of Testing and Disclosure on the Family Dynamics 
Understanding of the inheritance of a BRCA mutation and the implications of 
testing is highly complex and multifaceted for women and their families.  
Katapodi et al., (2013) found that both individual and family characteristics 
influence the decision to be tested and that testing was positively associated 
with ‘family hardiness’, that is, a family’s cohesion and ability to overcome 
adverse events. However, many individuals still find it particularly difficult 
knowing when and how to disclose information about testing and risk-reducing 
surgery to the family, and children in particular, (Kenen et al., 2006; 
d’Agincourt-Canning, 2006a) due to the emotional impact for themselves and 
their children. 
  
4 
 
Rowland et al., (2016) in their qualitative study with eleven families that 
included thirteen children and young adults aged between ten and twenty-one, 
found that the majority of mothers disclosed their own risk but avoided 
disclosure of their children’s risk, disclosing even less to their sons. 
Importantly, many of the women who had undergone surgery avoided 
disclosing any information about the negative psycho-social effects because 
they tried to protect their children from the impacts of surgery.  However, this 
withholding and downplaying of information inadvertently made it more difficult 
for their children to have an awareness of the risks and the implications of 
having a BRCA mutation and surgery.   As a consequence, many of these 
young adults had a blasé attitude towards the surgery with reconstruction and 
often failing to differentiate this from cosmetic augmentation, additionally 
preventing them from fully understanding the implications and the risks of 
major surgery (Rowland et al., 2016). 
 
Thus, in addition to coming to terms with the inheritance of a gene mutation 
and the implications of risk-reducing surgery, women also have to consider the 
wider consequences, which involve and affect the whole family. A qualitative 
study examining the impact of BRCA testing on family dynamics and 
relationships (eleven women and one male from eight different families with 
the mutation), demonstrated emotional consequences for both the individual 
tested (the index case) and their relatives, impacting negatively on the family 
dynamics and their relationships.  Discussions within the family also changed 
and some members of the family were found to become less connected to 
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other family members and reported that they felt burdened to disclose their 
results within their family (Douglas et al., 2009). 
 
Crotser and Dickenson (2010) in their qualitative hermeneutic study of 
nineteen women from seventeen nuclear families, gained an understanding of 
the experiences of younger women with the BRCA mutation (n=12) and the 
communication within their families.  Receiving and responding to the BRCA 
result was found to have more of an effect than expected, evoking a paradox 
of both reported fear and empowerment for these young women.  This caused 
an additional ripple effect throughout their families.  Relationships changed as 
a result of their limited communication about the BRCA result and a need to 
protect family members, resulting in a change to the sense of connectedness 
to family members, with some young women seeking support and help outside 
of the family. The reported emotions amongst family members who receive 
news of a mutation also included sadness, guilt, resentment, anger and blame 
(Bradbury et al., 2007).  
 
How these factors affect women and their families in their everyday lives and 
how they influence decisions about genetic testing and preventative treatment, 
however, is less understood.  Thus, it is important for health care professionals 
working with BRCA individuals and families who are seeking testing and 
surgery to be aware of the implications of this process for the wider family 
dynamics and the difficulties they may have already experienced in their 
pathway to the clinic and surgery. In order to fully understand and support 
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women in the context of their family, a deeper exploration of these experiences 
and impacts using qualitative research perspectives can aid understanding 
and benefit clinical practice. 
 
1.1.3 Implications of the Decision to Elect to have Risk-Reducing Breast 
Surgery for the Woman 
Bilateral mastectomy as preventative risk-reducing surgery is not without 
consequences and has been associated with physical complications, 
psychological problems, decreased quality of life (Gahm et al., 2010; Hallowell 
et al., 2012; den Heijer et al., 2012; Gopie et al., 2013) and in some cases, 
regret (Borgen et al.,1998; Frost et al., 2000; Payne et al., 2000). Indeed, 
Bresser et al., (2006) refer to this type of surgery as very radical. Furthermore, 
decisions about surgery have often been found to reflect an emotional heuristic 
approach, that is, a reflection of a woman’s own fear, worry and perceived 
control rather than a perceived rational weighing up of both risk and benefits 
(Kenen et al., 2003a; Beesley et al., 2013; Heiniger,et al., 2015). 
 
A great deal of uncertainty and stress has been associated with the decision 
about risk-reducing surgery including what surgery to undergo and when.  A 
qualitative study carrying out in-depth interviews with thirty-two women (of 
which eight were BRCA positive) to determine their experience of making such 
decisions, identified that these women initially turned to their doctors to 
address their uncertainties, reporting that some providers were too directive 
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whilst others too non-directive.  Women were left feeling very disappointed 
and turned to family, friends and the wider breast cancer community for 
direction (Klitzman and Chung 2009).  These decisions are often already made 
by women by the time they and their families attend the surgical appointment. 
However, an understanding of how women come to their decision is necessary 
in order to identify their expectations, their informational and support needs. 
 
McQuirter et al., (2010) in their qualitative study of ten BRCA positive 
Canadian women found that the decision to proceed with surgery was an 
emotional and intuitive process that involved interpersonal factors, contextual 
factors and informed by relationships rather than a ‘rational’ weighing up of the 
pros and cons of surgery.  A literature review by Glassey et al., (2016) also 
found that women are not well informed prior to making a decision about RRM 
identifying that younger women needed more information and support.  
Overall, fear and worry strongly influence decision making (Beesley et al., 
2013; Heiniger et al., 2015). 
 
However, health care professional’s especially surgical teams, often 
underestimate the impact of the test result or how women and families came 
to the decision of surgery. They also underestimate the consequences and 
experience of such surgery for women and families with a BRCA mutation 
because they do not have cancer (Rolnick et al., 2007; DiMillo et al., 2013).  
Rolnick et al., (2007) surveyed nine hundred and sixty-seven women who had 
a prophylactic mastectomy and found that of the 80% who had bilateral 
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mastectomy, two thirds wanted more information and to be better prepared for 
the physical changes experienced post-surgery. Moreover, in a qualitative 
study by Patenaude et al., (2008), that explored the psychological consultation 
with women who were considering RRM, more than 50% of the one hundred 
and eight women felt that psychological consultation pre and post-surgery was 
required to aid decision making and prepare them for surgery. Despite this 
finding, formal clinical psychological services for women and their families with 
a BRCA mutation vary considerably in the UK and is not standard practice in 
many areas (Glassey et al., 2016).  In Wales, for example, the cancer genetic 
clinic may be on a different hospital site to the surgical clinics and there is no 
formal clinical psychological consultation before surgery.  
 
Furthermore, differences in service provision from breast care nurse 
specialists exist in the UK, for example, in many breast care services in the 
UK and in many parts of Wales, there is no routine pre and post-operative care 
from a specialist nurse dedicated to these patients or their families. This gap 
in service provision is because they do not have cancer, their risk has been 
removed by surgery and their physical care and psychological support needs 
have yet to be fully identified. Thus, the precise physical, psychological and 
informational needs from testing through to surgery and beyond from a clinical 
perspective for the woman and her family is less understood. Indeed, only one 
study, with seven participants, has included Welsh women with a BRCA gene, 
these were aged eighteen to thirty, and the study focussed on genetic testing 
and not the experiences of surgery (Brunstrom et al., 2016). 
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This first section introduced the study, the start of the journey from genetic 
testing to decisions about risk-reducing mastectomy, demonstrating that this 
process involves not only individuals but also their wider families. It introduces 
the justification for the need to conduct this study and the importance of clinical 
practice. The remainder of Chapter One provides background information that 
puts the study into context. 
 
1.2 Access to Testing Policy, Practice and the Media 
1.2.1 Policy and Practice 
The updated family history guidelines by the National Institute for Health and 
Care Excellence (NICE, 2013) has widened the eligibility criteria for testing 
meaning that many more women have been able to request genetic testing for 
a BRCA mutation. These guidelines have lowered the threshold for testing from 
a greater than 20% risk to now include individuals assessed as having at least 
a 10% risk of carrying a mutation, making more women eligible to be tested. 
(NICE, 2013).  The criteria for testing in the UK can be seen in Appendix Two.  
 
These guidelines also require that discussions about risk-reducing surgery 
should be more implicit throughout the process of assessment and testing.  
Although surgery is not a recommendation, it is presented as an option for risk 
management for women with a BRCA mutation that should be discussed (See 
Appendix Two).  
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Importantly, this expanded eligibility criteria has prompted a dramatic increase 
in referrals for both genetic testing and risk-reducing surgery. In the UK for 
example, there has been a two-and-a-half-fold increase in referrals and the 
demand for testing has doubled (Skytte et al., 2010; Evans et al., 2015), 
Indeed in Wales, the number of tests being performed has quadrupled. 
Moreover, in 2009, there were one thousand one hundred and sixty three 
women having RRM in the UK (Neuberger et al., 2013) and numbers are now 
estimated to be much higher. Within the UK breast centre where this study 
took place, since 2013 there has been a threefold increase in the number of 
referrals or surgery and without any associated increase in resources for 
nursing care and psychological support for this group. 
 
1.2.2 The Influence of Media 
In addition, wider knowledge of the BRCA genes and availability of testing via 
the media has also resulted in many more women with a family history of 
breast or ovarian cancer attending cancer genetic clinics seeking screening 
and preventative surgery (Parks, 2014; Sherkow and Scott; 2014; Evans et 
al., 2015). Media coverage of Angelina Jolie, the American actress, and her 
decision to disclose her BRCA mutation and surgery (New York Times, May 
2013) is just one example. The role that the media play in both normalising 
and influencing risk-reducing mastectomy decisions should not be 
under-estimated. As with the Angelina Jolie story, Crabb and Le Couteur 
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(2006) utilise discursive analysis to demonstrate how a popular magazine 
account portrays one woman’s story of the removal of her healthy breasts as 
morally acceptable. ‘Fiona Farewells her breasts’ situates Fiona as a 
responsible self-sacrificing mother who is removing her asymptomatic breasts 
in order to survive, intimating that if she does not do it, then she will die. She 
is presented as both a rational and reasonable individual. 
 
These portrayals contrast to some of the earlier suggestions that women’s 
decision to have risk-reducing surgery is influenced by an over-estimation of 
risk or intense anxiety and viewed by professionals and family, as extreme 
behaviour (Meiser et al., 2000).  The fact that woman and their families are 
now able to accurately determine the probability that they will contract breast 
or ovarian cancer with the diagnosis of a mutation in either the BRCA1 or 2 
genes also makes it a more acceptable decision and less controversial.  
 
To put the study into context and prior to examining what is already known 
about the experience of a BRCA mutation and RRM, it is pertinent to give a 
brief overview of the wider literature examining the experiences of women with 
a diagnosis of breast cancer who have a mastectomy and reconstructive 
surgery to identify any similarities, but also to examine and understand why 
women seek preventative surgical interventions. 
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1.3 Overview: Breast Cancer, Mastectomy and Reconstruction  
In the United Kingdom (UK) there are approximately fifty-four thousand new 
cases of cancer a year and one hundred and fifty cases a day, of women 
diagnosed with breast cancer. It is the most common cancer occurring in 
females accounting for 31% of all new female cancers. One in eight women 
will be diagnosed with breast cancer during their lifetime and although rare in 
men, approximately four hundred men are diagnosed each year in the UK. 
Even though mortality rates have fallen by 40% since 1989, breast cancer 
remains the second leading cause of cancer deaths in women (Cancer 
Research UK (CRUK), 2013). 
 
1.3.1 Treatment for Breast Cancer 
The treatments for breast cancer can be lengthy and debilitating, consisting of 
surgery and adjuvant therapies such as chemotherapy, radiotherapy, hormone 
treatments or any combination that can take up to a year to be completed. Both 
surgery and adjuvant therapy can have immediate and long-term negative 
effects on an individual, for example depression, anxiety, body image 
problems, especially from breast and hair loss and weight gain, all associated 
with psychological problems (King et al., 2000; Avis et al., 2005; Mols et al., 
2005; Kayl et al., 2006; Mehnert and Koch, 2008; Lemieux et al., 2008) and a 
reduced quality of life (Crompvoets, 2003; Ohsumi et al., 2007; McLachlan, 
2009; Karaoz et al., 2010; Adams et al., 2011; Rosenberg et al., 2013).  
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1.3.2 Psychological Effects of Breast Cancer  
Cancer related distress has been identified as especially high following breast 
cancer diagnosis (Voorwinden and Jaspers, 2014) and associated with reports 
of anxiety, depression and adjustment (Walker et al., 2014). It has been 
estimated that up to 38% of these women suffer from anxiety and depression 
(Vahdaninia et al., 2010) with up to 50% experiencing sexual problems (Fobair 
et al., 2006).  Breast cancer treatments can impose unwanted changes to the 
body following mastectomy. This can distance a woman from her body even 
with reconstruction, challenging femininity and identity (Rosenblatt, 2006; 
Everson, 2009; Piot-Ziegler et al., 2010). Furthermore, although breast 
conservation is an option for women diagnosed with breast cancer, it offers a 
modest benefit when compared to mastectomy, of experiencing cancer related 
fears and changes in body image. Body transformation from the scars of both 
surgeries and the effects of chemotherapy, constantly remind women of the 
impact of the treatment on their lives (Thomas-Maclean, 2005).  Women with 
breast cancer can often access psychological counselling, either provided by 
cancer charities or from a referral to a trained counsellor in a General 
Practitioner (GP) practice. In contrast, women electing to have RRM, find it 
difficult to access such services because they do not have cancer. 
  
It is widely acknowledged that mastectomy following a breast cancer diagnosis 
is associated with considerable psychological morbidity resulting specifically in 
dramatic alterations in body image (Petronis et al., 2003; van Oostrum et al., 
2003; Marshall and Kiemle, 2005; Hawkins et al., 2009; Manganiello et al., 
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2011; Rosenberg, et al., 2013).  Studies have identified that women with a 
BRCA mutation are aware of this morbidity and feel a responsibility to act on 
their opportunity to prevent cancer from occurring (Howard et al., 2009; 
McQuirter et al., 2010). 
 
1.3.3 Breast Cancer and BRCA Mutations  
Importantly, breast cancers that develop in women with the BRCA1 mutation 
can be more aggressive, develop at a younger age when compared to those 
with BRCA2  (Skytte et al., 2011), and can be triple negative cancers. Triple 
negative cancers do not have receptors for the hormones oestrogen or, 
progesterone or for the HER2 protein, which means that women have limited 
options of adjuvant treatment (hormonal therapy and Herceptin) post-surgery 
that will help to prevent cancer from recurring (CRUK, 2013).  Between 10% 
and 30% of cancers in women with a BRCA1 mutation will be triple negative 
and increasingly, in clinical practice, more BRCA mutations are being identified 
in women who present with breast cancer and who, because of examining 
tumour pathology, are found to have a triple negative cancer (Vargas et al., 
2010). 
 
1.3.4 Treatment Decisions of Women with Breast Cancer and the BRCA 
Mutation 
Many of the women found to have triple negative breast cancers request 
genetic testing for a BRCA mutation and if a mutation is identified, choose to 
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have bilateral mastectomy (Jeffers et al., 2014). It is also known that younger 
women diagnosed with breast cancer choose the most aggressive treatment 
in order to reduce their risk of further disease (Finch et al., 2013).  Women with 
breast cancer have different motivations and expectations to healthy at-risk 
women when it comes to testing and surgery. Affected women, for example, 
want to identify why they developed cancer thus trying to prevent family 
member’s from developing it, whereas healthy at-risk women prioritise 
assessing and understanding their own risk (Iredale et al., 2003). In addition, 
those women with breast cancer and a BRCA mutation who choose RRM, do 
not report statistically significant reductions in their cancer worry following 
surgery compared to BRCA women unaffected by cancer (Brandberg et al., 
2004; Borreani et al., 2014).  Nevertheless, those diagnosed with breast cancer 
with an additional BRCA mutation are increasingly choosing to have bilateral 
risk-reducing mastectomy.  
 
In a grounded theory study by Jeffers et al., (2014), women with breast cancer 
who also had a BRCA mutation, chose to remove their breasts and their ovaries 
in order to ‘maximise survival’. The process of maximising survival was found 
to begin even earlier than the genetic test, during their cancer journey, with a 
focus on survival for the sake of themselves but importantly, for their family. 
These women’s focus moved from living with a cancer diagnosis to living with 
an inherited disease which demonstrates the significant psychosocial impact 
of living with both genetic inherited disease and cancer (Jeffers et al., 2014). 
Kwong and Chu (2012) also found in their qualitative study of twelve Chinese 
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women with breast cancer (of which eleven were BRCA positive) and who 
chose to have the other breast removed in response to this genetic information, 
a quarter were found to experience regret and had psychological problems up 
to three years post-surgery, despite breast reconstruction. 
 
1.3.5 Breast Cancer, Mastectomy and Reconstruction 
Breast reconstruction following surgery can have both positive and negative 
effects on quality of life and cosmetic satisfaction (Brandberg et al., 2000; 
Malata et al.,2000; Nissen et al., 2001; Harcourt et al., 2003; Elder et el., 2005; 
Bresser et al., 2006; Isern et al., 2008).  Within some studies, significant 
dissatisfaction and regret have been identified (National Mastectomy and 
Reconstruction Audit, 2011, Harcourt and Rumsey, 2004; Sandham and 
Harcourt, 2007; Sheehan et al., 2007). 
  
Reconstruction can never replace a woman’s breast and women’s 
expectations are often unclear, with decisions based on individual preferences 
(Denford et al., 2011), and influenced by a woman’s concern for her husband. 
Piot-Ziegler et al., (2010) conducted a qualitative study using semi-structured 
interviews with nineteen women who had mastectomy following breast cancer 
and nine had been offered reconstruction. Many reported that they had 
reconstruction for their husband’s sake. The authors found that despite 
reconstruction, mastectomy led to a body that was deconstructed, which 
challenged the women’s gendered identity causing feelings of 
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embarrassment, loss, mutilation and dissonance from her former integral 
body.  
 
It is not unsurprising, therefore, that most young women with breast cancer 
decide not to reconstruct their breast.   However, evidence also suggests that 
those women with breast cancer who do not have reconstruction following 
mastectomy, report a negative impact on their relationships and on 
psychological wellbeing. Within one study over 30% of women feel that their 
partners perceive them as less attractive and over 80% covered up their 
bodies during intimacy (Andrzejczak et al., 2013).  Importantly, it has been 
suggested that there may be an over reliance on using surgical reconstruction 
in an attempt to solve the bodily loss caused by this surgery (Holland et al., 
2014). Indeed Fang et al., (2013) and Harcourt et al., (2003) advise that 
reconstruction should not be seen as a panacea for the distress caused by 
mastectomy. 
 
1.3.6 Partners and Reconstruction 
The literature examining the experiences of partners or family members 
following mastectomy and reconstruction is particularly limited and has 
focused on the experiences of having a family member diagnosed with breast 
cancer, not those who are living with risk.  However, these studies have 
demonstrated negative outcomes for partners especially with regard to their 
relationship, sexuality, and body image adjustment (Sandham and Harcourt, 
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2007; Rowland and Metcalfe, 2014). They report mourning the loss of their 
partners’ breast with experiences of distress, distaste and avoidance of 
intimacy.  The systematic review by Rowland and Metcalfe (2014), reported 
that men found it particularly challenging talking to their partner about 
alterations to body physique and image and requested more information and 
support from professionals to prepare them personally for the change but also 
to help them to support their partners.  In response, the inclusion of partners 
in this study will explore some of these issues and examine the experience of 
breast loss for partners in the context of risk reduction. 
 
1.4 The Function of the BRCA Gene 
Cancers develop as the result of a disruption in the normal functioning of genes 
and in the majority of cases, they occur by chance, from exposure to 
environmental factors or problems in the replication of DeoxyriboNucleic Acid 
(DNA). DNA is a self-replicating material present in all living cells and a major 
component of chromosomes (National Institute for Health (NIH), 2016). The 
two main breast cancer genes BRCA1 and BRCA2 produce tumour suppressor 
proteins and these have been located on chromosomes 17 and 13, 
respectively.  These proteins help repair damaged DNA thus ensuring that the 
cells genetic material is stable.  
 
When either of the genes is mutated, or there is an alteration, it results in the 
protein being unable to function properly. DNA damage is not repaired 
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properly; as a result, cells develop additional genetic alterations that can lead 
to cancer (NCI, 2015). In this case, there is the uncontrolled growth of breast 
and ovarian tissue because the tissue does not respond to the body’s normal 
signals to stop growing. 
 
1.4.1 The Discovery and History of the BRCA Gene Mutation 
BRCA1 and BRCA2 are the most common genes that put an individual at the 
greatest risk of breast and ovarian cancer (CRUK, 2013). The region of the 
genome that became known as BRCA1 was discovered, in 1990, on 
chromosome 17 in a laboratory in Berkeley, USA by Mary-Claire King, 
Professor of Genome Sciences and her colleagues, at the University of 
California. Four years later, the gene was cloned at the University of Utah and 
by Myriad Genetics. In 1995, the BRCA2 gene was also discovered and cloned 
by Myriad Genetics, a company in Salt Lake City who patented the genes in 
1998 and was the only company to exclusively offer a genetic test from the late 
1990’s until 2013, when the ‘US Supreme Court revoked’ the patent (NCI, 
2015). 
 
The discovery of both genes has made genetic testing possible for women and 
their families. Genetic testing refers to the examination of an individual’s DNA, 
focusing on one or more specific genes and testing for BRCA gene mutations 
became available in the UK in 1996 (Bancroft et al., 2010). Since the NICE 
(2013) guidelines were implemented in Wales in 2015, those with a personal 
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history of breast cancer (affected) and testing of unaffected individuals with a 
strong family history of a greater than 10% chance of having a mutation, has 
been possible. Women can also fund the test themselves if they do not meet 
the criteria for testing within the National Health Service (NHS). The costs vary 
considerably, but in Wales, private testing costs approximately five hundred 
pounds. In some parts of the UK, women and their families are self-funding 
private genetic testing, especially where their family history is not available for 
example in cases of adoption or if there are estranged relationships within 
families or where communication problems exist. Women diagnosed with 
breast cancer within a family with high risk can initiate a test if they are also 
assessed as having a 10% or greater risk of having a mutation; this is called a 
diagnostic test and takes forty days for the results (UK Genetic Testing Network 
(UKGTN), 2016).  This, in turn, has increased the case load of multidisciplinary 
breast teams especially breast care specialist nurses.  Cancer genetics centres 
in the UK offer predictive testing to those unaffected by cancer over the age of 
18 if there has been an identified BRCA mutation in a family member. A blood 
test is performed and results are expected in twenty days (NICE, 2013)  
 
1.4.2 The Risk of Breast Cancer with a BRCA1 and 2 Mutation 
Hereditary breast cancer accounts for approximately 5-10% of all breast 
cancers and BRCA1 and BRCA2 mutations account for 20-30% of hereditary 
breast cancer in families (Ford, 1998; NCI, 2015).  These cancers usually occur 
below the age of fifty (Rogozinska-Szczepka et al., 2004) and put the affected 
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person at risk of other cancers, particularly ovarian cancer, accounting for 
approximately 15% of ovarian cancers overall (NCI, 2015). 
 
Although women with a family history of breast and ovarian cancer generally 
overestimate their risk (Meiser et al., 2000; Kenen et al., 2003; Braithwaite et 
al., 2005) with younger women found to have higher cancer related distress 
(Vodermaier et al., 2010; Patenaude 2013;), the risk of developing breast 
cancer is significantly higher for women with a BRCA mutation. Women who 
have inherited a BRCA1 or BRCA2 mutation have an approximate lifetime risk6 
of 60-85% of developing breast cancer and a 40-60% chance of developing 
ovarian cancer compared with a 12% risk of breast cancer in the normal 
population (Barcenas et al., 2006; Chen and Parmigiani, 2007).  
 
These cancers develop pre-menopausally and women have up to a 64% 
chance of developing bilateral breast cancer (Evans, et al., 2009). In 
comparison, men with a BRCA mutation have up to a 16% risk of prostate 
cancer and approximately an 8% risk of breast cancer (Evans et al., 2009). 
Prostate cancers that develop in men with a BRCA mutation have poorer 
survival rates than those who test negative because the cancers are more 
aggressive and develop faster (Narod et al., 2008).  This is important in the 
context of this study because there were three men in the sample who tested 
                                            
6 Risk calculated up to the age of eighty years. 
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positive for a BRCA mutation and thus had to consider their own risk as well 
as their family members.  
 
The inheritance pattern of the BRCA mutation is autosomal dominant, which 
means that both females and males have an equal chance of inheriting the 
abnormal copy of the gene from their parents. Thus, a mutation in BRCA1 and 
BRCA2 can be inherited from either an individual’s mother or father with each 
child having a 50% chance of inheritance (NCI, 2015). In families where there 
are many incidences of young female cancers and within certain ethnic groups 
such as the Ashkenazi Jewish population, there is much more likely to be an 
alteration in BRCA1 and BRCA2 (Bleiker et al., 2003; d’Agincourt-Canning, 
2006b; Julian-Reynier et al., 2010; Gopie, 2013). In the Ashkenazi population, 
for example, there is a tenfold increase in the mutation compared to the general 
population. Clusters present in families within the Jewish populations and these 
are primarily located in Iceland, Sweden and Quebec (Frank et al., 2001; 
d’Agincourt-Canning, 2006b; John et al., 2007). 
 
1.5 Genetic Risk, Screening and Counselling 
1.5.1 Genetic Risk 
Over the past twenty years, there has been a growing interest in the concept 
of risk amongst health care professionals.  Risk information informs both public 
health policy and clinical practice with its focus on prevention of disease and 
management of risk. With increasing access to genetic risk information, it is 
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imperative that clinicians understand what it is like living with increased health 
risks and thus the information and support individuals require. One of the  most 
significant findings from a qualitative study exploring the experiences of women 
living with an increased risk of breast and ovarian cancer was that they wanted 
more information from health care practitioner’s (McEwan, 2011). 
 
Many women will make decisions about risk-reducing surgery based on their 
perceived rather than their actual risk.  Within health care, the term ‘risk’ refers 
to the probability that members of a certain category will develop or contract a 
disease and is a term interpreted by some as ‘harm’, relating to many 
uncertainties, including the future (Zinn, 2005). Indeed, Palmer and Sainfort 
(1993) conceptualise risk as ‘a combination of probability and something 
adverse, unpleasant or dangerous’ (pg. 275).  However, more recent research 
would argue that for some individuals, the concept of ‘risk’ can be a motivating 
force that positively affects future actions (Horlick-Jones and Prades 2009; 
McEwan, 2011).  Within this study, ‘risk’ is that which concerns women and 
their wider family members with a BRCA1 or 2 mutation at risk of developing 
breast, ovarian and prostate cancer either now or in the future.  Thus, for many 
of the participants in this study, ‘risk’ may represent both harm and a motivating 
force.  Harm because they have a confirmed significant risk of getting cancer 
and motivation because they have the ability to reduce that risk and have 
elected to have risk-reducing breast surgery.  
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Increasing biomedical knowledge of the genetics of breast cancer alongside 
an increasing ability to access risk assessment technology such as genetic 
testing and risk-reducing surgical techniques has had profound implications for 
women with a family history of breast cancer and their wider family. Firstly, it 
exposes women to make choices about medical and surgical interventions, 
when there is no actual disease. Secondly, it has the potential to affect both 
men’s and women’s emotional wellbeing and sense of self. Thirdly, it can raise 
moral and ethical issues of disclosure and secrecy of risk information that can 
impact on the wider family network (Hopwood, 2005; Featherstone et al., 
2006). Indeed, genetic risk and predisposition to a disease are a complex 
family matter with considerations that go beyond the family member who 
initiates testing. These include ethical and moral issues, confidentiality, who 
‘counts’ as family and the possession of different levels of knowledge and 
understandings. Thus, it is never an individual matter (Featherstone et al., 
2006).  Furthermore, despite the ways ‘risk’ is communicated to individuals in 
terms of either percentage’s or ratio’s, other factors are also involved in how 
individuals make sense of that risk and they will have different interpretations.  
 
Despite evidence that genetic counselling for cancer risk improves the 
accuracy of an individual’s understanding of risk (Meiser and Halliday, 2002 
Keller et al., 2008).   Sivell et al., (2008) systematic review found that not only 
do individuals find it difficult to accurately quantify their risk, but the way they 
understand risk is strongly affected by their lived experience.  Kenen et al., 
(2003b) in a qualitative UK study with twenty-one women at high risk of breast 
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and ovarian cancer found that most women perceived their risk as a ‘chronic 
risk’ which resulted in a change in their self-identity.  Those participants whose 
mothers or sisters had died of breast cancer experienced the saliency of their 
risks much more acutely than those whose family members had recovered 
from their cancers. These are important factors that are likely to influence 
women requesting risk-reducing surgery. 
 
1.5.2 Family Risk and Responsibility  
Genetic testing and the resulting information about the risk of developing a 
condition involves a consideration of an individual’s relationship’s, both 
biological and social (Hallowell, 2009).  Receiving genetic test results often 
bestows individuals with a responsibility to manage their risk and thus their 
bodies, in order to prevent any potential health issues (Hallowell, 1999; 
d’Agincourt-Canning, 2006a; Bury, 2008., McEwan, 2011). Therefore, a BRCA 
mutation will affect the way in which women and families think about their 
bodies. This, in turn, will affect their sense of self-identity and even before the 
risk is identified, some women may already have an uneasy relationship with 
their bodies. This uneasiness will affect how they perceive themselves and 
their body image leaving them feeling vulnerable, especially when faced with 
decisions regarding risk management and in particular, risk-reducing surgery. 
This, in turn, can have an impact on relationships, dating and marriage 
(Hamilton et al., 2009, Matloff et al., 2009; Hamilton and Hurley, 2010). 
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The responsibility of risk, testing and disclosure of genetic information is 
considered a matter for the individual and their family as opposed to the 
professionals, but the timing and the content of the disclosure, with children 
especially, varies within families. The difficulties and challenges of this have 
been explored in a qualitative study by Hallowell et al., (2005b), using 
semi-structured interviews with twenty-nine family members.  Parents 
described how they felt it was their responsibility and obligation to undergo the 
test and to disclose the results to their children. 
 
However, individuals perceive ‘family’ in many different ways. Family life 
involves a number of different relationships, which can lead to complexities and 
vulnerabilities (Hughes and Ferguson, 2004). Families who are assessed as at 
high risk of a disease are particularly vulnerable because the risk exposes them 
to difficult decisions. This can be challenging, particularly if there are changes 
in family relationships with the potential for secrecy and the associated 
difficulties in communicating genetic risk information (van Oostrum et al., 
2007).  This may even lead to a re-evaluation of the self and Novas and Rose, 
(2000) suggest that genetic testing creates ‘new categories of persons’ who 
have an obligation to manage themselves and others once provided with 
genetic risk information.  
 
Communication and disclosure of genetic results within families, especially 
when male carriers are involved, is felt to be a family matter (Hallowell et al., 
2005b).  However, Featherstone et al., (2006) also remind us that it is not as 
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straight forward as we may think. Although practitioners may assume that the 
genetic risk information is disseminated unproblematically through families, 
there is no way of knowing who, what, or how family members are told or 
indeed, who counts as family in the context of genetic risk information. This is 
important for clinical teams because many of the individuals and families who 
seek surgery are related and although some attend surgical consultation 
together, others attend separately and do not have clear lines of 
communication.  
 
1.5.3 BRCA Screening  
If an individual’s family history of breast and ovarian cancer indicates that this 
may be associated with a mutation in a BRCA gene, the clinical team will 
construct a detailed family history or ‘pedigree’. Screening for a mutation is 
based on family history and the Breast and Ovarian Analysis of Disease 
Incidence and Carrier Estimation Algorithm (BOADICEA), is one example of a 
computer programme used to calculate a person’s risk, recommended by NICE 
(Lee et al., 2013, NICE, 2013).  The National Institute for Health and Care 
Excellence (NICE) Guidelines (2013) on family history, recommend that in both 
primary and secondary health care, a history should be taken and if it meets 
the criteria, that a referral is made to a cancer genetic service.  
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1.5.4 Genetic Counselling 
In the UK, in line with current guidelines (NICE, 2013), before performing a 
genetic test, an NHS clinic requires that at least two sessions of genetic 
counselling take place with the individual and their family seeking testing. This 
is the case in Wales where the study took place but often only one session is 
attended.  The woman and her family will see a geneticist or a trained 
counsellor who discuss with them the implications of both a negative and a 
positive test result, to help them understand the available risk management 
options, and make the best possible adjustment to the risk presented to them. 
Genetic counsellors are specialists who assess risk and explain inheritance to 
those who seek information. They discuss choices with individuals and their 
work is directed at families (Featherstone et al., 2006).  
 
Genetic counsellors are trained in counselling and communication and provide 
psychosocial assessment and support to those attending the genetic clinic 
(Gregory et al., 2010).  In many units across the UK, but especially in Wales, 
following the genetic test result, if a woman requests to see the surgical team 
to discuss the surgical options regarding risk-reducing mastectomy, she is 
referred.  However, in Wales, the surgical consultation may not occur for some 
months or years after the genetic test.  Furthermore, cancer genetic services 
vary across the UK in terms of inter-professional working and therefore some 
services will be integrated and on one site whilst in some parts of Wales, the 
surgical consultation is on a different site and as already mentioned, can occur 
months or years following a test. An interdisciplinary approach with good 
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communication is therefore essential because there is wide variation in the 
amount of information that geneticists and genetic counsellors provide about 
the surgical techniques of breast surgery and reconstruction.  There is also a 
wide variation for women to have access to a specialist breast care nurse. 
 
Genetic counsellors, as well as the surgical team, need to be up to date with 
information in order to give women and their families informed choices. This is 
important because the quality of the information given to them and their families 
regarding their surgical options and the way in which the information is 
communicated will have a major influence on the subsequent decisions that 
are made, including a decision to elect to have RRM. The issue of 
reconstruction is complex, with many different techniques to discuss and 
consider including the woman’s and family expectations and post-operative 
recovery. It is therefore essential that professionals working with this patient 
group are up to date with their knowledge and trained to provide appropriate 
information and support to women and their families.  
 
1.5.5 The Role of the Breast Nurse Specialist  
Nurse specialists working in breast disease are highly experienced key workers 
in the Multi-Disciplinary Team (MDT) (NICE, 2009). They provide specialist 
support and information to women with breast cancer and their families from 
diagnosis to recovery, having undergone extensive training. Their goal is to 
prepare individuals and the family for treatment and set realistic expectations, 
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for example, by showing photographs of the different stages of surgery. More 
frequently, many nurse specialists have undergone extended training to 
provide psychosocial interventions, for example, Cognitive Behavioural 
Therapy (CBT).  
 
Evidence suggests that women with breast cancer who are cared for by 
specialist nurses have reduced psychological morbidity and an improved 
quality of life (McArdle et al., 1996; Rustoen and Begnum, 2000; Eicher et al., 
2006). NICE guidelines on acute and advanced breast cancer (NICE, 2009) 
recommend that all women diagnosed with breast cancer should have access 
to a key worker such as a clinical nurse specialist. However, women and their 
families with the BRCA mutation in many parts of the UK, but especially in most 
of Wales, do not routinely have any pre-surgical support from a specialist nurse 
and the only contact may be with a geneticist or a surgeon.  Furthermore, a 
multidisciplinary approach for patients with a BRCA mutation undergoing 
breast surgery has been shown to improve both the experience and the 
outcome for such patients (Alamouti et al., 2015). 
 
Evidence demonstrates that decisions to proceed with surgery made by 
surgeons as opposed to the woman herself, result in higher levels of 
dissatisfaction and regret post-surgery (Borgen et al., 1998; Frost et al., 2000; 
Payne et al., 2000). 
 
  
31 
 
1.6 The Impact of Testing and Disclosure  
1.6.1 The Impact on Women 
When a woman receives a positive mutation result, she is confronted with 
difficult life-changing decisions that carry many risks both physical and 
psychological (Howard et al., 2009). The fear of cancer, uncertainty about the 
future, risk to family members and the consequences of surgery are just some 
of their concerns (Lodder et al., 2002; Van Dijk et al., 2003; Watson et al., 2004; 
Antill et al., 2006; Graves et al., 2012). The decision to pursue testing is 
complex and difficult for many women and their families to comprehend 
(Hamilton and Hurley, 2010). Interestingly, women at risk of breast or ovarian 
cancer from a paternal family history are less likely than those who have a 
maternal family history, to initiate a test or visit a genetic clinic, believing it 
unlikely that they will have an increased risk (d’Agincourt-Canning, 2001; 
Forrest et al., 2003).  Consequently, many women fear rejection after 
disclosing a positive gene mutation result (Hoskins et al., 2008; Klitzman and 
Sweeney, 2011) and greater distress levels have been found in BRCA positive 
women when compared to those who tested negative or received uninformed 
results, up to five years after testing (Graves et al., 2012).  Reports of the need 
for psychological counselling has been consistently reported (Vos et al., 2013) 
with long term distress noted up to seven years post-test (Hughes et al 2011). 
 
To assess the impact of testing on women and men with a mutation, Watson 
et al., (2004) conducted a multi-centre prospective study in the UK using 
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questionnaires (obtaining a 92% response rate).  A total of two hundred and 
sixty-one participants took part. Cancer worry, intrusive thoughts and a 
negative impact on quality of life were apparent for the ninety-one mutation 
carriers compared to the one hundred and seventy non-carriers, and this 
impact continued up to a year post-test.  More importantly, despite 28% of 
carriers electing to have RRM, this did not reduce their cancer worry or the 
intrusive thoughts at twelve months.  
 
This is in contrast to other studies (Hatcher et al., 2001; Lodder et al., 2002; 
Brandberg et al., 2008; Patenaude et al., 2008) which identified a significant 
reduction in cancer fear. Moreover, two non-carriers elected to have RRM 
before genetic testing and twenty-nine participants sought professional help 
post-surgery. It is unclear, however, how and why the non-carriers came to 
their decision, what the professional help involved, why they required it or how 
many of those seeking help had undergone RRM. Compared with the women, 
the twenty-five BRCA positive men in the study did not report poorer mental 
health scores, but three also required professional help post-testing. Again, it 
is unclear what professional help consisted of or any explanation of why it was 
necessary. The strength of the study lies in the prospective design and the 
inclusion of nine centres across the UK.  
 
The concept of self and self-identity is very subjective for both men and women. 
In a qualitative study by d’Agincourt-Canning (2006b) in depth interviews were 
conducted with thirty-nine participants, five of whom were men. The study 
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attempted to explore the impact of a positive BRCA mutation on self and 
self-identity.  Themes that emerged linked their positive mutation results to 
becoming much more aware of three types of self. Their embodied self 
(physical), their familial (relational) self and their (social) self.  For the majority 
of participants, knowing their genetic results enabled them to take control and 
plan measures such as surveillance or surgery. 
 
However in contrast, for a minority of younger women, they reported being 
thrust into an uncertain state of neither ill nor completely well, what Dagan and 
Goldblatt (2009) refer to as the ‘twilight zone’ (pg. 273).  In their study with 
seventeen Israeli BRCA positive women, a state somewhere between health 
and sickness was experienced which led to a reconsideration of the women’s 
social identity, with one participant reporting regret in having had the genetic 
test. In d’Agincourt-Canning’s study, (2006b), the knowledge of their genetic 
risk following a positive test result had a profound and limiting effect on the 
younger women who were extremely vulnerable and frightened by the certainty 
(a mutation) and the uncertainty (when they would get cancer and how severe 
it would be) of the genetic information.  This information gave them a confirmed 
risk that they did not have before and a future that they perceived as having no 
control over, their expectations therefore was that of a grim future. 
 
The strength of d’Agincourt-Canning’s study highlights the fact that individuals 
do not interpret their risk or the information imparted in a neutral manner but 
as part of their wider social experience. What the study does not highlight 
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however is why women, especially younger women, experience such 
disruption whilst others report they are able to take control. Some limitations of 
the study include the following, the sample were all highly motivated to take 
part, many had already had cancer and received treatment and it only captured 
experience at one moment in time. Responses to genetic information, for 
example, may shift over time (d’Agincourt-Canning, 2006b). 
 
1.6.2 The Impact on Men 
Compared to women, the rates of men seeking and receiving testing are much 
lower (Julian-Reynier et al., 2000; Foster et al., 2002). Hallowell et al., (2005a, 
2006), explored the influences on the decision to be tested and men’s role in 
the transmission of the gene mutation within the family. Similarly, to women, 
men were found to portray themselves as morally responsible for their children 
and testing was seen as a family duty, findings supported by other studies 
(Liede et al., 2000; d’Agincourt-Canning, 2001,2006a; Lodder et al., 2001). 
 
Males who are BRCA positive can experience increased anxiety and stigma 
because of their risk of cancer (Daly et al., 2003, Heshka et al., 2008, 
Stromsvik, 2010) but it is not always related to the implications for themselves 
or their options, because currently there is a lack of preventative or 
risk-reducing measures for this group (Lodder et al., 2001, Hallowell, 2005a). 
Shiloh et al., (2013) studied fifty-one men with a positive mutation and thirty-
who were negative in a cross-sectional study, to examine the cognitive, 
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emotional and behavioural impact four years after receiving their test result. 
Telephone interviews identified that those with a BRCA mutation had increased 
perceptions of their risk and their distress levels were significantly higher than 
they were before the test, with this impact continuing after the four years.  
 
Men were much more aware of their physical self and relational self, especially 
their responsibility to others. More significantly, their distress concerned and 
focussed on their children, especially their daughters, findings that are 
supported by other studies (Mc Allister et al., 1998; Lodder et al., 2001). 
However, the limitations of this study include the fact that many of the mutation 
negative men did not complete the full survey, the majority were from the 
Ashkenazi Jewish population who hold particular cultural beliefs, and there 
were no pre-test measures of distress to compare with. Using self-report 
measures to identify health behaviours and the length of time following testing 
is also a limitation. 
 
Overall, men express less negative feelings about testing positive than women 
(Hesse-Biber and An, 2016) and in constructing their own perspective on the 
role they play in the inheritance of the mutation, they drew upon discourses of 
guilt, blame or fate even if they test negative (Hallowell et al., 2006). 
Significantly, if men are included in family conversations about women in the 
family with a breast cancer diagnosis, very few become involved in the decision 
about RRM (Leide et al., 2004).  Indeed, men have been found to deliberately 
avoid any conversation regarding surgery (Mc Allister et al., 1998). However, 
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despite it being a difficult task, men describe feeling empowered about 
informing their children of the result because they were giving them the 
opportunity to act upon it.  However, this was always weighed against the risk 
of causing their children additional emotional harm (Hallowell et al, 2006).  
 
1.6.3 Family Disclosure 
Disclosure of a mutation within the family depends on individual personality 
traits that is, whether family members are described as information gatherers, 
disseminators or blockers of information (Peters et al., 2011), as well as having 
the knowledge and support to communicate with the family which will depend 
on the pre-existing culture of discussion about cancer within the family 
(Lafreniere et al., 2013). Lafreniere et al., (2013), in a retrospective study, 
examined the process and factors involved in influencing communication of 
genetic test results to family members.  Although the interviews were 
conducted four to nine years post-testing, the study identifies three phases to 
the process and offers insight into the complexities.  There is a decision-making 
phase where individuals take the time to decide whether to share and what 
they share, a disclosure phase where certain family members are told and the 
reaction phase, which will influence any subsequent disclosure.  
 
Family members have also been found to adopt different communication 
strategies.  Hallowell et al., (2005b) in their study identified three strategies. 
Complete openness where information to children was transparent, limited 
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disclosure where some information was shared and total secrecy where testing 
and the implications of the test was kept a guarded secret.  All parents focused 
on protecting children from anxiety, with limited disclosure being adopted in the 
majority of cases.  Unlike previous research which has focused on disclosure 
patterns within the wider family (Forrest et al., 2003; Claes et al., 2005), 
Hallowell’s study focuses on the immediate family and on male mutation 
carriers in particular. One explanation for the use of different disclosure 
strategies within families is the guilt, blame and resentment identified in some 
individuals following testing for the gene (d’Agincourt-Canning, 2006b; 
Stromsvik, 2010; Shiloh et al., 2013). 
  
However, the initial experience of having a genetic test is not always a negative 
experience; it has been found to empower women to make decisions and to 
take responsibility for their past, present and future family on moral grounds, 
such as the responsibility of being a good mother and doing the right thing 
(Hallowell, 1999; 2003).  However, by taking this morally responsible 
perspective, Hallowell argues that this approach means women actually 
remove their right not to know, putting their own needs aside.  Furthermore, if 
the result is positive, women then feel a moral obligation to act upon the result 
thus subjecting themselves to risk management options such as surgery with 
uncertain consequences that potentially cause physical and psychological 
harm, in addition to unexpected cosmetic results (Hallowell 2000; Hallowell et 
al., 2012). Consequently, following a positive BRCA test there is an increase 
in distress levels leading to anxiety and depression, a reduction in the quality 
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of life and many problems associated with an altered self-image (van Oostrum 
et al., 2003; Watson et al., 2004; Foster et al., 2007; Kenen et al., 2007; van 
Dijk et al., 2008; Crotser and Boehmke, 2009; Esplen et al., 2009).  Often these 
increased distress levels continue in the long term (Watson et al., 2004; Graves 
et al., 2012). 
 
1.6.4 Impact on Younger Women 
Younger women, in particular, are often unaware of the serious implications of 
having a test that could identify an altered BRCA gene. They have less 
experience to draw upon in decision-making (Hamilton et al., 2009) and 
therefore suffer from higher than normal cancer related distress. Over a third 
of patients within two studies experienced high cancer related distress 
associated with uncertainty about the available options, the inheritance of the 
gene and concerns about its impact on childbearing (Linden et al., 2012; 
Patenaude, 2013).  
 
In the study by Patenaude, forty daughters of BRCA positive women, some of 
who were told before they were eighteen years old, participated in a qualitative 
telephone interview to identify the impact of their mothers’ result and their 
cancer related distress. Findings demonstrate that their genetic knowledge 
was suboptimal, having many uncertainties and misconceptions. For example, 
many believed that a negative mutation could still lead to a child with a 
mutation. Thus, despite having normal levels of general distress, their cancer 
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related distress, using well-validated measures, was high.  However, this was 
a retrospective study, three years post-test and not having any pre-test 
distress scores, demonstrates its limitations. The daughters were of different 
age groups and all the mothers in this study were still alive.  
 
Daughters of deceased women with a BRCA mutation have been found to 
demonstrate even higher cancer related distress (Patenaude et al., 2013). 
Young women who are BRCA positive face many difficult decisions including 
the disclosure within relationships, the issue of being single and childless and 
the uncertainty about breast cancer (Hamilton and Hurley, 2010). Indeed, the 
impact of uncertainty regarding decisions and future health following a positive 
mutation result has been compared and equalled to that of a diagnosis of 
breast cancer.  Dimillo et al., (2013), conducted a grounded theory study with 
six BRCA positive women under the age of forty-five who had decided not to 
have surgery. This group was found to be constantly fearful of a cancer 
diagnosis with many uncertainties, feelings of powerlessness and 
vulnerability. 
 
The negative consequences of testing, therefore, have to be weighed against 
the benefits (DiProspero et al., 2001; Beran et al., 2008). Younger women 
have been found to be particularly vulnerable as they misinterpret their lifetime 
risk as their short-term risk, making them believe that cancer is imminent 
(Werner-Lin et al., 2012).  This is important as many younger women are 
seeking bilateral mastectomy.  Evidence suggests that compared to older 
  
40 
 
women with the mutation, younger women are more distressed following a 
BRCA mutation result (Lodder et al., 2002; Watson et al., 2004) and find it 
more difficult to adjust (Lodder et al., 2002; van Oostrum et al., 2003; Watson 
et al., 2004). 
 
1.6.4 Impact on Adolescence 
In early childhood when young girls are observing their mother’s body in 
comparison to their own, sexual self-image and sexuality are beginning to 
develop. Breasts should represent sexual maturity, pleasure, motherhood and 
breast feeding (Matloff et al., 2009). However, in families where a BRCA 
mutation exists, breasts for the young female, in particular, can often become 
objects of fear, anxiety, scars, reconstruction and fear of death (Hamilton and 
Hurley, 2010; Werner Lin, 2001).  Indeed, in families where women have lost 
their breasts, the young female may experience feelings of guilt about her 
young, healthy, intact body (Matloff et al., 2009). For adolescents in families 
where a BRCA mutation exists, excitement about sexual development is 
clouded by the risk and fear of cancer (Matloff et al., 2009). Moreover, 
experiences of cancer with a significant family member at the time of puberty 
can have a negative impact on sexual development and psychosocial 
functioning. For example, the breasts may signify danger and these feelings 
can continue into adult life, affecting both partnering and family planning 
(Werner-Lin, 2008). 
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1.6.5 Impact on Partners and the Family 
The process of genetic testing and the decisions that follow will always have 
implications that go beyond the individual who seeks testing (Featherstone et 
al., 2006., Hallowell, 2009). The literature examining the experience of partners 
is limited, however it has been identified that partners of women diagnosed as 
BRCA positive find the process of testing and the decision to elect RRM 
particularly stressful (Metcalfe, et al., 2002; Mireskandari et al., 2006; Matloff 
et al., 2009; Sherman et al., 2010). Studies have examined the role of the 
spouse in the decision to be tested (Kessler, 1993; Williams et al., 2000; 
Bluman et al., 2003) and found that they wanted to be more involved in this 
process and included by professionals (Metcalfe, et al., 2002; Mireskandari et 
al., 2006). Indeed, some partners feel alienated from the testing process 
altogether (Sherman et al., 2010).  
 
Feelings of lack of support at all stages of the process for partners and women 
with a BRCA mutation is associated with higher levels of distress (Sherman et 
al., 2010). The need for more support and information from health 
professionals around the time of disclosure and a wish to meet other partners 
has therefore been identified (Metcalfe et al., 2002; Mireskandari et al., 2006). 
Studies that have assessed knowledge levels with regard to the whole process 
of testing, identify that knowledge in partners and family members is 
suboptimal.  This lack of knowledge adds to their overall distress (Lerman et 
al., 1996; Wonderlick and Fine, 1997; Bluman et al., 2003; Mireskandari et al., 
2007; Patenaude et al., 2013). Studies have also highlighted that the increase 
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in distress immediately following genetic testing and a positive mutation, 
concerns fears of breast cancer and their children’s risk (Lodder et al., 2001; 
Metcalfe, 2002; Kenen et al., 2006; Mireskandari et al., 2006; Mireskandari et 
al., 2007; Jeffers, 2014; Mauer et al., 2015).  
  
Support from health professionals, in general, is limited for women with the 
BRCA mutation and their partners, despite evidence that demonstrates 
elevated levels of distress and the need for more support (Lloyd et al., 2000; 
Metcalfe et al., 2002; Mireskandari et al., 2007). Importantly, the overall 
adjustment of the partner to the whole journey is significant in providing support 
to the BRCA positive woman, as support received from spouses and social 
support networks have been identified by women to aid their coping and 
adaptation (Wylie et al., 2003; Metcalfe et al., 2004a).  However, no studies to 
date have focused specifically on the support needs and the whole experience 
for the woman, her partner and family member following a positive BRCA result 
and the experience of RRM.  
 
1.7 Prevention and Risk Management Options in the UK 
There are several available risk management options for women with a BRCA 
mutation, these include the decision of no intervention. Currently, women can 
choose to have screening in the form of mammography or magnetic resonance 
imaging (MRI), bilateral risk-reducing mastectomy (RRM) and/or bilateral 
salpingo-oophorectomy (RRSO) (Zakaria and Degnium, 2007). The updated 
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family history guidelines have also given more options for women and families 
in the form of chemoprevention, anti-oestrogen medication, Tamoxifen and 
Raloxifene (NICE, 2013). Risk management for men relies on breast 
awareness and screening for prostate cancer.  
 
1.7.1 Surveillance and Screening 
Following a BRCA mutation result, women can choose to have surveillance in 
the form of mammography and Magnetic Resonance Imaging (MRI), which are 
images of the breast, performed yearly, commencing at the age of thirty. 
However, screening enables the early detection of cancer, but it is not 
risk-reducing. Consequently, for women who decide on screening, the early 
detection of cancer will still require the need for surgery, chemotherapy, 
radiotherapy and chemo-prevention medication.  All of the treatment modalities 
that women with the mutation are trying to avoid (Hoskins and Greene, 2012). 
There is no evidence at this current time that such surveillance reduces 
mortality in high-risk women (Evans et al., 2009; De Brock et al., 2013).  
Indeed, a cumulative effect of yearly mammograms may compound the risk of 
breast cancer due to the radiation exposure. Furthermore, the fact that young 
women have dense breasts means that cancers can be missed on 
mammography. More significantly, the risk management options in the UK are 
limited for those women under the age of thirty who are BRCA positive. This is 
due to the fact that any form of available screening starts at the age of thirty as 
recommended by NICE (2013) and this leaves young women feeling 
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vulnerable, abandoned or stuck waiting for screening to begin (Brunstrom et 
al., 2016). It is proposed that this is one of the reasons why younger women 
are increasingly electing to have RRM. 
 
For men with the mutation, risk management is very limited, consisting mainly 
of breast awareness and screening for prostate cancer. This latter option 
involves having a blood test at the age of forty for prostate specific antigen 
(PSA), a tumour marker, (Rebbeck et al., 2004; Madalinska et al., 2007; Nelson 
et al., 2009).  PSA is a protein produced by normal cells in the prostate but also 
by prostate cancer cells and it is normal for men to have a small amount in their 
blood. A raised blood test result, therefore, may not necessarily indicate 
prostate cancer.  
 
1.7.2 Chemoprevention 
Chemoprevention is the use of drugs, vitamins or agents in an attempt to 
reduce the risk of cancer or its recurrence. Women with the BRCA gene and 
those with a strong family history now have the additional option of taking 
Tamoxifen or Raloxifene, which are anti-oestrogen medications in the form of 
a tablet. They are known to reduce the risk of breast cancer occurring (Nelson 
et al., 2009) and have been recently approved by NICE (2013). However, the 
drugs have many side effects including weight gain, the risk of thrombosis 
(blood clots) and menopausal symptoms. Importantly, the drugs only offer a 
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40% reduction in the risk of developing breast cancer (De Leeuw et al., 2008; 
Beattie et al., 2009). 
 
1.8 Surgery: Risk-Reducing Mastectomy 
Despite alternative options, a large proportion of women with a mutation, 
choose to have bilateral Risk-Reducing Mastectomy (RRM), which involves the 
complete removal of both breasts and/or Risk-Reducing Salpingo-
Oopherectomy (RRSO), the removal of the ovaries and fallopian tubes. It is 
estimated that over 50% of women choose risk-reducing breast surgery but up 
to seventy-five percent choose ovarian surgery (Evans et al., 2009; Skytte et 
al., 2010).  
 
RRSO is usually performed at a different time point to RRM, with some women 
choosing to have it before breast surgery, whilst others wait until after. The 
number of women seeking testing with the expectation of having risk-reducing 
surgery if they have the mutation has increased (Evans et al., 2009; Gopie et 
al., 2013). The fear of breast cancer and concern about caring for their children 
if a breast cancer occurred, has been found to be the biggest predictor for this 
decision (Lodder et al., 2002; Hatcher and Fallowfield, 2003; Antill et al., 2006; 
Howard et al., 2009; Haroun et al., 2011).  Understanding what influences 
women and their families in their decisions is important for the breast and wider 
team who are in a position to provide decision making support because this 
surgery is irreversible and women are often very young when electing to have 
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it (Hamilton et al., 2009; Hamilton and Hurley, 2010; Hoskins and Greene, 
2012; Glassey et al., 2016). 
 
In the UK, new guidelines recommend that risk-reducing surgery should be 
discussed with all BRCA positive women and that a suitably trained 
professional should lead the discussion. The offer of immediate reconstruction 
should also be included (Evans et al., 2013; NICE, 2013). Women and their 
families are referred to a surgical team if they decide to proceed with surgery, 
but ultimately it is the surgeon’s decision whether surgery goes ahead 
(Heemskerk-Gerritsen et al., 2007; Schwartz et al., 2012; Hampel et al., 2014). 
 
Bilateral Risk-Reducing Mastectomy (RRM) leads to the greatest risk reduction 
of developing breast cancer in women with the BRCA mutation (Meijers-
Heijboer et al., 2001; De Felice et al., 2015).  Evidence has consistently 
demonstrated that RRM reduces risk by 90-95% (Evans et al., 2009; Rebbeck 
et al., 2009; De Felice et al., 2015). Risk-Reducing Salpingo-Oophorectomy 
(RRSO) also offers a significant decrease in the incidence of both ovarian and 
breast cancer, offering a 50% reduction in breast cancer and a 95% risk of 
ovarian cancer (Rebbeck et al., 2009; Evans et al., 2009). Furthermore, it 
appears to be a far more acceptable procedure than RRM because it leaves 
no visible outward bodily change, unlike breast surgery (Phillips et al., 2006; 
Crotser and Boehmke, 2009). 
 
  
47 
 
Recent evidence has shown that a combination of RRM and RRSO at the age 
of forty results in the best way of increasing survival rates for women with a 
BRCA mutation, a significant reduction in all cause breast cancer specific and 
ovarian cancer specific mortality (Domchek et al., 2010). This evidence also 
suggests that performing RRM any earlier has little impact on survival rates 
(Kurian et al., 2010).  However, RRSO is not recommended until the age of 
forty because of the implications of early menopause, including the negative 
effects on bone health (Evans et al., 2009; Kurian et al., 2010).  Increases in 
anxiety (van Oostrum et al, 2003), anger and distress (Dorval et al., 2000) as 
well as issues regarding quality of life and vulnerability have all been noted 
(Hallowell 2000; Hallowell and Lawton, 2002; Esplen et al., 2009). 
 
By electing to have RRM, women have both breasts removed and also have 
to consider the removal of the nipple areolar complex (NAC). Currently, if all 
the breast tissue and the nipple is removed, there is up to a 95% chance that 
breast cancer will not occur.  In some breast units in the UK, surgeons will 
preserve the NAC once a woman has been fully informed of the associated 
risks because if the nipple is preserved, the actual risk reduction is unknown 
(Reynolds et al., 2011; Yao et al., 2015).  British, Dutch and American women 
are more in favour of RRM with over 50% choosing this option when compared 
with the rest of the western world (Evans et al., 2009; Gopie et al., 2013). 
Furthermore, international variation exists amongst physicians’ attitudes 
towards RRM, in France and Germany for example only 30% and 27% 
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respectively, believe that it should be an option for BRCA women which may 
account for the difference in uptake (Gopie, et al., 2013). 
 
1.8.1 The Psychological Effects of Risk-Reducing Mastectomy 
Studies have consistently reported a reduction in fear, reduced anxiety and 
reports of relief following risk-reducing mastectomy (McGaughey, 2006; 
Hallowell et al., 2012; Hagen et al., 2014; Glassey et al 2016).  However, a 
literature review of thirteen studies examining the impact of RRM focussing 
specifically on body image identified that up to 50% of women suffer a negative 
effect on body image and experience adverse effects on sexual life 
(McGaughey, 2006).  A reduction in quality of life has also been identified 
(Frost et al., 2000; Hopwood et al., 2000; Lloyd et al., 2000; Payne et al., 2000; 
Dowdy et al., 2004; Metcalfe et al., 2005; Geiger et al., 2007; Brandberg et al., 
2008; Lostumbo et al., 2010; den Heijer et al., 2012; Gopie et al., 2013) with 
impacts on femininity and sexuality noted (McEwan, 2011).  Many of these 
studies, however, fail to provide a deeper understanding of these impacts, 
especially in the context of the wider family.  The family is an integral part of 
the decision and the experience (Sherman et al., 2010; Rowland and Metcalfe, 
2014; Mauer et al., 2015).  However, there are no qualitative studies to date 
that include the experiences of BRCA positive women specifically who have 
not had breast cancer and the experience of risk-reducing mastectomy, their 
partners and members of the family. Only three studies have been identified 
that include partners and RRM (Lloyd et al., 2000; Mireskandari et al., 2006., 
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Mauer et al., 2015).  It is argued that it is important for clinical practice to 
identify the informational and psychosocial needs of women including their 
family and to provide an appropriate care pathway that is in line with that 
experienced by women who have breast cancer. 
 
1.8.2 The Decision to Elect to have Breast Reconstruction 
The majority of women in the UK elect to have breast reconstruction following 
RRM (Evans et al., 2005; Bresser et al., 2006). America, Australia and the 
Netherlands also have high rates of RRM with immediate breast reconstruction 
(Howard et al., 2009; Skytte et al., 2011; Nelson et al., 2012).  The option and 
availability of breast reconstruction strongly influences a woman’s decision to 
undergo RRM (Rolnick et al., 2007; McQuirter et al., 2010; Nelson et al., 2012). 
Nelson et al., (2012) conducted a survey of forty women who had elected RRM, 
utilising various reconstructive techniques.  
 
Having the option of different reconstruction techniques strongly influenced 
92% of the participants to have RRM. However, there were a few limitations of 
the study, its retrospective survey design and the inclusion of BRCA positive 
women who also had previous breast cancer and were removing their opposite 
breast (contra-lateral). The sample size was small and therefore the power of 
the study was low. The opportunity for further exploration of decision-making 
is also lost in the survey design. 
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Women have the option of either immediate or delayed reconstruction using 
various surgical techniques. This will depend upon their breast size, their 
general health, their preferred technique and the expertise of the surgeon. 
Breast implants are the simplest way to reconstruct the breast but advances in 
surgical techniques have given women the option of using their own tissue 
(autologous) alone or in combination with their own muscle (a pedicled flap) to 
reconstruct a breast. There is also the transfer of skin and fat (a free perforator 
flap) from either the abdomen, buttocks, back or the inner thigh and many 
women prefer this option as the final cosmetic result resembles a more natural 
looking breast (Majdak-Paredes and Fatah, 2009).  
 
Counselling for such procedures takes time and women need adequate 
information and preparation in order for the final outcome to meet their 
expectations (Frost et al., 2000; Altschuler et al., 2008; Hallowell, 2012). Thus, 
although there have been reports of satisfaction following breast 
reconstruction, (Brandberg et al., 2000; Nissen et al., 2001; Harcourt et al., 
2003; Elder et el., 2005; Hallowell et al., 2012) surgery has been shown to have 
negatively affected a woman’s sense of self and identity, quality of life and 
psychological health (Hallowell, 1998; Patenaude, 2005; McCullum et al., 
2007; Gahm et al., 2010; den Heijer et al., 2012; Gopie, 2013).  However, a 
deeper exploration and understanding of these findings is required so that it 
can be acknowledged and addressed in clinical practice. Moreover, although 
RRM is now accepted as an option to offer women for risk management (NICE, 
2013), some still consider it in parallel to mutilation (Press et al., 2005). 
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The more complex techniques require the input of a plastic surgeon and take 
up to ten hours of operation time (Isern et al., 2008) carrying the possibility of 
complications and several months of healing and recovery. It has been 
estimated, for example, that up to 64% of women have one or more 
complications (Barton et al., 2005), with many women requiring re-operation 
(Gahm et al., 2010; Arver et al., 2011). Two hundred and twenty-three women 
in a study by Arver et al., underwent RRM with two hundred and twenty electing 
reconstructions. 64% had unanticipated second operations as a result of 
infection, necrosis, capsular contraction of the implant and flap failure (Arver et 
al., 2011). These long-term problems and the experience for women and their 
family need further exploration.  
 
1.8.3 Surgery Versus Screening Programmes 
Many studies have explored the emotional well-being of high-risk women 
attending screening programmes for breast cancer. These suggest that 
screening may actually increase anxiety (Lerman and Schwartz, 1993; Howard 
et al., 2009), while a range of studies suggest that women who elect RRM 
experience a decrease in cancer worries, anxiety and psychological distress 
(Stephanek et al., 1995; Josephson et al., 2000; van Geel, 2003; Brandberg et 
al., 2008; den-Heijer et al., 2012).  However, Bresser et al., (2007b) found that 
women who experienced high levels of distress prior to RRM continued to 
experience high levels post-surgery and concluded that other factors such as 
personality and coping strategies may also be relevant, factors which are 
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important for psychosocial assessment. Furthermore, evidence suggests that 
many women electing to have RRM need more information and support than 
women having a risk-reducing contralateral mastectomy (the opposite breast 
to their breast cancer), pre-surgery, regarding all aspects of the process. This 
may also be one explanation for the high level of distress (Josephson et al., 
2000; Bresser et al., 2006; Rolnick et al., 2007 Bonadies et al., 2011).  In the 
UK, women with breast cancer who elect to have contral-lateral risk reduction 
will have also had support from their key worker which could explain their 
reduced need for information and support. 
 
1.9 Summary  
This chapter has provided the background to the study and outlined the factors 
relevant to the study including the incidence and treatment of breast cancer, 
one of the main preventative aims of bilateral risk-reducing mastectomy. It has 
provided an overview of a BRCA mutation, the complexities, and impact of risk, 
genetic testing and decision making for the individual and the family.  It has 
also provided an overview of the decision to elect to have risk-reducing 
mastectomy and what is known about some of the psychological impacts of 
this decision thus far.  This chapter identified that the literature does not provide 
a deeper exploration of these impacts in the context of the wider experience 
for the woman, her partner and family. Thus, there is a need to add further 
insight and knowledge into the experience so that nursing care if necessary, 
can be tailored and developed to meet their needs. The next chapter will draw 
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upon more clinically focused literature to identify and establish what is known 
and what is yet to be explored. 
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CHAPTER TWO – The literature review (The Current Horizon 
of Understanding, Gadamer, 2004) 
2.1 Introduction 
This chapter focuses on the identification of the ‘pre-understandings’ 
(Gadamer, 2004) related to the phenomenon of living with a BRCA mutation 
and undergoing bilateral risk-reducing mastectomy from which my research 
question was developed.  Examining the available literature (The Current 
Horizon of Understanding Gadamer, 2004), developed the foundations 
presented in Chapter One. 
 
This literature review is not a systematic review, however, I used a systematic 
approach to locate relevant literature. In keeping with the phenomenological 
approach to my study, the focus of this literature review is understanding the 
phenomenon of living with the BRCA mutation and the experiences of RRM 
for the woman, her partner and the wider family. This approach was adopted 
to allow for more openness to the phenomenon studied by having fewer 
pre-conceptions, this added to the rigour of the study (Speziale and Carpenter, 
2007). 
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2.2 Systematic Search Strategy 
2.2.1 Preliminary Search January 2011 until April 2011 
The literature search started in January 2011 before the commencement of 
the Ph.D.  Teaching students inter-professionally and enabling them to 
shadow me in clinics, in addition to my personal interest, meant that I needed 
to stay up to date with the literature.  I identified the literature for conferences 
and workshops that I was attending, observing that more women were being 
identified and referred for risk-reducing surgery.  The team of surgeons with 
whom I worked were particularly concerned about performing the surgery 
without an identified BRCA mutation. These preliminary searches identified a 
lack of qualitative research on both young women with a BRCA women, who 
had not had cancer and were undergoing risk-reducing mastectomy and their 
partners and family. My research question and approach started to develop 
from this initial search.  
 
The initial search focused primarily on women with a BRCA mutation 
undergoing bilateral risk–reducing mastectomy. This was too narrow and the 
focus of the review developed and broadened as the study progressed. Initial 
key words included ‘BRCA1/2 ‘proband‘, ’experience’, ‘risk-reducing 
mastectomy’ and ‘prophylactic mastectomy’. A broader search using the 
additional search terms, ‘risk’ ‘partners’, ‘family’, ‘relatives’, ’qualitative’, 
’interpretive phenomenology’ and ‘phenomenology’ was adopted. 
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Much of the included literature was found in two databases Medline and Web 
of Science.  Seventy-nine papers were found using the above search terms. 
An example of the Medline search can be seen in Appendix Three.  As I 
developed my question, I expanded my search strategy to include other 
databases, PsycINFO, Cumulative Index to Nursing and Allied health 
Literature (CINAHL), Scopus and British Nursing Index (BNI).   Initially, the 
search term ‘proband’ was used with the use of Boolean operators, no 
qualitative studies were located.  By removing ‘proband’, ‘qualitative’ and 
‘relatives’ and broadening the search to include ‘risk’, more literature became 
available 
 
I accessed professional documents including professional nursing bodies 
Royal College of Nursing (RCN), Nursing and Midwifery Council (NMC) 
Department of Health databases (NICE), grey literature (Open Grey) and used 
back chaining.  
 
The searches were repeated towards the end of the data collection in 2014 
and again following analysis in 2015 to check for any new literature.  I 
accessed specific qualitative journals, Psych-oncology and Qualitative Health 
Research and specific authors such as Nina Hallowell, Kelly Metcalfe and 
Regina Kenen who had done research in the field.  There were no qualitative 
prospective studies found that included women, their husbands and family 
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members and specifically mastectomy. In particular, no studies were located 
that used Gadamerian or Interpretive Phenomenology.  
 
2.2.2 Inclusion Criteria 
The search included literature in English but no limits on dates were set.  Due 
to the limited number of qualitative studies specific to BRCA women who were 
undergoing risk-reducing mastectomy and who had not had breast cancer and 
the experience of family members, data was accessed which included women 
at high risk. This approach enabled research conducted prior to the 
introduction of clinical protocols and before genetic testing was more readily 
available, to be found. Articles were accessed that were primary research, 
where the experience of being BRCA positive and undergoing risk-reducing 
mastectomy for the woman and her family was the focus, peer reviewed where 
possible, including systematic reviews, meta-analysis and literature reviews. 
Below is a summary of the papers found in the various databases. 
Medline/Ovid-79, Psychinfo-8, Scopus-345, CINHAL-29, BNI-3, web of 
Science -161. Total - 622 papers. 
 
2.2.3 Exclusion Criteria 
The search excluded studies that were:  
 Not written in English. 
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 Women only having bilateral risk-reducing oophorectomy.  
 Women with breast cancer choosing risk-reducing, prophylactic or 
contral-lateral mastectomy. 
 Satisfaction following breast reconstruction.  
 
2.2.4 Expanded Search 
The following additional databases were accessed, Google scholar, Orca, 
Cardiff University libraries and the Royal College of Nursing Libraries. One 
recently published literature review relevant to younger high-risk women 
electing to have risk-reducing mastectomy was found (Glassey et al., 2016). 
Two Ph.D. thesis, one from Australia, (Crabb, 2006) and one from New 
Zealand (McEwan, 2011) that focussed on living with the experience of 
increased breast and ovarian cancer risk and which included BRCA women 
who had undergone breast surgery, informed the study.   
  
2.2.5 Final Search 
In January 2017, I ran another search.  An updated Medline search found 104 
papers, 647 papers were assessed in total.  After reading the abstracts and 
excluding many of the medically focussed or genetically focussed papers that 
were unrelated to the experience of BRCA positive women and their family 
undergoing mastectomy specifically, removing the duplicate studies and 
including studies found from back chaining all the papers, 21 papers were 
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included in the review and the table of included studies can be seen in 
Appendix Three. 
 
This literature review explores what is known of the experiences of women 
identified as being BRCA positive and their families who elect to have bilateral 
mastectomy.  However, an understanding of risk and embodiment is 
necessary in order to critically review the available literature on such 
experiences.  The review has been divided into three sections: risk and 
embodiment, pre-surgery, and post-surgery experiences. 
 
2.4 Risk and Embodiment 
This study involves the body, in particular, the bodies of women who carry a 
genetic mutation, which puts them at increased risk of cancer and specifically 
female cancers.  For some women being at high risk of these cancers and of 
the decision to undergo surgery with reconstruction can be a stigmatising 
condition. Stigma refers to a negative attribute that sets an individual apart 
from what is considered ‘normal’ to other individuals in society. Kenen et al., 
(2007) over a four-year period reviewed the messages on the archived 
message board devoted to women at high risk for breast and ovarian cancer 
on the Facing Our Risk of Cancer Empowered (FORCE) website. Twenty-one 
women’s posts were analysed using a qualitative thematic analysis and results 
found that women worried about whether or not to disclose any information 
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about their risk and surgery to friends and family because they feared negative 
and stigmatising comments especially in revealing their body and the loss of 
their natural breasts.  
 
In trying to consider and understand risk, therefore, Kavanagh and Broom 
(1998) have identified three types. Environmental risks such as pollution and 
toxic chemicals, lifestyle risks such as cigarette smoking and alcohol and 
embodied (corporeal) risk such as the inheritance of a genetic mutation. They 
propose that environmental risks have very different social and personal 
consequences, for example, they are often viewed as out of the control of the 
individual.  Lifestyle risks, on the other hand, are seen as occurring as a 
consequence of the person’s behaviour. Importantly, the third type of risk, 
embodied or corporeal risks are distinguished from other types of risk by being 
located in the body of individuals, threatening them from within.  
 
The inheritance of the BRCA gene mutation is one example of a corporeal risk 
which is perceived as being out of the control of individuals and less avoidable 
when compared to environmental or lifestyle risks. It poses a worry for the 
present and for the future, defining who a person is, for example ‘being a 
carrier’, rather than what they do. Furthermore, unlike environmental and 
lifestyle risk where both the body and the self are at risk together, with 
corporeal or embodied risk there may be a dissociation of the body from the 
self to counteract the threat of the particular body part (Kavanagh and Broom, 
1998). In this sense, therefore, the decision to elect RRM could be initially 
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viewed as one way of managing the corporeal risk of a BRCA mutation and 
breast cancer. 
 
However, the dissociation of body and self is more complex than that because 
the risk in some body parts may be easier to dissociate from the self than 
others. For example, having an abnormal pap test which indicates cervical 
cancer and removing the womb, as in the study by Kavanagh and Broom 
(1998), or having the ovaries removed to prevent ovarian cancer, may be seen 
as easier to dissociate from because these organs are not as visible (Hallowell 
and Lawton, 2002; Howard et al., 2011). The body in this sense can be thought 
of as an object, made safe after the removal of its threatening parts. All of the 
participants in Hallowell and Lawton’s (2002) grounded theory study which 
included forty-nine high risk women of which twenty-three had undergone 
prophylactic ovarian surgery, felt that the decision to lose their ovaries was 
much easier because they were internal and invisible.  They felt oophorectomy 
was not an explicit threat to body image and thus body integrity or self, 
compared to women having a mastectomy (Hallowell 2000).  
 
Indeed, Howard et al., (2011) in their grounded theory study found that being 
at risk for breast and ovarian cancer and having to make decisions about 
risk-reducing surgery threatened the women in four aspects of self which were 
interconnected and which had different significance over time. The four 
dimensions of self were physical health, self-identity, relationships with others 
and the emotional self.  Preserving these aspects of self-represented the most 
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salient themes and thus only three out of twenty-two women chose to elect 
RRM, compared to nineteen women who chose RRSO.  This finding implying 
that the disconnection between the body (their breasts) and self was much 
more difficult and that preservation of self-identity for these three women was 
most important.  The authors conclude that all aspects of self should be a 
consideration and seen as equally important. These dimensions of self are 
also important because they provide direction for appropriate targeted support 
from health professionals whose general focus is on physical health (Howard 
et al., 2011).  This is significant because the overall adjustment to the loss of 
a breast is directly related to an individual’s pre-existing construct of self, 
including feelings about one’s femininity, womanliness and physical 
attractiveness (Lloyd et al., 2000; Piot-Zeigler, 2010). 
 
It follows, therefore, that labelling previously healthy women into an ‘at risk’ 
category whether it be BRCA positive or those with an unknown gene status, 
leads to vulnerability and a tendency to think of the body as ‘dangerous’, thus 
exacerbating the Cartesian split between body and self. This disconnection 
between body and self may help to facilitate and justify the risk management 
decisions made by individuals as in the studies by Hallowell and Lawton (2002) 
and Kavanagh and Broom (1998) where it is argued that these women were 
able to implicitly dissociate from self because the ovaries and womb are 
considered as less obviously connected to feminine identity. 
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However, this splitting of self and body only appears to occur with particular 
types of risk such as ‘cancer risk’. One explanation for this is proposed by 
Kavanagh and Broom (1998) who argue that within Western society and 
culture, cancer is commonly constructed as the ‘other’ and is frequently 
portrayed as an ‘invader’ of bodies. Therefore, these cultural constructions of 
cancer may be the reason for the Cartesian splitting observed in their study 
(Kavanagh and Broom, 1998).  However, Hallowell (2000) points out that this 
is not observed in studies of women who have undergone mastectomy for 
breast cancer. The evidence suggests that although a disruption of self and 
body occurs during treatment, there is also a deep sense of loss for the breast, 
albeit, a cancerous breast (Hallowell, 2000; Rosenblatt, 2006; Sandham and 
Harcout, 2007; Mehnert and Koch, 2008).  As a result of this loss, a profound 
effect on the self is experienced which challenges a woman’s identity leading 
to a need to reconstruct ones’ self-identity (Langellier and Sullivan, 1998; 
Crompvoets, 2003; Montazeri, 2008, Piot-Ziegler, 2010).  
 
Moreover, women who experience a loss of their body integrity feel alienated 
and report less psychological and social well-being (Petronis et al., 2003). A 
few explanations for this loss are offered.  The location of the risk within the 
body is significant in that some body parts may be easier to dissociate from 
than others, those body parts for example that are less visible to the social 
world (Hallowell, 2000; Howard et al., 2011). It is also argued that in the case 
of women at high risk or with a BRCA mutation who remove their breasts, it is 
more difficult than expected to split body and self because these women do 
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not have cancer. Finally, the cultural and symbolic significance of the body, 
particularly in regard to breasts and pressure to conform to the norms of 
female beauty, further prevents this splitting of body and self.  As Douglas 
writes of the body: 
‘The body itself is a highly restricted medium of expression.  
The forms it adopts in movement and repose express social 
pressures in manifold ways. The care that is given to it, in 
grooming, feeding and therapy, the theories about what it 
needs in the way of sleep and exercise, about the stages it 
should go through, the pains it can stand, its span of life, all 
the cultural categories in which it is perceived must correlate 
closely with the categories in which society is seen, in so far 
as these also draw upon the same culturally processed idea 
of the body’ (Douglas, 1996; pg. 69). 
 
The importance of the body in respect of its physical, social and cultural 
significance has been highlighted by Douglas (1996). As the quote above 
illustrates, the body is a medium of expression in which appearance, function 
and compliance with cultural norms are judged. Disease and illness are not 
the only aspects of its focus and importance.  Patient stories and personal 
lived experiences are now the focus of healthcare improvement.  
 
The breasts, in particular, play a much larger role in the way women live their 
lives and the way they are perceived in society than is acknowledged.  As a 
result of the richness of their associated meanings, for example, Douglas 
(1996) argues that the constituent parts of the body such as the breasts or 
genitals, are substrates for symbolism and play a part in justifying a position in 
society as part of a particular group, that of being a ‘woman’. A social lived 
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body, therefore, must be acknowledged as having equal importance to the 
biological body as together these have consequences for an individual’s 
overall experience of living. 
 
2.4.1 The Significance of the Breasts  
As Dworkin (1974) writes:  
‘In our culture, not one part of a woman’s body is left 
untouched, unaltered. From head to toe, every feature of a 
woman’s face every section of her body is subject to 
modification’ (pg. 113-4). 
 
Thus, breasts are the most visible important symbol of female sexuality and 
womanliness and a part of a female body subjected to much modification.  
Sexuality encompasses the whole self, including thoughts, desires, 
sensations, emotions and identities (Moloney and Kirkman, 2005). Jackson 
and Scott (2010) also remind us that sexuality is one of the ways in which we 
live our lives, is a part of everyday ordinary life, incorporating relationships and 
roles.  Yet many health care professionals find it difficult to initiate 
conversations about sexuality and sexual functioning, believing that they are 
not trained to do so. This is especially so in the case of caring for cancer 
patients (Fobair et al., 2006; Hordern and Street, 2007). 
 
Breasts not only provide women with a secure sense of identity and sexual 
pleasure, but they expose them to risk, uncertainty and fear, with the potential 
of threatening their existence. It follows therefore that being  a  real woman 
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means having two breasts and having a gender identity entails having a body 
which is not only seen to be feminine (the way it looks), but also dependent 
upon being a feminine body, for example experiencing a particular type of 
material embodiment (the way it feels) (Hallowell, 1998, 2000, 2012).  Gender  
refers to the way an individual recognises themselves as either male or female, 
masculine or feminine (De Franscisco and Palzowescki, 2007).  Therefore, as 
the Dworkin quote suggests, women tirelessly work to ensure that they have 
a body which is feminine in both shape and appearance and which indicates 
that they are female even if it requires modification with surgery.  Undergoing 
breast augmentation is just one example of the ways in which women seek to 
achieve this ‘normal’ looking feminine body.  In this way, women are seen to 
be conforming to the cultural and social norms of being and looking like a 
woman (Bartky, 1998).  Cultural expectations, for example, of what it means 
to be a woman, require women to make themselves sexually attractive to men, 
being constantly pressured to look and behave in certain ways and then 
judged to identify how well they fit with these norms (De Francisco and 
Palczewski, 2007).  
 
2.4.2 A Symbol of Femininity - The Social Significance of the Breast 
Breasts are also symbols of motherhood and of femininity, factors extremely 
important to women. Indeed, according to Pelters (2014), breasts are the 
‘iconic image of femininity’ (pg. 95). They represent the female potential for 
nurturing in addition to a sexual power and are the most common 
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representation of femininity.  In McEwan’s (2011) study, exploring the 
experiences of thirty-two New Zealand women at high risk of breast and 
ovarian cancer, the maternal representation of their breasts were privileged 
over the sexual aspects and the four women who chose risk-reducing 
mastectomy sacrificed these sexual aspects of femininity for the sake of their 
children.The symbolic significance and functionality of breasts therefore for 
individuals and families with a BRCA mutation, needs to be addressed. 
 
Femininity is socially constructed (Wimberley et al., 2005; Everson, 2008) and 
is achieved from behaviours that make a body recognisable as feminine, such 
as moving or acting in a feminine way and by disciplining the body. Women 
constantly strive to achieve the optimum feminine body, shape, size and 
appearance (Bartky, 1998) and so losing such an organ can result in a crisis 
in a woman’s gendered identity (Sabo et al., 1986; Piot-Ziegler, 2010). 
Femininity, however, can be experienced differently and queer this normative 
view.  In a paper by Pelters (2014) on BRCA femininities, she presents some 
of her interview data where she examined the phenomenon of ‘doing health’ 
with BRCA positive German women, who construct an alternative and self-
determined femininity.  One woman for example who had already undergone 
a breast reduction years earlier to free herself from ‘too much femininity’ (pg. 
102), was left feeling liberated from the physical symptoms of back and neck 
problems and this helped to remove the sexually objectifying attention she was 
receiving from her very large breasts.  Thus she was planning a RRM in the 
future and being ‘breastless’ (pg. 102) was not viewed a problem because she 
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gained agency through her BRCA status and her self-regulating femininity.  
Her oophorectomy since a BRCA mutation result also freed her from ‘way too 
many female hormones’ (pg. 102) and painful menstruation. For another 
participant in Pelter's study who chose screening instead of surgery, she also 
took up Karate in order to feel empowered. Karate represented toughness and 
a more masculine related femininity.  This masculine performance was 
balanced by her ability to remain looking feminine but it also secured a 
heterosexual relation.  This was done in order to be seen as equal in her 
relationship with men and not a sexually objectified stereotype that she had 
relied on in the past.  Thus, she had expanded her range of gender expression 
(Pelters, 2014).  
 
If one accepts that the body is socially constructed (Bartky, 1998; Fox, 2012), 
the location and the significance that different body parts have for an individual 
in terms of their identity, will greatly influence the effect on their self-identity. It 
may be easier for individuals to objectify those body parts such as the ovaries 
or uterus which are invisible and far less connected to feminine identity, 
without having an effect on self-identity, because they are perceived as 
separate, unlike the more visible breasts (Hallowell, 1998). Indeed, in 
Hallowell’s (2000) study involving six case studies of women with a family 
history of breast and ovarian cancer, some of who pursued prophylactic 
mastectomy, the self was seen as intrinsically linked to the body and 
mastectomy was seen to be a major threat to self-identity and femininity. 
Although the women reduced their risk of the threat of cancer, mastectomy 
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with reconstruction caused a major change in the way they experienced their 
body and thus their self-identity, they described themselves as ‘incomplete’. 
Moreover, femininity was seen to incorporate both how the breasts looked to 
be feminine as well as how breasts felt feminine (Hallowell, 2000).  Young 
(1998) supports this and suggests that what matters the most to women is the 
feeling in the breast, not the look of them.  Thus, even when reconstruction 
aims to hide the loss from a mastectomy, there is a loss of sensitivity in the 
breast and  the loss of feeling like a woman feels in the world of other women 
with two breasts (Young, 1990).  The consequences of mastectomy for identity 
and corporality has also been identified by Piot-Zieglar et al., (2010).  Although 
this qualitative study involved women with breast cancer, the aim of this study 
was to understand the consequences of mastectomy and therefore it is argued 
that the findings are relevant to women undergoing a mastectomy to reduce 
their risk. Nineteen women aged between thirty-seven and sixty-two 
participated in semi-structured interviews in a prospective design.  Despite ten 
women having a reconstruction, the findings demonstrated that mastectomy 
leads to a painful experience of ‘body deconstruction’.  Thirteen women 
described a mutilated body and mastectomy represented an ‘amputation’, 
leading to a deep identity crisis which threatened what is socially expected 
from a woman’s appearance, that is, to look feminine.  Therefore, mastectomy 
modified the relationship that women had with their bodies but also their 
relationships with other people.  One of the reasons for this is offered by Weitz 
(2004), who concludes that: 
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‘Those whose bodies differ in some critical way from the norm, 
must develop a self-concept in the context of a culture that 
interprets bodily differences as signs of moral as well as 
physical inferiority. The resulting stigma leads individuals to 
feel set apart from others’ (pg. 177).  
 
 
The significance of the breasts in society has also arisen from the many 
cultural meanings assigned to the breasts produced in the context of the wider 
social environment, including gender relationships (Robertson, 2000). It has 
been suggested that cultural and social factors are responsible for the 
international differences in the uptake of risk-reducing surgery (Howard et al., 
2009). For example, the Ashkenazi Jewish population in Israel, where the 
incidence of the BRCA mutation is higher (King et al., 2003; Simchoni et al., 
2006), view RRM as totally unacceptable (Dagan and Goldblatt, 2009). In the 
qualitative study by Dagan and Goldblatt (2009) seventeen Israeli BRCA 
positive women despite fearing breast cancer and ten of the seventeen women 
undergoing oophorectomy to reduce their risk of ovarian cancer, the decision 
of risk-reducing mastectomy was out of the question, choosing surveillance 
instead, fearing the consequences of such surgery on femininity. 
 
2.5 Pre-Surgery – Decision Making 
The decision to elect to have RRM is a complex process with many factors 
that can influence a woman’s decision. These include her relational networks 
such as the family (especially the age at which family members died), health 
care professionals, friends and social systems (Donchin, 2000; Lloyd et al., 
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2000 Hallowell et al., 2005b; d’Agincourt-Canning, 2006b). McQuirter et al., 
(2010) conducted a Canadian qualitative study with a convenience sample of 
ten BRCA women to explore their decision-making with regard to RRM.  They 
concluded that these women did not carry out a rational weighing up of 
advantages versus disadvantages but rather a complex interplay of contextual 
factors, for example, personal prior cancer experiences or family members 
with cancer as well as interpersonal factors such as concerns about body 
image and support.  Findings that support other studies (Beesley et al., 2013; 
Heiniger, 2015).  These findings sit in contrast however to some of the earlier 
studies.  Prevention of breast cancer and survival, for example, took priority 
over the cosmetic results of surgery in studies conducted by Hopwood (1998); 
Lodder (1998) and Julian-Reynier et al., (1996). 
 
Decision-making is not separate from the complexities of a woman’s life and 
there are pivotal points when the decision to elect RRM becomes clear. 
Testing positive for the BRCA gene and having a close family member 
diagnosed or die with cancer are two examples (McQuirter et al., 2010, 
McEwan, 2011).  Findings that are consistent with other studies (Lodder et al., 
2002; Metcalfe et al., 2008, Howard et al., 2009). The systematic review by 
Howard et al., (2009) reported that Australian and New Zealander women with 
the mutation were seven times more likely than women without it, to elect RRM 
and that previous cancer within the family including age at diagnosis strongly 
influenced decisions.  Uyei et al., (2006) also found amongst American women 
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that having the mutation and the efficacy of the procedure, were the main 
reasons for electing RRM. 
 
Health care providers may be unsure how to support women’s risk-reducing 
mastectomy decisions and do not always have the time or in some cases, the 
training to respond to the needs of women electing RRM (McCullum et al., 
2007). Indeed, women and their families find it difficult to translate the 
information they have been given by cancer genetic departments about 
risk-reducing surgery, when an altered mutation is found (Josephson et al., 
2000; Smith et al., 2008; Hamilton et al., 2009). Yet women and families are 
expected to make life-changing decisions and as a result, many women report 
a lack of psychological support from different practitioners throughout the 
journey, especially with the decision to have surgery (Lloyd et al., 2000; 
Josephson et al., 2000; Payne et al., 2000; Hatcher et al., 2001; Rolnick et al., 
2007). 
 
Rolnick et al., in (2007) for example conducted a survey with nine hundred and 
sixty-seven women at high risk of breast cancer to identify what they wished 
they had known before their surgery.  The findings demonstrated that many of 
their informational needs had not been addressed prior to making their 
decision.  Most of what they wished they had been told revolved around the 
reconstruction of the breasts and the expectations of surgery including the 
look, shape and feel. Two thirds of these women felt unprepared for the 
changes to their body and wished that they had received more information and 
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support, especially women undergoing risk-reducing mastectomy, compared 
to women undergoing contra lateral mastectomy.  Many women felt that the 
need for emotional counselling should not be optional. Although there are 
limitations to this study in that women completed the survey three to twenty-
two years following their mastectomy, many of the women had also had breast 
cancer and none of the women had a proven BRCA mutation, the response 
rate was high with 71% responding and it included a substantial number of 
women from six healthcare systems. Many of the findings have relevance for 
clinical practice by highlighting the need for practitioners to aid decision-
making, offering support before and after surgery.  However, a deeper 
exploration and understanding of what type of support and emotional 
counselling needs further clarification.  
 
2.5.1 The Timing of Surgery  
Studies have identified that women and families find the whole process of 
decision-making and surgery extremely difficult (Mireskandari et al., 2006; 
Rolnick 2007; Matloff et al., 2009; Sherman et al., 2010; Mauer et al., 2015). 
Many women have to construct a ‘right time’ to undertake the surgery. For 
example, some women can take as long as nine years following a mutation 
result before they proceed to surgery, prioritising their decisions in order to 
consider them one at a time. Howard et al., (2010) in a qualitative study 
utilising interviews with twenty two BRCA Positive women found that some 
women do not make immediate decision’s about risk-reducing surgery 
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following genetic testing, taking from three months up to nine years before 
deciding.  Their decisions will depend on many factors such as how much time 
they have had to think about the implications, where surgery fits in with their 
normal life, when and if all family conflicts have been dealt with and 
interestingly when the health service can accommodate them (Howard et al., 
2010).  
 
An additional influence on decision-making is the wider impact of a confirmed 
mutation on the whole family (Howard et al., 2010). Those with young children 
or whose relatives have developed or died of cancer will take far less time to 
decide on surgery because of the fear of leaving children behind (Lodder et 
al., 2002; Van Dijl et al., 2008; Haroun et al., 2011). They have very often 
decided on risk-reducing surgery even before the test or the result (Julian-
Reynier, 2010). 
 
Decisions about surgery may also shift over time and in response to receiving 
relevant and adequate information. McCullum et al., (2007) explored three 
women’s decision-making experiences and outcomes using case studies, all 
of whom were BRCA positive and who made different decisions, with regard 
to RRM.  They were selected in order to demonstrate the complexity of the 
process of decision making, showing how women deliberated and revisited 
their decision’s over time. The study employed a mixed methods approach 
using standardised measurements in a questionnaire and open-ended 
interview questions.  Participants received a booklet describing RRM that was 
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developed by the research team and which included benefits and risks to 
RRM. The women were followed up at three and six months after the booklet 
was given.  Initially, all three women wanted to have RRM but after receiving 
the booklet, each woman reported a different decision. Case one decided 
against RRM, explaining that it was ‘too radical’, case two remained undecided 
and with time wanted more information to be able to make a final decision and 
case three had undergone a RRM by the time of her second follow up 
interview. Findings illustrate the complexities of decision-making, how they 
may shift over time and the need for sufficient information and support to assist 
in the process. 
 
2.5.2 The Decision to Elect Breast Reconstruction Following RRM 
Compared to younger women with breast cancer who often choose not to 
reconstruct their breast (Holland et al., 2014), most women who have a BRCA 
mutation, take up this treatment option (Frost, 2000; Evans et al., 2005; 
Wasteson et al., 2011).  Although there have been some reports of satisfaction 
with the way the breasts look following RRM and reconstruction, (McGaughey, 
2006; Spear, 2008; Wasteson et al., 2011), there have been many reports of 
dissatisfaction, loss, (Altschuler et al., 2008; Gahm et al., 2010; Gopie et al., 
2013) and  some regret (Frost, 2000; Payne et al., 2000).  Even though breast 
reconstruction has improved in both the technique and its availability, 
satisfaction with the aesthetic result amongst BRCA positive women is still 
varied and has been reported to range between just 40% and 60% satisfaction 
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(Metcalfe et al., 2004b; Bresser et al., 2006; Isern et al., 2008; Gahm et al., 
2010; Wasteson, 2011).  Moreover, in BRCA women, in particular, evidence 
suggests that the cosmetic expectations of surgery are very high and often not 
achieved. Post-surgery, much lower satisfaction rates are reported when 
compared to women who have had breast cancer (Gahm et al., 2010; 
Brandberg et al., 2012; Hallowell et al., 2012). The underlying factors for this 
lower satisfaction needs further exploration.  
 
2.6 Post-surgical Impact  
The literature reviewed highlighted four overarching themes following 
risk-reducing mastectomy relevant to this study; regret following surgery, the 
impact of surgery on body image and sexuality, experiences of the partner and 
the long-term quality of life.   Due to the importance of the themes identified 
for clinical practice, each will be examined in turn, with a number of these 
studies presented and critiqued in detail.   
 
2.6.1 Regret Following Surgery 
Anxiety about cancer risk is not always reduced following RRM (Watson et al., 
2004) and there has been some reports of regret (Borgen et al.,1998; Frost et 
al., 2000; Payne et al., 2000). A retrospective study by Payne et al., (2000) 
specifically explored regret following bilateral mastectomy with twenty-one 
women who had completed an initial questionnaire as part of enrolment into a 
national prophylactic mastectomy registry and who had reported significant 
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regret in having the surgery. Nineteen women agreed to have a telephone 
interview; an experienced psychologist and psychiatrist conducted the 
structured clinical interview, which focused on the decision of RRM.  Fourteen 
women had undergone reconstruction with implants.  The physical and 
psychological trauma, in addition to the lack of psychological support, were 
found to be significant reasons for regret although the exact nature and extent 
of the trauma is unclear.  Regret also related to poor cosmetic results, 
complications of the surgery and the effects on body image and sexuality.  The 
exact nature of these problems were not reported, however. 
 
Although this study offers some insight into the experience of RRM, there are 
many limitations, none of the women were BRCA positive and all the women 
had a varied and elevated perception of risk. They reported a general overall 
fear of breast cancer based on what they had read, which did not reduce post-
surgery. The sample were self-selected, resulting in a biased representation 
(Flick, 2014). Furthermore, the physician had initiated the discussion and 
decision of RRM rather than the women themselves which, evidence 
demonstrates, leads to higher levels of dissatisfaction and regret (Borgen et 
al., 1998; Frost et al., 2000). Using a clinical interview as opposed to a 
qualitative interview was also a limitation and as such, there are no quotations 
from the participants to aid trustworthiness or establish rigour.  Importantly, 
had the women received more information or support about the consequences 
of surgery before making the decision, the majority reported that they would 
have reconsidered their decision. 
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These findings concur with the study by Borgen et al., 1998, who also found 
significant regret fifteen years following surgery, especially in women whose 
physician had initiated the surgery. However, this study is now over fifteen 
years old and since the introduction of protocols and shared decision-making, 
a different experience may be found. Furthermore, the sample relied on 
volunteers who answered an advertisement in a magazine and who completed 
a questionnaire. The selected sample may have included women with more 
positive or negative experiences, thus the actual degree of regret is difficult to 
determine. The sample did not include any BRCA positive women and many 
had undergone reconstruction, this results in many limitations of the study in 
its relevance to this study.  Frost et al., (2000) also found that 18% of women 
in their long-term study were dissatisfied with the outcome and on reflection, 
would not choose to have the surgery again, implying a degree of regret. 
 
A more recent retrospective Swedish study by Gahm et al., (2010) that utilised 
questionnaires to analyse the impact of RRM and reconstruction performed by 
a plastic surgeon, found that although the fifty-nine women did not explicitly 
report regret in having the surgery, ten women expressed that it was not the 
right decision and was not wise to have had the surgery, again implying a 
degree of regret.  Acknowledging the limitations of this study in that it was a 
retrospective study using a quantitative approach two years post-surgery, the 
findings offer insights into the many complications and physical effects of 
RRM.  Thus, the findings have implications for clinical practice that can inform 
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practitioners who care for these patients and women who are considering such 
surgery. 
 
2.6.2 The Impact on Body Image 
There have been three prospective (Brandberg et al., 2008, 2012; Gopie et 
al., 2013) and two retrospective studies conducted (Hopwood et al., 2000; 
Metcalfe et al., 2004a) that provide insight into the experiences of women 
following RRM but they specifically focus on cosmetic result and the impact on 
body image. These studies demonstrate mixed findings, some report a 
negative impact on body image, whilst others report satisfaction.  These 
studies utilised questionnaires that focused on pre-determined outcomes such 
as body image, cosmetic result or mental health and included BRCA positive 
and negative patients, which have limitations in its relevance to this study 
because the risks, circumstances and experience will be different for those 
who do not have a mutation. 
 
The study by Brandberg et al., (2008) was prospective which is its strength, it 
assessed psychological reactions and body image following RRM and 
reconstruction. Well-validated questionnaires, with ninety women of whom fifty 
were BRCA positive, were completed and the response rate was 90%. 
However, attrition increased over time with only eight women completing the 
questionnaire at twelve months and the power to reach statistical significance 
was low and therefore a limitation. Women were seen by a psychologist 
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pre-operatively and overall the majority of women were satisfied with the 
cosmetic result, however, it is unclear what percentage of these satisfied 
women were BRCA positive. It is also unclear what type of reconstruction was 
performed, important factors that determine the overall cosmetic result.  
 
Although anxiety levels decreased post-surgery, consistent with other studies 
(McGaughey, 2006; Hallowell et al., 2012; Gopie, 2013), there was no 
difference in depression scores. Importantly 50% of women reported problems 
one-year post surgery with 48% experiencing body image and sexual 
problems, sexual pleasure was rated lower and women felt less attractive and 
more self-conscious. Findings that concur with Lodder, et al., (2002).  It is 
worth noting, however, that 25% of the women in Brandberg et al’s (2008) 
study had undergone prophylactic oophorectomy, which could also have 
accounted for their experiences especially the effects on body image and 
sexuality.  Although 61% reported a positive change in their life, 46% reported 
a negative impact on intimate situations and femininity.  
 
One explanation for the contradictory findings of having a positive life change 
yet negative impacts on aspects of life is that the questionnaire was unspecific.  
One of the many limitations of this study is that cancer specific distress was 
not measured, this is important when studying women with the BRCA mutation 
because many are electing surgery in order to reduce their distress. 
Furthermore, many of the participants were not BRCA positive which affects 
the relevance of the findings to the current study, family members were not 
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included and pre-determined specific aspects of the experience were 
measured. 
 
Cosmetic results and satisfaction with surgery were again the focus in 
Brandberg et al’s (2012) study with the aim of assessing expectations before 
and after surgery. The study utilised questionnaires six months and one year 
following bilateral mastectomy and reconstruction.  Forty-nine of the 
ninety-one participants were BRCA positive and measurements of cosmetic 
satisfaction, sexual activity and body image were conducted using instruments 
designed for cancer patients, a different group who would have very different 
experiences and needs. Although the majority of women reported being 
satisfied with the cosmetic result, a larger proportion of those with a BRCA 
mutation, reported unmet expectations with over 40% complaining about the 
feel and the look of their breasts. The prospective nature of the study is a 
strength but further exploration and a deeper understanding of what the 
expectations were and why expectations were not met in the BRCA positive 
women, in particular, would have increased knowledge, however, this 
exploration was limited by the use of questionnaires.  
 
One would have expected that with the inclusion of a plastic surgeon, a nurse 
and a psychologist as part of a recommended multidisciplinary team approach, 
that both groups of women would have had similar expectations. Women had 
also undergone oophorectomy and the NAC had been preserved in the women 
who underwent reconstruction, which would have given a superior cosmetic 
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result, all factors which affect expectations. The inclusion of BRCA negative 
women would have affected the results because their experience and risk is 
different, resulting in some limitations of the study in terms of the relevance to 
the current study. 
 
Similarly, Gopie (2013) specifically explored the effects on body image 
following RRM, using questionnaires with fifty women of which forty-four were 
BRCA positive and four women had a strong family history. Although fifty 
women initially consented to the study, two were later excluded as breast 
cancer was found in the surgical specimen, seven dropped out and nine did 
not respond. Having a heterogeneous group of women especially those with 
breast cancer, unspecified high risk and BRCA positive, one would view the 
results and therefore the relevance to this study, with some caution because 
of the difference in sample, circumstances and therefore experiences. The 
prospective design of this study is a strength with questionnaires completed 
pre-surgery, six months post-surgery and following completion of the 
reconstruction, with a median of twenty-one months. However, the techniques 
of reconstruction varied amongst the women, a factor known that affects 
different satisfaction and so the results were again, not comparable.  
 
There was a high attrition rate, one of the limitations of surveys with only 
thirty-two completing the final questionnaire making the sample low and results 
less convincing. The study aimed to assess partner satisfaction with 
relationships but it appears that partners were not included and results relied 
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on the women to comment on this aspect, questioning the trustworthiness and 
rigour of the effects on partner relationship measurements. The women had 
undergone oophorectomy, which would also have affected their body image 
scores. Body image and sexual relationship satisfaction was found to be 
significantly decreased and remained unchanged for 30% of the participants, 
although no sexual dysfunction scale was utilised. Results demonstrated that 
29% of the women were unhappy with their breast appearance and 21% felt 
embarrassed with their naked body. However, the lack of body image data in 
a comparable age matched healthy group makes it difficult to compare how 
these differ from normal scores.  Moreover, the ability to gain a deeper 
exploration of their dissatisfaction and their embarrassment is one of the 
limitations of utilising a questionnaire.   
 
Conversely, the retrospective Canadian study by Metcalfe et al., in (2004a), 
suggested that the majority of women were happy with their decision to 
undergo surgery although younger women less so. Their study utilised 
questionnaires with seventy-five women to determine the psycho-social 
functioning following prophylactic mastectomy. Of the sixty women who 
returned their questionnaire, only thirteen women had a BRCA mutation, 
making it difficult to draw comparisons with a heterogeneous group. A mean 
of five years had elapsed since surgery and thirty-eight of the women had 
undergone reconstruction with seven women having a subcutaneous 
mastectomy.  
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Most women without a mutation were not experiencing any abnormal levels of 
distress nor any major problems with body image or sexual activity. A third of 
the women with a BRCA mutation, however, were still experiencing high levels 
of both general and cancer related distress, but it is unclear why. The 
limitations of the study in terms of the relevance to this study, include its 
retrospective design as women were expected to remember how they felt five 
years previously, the inability to explore the reasons why cancer related 
distress was still evident especially in the BRCA positive women or why 
younger patients, in particular, were less satisfied.  Moreover, the small 
sample size, the fact that women had different types of mastectomy including 
subcutaneous mastectomy (where the skin and the nipple are preserved), 
would also have affected satisfaction and are therefore limitations.  There were 
no pre-operative measures of anxiety or quality of life to compare with post-
surgery, which would have increased knowledge, had relevance for practice 
and contributed to the rigour of the study. 
 
In support of this, Hopwood et al., in (2000) in Manchester UK, utilised 
questionnaires in a retrospective design with a 79% response, to assess the 
mental health and body image of seventy-six women, up to three years post 
RRM.  Overall, the findings showed no evidence of significant mental health 
or body image problems but women felt less attractive, less feminine and there 
were negative effects on sexual relationships, the reasons for which were not 
reported. It is unclear from the findings what the ‘serious psychological’ or 
‘body image problems’ were and how many women experienced them. The 
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women in this study were treated within the only known protocol at that time, 
for high-risk women in the UK and received two genetic counselling sessions, 
a psychological assessment, surgical consultation pre-operatively and an 
annual follow up. Interviews with the psychiatrist were conducted only when 
body image scores or general health scores were high at follow up.  
 
The interview in this sense had a different function to that of a research 
interview, a therapeutic interview with the aim of treating psychological 
problems. There were only six BRCA positive women in the sample and three 
of these had breast cancer, the women underwent different types of 
reconstruction or no reconstruction, resulting in many limitations of the 
relevance to this study. The focus of their study was on pre-determined 
outcomes, rather than overall experience and the authors conclude 
themselves that it was not a systematic research evaluation and a baseline 
questionnaire was not routinely collected, with some reports of missing data. 
 
2.6.3 The Longer-Term Impact on Body Image  
The following studies aimed to explore the psychosocial consequences of 
being BRCA positive and electing to have surgery in the longer term.  They 
are both retrospective and prospective with changes in body image being the 
focus. 
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In contrast to the previous studies, van Oostrum et al., (2003) used a mixed 
methods approach that aimed to explore the long-term psycho-social 
consequences of being BRCA positive (twenty-three participants) and BRCA 
negative women (forty two participants) five years after the test in order to 
identify risk factors for long-term distress. Sixty-five women completed a 
questionnaire and fifty-one were interviewed (twenty positives and thirty-one 
negatives).  More women with a mutation underwent RRM and reconstruction 
(twenty-one out of twenty-three) and had a less favourable body image with 
70% reporting changes in sexual relationships. Of particular note is that 50% 
of the mutation positive women consulted a psychiatrist or psychologist for 
support during the five years following testing, potentially highlighting the 
difficulties experienced by those with a mutation.  Long term distress was 
associated with higher risk perception pre-surgery, the loss of family members 
to cancer and less open communication within the family. 
 
Well validated assessment tools were used to measure body image, anxiety 
and depression but questionnaires did not allow a further in-depth exploration 
of the experience. Women had also undergone bilateral oophorectomy, factors 
that could have affected the experience, and two of the women with a mutation 
were diagnosed with breast cancer during the study. Anxiety and depression 
scores between years one and five were increased for both mutation positive 
and negative women, suggesting that factors other than testing and RRM 
affect the long-term distress noted. 
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Limitations of this study include its retrospective design and the quantifiable 
measurement of outcomes as opposed to rich, qualitative data examining 
experiences, for example, there was no data from the interviews nor any 
quotations from participants to draw any conclusions about the experience. 
The inclusion of women with breast cancer whose issues will be different 
(Metcalfe et al., 2005) and women who had undergone oophorectomy in 
addition to a 24% dropout rate, were also limitations to increasing knowledge 
relevant to this study.  
 
Similarly, the study by Altschuler et al., (2008) was retrospective, and 
examined the long term psychosocial experiences of bilateral mastectomy but 
also included women with breast cancer having a contra lateral (opposite 
breast to breast cancer) mastectomy.  A total of nine hundred and sixty-seven 
women were sent a survey, three to twenty-two years following a mastectomy 
with a response rate of 71%. One hundred and ninety-five women had RRM 
and seven hundred and seventy-two had a contra lateral-mastectomy. The 
qualitative aspect of the survey used open-ended questions which were coded 
independently by three of the authors, this ensured trustworthiness and an 
audit trail. Compared to women having contra-lateral mastectomy there were 
over twice as many negative responses from the women who had undergone 
RRM. Reports of decreased sensation in the breast, body image with sexual 
problems and chronic pain, were all reported.  
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The limitations of this study include the long and varied time points since 
surgery in terms of expecting the women to recall their feelings or experience 
after twenty-two years, the majority of women had breast cancer and more 
importantly, it appears that none of the participants were BRCA positive, so it 
is difficult to make comparisons. Although direct quotes from the participants 
were taken from the open-ended responses, it is difficult to interpret the 
meaning or explore the responses. There were contradictions from the 
responses, for example, some women reported satisfaction in the closed 
ended section of the questionnaire, but in the open-ended section they 
reported negative psychosocial outcomes. It is also unclear if any of the 
women had reconstruction and if so, what type, as this would have affected 
the experiences. 
 
Conversely and importantly, the majority of women in den Heijer et al’s (2012) 
prospective long-term study were BRCA positive, offering results more 
relevant to this study. They explored the psychological distress following 
prophylactic mastectomy six to nine years post-surgery in thirty-six high-risk 
women who had undergone mastectomy with reconstruction. Questionnaires 
were completed shortly after consent for the study in (2003), pre-surgery, six 
months and finally at six to nine years post-surgery with all of the BRCA 
positive women completing the questionnaires at nine years. Well validated 
questionnaires were used to specifically identify anxiety and depression, body 
image scores and impact of events. Results showed a decrease in cancer 
specific distress and general distress long term.  Findings consistent with other 
  
89 
 
studies (McGaughey, 2006; Hallowell et al., 2012; Hagen et al., 2014; Glassey 
et al., 2016).  
 
Body image problems were still evident, however, at six months and in the 
long term.  One explanation for the findings at six months is that reconstruction 
was incomplete as many women were still waiting for surgery. However, 
women were still dissatisfied and reported problems at nine years when 
surgery was completed. Women with body image problems pre-surgery were 
more vulnerable to having body image problems post-surgery, social support 
and having an active coping style was found to increase body satisfaction long 
term, important factors that have relevance for clinical practice. 
 
Although this study is prospective and therefore, its strength, there is a 
long-time interval between the questionnaires given at six months and again 
at nine years.  The expectation that women could accurately report how they 
felt in the previous nine years questions its trustworthiness. Furthermore, the 
outcome measures were pre-determined, specific for body image and 
psychological distress.  
 
Although these measures are aspects of experience, the opportunity to 
explore the experience further is lost when a survey design is utilised. Within 
the sample, women had undergone both mastectomy and oophorectomy and 
this would be captured in the measurements. It also included women with 
breast and ovarian cancer, who would have different experiences and 
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concerns. Finally, the women had different reconstruction and not all the 
participants were BRCA positive, factors, which contribute further to some 
limitations of the findings. 
2.6.4 The Impact on Sexuality 
Sexuality has consistently been shown to be adversely affected following 
RRM, but in some studies without adequate explanation and with some 
contradictions. Importantly, both quantitative and qualitative studies have been 
conducted. Hatcher and Fallowfield, (2003) conducted a qualitative 
prospective study as part of a larger quantitative study by Hatcher et al., (2001) 
in the UK, where questionnaires with one hundred and fifty-four women were 
utilised in order to measure psychological and sexual morbidity following 
prophylactic mastectomy. Seventy-nine women chose surgery, sixty-four 
declined and eleven deferred making a decision.  Findings demonstrated that 
overall, there were no significant changes in sexual pleasure post-surgery.  
However, these women were a heterogeneous group, not all women 
underwent reconstruction and those that did, had different techniques, 
important factors that could affect sexuality. Some of the women also had 
breast cancer, which would have had an influence on their satisfaction. For the 
qualitative aspect of this study, in depth interviews were conducted at home 
pre-surgery and again at six and eighteen months with sixty women who 
underwent surgery. Interviews were conducted pre-surgery and at eighteen 
months with the twenty women who declined surgery.  
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The aim was to identify the psychosocial implications of the surgery.  Although 
anxiety was reduced post-surgery, the majority of women were not prepared 
for many of the effects of surgery.  Findings consistent with Gopie et al., (2013) 
and den Heijer et al., (2012).  Some women experienced pain, dissatisfaction 
with their sexual relationships and dissatisfaction with their reconstruction, with 
complications still being reported at eighteen months. Most of the women did 
not see any photographs of surgery, they had not received any information 
pre-surgery from a surgeon or any nursing staff, thus support and information 
were requested. No difference in sexual pleasure was noted which sits in 
contrast to other studies (Frost et al., 2000; Lodder et al., 2002; Bresser et al., 
2006; Brandberg et al., 2008).  
 
However, there were some contradictions in the findings. A third of women 
reported that their husbands did not want to touch their breasts and their 
sexual relationships were adversely affected. There were also limitations to 
this study, only eight of the women were BRCA positive and a proportion did 
not have surgery, making it difficult to compare the groups. Although it is a 
qualitative study and there is some explanation about the process of data 
analysis, it is unclear what the underpinning methodology was which questions 
the trustworthiness and rigour of the study. The study included BRCA positive 
and negative women in addition to patients with breast cancer, which is also a 
limitation because they are different groups of women with different 
circumstances and needs. 
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Bresser et al., in (2006) found adverse experiences in sexual relationships with 
altered feelings of femininity for over half of the participants in their study and 
they reported that were more likely not to choose the procedure again.  It was 
a retrospective study using questionnaires three years following surgery with 
one hundred and fourteen women, sixty-three of whom were BRCA positive. 
The women underwent RRM or contralateral mastectomy with reconstruction 
and fifteen had previous breast cancer.   Although there are limitations in this 
study in that it was retrospective and included a heterogenous group of women 
such as those with cancer, it does demonstrate the impact of RRM on 
femininity and thus sexual relationships.  A deeper exploration into these 
findings with a qualitative design would add further knowledge. 
  
Few pure qualitative studies have been conducted with BRCA positive women 
without cancer, specifically undergoing risk-reducing mastectomy but Nina 
Hallowell from the UK has studied high risk women extensively. In the most 
recent study, Hallowell et al., (2012) utilised a qualitative design, whose aim 
was to identify and understand the women’s experiences with no fixed, forced 
questions. Semi-structured telephone interviews were conducted with forty 
Australian women three years after undergoing risk-reducing surgery. 
Twenty-five of the sample had a BRCA positive mutation and nineteen of the 
twenty-one women who had RRM mastectomy underwent reconstruction. Two 
themes of looking different and feeling different were developed from the data. 
Although the surgery was seen as positive in reducing risk and worry, as found 
in other studies (Frost et al., 2000; van Oostrum, 2003; Dowdy et al., 2004; 
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Brandberg at al., 2008; Miller et al., 2010), many negative consequences of 
surgery were reported. These effects had an impact on the women’s sexuality 
and have important relevance for clinical practice, highlighting a need for those 
involved in their care to identify and address the issues, for example, the 
women reported being unprepared for many of the consequences of surgery 
including the altered sensations in the breast. 
 
The majority of women were BRCA positive, this is a strength of the study, 
comparing a comparative group, but there were some limitations to consider. 
Women in Hallowell’s study also underwent risk-reducing oophorectomy either 
alone or in combination with breast surgery and this would have affected their 
experience, especially their sexuality because of the implications of 
menopause on sexuality. The type of reconstruction that women underwent 
also differed which would have affected the satisfaction with their cosmetic 
result. Women who had implants, for example, described their breasts as 
feeling hard and different whereas women who had muscle flap surgery 
described how they were able to have a ‘tummy tuck’, which was seen as a 
bonus. The retrospective nature of the study is also a limitation because 
participants were trying to recall how they felt three years previously. The fact 
that they were all interviewed after the same three-year period, however, is a 
strength.  
 
The qualitative study by McEwan, (2011) also has relevance to this study and 
for clinical practice. The experiences of thirty-two New Zealand women living 
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with an increased risk of breast and ovarian cancer were explored as part of a 
Ph.D., with the author working as both a practitioner and a researcher. The 
study investigated the impact on body image and sexuality following 
risk-reducing surgery by removing significant female organs associated with 
sexuality and femininity, the breasts and ovaries. Semi structured interviews 
were conducted and a narrative thematic analysis resulted in a core category 
’getting on with it’. This was found to be a dominant theme in the way women 
approached their risk and their decision to have surgery. Nineteen women had 
undergone surgery and although the majority of these women had elected to 
undergo RRSO and therefore the experiences of an altered femininity and 
sexuality were mainly related to these individuals, only four women had 
elected RRM.  ‘Getting on with it’ proved more difficult for some of the women 
in sacrificing the sexual aspects of femininity for the maternal representation 
of their breasts and the gendered representation of women as nurturers.  Many 
of the women, for example, expressed a desire to ‘be there for their children’ 
as the main reason for their decision.  Many women who had not had surgery, 
however,  identified worries about RRM on body image and sexuality.  For 
those who had undergone surgery, loss, changes to body image and sexual 
problems had been experienced mainly by women who had RRSO.  Pressure 
from husbands to undergo some form of breast reconstruction to replace the 
loss was also reported in this study, demonstrating the importance of a 
woman’s breasts for sexuality.  The strengths of the study include that sixteen 
of the women were BRCA positive and the sample included two lesbian 
women who are not represented in the majority of studies on high-risk women 
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and whose breasts were equally as important to those in a heterosexual 
relationship.  Five of the women in this study had breast cancer which would 
have affected their experience especially ‘loss’ and is one of its limitations. 
Further exploration of women’s sexuality problems with regard to risk-reducing 
mastectomy in a prospective study with a larger sample size would add further 
knowledge. 
 
Adding to current knowledge, similarly, Lloyd et al., (2000) conducted a 
grounded theory study three years post-surgery, the aim of which was to 
explore the personal experiences of surgery and psychological adjustment for 
the woman and her partner. Ten women and eight men were included, using 
semi structured interviews with a purposive sample. The time since surgery 
ranged from six weeks to three years and nine women had implant based 
reconstruction. Sexuality and feelings of womanliness had been adversely 
affected, although further exploration of the reasons why and how would have 
increased knowledge and informed practice. 
 
The aim of grounded theory is to develop a theory that is grounded in the 
analysis (Flick, 2014) and thus a core category of ‘suffering and countering 
multiple losses’ was found to be central to their experiences, the loss of 
femininity and womanliness as well as the loss of close members of the family. 
However, the studies limitations include its retrospective design, only two 
women were BRCA positive and three of the ten women had also undergone 
oophorectomy which would have affected the results. Furthermore, all the 
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women in the sample were married; single women may have had a different 
experience. Participants waiting for surgery or in the decision-making process 
could have been asked to participate in this study and was also recognised as 
a limitation by the authors. 
2.6.5 The Experience of Partners Following Risk-Reducing Mastectomy 
Currently, only three studies include the partners’ experience following RRM 
in women known to be BRCA positive (Lloyd et al., 2000; Mireskandari et al., 
(2006); Mauer et al., 2015).  
 
In the retrospective qualitative study by Lloyd et al., (2000), although sexuality 
was not explored specifically, the majority of the eight men felt surgery had no 
negative consequences on their sexual relationship. However, the men did 
report that their sexual relationships had deteriorated, resulting in some 
contradictions. There were only two quotes from the partners to validate any 
findings and aid trustworthiness and therefore, there were some limitations of 
the findings. Interviews were conducted between four months and three years’ 
post-surgery and the aim was to determine the effect of surgery on their 
relationship and family life.  Although partners did not feel that their relationship 
was negatively affected by surgery, the cosmetic result was described as 
‘shocking’ and they reported a need to ‘adjust’ to it. It is unclear however what 
the shock entailed and in what way the sexual relationship had been affected 
or what they had to adjust to. Partners also described a strain on the 
relationship due to the extra work that had to be undertaken over the 
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post-operative period in trying to work yet simultaneously care for their 
children. These factors have importance for clinical practice in meeting the 
needs of the whole family and thus a further exploration of the deeper issues 
would add to the current knowledge.  
 
Similarly, Mauer et al., (2015) identified problems with sexuality following 
RRM. An online retrospective survey was conducted with twenty-five male 
partners of women who were BRCA positive. Women were asked to forward 
the link to the study to their partner and the link was posted on a forum notice 
board. Eleven of the women had undergone mastectomy and ten had 
reconstruction, seven women had also undergone bilateral oophorectomy.  
 
The focus of the study was on male partners’ thoughts about changes in 
sexuality and thoughts about prophylactic surgery. Fourteen women had not 
undergone a mastectomy at the time of the study but when asked if they would 
want the women (partner) to have reconstruction after a mastectomy, the 
majority of the men said ‘yes’.  Although the results concluded that this sample 
of men was still attracted to their partner who had undergone mastectomy, 
there were problems and concerns with breast sensation loss, sexual 
problems and physical attractiveness.  
 
The information was limited however and it is unclear precisely what the 
concerns were. It was not possible to gain a deeper understanding of the 
experience due to the limits of using a survey design. Women had also 
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undergone oophorectomy and many of the concerns regarding sexual 
problems may have been linked to this and menopausal symptoms. The 
sample size was small and it focused on men currently in relationships who 
were recruited via their partners. The results may have been very different if 
the men were single and had been contacted directly. 
 
The study by Mireskandari et al., (2006) was a qualitative retrospective study, 
this aimed to explore the needs and concerns of partners of women at high 
risk of breast cancer. Fifteen male partners were interviewed by telephone, 
only seven had a partner who was BRCA positive and only one woman had 
undergone RRM compared to four women who had undergone bilateral 
oophorectomy. This latter surgery may have been responsible for the majority 
of relationship problems reported. Data analysis was conducted using 
methods described by Miles and Huberman and this is clearly documented, 
thereby aiding trustworthiness and an audit trail with a number of participant 
quotes. Relationship problems, greater distress and adjustment problems 
were reported in more of the men where there was a BRCA mutation. 
However, it is unclear what these relationship, distress or adjustment problems 
were.  
 
Findings demonstrated that partners identified RRM as one of the most 
challenging decisions they had to make but there was no further exploration. 
They reported a need to meet other partners in the same situation as well as 
a need for information and support from health professionals, the reasons for 
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which were not explored. The time since testing for those who were positive 
ranged from one to sixty-six months and this was not accounted for in the 
analysis, which is another limitation. This variation in time would have affected 
the experience because the partners may have adjusted to the situation if 
interviewed at three years, as opposed to one year.  
2.6.6 Summary of Literature on Body Image and Sexuality 
Although there have been some reports of satisfaction following RRM, overall 
the studies demonstrate a number of problems following RRM in terms of the 
negative effects on body image, identity and sexuality, for both the women and 
their partners.  A literature review conducted by McGaughey (2006) 
summarises the research on body image specifically following RRM, 
concluding that 50% of women undergoing RRM suffer negative effects on 
body image, however, the exact reasons for which need further exploration 
and understanding. In some cases, there have been reports of regret, 
especially where there has been no support for women and the family or where 
the decision to elect RRM has been doctor led as opposed to being led by the 
women themselves. Following RRM, there is less anxiety and fear of 
developing breast cancer overall, but these studies demonstrate that there is 
still a surprisingly high level of anxiety and distress experienced by some 
women with a BRCA mutation and their partners post-surgery.  This 
knowledge alongside the many negative impacts with identity and sexuality for 
BRCA women, in particular require further exploration. 
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2.8 Long-Term Impacts of Risk-Reducing Mastectomy 
The remaining literature considers the long-term effects and impact of 
risk-reducing mastectomy on the quality of life.  Three retrospective studies 
utilised questionnaires and one qualitative study that also considered family 
members. 
2.8.1 Quality of Life  
The assessment of Quality of life (QOL) has also been the focus of a few 
studies post RRM. Three such long-term retrospective studies utilised 
questionnaires. A descriptive study by Frost et al., in (2000) involved five 
hundred and seventy-two women who had undergone RRM but none of the 
women had a BRCA mutation. The main outcome measures were satisfaction 
with surgery and psychological quality of life although it is unclear which 
validated questionnaire was utilised. Time from surgery to the questionnaire 
was fourteen years and findings demonstrated that post-surgery, women had 
less concern about developing breast cancer, findings that are consistent with 
other studies (van Oostrum, 2003; Dowdy et al., 2004; Brandberg at al., 2008; 
Miller et al., 2010) and most women were satisfied with the procedure.  
 
However, there were many negative consequences of surgery, problems with 
sexual relationships, feeling less feminine, lower self-esteem and 36% had a 
diminished overall satisfaction with their body, with 18% of women who would 
not choose to have the surgery if given the chance again. Women who 
reported that they had undergone surgery based on the advice of their 
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physician were the most dissatisfied, with adverse effects found in emotional 
stability and quality of life. Seven women developed breast cancer during the 
study and this is a limitation of the study because they were included in the 
analysis and their circumstances and experiences would be different. There 
was a fourteen-year time lapse since surgery and therefore a problem of recall 
bias is a consideration. Women had undergone different types of 
reconstruction or no reconstruction and this would have affected cosmetic 
satisfaction. Indeed, women who did not have reconstruction were the most 
satisfied.  A deeper exploration of the reasons for dissatisfaction and reasons 
for low self-esteem and sexual problems would have added further knowledge. 
 
Similarly, the study by Geiger et al., (2007) specifically looked at the quality of 
life after RRM for high risk women who had surgery between 1979 and 1999 
but who did not have a BRCA mutation. This is important when considering 
the results because the needs of high-risk women will be different to those 
carrying a mutation. Three hundred and twelve women were emailed a 
questionnaire of which a hundred and seventeen were women with a high risk 
but who did not have surgery. These women had ovarian cancer and early 
changes within the breast thus not a comparative group. The response rate 
was poor with only a 58% response (one hundred and six who had surgery). 
Diminished quality of life was associated with dissatisfaction with sex life prior 
to the surgery and this was also evident in women who did not undergo 
surgery.  
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Although this is a long-term study, asking women to recall their feelings or 
experiences from twenty-three years prior is a major limitation and a 
consideration toward the trustworthiness of the findings. In addition, the 
accurate risk status of the women in the comparative group is unclear, an 
important factor that would affect QOL.  Furthermore, without pre-mastectomy 
assessment of the quality of life or psychosocial factors, it is difficult to identify 
whether the two groups of women differed systematically before the 
procedures and if so, how much this would have affected the results.  It is also 
unclear whether the comparison group were on any chemotherapy-prevention 
programmes or surveillance programmes due to their high risk, which again 
would have affected the results.  The inclusion of women with ovarian cancer 
and early breast changes is also a limitation of the study because the 
difference in circumstances makes it difficult to compare to high risk women 
and BRCA positive women in particular. 
 
Metcalfe et al., (2005) also report on the overall quality of life following RRM 
as part of a larger study assessing psycho-social functioning following RRM 
(Metcalfe et al., 2004a). This QOL study however specifically assessed the 
predictors of QOL with seventy five women age range from twenty to sixty-two 
of whom sixty returned the completed questionnaires.  A mean of fifty-two 
months had elapsed since RRM and completion of the questionnaire, thirteen 
women were BRCA positive.  The levels of QOL for the study participants were 
found to be slightly above the average levels for the normal population and 
higher than the mean levels reported for women with breast cancer. 
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Importantly, two significant predictors of QOL were found, vulnerability and 
psychological distress.  Those found to have higher levels of vulnerability were 
more likely to experience a lower level of QOL.  Vulnerability included feelings 
of susceptibility to an invasion of the body by cancer and thus a loss of trust in 
the body to stay healthy.  Psychological distress such as continuing to perceive 
high breast cancer risk predicted lower quality of life.  These findings offer 
important insights for members of the multidisciplinary team who care for 
women who elect RRM by providing understandings of how the overall 
psychological health of women can be promoted.  QOL was measured after a 
period of adjustment possibly accounting for the above average scores seen. 
Had QOL been measured immediately following RRM for example, transient 
effects may have been observed. 
 
Wasteson et al., (2011) has carried out the only study examining long-term 
satisfaction following bilateral mastectomy that includes perspectives of the 
family.  This was the long-term study building on an earlier study (Josephson 
et al., 2000).  Semi-structured interviews were conducted in a qualitative 
design with thirteen women who also took part in the earlier study, only one of 
whom was BRCA positive.  All participants had undergone reconstruction 
using implants and three main areas were explored, daily activities, risk 
perception and cosmetic results. 
 
Although all women reported satisfaction with their decision to have surgery 
and there was a reduction in their risk, negative consequences of surgery were 
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reported mainly due to a change in the women’s bodies which affected 
relationships. Family relationships had been adversely affected especially with 
regard to their spouse and for many, there were ongoing complications from 
surgery, which necessitated further surgery.  There are a few limitations to this 
study that need consideration. The retrospective design would have affected 
the ability to recall experience ten years earlier as there may have been many 
other factors prior to the study that influenced their overall experience. Only 
one woman had a BRCA mutation, which may have affected the satisfaction 
rates as BRCA positive women appear to be less satisfied following RRM and 
have different concerns and experiences (van Oostrum et al., 2003; Gopie, et 
al., 2013; Heijer, et al., 2012). The underlying methodology in the study is 
unclear and there are no quotations from participants to support 
trustworthiness in the analysis, auditability or rigour. In addition, there were no 
assessments of psychological measurements using any well validated 
assessment tools either pre or post operatively. 
 
2.8.2 A Summary of the Review  
The focus of the literature examining the experience of women with BRCA1 
and 2 has primarily concentrated on using ‘satisfaction’ and ‘body image’ as 
key outcome measures following breast removal rather than overall 
experience.  Satisfaction with surgery overall was found to be variable with 
many studies adopting quantitative methodologies. Some studies were 
predominantly conducted before any clinical protocols were established and 
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across a wide range in time points following the surgical intervention. Thus, 
asking women to recall how they felt many years after the experience, results 
in the problem of recall or response bias (Borgen et al., 1998; Frost et al., 
2000; Hatcher et al., 2001; Hatcher and Fallofield, 2003; Bresser et al., 2006; 
McGaughey 2006; Brandberg et al., 2008; Gahm et al., 2010).  
 
Only seven studies addressed some of the longer term effects and again, 
these primarily concentrated on using specific outcome measurements 
associated with the surgery, included women of different risk categories but 
did not include the experiences of their wider family (Frost, 2000; van Oostrum 
et al., 2003; Metcalfe et al .,2005, Geiger et al., 2007; Altschuler et al., 2008; 
Wasteson, 2011 and den Heijer et al., 2012).  Only six studies have used 
qualitative methods to examine the experiences (Lloyd et al 2000; Hatcher and 
Fallowfield, 2003; Mireskandari et al., 2006; Howard et al., 2011; McEwan, 
2011; Hallowell et al., 2012). 
 
The majority of the studies were retrospective and included BRCA positive 
women and women with breast cancer, different categories of high risk or 
women who had undergone contra-lateral mastectomy as a risk-reducing 
procedure. This makes it difficult to identify the experiences of BRCA positive 
women alone. In addition, the studies included women who underwent 
different reconstruction techniques at different time points and women who did 
not have reconstruction.  Thus, these studies focus on a very small part of the 
experiences of a heterogeneous group of women. This makes overall 
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comparison difficult.  However, the review does offer valuable insight and 
knowledge in terms of identifying some of the impacts of RRM on body image, 
sexuality and quality of life for women with and without the BRCA mutation, 
leaving scope for further research with BRCA positive women specifically, 
including their family.  
 
Many of the studies used structured questions, this can mean that the results 
reflect the researcher’s focus, rather than the focus of understanding the 
experiences of participants. The use of assessment tools that have not been 
well validated in some of the studies also raises issues of credibility and 
validity. The sample size varies within studies and the methodology in some 
of the studies is unclear. Only three qualitative studies have included the 
partners’ experiences, these were retrospective and the data is limited.   Many 
of the studies, therefore, lack a deeper understanding of the experience of a 
BRCA positive woman, in particular, electing RRM in the context of her wider 
family.   The family perspective, especially those of the partner, is important 
for clinical practice as the decision to elect RRM and to maintain a positive 
mental health post-surgery, is a family matter and research with this particular 
group is required to increase knowledge and understandings. 
 
None of the studies identified in this or the previous chapter offered a deeper 
examination of the experiences of body image, sexuality and quality of life and 
thus how practitioners can support women and their families.  Finally, there 
were no studies found that adopted a phenomenological approach, in 
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particular, an interpretive design utilising Gadamerian philosophy, that 
explores the phenomenon of living with the BRCA mutation and electing RRM.  
 
2.8.3 Conclusion 
The current horizon of understanding, therefore, highlights many limitations, 
some contradictions and some gaps in the literature. A table of the included 
studies is summarised in Appendix Three. These and other factors led to the 
identification of the professional clinical need to conduct research that aims to 
provide a deeper exploration of the meaning of being a BRCA positive woman 
who elects RRM in the context of the wider family. The overall aim is to find a 
new horizon of understanding that will benefit patients in clinical practice. One 
consistent finding is the need for support and information from health care 
providers. However, the reasons for and detailed requirements underlying this 
support, still require exploration. An interpretive phenomenological approach I 
believed, would achieve this deeper understanding and the research 
questions therefore emerged.  
 
In particular, what does it mean to be a BRCA mutation carrier and what is it 
like living with someone who is a carrier?  How do women and their families 
make sense of the BRCA mutation, come to the decision of surgery and what 
are their experiences?  What is the experience of undergoing RRM and why 
is body image, identity and sexuality so adversely affected? What are the 
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needs of the women and their families in terms of information, assessment 
and nursing care? 
 
The next chapter introduces the research process and the methods used in 
the study. 
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CHAPTER THREE – Methodology and Methods 
3.1 Introduction 
This study employs an interpretive hermeneutic phenomenological approach 
guided by the philosophy of Gadamer. It was conducted using in-depth, 
longitudinal qualitative interviews with eight BRCA mutation positive women 
(probands), following their results (pre-surgery) and at six and twelve months 
post-surgery. A final interview was conducted at eighteen months with a 
subset of four of the probands to capture an indication of the longer-term 
effects of RRM. To explore the wider impacts of their decision making and 
surgery, five of their husbands were interviewed pre-surgery and again at 
twelve months and five members of their family were interviewed pre-surgery.  
A total of forty-three interviews were conducted. Due to limitations of the 
requirements of the Ph.D., and the amount of data that would be generated, it 
was felt that interviews at two-time points with the partners and one with the 
relatives would add a contribution to knowledge Analysis was conducted using 
the hermeneutic circle guided by the philosophy of Gadamer (2004).  
 
To promote, ‘credibility, depth and coherence’ as explicated by Finlay, (2006 
pg. 17) and to put the study into context, the theory underpinning this study 
and its methodology needs to be discussed.  This chapter will, therefore, 
include the starting point and decisions made by the researcher including the 
choices that were made throughout the study. Here, the researcher and 
participants are situated, the research question is defined and the methods 
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used are explicated. The ontological and epistemology standpoints are also 
included (Durant Law, 2005; Guba and Lincoln, 2005).  
 
3.2 My Starting Point - The Emergence of the Research 
Question from Practice  
It is necessary, as the researcher, to situate myself within the study but also 
to provide some reflection on my starting point and what drove my desire to 
conduct the study. It also gives me an opportunity to give you, the reader, a 
sense of what it was like to undertake this study and the thesis generally.  In 
Appendix One, I also offer a short autobiography of myself in order to reveal a 
little more about my background. Watts, (2009) contends that situating the 
researcher and providing an autobiography enables a better understanding 
and awareness of how one’s own prior experience can influence the values, 
beliefs and decisions made along the journey. 
 
Reflection is also an important aspect of any form of awareness and indeed in 
nursing practice generally. In trying to understand and interpret human 
experience about any phenomenon, a reflection on pre-understandings or 
what Gadamer calls ‘prejudices’ is necessary.  It is important and worth noting 
at this point that the term prejudice should not be viewed with any negativity 
as in the modern use of the word.  In this context, it represents the productive 
pre-understandings that aid any future understanding (Fleming and Robb, 
2003). Thus, not only does this reflection legitimise the pre-understandings, it 
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also helps to contain any influence that they may have on future understanding 
(McManus Holroyd, 2007). 
 
Pre-understanding, therefore, derives from knowledge of the current literature 
(The Current Horizon of Understanding, Chapter Two) from my previous 
experience as a nurse and from my place as a woman in society. Furthermore, 
history and culture are very much a part of one’s pre-understanding.  
According to Gadamerian philosophy, it becomes impossible to step outside 
of history, to look at the past. Indeed, a researcher’s personal experience and 
pre-understanding should be viewed positively in studies underpinned by 
hermeneutics (which is the science of understanding human experience and 
meaning gained through interpretation) by providing some context to the study 
(Fleming et al., 2003). Furthermore, Durant-Law (2005) proposes that the 
inclusion of a researcher’s experience enables them to situate ‘self’ within the 
study. It also makes visible the close relationship between the researched and 
the researcher. 
 
The term hermeneutics is the philosophy of understanding gained through 
‘interpretation’ and has been used in both ancient and modern times. 
(Dahlberg et al., 2008; Vandermause and Fleming, 2011).  Philosophers such 
as Heidegger, and especially Gadamer, viewed the historicity of existence 
including background, pre-understanding and co-constitution as central to 
being able to understand ‘being’ in the world. Within the hermeneutic circle 
where Gadamer describes how understanding takes place by considering the 
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‘parts’ of the phenomenon with the meaning of the whole’, the interpreter 
(researcher) brings their historicity into the interpretation. Furthermore, 
Gadamer also placed emphasis on culture and was interested in what culture 
brought to the situation. How it happened to be, for example. For all these 
reasons, therefore, it becomes important to situate the researcher (Gadamer, 
2004). 
 
3.2.1 Situating the Researcher 
I qualified as a Registered General Nurse in 1985 following training that 
involved learning whilst working in the ward environment. It was as a ward 
sister that my interest in breast care started when I observed that women 
would unsympathetically be told that they had breast cancer on a Friday 
afternoon in a dreary side ward, by a surgeon with limited communication skills 
and where maintaining confidentiality was a problem due to the unsuitable 
environment.  The women were then admitted on the Monday for a 
mastectomy (complete breast removal) with no psychological care or general 
information pre-surgery.  
 
At this time, the specialist nurse role in breast care was in its infancy and 
running a ward with sufficient nursing staff was a daily challenge.  
Furthermore, specialist nurses were seen as an expensive extra.  However, 
as a ward sister I had more autonomy to influence service delivery and 
consequently, I made the first effort to set up some ward based psychological 
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care for the patients with breast disease.  This involved listening to the women 
and supporting them and their family in a private room.  
 
In 1991, I became the first specialist nurse in breast care in a large teaching 
hospital in Wales. It was from here that I had the autonomy, authority and 
opportunity to introduce a service for women and their families with breast 
disease with support from a surgeon who had excellent communication skills 
and valued the specialist nurse role.  Much of the attention and care from a 
nursing point of view was directed at those with breast cancer both 
symptomatic7 and screen detected8 and little attention was given to those with 
a strong family history. This was mainly due to workload priorities and only one 
breast care nurse specialist in post. Furthermore, the Breast Cancer 
Susceptibility Gene (BRCA1/2) was not identified until 1994 and thus requests 
for risk-reducing surgery at that time was not possible and an uncommon 
practice.  
 
In Wales, since 1996 when the test became available and since NICE 
introduced family history guidelines, women with a positive BRCA mutation 
who elect to have RRM have been referred to a surgical breast care unit.  They 
are referred from a cancer genetic unit to discuss reconstruction options and 
undergo the surgery. The women are often positioned on a ward with women 
having surgery for breast cancer and although the women will have a 
                                            
7 Women presenting with breast cancer symptoms to a designated clinic. 
8 Women found to have breast cancer on routine mammography as part of the national screening programme. 
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consultation with a breast surgeon, they may not see a specialist nurse or have 
access to any pre-surgical support or information.  Psychological care is 
limited for those women with breast cancer and in many areas of practice, 
non-existent for women with the BRCA mutation. At the time of 
commencement of this study, there was only one known unit in the UK offering 
psychological assessment prior to surgery.  
 
From my experience as a Consultant Nurse working in breast care, I know that 
women elect to have their breasts removed following the detection of the 
BRCA gene mutation but I do not know what it is like to be given that result. 
Nor do I know how women make sense of it or how they are able to make the 
decisions that they do because of it.  Furthermore, I do not know what it is like 
living long term with the knowledge of carrying such as mutation, the effect on 
the family or importantly, the long-term effects of the experience, both 
psychological or physical following bilateral RRM surgery. It was my 
pre-understanding for example that the fear of breast cancer may be reduced, 
but at what expense?  However, neither I nor the team knew the answer to this 
and many more questions. 
 
All resources are allocated to women with breast cancer and until recently, it 
was a general assumption in clinical practice in many different areas of the 
country, that women at high risk or carrying the gene were not a priority 
because they do not have cancer. In addition, in the past in Wales, many of 
these women have had to fight for an opportunity to see a surgeon because 
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they have not been regarded as a priority. This has now changed with the 
National Institute of Care and Clinical Excellence (NICE) guidelines and the 
increase in testing. The guidelines clearly state that for those women with the 
BRCA1/2 gene mutation, risk-reducing surgery with immediate breast 
reconstruction should be discussed (NICE, 2013). Therefore, the number of 
referrals nationally have trebled in the last few years.  Colleagues welcomed 
the knowledge and understanding that would be gained from this study and 
the insight that would be generated in order to establish a service dedicated 
to BRCA positive women and their families.   
 
3.2.2 Situating the Others 
Without the individuals that took part in this study, making a further contribution 
to gaining knowledge would not have been possible. To ensure anonymity, the 
women in this study are referred to as probands, the partners as husbands 
and the family members as relatives. I resist the title of patients despite the 
fact that I came to know them in a clinical capacity because not all the 
participants were patients at a given time and the probands were only in the 
role of being a patient for a very short period. 
 
This study was therefore purposely conducted in order to explore the 
experiences of a different group of patients to those with breast cancer and 
those whom I felt were a forgotten, but important group. The inclusion of 
husbands and family members in addition to the women in the study is novel 
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and it was felt that to fully understand the experience for the woman with a 
BRCA1/2 mutation, it was necessary to position her in her social environment 
that engages with significant others. These others would inevitably be 
contributing to and affecting in some way the decisions made after the test and 
before subsequent surgery because I had witnessed this in clinical practice. 
They would also be living the experience and it was this experience that I 
wanted to capture, understand and learn from to meet their clinical needs. 
Many of the family members (including partners, parents, sisters and brothers) 
for example, also attended the clinic for the surgical consultation. Furthermore, 
little if anything is known about the effects of the whole process for the woman 
and her immediate family, including their past history, especially the 
consequences of RRM on the family. Thus, a gap in knowledge was identified. 
I imagined that the psychological effects were on a scale that matched the 
breast cancer patients, but I did not know if this was really the case. I felt 
privileged to be a caring, empathic nurse and to have access to their world 
and an opportunity to understand it. 
 
3.2.3 My Academic Role 
My role as a lecturer in adult nursing complements the desire of lifelong 
learning by conducting this study as part of my Ph.D.  The motivation to lead 
and improve clinical services for patients and to bridge the theory practice gap, 
I believed, would also benefit students. These include student nurses, medical 
students and inter-professional groups that I teach both pre and 
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post-registration. My interest in high risk women and those with the BRCA 
gene mutation has followed on from this lifelong learning and a desire to 
improve clinical services by attempting to understand real people who live in 
a world that has social, cultural and political connotations. It soon became 
apparent that as the main breast unit treating high risk and BRCA positive  
women and performing RRM much more frequently, that we knew very little 
about their experience.  
 
An opportunity to research this as a Ph.D. student came to me as part of the 
necessary ‘desirable’ criteria for appointment as a Consultant Nurse and 
ultimately wanting a career as a clinical academic, I seized the opportunity. I 
was also fortunate to apply and gain a ‘Florence Nightingale Research 
Scholarship’ three years in a row in order to conduct this study. 
 
As the researcher, therefore, I felt my knowledge, experience of the speciality, 
my involvement with the women and my counselling training, would add to 
rather than detract from the findings of the study. This belief was grounded in 
the fact that I, as a researcher, would be acknowledging throughout the study 
the factors that could influence the study and the constant reflection process 
would help to ensure the rigour of the study. Furthermore, reflexivity and the 
researcher’s use of self is central to hermeneutic phenomenology and 
Gadamerian philosophy (Greatrex-White, 2008).  
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3.2.4 The Research Question and Aim 
My research questions developed from clinical practice and from identifying 
the gaps in knowledge from the literature. My overall aim, therefore, is to 
explore, interpret and develop an understanding of the experiences of women 
and their families who elect for bilateral RRM after inheriting a BRCA mutation. 
My overall research question is 'What are the experiences of living with the 
BRCA gene mutation and electing bilateral risk-reducing mastectomy for the 
women, partners and family?’. 
 
I attempt to contribute to the body of knowledge and find a new fused horizon 
of understanding by exploring the whole experience from diagnosis to surgery 
and beyond as lived and experienced by the women primarily, and family 
members. I also endeavour to contribute to the introduction of a minimum 
standard of care for BRCA positive women and their families that reflect the 
needs identified in my study and develop a service that meets the needs of 
the participants and their families. 
 
3.3 Hermeneutic Philosophy 
The philosophy of hermeneutics underpins interpretive phenomenological 
methodology which informs this study (Gadamer, 2004). This research is, 
therefore, an interpretive hermeneutic phenomenological study underpinned 
and guided by the philosophy of Gadamer, (2004). Interpretive 
phenomenology seeks to reveal and convey deep insight and understanding 
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of concealed meanings of everyday experiences (Annells, 1996; 
Vandermause and Fleming, 2011).  Its goal is to increase understanding of the 
multiple interpretations of the meaning of human experience (Crist and Tanner 
2003; van Manen., 2014) and can be used to challenge pre-understandings in 
order to understand experience differently. It is not used to prove or disprove 
the theory (Tapp, 2004; Cresswell, 2014). 
 
Moreover, Gadamer posited that the interpretivist approach does not seek to 
establish a concrete view of a phenomenon but seeks to enable the researcher 
to understand the phenomena in itself.  Thus, there is no such thing as 
absolute truth and no such method to human truths (van Manen, 2014).  For 
Gadamer (2004) hermeneutic phenomenology is about how people 
understand the world they live in and he proposes a hermeneutic circle of 
understanding that considers the ‘parts’ of a phenomenon and the relationship 
to the ‘whole’ of the phenomenon.  
 
The hermeneutic circle is the back and forth movement between partial 
understanding and the more complete whole. The ‘parts’ in this study, 
therefore, refer to my pre-understandings gleaned from experience and from 
the literature, the experiences of the women, the husbands and the family. The 
‘whole’ refers to the understanding that emerged from ‘being’ a woman with 
the BRCA mutation who elects to have RRM in the context of her family and 
the interpretation of all the texts. The ‘whole’ in this sense is the united 
experience for the woman and her family living with the BRCA mutation, 
  
120 
 
electing to have RRM and the fusion of horizons that contribute to the body of 
knowledge.  
 
Understanding is therefore at the heart of Gadamer’s philosophy where 
understanding and interpretation are intrinsically linked and occur as a 
consequence of ‘being in the world’ (Gadamer, 2004). Understanding is said 
to occur when the horizon of the researcher fuses with the horizon of the 
participants under study. A horizon is ‘the range of vision that includes 
everything that can be seen from a particular vantage point’ (Gadamer, 2004, 
pg. 301). Furthermore, the researchers’ preconceptions, biases and 
assumptions are clarified and they become an integral part of the study 
findings; (Whitehead, 2004; Koch, 2006). The findings of studies using an 
interpretive approach are consequently never neutral or value free and so this 
is made explicit right at the start.  
 
This hermeneutic study, therefore, does not intend to establish a truth about 
the phenomenon or create a theory about it, but to challenge and question pre-
understandings in order that new understandings and knowledge can emerge. 
In this way, practice and assumptions may be challenged to improve care for 
women and their families. Indeed, within Gadamer’s philosophy and ‘fusion of 
horizons’, there is a strong movement away from traditional research and its 
focus on method and methodology. His focus was on trying to build a new 
bridge back to the humanist tradition and the notion of culture, which he 
believed constitutes knowledge.  Gadamer (2004) believed that the 
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importance of culture was abandoned at the expense of the dominance of 
method (Grondin and Plant, 2014).  
 
3.3.1 The Philosophical Beliefs Guiding the Research 
When conducting a study using a qualitative design, it is crucial to position the 
researcher in terms of their beliefs within the study (Cresswell, 2014) and there 
are three philosophical areas that need explication which both Crotty (1998) 
and Durant Law (2005) highlight. These include the ontological (what exists, 
how things really are?) and epistemological (what is known and what is the 
relationship between the knower and what can be known?) considerations, the 
theoretical perspective and the methodological considerations (how do we find 
out?).  
 
3.3.2 Ontological Position 
When reflecting upon the influences on my Ph.D., I have been guided and 
influenced by philosophers such as Husserl, Heidegger, Merleau-Ponty but 
particularly by Gadamer (2004).  Authors such as Guba and Lincoln (1998), 
Annells (1996), Crotty (1998), Ritchie et al., (2013) and David and Sutton 
(2011) also helped in establishing my positioning and beliefs which is that 
multiple realities exist but that experiences can be shared. There can be 
commonalities between individuals, only those who experience the BRCA 
mutation result and the surgery can really know the reality and these realities 
will depend upon their experience, their social and cultural background and 
  
122 
 
their beliefs. The ontological position, therefore, sitting in a relativist 
perspective because relativism proposes that knowing can only be achieved 
by being (Gadamer, 2004).  Reassuringly, both Heidegger and Gadamer with 
their emphasis on hermeneutic philosophy took a relativist ontological 
approach by the explication of their notions of historicity and understanding 
(Annells, 1996). Guba and Lincoln’s (1998) view of relativism also contends 
that realities exist in multiple constructions and these mental constructions are 
socially based and depend on the person who holds them.  
 
Ontology is concerned with the nature of reality and knowing about the world 
in which we live (Ritchie et al., 2013).  It asks what kind of being is the human 
being (Denzin and Lincoln, 2011).  Some ontological questions inquire about 
how things really are? What is the real experience? What does it all mean? 
These questions were, therefore, a driving force in my research.  A number of 
the studies examining women with the BRCA mutation were mainly driven by 
an objectivist, realist perspective (Hopwood et al., 2000; Frost, 2000; van 
Oostrum et al., 2003; Metcalfe et al., 2004a; Metcalfe et al, 2004b; Geiger et 
al., 2007; Wasteson, 2011) where there is a belief that an external reality exists 
and this is independent of our own beliefs or of our understanding (Ritchie et 
al., 2013).  
 
This would assume that all women with the BRCA mutation have the same 
experience and that it could be objectively measured, I did not believe this to 
be the case. In addition, the research questions and aims in the 
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above-mentioned studies were very different to the aims and objective of this 
study. This may then account for the lack of true understanding about being 
BRCA positive and the experience of living with the mutation and electing 
RRM.  
 
At the opposite end of realism is the belief that reality is mind dependent and 
only knowable through socially constructed meanings, known also as 
relativism (Ritchie et al., 2013). By keeping a reflective diary and following 
many discussions and much debate with my supervisors, I was able to identify 
and clarify my own ontological and epistemological standpoints. I, therefore, 
believe that this study is positioned in a relativist subjective ontology and that 
no external reality can exist outside of our beliefs or our understandings.  
 
It is a reality that women have the BRCA mutation and elect surgery, but the 
construction of the meaning and the experience of this, I believe, is different 
for each person.  However, I also propose that multiple realities exist, but there 
can be a shared understanding.  Furthermore, these realities can change over 
time and can be influenced by the social, cultural and individual past, present 
and future experiences. Gadamerian philosophy is therefore primarily 
ontological and focuses on being, as opposed to knowing (Annells, 1996; 
Gadamer, 2004). 
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3.3.3 Epistemological Position 
There are two main philosophical theoretical frameworks that underlie 
research methodology, these can be broadly divided into positivist and 
interpretivist paradigms (David and Sutton, 2011; Silverman, 2011). 
Epistemology is concerned with ways of knowing about the world we live in 
and about what contributes to that knowledge and its sources.  It also attempts 
to discover the relationship between the inquirer and the known (Denzin and 
Lincoln 2011; Ritchie et al., 2013). There was a need for me, the researcher, 
to understand the experiences of the participants and to learn from them and 
use this information to increase knowledge. There also existed a link between 
the subject and myself because of my role as a Consultant Nurse in breast 
disease, my clinical knowledge and my place as a woman in society.  I knew 
what the literature had identified as to why women removed their breasts and 
the issues surrounding body image, but I did not actually know what it was like 
to have breasts removed or make that decision.  Moreover, I did not know what 
body image and sexuality issues existed or why, nor did I know what it means 
to be a carrier, live with a carrier or what the whole experience entails.  
 
This study fitted most closely with an interpretivist, constructivist epistemology, 
totally removed from the objectivist / positivist perspective advocated by 
Husserl whose focus was more epistemological than ontological (Annells, 
1996; Vandermause and Fleming, 2011). The justification for a constructivist 
perspective developed for a number of reasons; there was a link between the 
researcher and the topic being researched, the belief that multiple realities 
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exist which are socially constructed and a belief that there could be a shared 
reality.  
 
Constructivism also recognises the uniqueness of experience (Crotty, 1998; 
Guba and Lincoln, 2005; David and Sutton, 2011; Ritchie et al., 2013) 
incorporating a relativist ontology. Studies conducted using hermeneutical 
phenomenology fall ontologically, epistemologically and methodologically into 
the constructivist paradigm (Guba and Lincoln, 2005; Ritchie et al., 2013). 
Constructivism focuses on understanding experience from those that live it 
and that knowing the reality is dependent on those experiencing it.  It proposes 
that knowledge is actively ‘constructed’ by humans rather than it being a 
passive role and constructivist researchers believe that in order to understand 
the experience, it must be interpreted (David and Sutton, 2011; Ritchie et al., 
2013). 
 
Both interpretivism and constructivism reject universal laws and value neutral 
observations and therefore sit at the opposite end of positivism (Guba and 
Lincoln, 1998; David and Sutton, 2011). The interpretivist view is grounded in 
philosophy and acknowledges the social world, which I believed, was crucial 
and pertinent in this study because of the social importance of breasts and the 
meaning of ‘being a woman’. In considering the theoretical perspective of this 
study, I, therefore, believed an interpretivist approach would be more 
appropriate in achieving the aims of the study. 
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3.4 Methodology and Theoretical Approach 
The methodology of any research involves a discussion about the way in which 
the research data were gathered (research methods) and the underlying 
theoretical approach that influenced the research (David and Sutton, 2011). 
This study is adopting a phenomenological approach, in particular, an 
interpretive hermeneutic approach, initially guided by Heidegger (2010) but 
more importantly, influenced and motivated by Gadamer (2004). There is, 
however, a need for clarification of the adopted philosophical stance because, 
without this, there is an absence of methodological clarity (Lowes and Prowse, 
2001).  
 
3.4.1 Phenomenology 
Phenomenology cannot be simplified to one research method (Crotty, 1996; 
Ratcher and Robinson, 2003; van Manen, 2014), which is often the reason for 
many of its criticisms. Nurse researchers, for example, have been criticised for 
misinterpreting and presenting the methods of phenomenology without full 
understanding (McNamara, 2005; Thomas, 2005). They have been accused 
of having ‘done a phenomenological study without knowing phenomenology’ 
(Porter, 1998 pg. 18). As a consequence, nurses have been advised and 
encouraged to explain the philosophical underpinnings of their research 
(Paley, 2005; Cooper and Endocott, 2007; Duncan et al., 2007). This lack of 
understanding may in part be due to the nature of phenomenology (Dowling, 
2007) and to the difficulties of interpreting the original texts, written in German, 
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by some of the most famous founders of phenomenology. Writers such as 
Husserl, Heidegger and Gadamer.  
 
Part of the confusion amongst researchers may also arise from the fact that 
phenomenology is seen both as a philosophy and as a methodology (Moran, 
2002; David and Sutton, 2011; Creswell, 2014). It is an umbrella term applied 
to research by many researchers who have a range of values, beliefs and 
assumptions and in many ways, it is not a clear defined rule based method or 
one recognised in the usual scientific sense (Finlay, 2012; van Manen, 2014). 
One only has to look at the different interpretations by writers such as Ricouer, 
1976; Gadamer, 2004; Georgi, 2006; Heidegger, 2010; van Manen, 2014; to 
understand this confusion. There is a big difference, for example, between 
phenomenology and hermeneutics (van Manen, 2014) yet the terms are often 
used interchangeably within the literature, without adequate explanation.  
 
Phenomenology is the science of phenomena and involves the human world, 
it can be described as a philosophical method for questioning and 
understanding rather than drawing concrete conclusions (van Manen, 2014). 
Finlay (2012) reminds us that the main concern for most phenomenological 
researchers is the embodied, experiential meanings and they generally agree 
that understanding the rich descriptions of a phenomena as lived by 
participants, is one of the main aims of phenomenological research. The 
debates around phenomenology, however, involve how best to conduct the 
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research because some approaches emphasise description, whereas others, 
emphasise interpretation (Finlay, 2012).  
 
Hermeneutics is a branch of philosophy concerned with the study of the 
interpretation of human behaviour, the structures of society and how they 
function within society, including the exposure of hidden meanings (Byrne, 
2001). Many nursing researchers have utilised hermeneutics to study 
phenomena (Byrne, 2001; Spence, 2001; Dowling, 2004; Spence, 2005; 
Dahlberg et al., 2008). Rather than attempting to generate new theory, 
hermeneutics strives to create new possibilities and to understand things 
differently by being open to the phenomenon, constantly questioning 
(Gadamer, 2004; Tapp, 2004).  
 
Phenomenology has its roots in both psychology and philosophy and the key 
terms many researchers will be familiar with include essence, experience, 
understanding and meaning (Moran and Mooney, 2002; Speziale and 
Carpenter, 2007). Hermeneutic scholars are also interested in the lived 
experience but address the interpretation of ‘meaning’ and ‘being’ rather than 
focusing purely on descriptive experience. Furthermore, hermeneutic scholars 
reject Cartesian dualism of the split between subject/object or mind/body 
which is important in the context of this study. Finlay (2012) suggests that there 
are five iterative processes that are helpful in uniting the divergent 
methodologies and these are; embracing the phenomenological attitude, 
entering the life-world, dwelling with horizons of implicit meanings, explicating 
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the phenomenon holistically and dialectically and integrating frames of 
reference.   
 
When first embarking on my research, I described it as a phenomenological 
study, naively not realising or understanding that there are as many 
phenomenological philosophies as there are phenomenologists (Caelli, 2000; 
Creswell, 2014). Indeed, eighteen different forms of phenomenology have 
been identified (Caelli, 2000). This is important because as mentioned earlier, 
what we understand to be reality (ontology) drives the epistemology (how we 
know what we know about the world) and the methodology (how we go about 
obtaining it). Furthermore, with the many perspectives offered, 
epistemologically, phenomenology can be located in the positivist (Husserl), 
post-positivist (Merleau-Ponty), interpretivist (Heidegger) and constructivist 
(Gadamer) paradigms (Racher and Robinson, 2003). Thus, there has also 
been a lack of explanation and therefore criticism, in many phenomenological 
studies as to where these assumptions fit in with the beliefs of the researcher 
(Paley, 2005; Thomas, 2005). The researcher has to account, during all stages 
of the research, for their underlying assumptions and ensure that their 
methods fit with these assumptions.  
 
3.4.2 Interpretive Phenomenology 
Primarily this study set out to explore, but importantly understand, the 
phenomenon of living with the BRCA gene and the experience of electing RRM 
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for women and their family. For this reason, a phenomenological approach 
seemed the obvious choice. I had no theory to prove, no laws or scientific rules 
to adhere to and nothing to measure. As van Manen points out: 
‘Phenomenology is primarily a philosophic method for 
questioning, not a method of drawing determinate 
conclusions. But in this questioning there exists the 
possibilities and potentialities for experiencing openings, 
understandings  and insights giving us glances of the meaning 
of phenomena’ (van Manen, 2014 pg. 29). 
 
I had to decide however whether the study would be descriptive or interpretive. 
The main aim of this study is to understand the experience and interpret 
meaning, so a purely descriptive approach I believed, would not completely 
help achieve my aims or do justice to the phenomenon. It would not provide a 
deeper understanding of the phenomenon nor would it identify the cultural and 
historical interpretations of the world. I felt an interpretive approach was more 
appropriate (Silverman, 2011; van Manen, 2014). Indeed, there is a debate 
about whether or not it is at all possible to describe a phenomenon, without 
interpretation (Pringle et al., 2011).  
 
Heidegger, went one step further in his explication of phenomenology which 
demonstrated the emphasis on interpretation and the belief that it was more 
than ‘to the things themselves’. Phenomenology is an inquiry that involves a 
dynamic play of showing and hiding. Thus, to Heidegger, phenomenology 
meant: 
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‘To let what shows itself be seen from itself, just as it shows 
itself from itself. That is the formal meaning of the type of 
research that calls itself ‘Phenomonology’. But this expresses 
nothing other than the maxim formulated above. To the things 
themselves’ (Heidegger, 2010 pg. 32). 
 
He proposed that the ‘let show itself’ was something that was hidden and 
concealed but belonged to the lived experience and to the ‘what shows itself’. 
In other words, its true meaning and ground that needed to be uncovered (van 
Manen, 2014). 
 
The aim of phenomenology, therefore, is to capture the richness of a 
phenomenon as it presents to the person who experiences it without any prior 
scientific hypothesis. It is a meaning-giving form of inquiry and a way of 
accessing the world as we experience it. It can be seen as a philosophical 
method for questioning in order to gain understanding (van Manen, 2014). 
However, Crotty (1998) emphasises that phenomenology ‘seeing’ is not easy. 
The researcher has to select purposively people who are equal and who are 
co-researchers, genuinely wanting to inquire into their own experience of the 
phenomenon in order to elucidate the essential elements (McNamara, 2005).  
 
Again, I did not feel that this could be done without interpretation because to 
describe the experiences of living with the BRCA mutation would not be 
challenging the taken for granted assumptions or understandings of the 
participants. The main schools of phenomenology that have often influenced 
and been utilised by nurse researchers are Husserlian, Heideggerian and 
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Gadamerian phenomenology. All three schools of philosophy in some context 
influenced this study but Gadamer was most influential and will now be 
explicated. 
 
3.4.3 The Work of Hans-George Gadamer (1900 - 2002) 
Although both Husserl and particularly Heidegger influenced my research 
approach, Gadamer (2004) and his work offered the missing piece and gave 
me the overall inspiration that provided the main lens to guide my research. It 
allowed me to both interpret and clarify the experiences. As Dahlberg explains: 
 
‘Hermeneutics is the philosophy of understanding gained 
through interpretation to explain something and to clarify it’ 
(Dahlberg et al., 2008, pg. 66).  
 
Through hermeneutics, beliefs, values and commitments become known. 
Understanding is achieved when the researchers’ horizon fuses with the entity 
or person under study (Gadamer, 2004). Thus, in considering the women and 
the family in this study, in addition to Heidegger, Gadamer’s (2004) philosophy 
fitted more closely with my aim and my personal philosophical beliefs. My aim 
attempted to gain a deeper understanding of how participants and their 
families made sense of a BRCA mutation. How for example did they come to 
the decision of surgery and electing to lose their breasts, what was it like living 
after the surgery in a world where meanings of risk, identity, femininity and 
embodiment are already laid down and experienced. This approach was 
adopted because an interpretive approach would look for ‘culturally derived 
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and historically situated interpretations’ of the world (Crotty, 1998 pg. 67) in 
addition to how life has been socially constructed (Miles, et al., 2013) and 
these were deemed important in this study.  
 
In addition, on reading further into Gadamerian philosophy, Caelli (2000) 
reveals that Heidegger was very critical of the role that culture and tradition 
has on understanding a phenomenon and did not initiate exploration of the 
cultural meanings for individuals. Heidegger seeks out the event that enables 
being, but Gadamer searches for the fusion of horizons between the past and 
the present. As my study involved culture and tradition, especially the culture 
and tradition of being a woman, I felt that Heidegger’s beliefs did not 
completely satisfy me. I also believed that the participants’ past experiences 
had influenced their present ‘being’ especially the decision to remove their 
breasts. Furthermore, as the women and family in my study are socially and 
historically conditioned, where breasts and illness have particular importance 
in a given culture, a hermeneutic study allowed me as a researcher to try and 
understand how the individuals interpret their world in a given context.  
 
Thus, Gadamer’s work inspired my thinking and bridged that gap. Moreover, 
hermeneutic understanding attempts to transport the horizon of the past to the 
horizon of the present (Crotty, 1998).  For Gadamer, the horizon of the present 
cannot emerge without knowledge of the past. Alongside the researcher, 
Gadamerian hermeneutics consists of dialogue as opposed to individual 
phenomenology, where interpretation uncovers every activity including the 
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social, cultural and gender implications. I believed this to be very important in 
my study (Koch, 1999; Gadamer, 2004).  
 
Gadamer and his work is now referred to as philosophical hermeneutics which 
expanded on the work done before him by Husserl and Heidegger and which 
was the focus of his magnum opus, Truth and Method (1960, 2004). Human 
beings according to Bryne (2001) experience the world through language and 
through language we gain both understanding and knowledge. These two 
assumptions form the basis of hermeneutics. Taking a step further, Gadamer 
regarded both conversation and the oral tradition as pre-suppositions for 
understanding written texts and believed that we are conversational beings 
where language is the reality (Gadamer, 2004).  He believed that only through 
language and openness to the experiences of others, can understanding be 
achieved (Vandermause and Fleming, 2011).  
 
3.4.4 Philosophical Hermeneutics 
Philosophical hermeneutics considers how an individual, who is socially and 
historically conditioned, interprets their world in a given context and so I 
believed this fitted more accurately with the aim, philosophy and my 
participants. According to Gadamer, human beings are self-interpreting 
historical creatures who through tradition and historical life, find a means of 
understanding (David and Sutton, 2011). 
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Hermeneutics, advanced by Gadamer, involves two important elements, 
pre-judgement which is a person’s pre-understandings or prejudices that make 
understanding possible and universality. According to Gadamer, it is an 
advantage not to be freed from prejudices or pre-understandings and he 
argued that the past, including all its traditions, must not be ignored because 
it is these prejudices, that makes understanding possible. Furthermore, if 
prejudices are not recognised, there is a possibility that one could fail to 
understand meaning (Fleming et al., 2003). As Gadamer explains: 
‘A person who believes he is free of prejudices, relying on the 
objectivity of his procedures and denying that he is himself 
conditioned by historical circumstances, experiences the 
power of the prejudices that unconsciously dominate him’ 
(Gadamer, 2004. pg. 354). 
 
Universality acknowledges the fact that the person who expresses and the 
person who listens is connected by a common consciousness, making 
understanding possible (Gadamer, 2004). Philosophical hermeneutics, 
therefore, made it possible to aid the process of understanding the 
experiences of the women, the husbands and the family because there was 
an existing link and bond between myself as a researcher and the 
phenomenon being interpreted. The bond as referred to by Gadamer (2004) 
is the relationship that must exist between the researcher who reads the text 
and the text itself, which details the phenomenon. The text must have 
relevance and meaning for the researcher, including the historicity of the 
research subjects.  
 
  
136 
 
I felt this historicity was very important, not least because of the women’s past 
history of losing close family members to breast cancer. There existed a strong 
bond between myself and the participants. This involved my role as a nurse 
but also as a woman living in the same world. Through interpretation using 
Gadamerian hermeneutics, the researcher is able to consider the social, 
cultural and gender implications by permeating every activity (Crist and 
Tanner, 2003; Koch, 2006).  
 
The hermeneutic circle of understanding is a circular movement of 
understanding and interpretation whereby knowledge is developed (Koch, 
1999; Gadamer, 2004). In this way, researchers approach a topic with 
preconceptions, these are then re-examined in light of ‘what the things 
themselves’ reveal to us (Gadamer, 2004, pg. 267). With this new 
understanding, we then return to a further exploration. The topic is understood 
by viewing the ‘whole in terms of the detail and the detail in terms of the whole’ 
(Gadamer, 2004, pg. 291).  
 
The hermeneutic circle was therefore utilised in this study to aid analysis and 
understanding. The hermeneutic circle is not to be reduced to the level of a 
vicious circle but viewed as a positive circle (Gadamer, 2004). The 
hermeneutic circle is the back and forth movement between partial 
understanding and the more complete whole. Gadamer’s notion of the circle 
includes pre-understanding, historicity, the linguistics of understanding and the 
fusion of horizons (Annells, 1996; Gadamer, 2004).  
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In following Gadamerian philosophy, therefore, it is important for researchers 
to demonstrate a research process that reflects the underpinning philosophy 
despite there being no prescribed, fixed method or methodological structure 
(Gadamer, 2004). In fact, Gadamer pointed out that there are no methods to 
human truth and that as soon as we start to employ a method to experience, 
we turn it into an object where the truth of the lived experience will be difficult 
to reach (van Manen, 2014). However, to reach understanding, Gadamer 
(2004) did believe that there was a need for some direction from a systematic 
approach and so Fleming et al., (2003) offered this direction and many 
researchers have utilised Gadamerian philosophy and principles using 
different systematic approaches (Annells, 1996; Crist and Tanner,2003; Tapp, 
2004; Howlin, 2008; Grassley and Nelms, 2008). 
 
3.5 Methods  
3.5.1 A Qualitative Approach 
Depending on the question, David and Sutton (2011) and Silverman (2011) 
explains that any method chosen for a study should be the most appropriate 
for answering the question. Both quantitative and qualitative methods can, 
therefore, be viewed as merely tools that solve research problems. In current 
health care, there is now much more of an emphasis on acknowledging the 
experiences of patients and their families (Department of Health, 2010) 
lending itself more to a qualitative paradigm. Furthermore, because historically 
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much of the current literature on BRCA women, and indeed on healthcare 
research generally, has focused on quantitative designs and measurement, I 
wanted to capture the deeper meaning of experience. 
 
It is also my belief that when studying experience, one cannot separate the 
multiple influences that have contributed to that reality, such as personal 
values, culture and social interaction. To answer the research question, 
therefore, I believed the most appropriate approach would be a qualitative one 
as I attempted to understand ‘meanings’ rather than make causal connections 
within the data, test hypothesis or generate figures (Ashworth, 2008; 
Silverman, 2011; Ritchie et al., 2014). Although accepting that both a 
qualitative and quantitative approach offer value in increasing knowledge, I did 
not and do not believe that to reduce the experiences of the women and 
families into a quantifiable analysis would be doing justice in providing a deep 
understanding of their experience. Knowledge in this sense can be derived 
through context specific understandings and therefore fitted well with the use 
of a qualitative method (Denzin, 2009; David and Sutton, 2011). 
 
Polkinghorne (2006, pg. 73) offers a definition of qualitative research: 
‘Qualitative study is an activity whose intended goal is the 
production and communication of an insightful and disclosing 
understanding of human phenomenon. Qualitative 
researchers engage in those activities that they believe will 
bring about the accomplishment of this goal as it relates to the 
particular phenomenon they are studying’. 
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Furthermore, qualitative researchers stress the socially constructed nature of 
reality and the intimate relationship between the researcher and what is being 
studied (Denzin and Lincoln, 2011). As Mason (2002) stresses, the qualitative 
approach is suitable when the phenomenon being studied is a social process 
or has social meaning. In addition, the researcher uses themselves as the 
research instrument as a means of gaining a deeper understanding of the 
phenomenon (Fleming et al., 2003). 
 
Taking a positivist view would assume that a reality about the experiences of 
the participants in my study already existed and could be generalised (Guba 
and Lincoln, 1998; Crotty, 1998; Denzin and Lincoln, 2011) and that value free 
research is possible (Ritchie et al., 2013). The researcher, in this case, would 
be seen as independent of the phenomenon of study and would have no 
influence over the research and the findings. This was impractical and did not 
fit with my philosophical beliefs. There was nothing to test, no laws that I 
needed to identify nor any known fixed reality about the experiences. 
Furthermore, a positivist approach would assume a theory of truth about the 
experiences that already existed.  
 
3.5.2 In-Depth Interviews  
Interviews conducted within a qualitative paradigm aim to add to the body of 
knowledge from the meanings gained from participants (DiCicco-Bloom and 
Crabtree, 2006; David and Sutton, 2011) and in qualitative research, the 
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interview is the most frequent data collection approach utilised (Sandelowski, 
2002; Nunkoosing, 2005; Silverman, 2011). For Gadamer (2004), some 
flexibility is required when applying methods that suit the phenomena under 
study and he favoured the spoken word in the interview as opposed to written 
texts thus allowing a two-way conversation and a deeper understanding.  
 
The aim of this study set out to understand the whole experience for the BRCA 
woman and her family and to consider how this experience may change over 
time. Therefore, in justifying my decision-making across the research process 
and being strongly influenced by Gadamer (2004), I felt interviews would allow 
this conversation leading to the generation of written texts from transcribing 
the interview data. Compatible with hermeneutic philosophy, interviews can be 
unstructured or semi structured (Cohen et al., 2000). 
 
3.5.3 Design 
In order to obtain full understanding of the particular historic situation in line 
with Gadamer (2004), speaking to participants on more than one occasion is 
recommended. Thus, the design used in-depth semi-structured, prospective 
interviews. There were at least three interviews with each proband as 
advocated by Seidman (1991) and they were conducted pre-surgery and 
again at six and twelve months following surgery. A final interview was 
conducted at eighteen months with four of the probands. The husbands were 
interviewed pre-surgery and again at twelve months and the relatives were 
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interviewed on one occasion pre-surgery due to time constraints. In total 
forty-three interviews were conducted and transcribed.  
 
All interviews took place either in the clinical area in a quiet private room or in 
their own homes. Interviews lasted between forty-five and sixty minutes and a 
digital recorder was used. All interviews were transcribed and analysed. 
Initially, I transcribed the interviews to familiarise myself with the data and then 
because of my time constraints, used my funding to employ a senior member 
of the faculty to transcribe the remaining interviews. 
 
3.5.4 The Interview Approach: Hermeneutic Interviews 
Within hermeneutic interviews, the goal of the researcher is to co-create the 
findings with the participants through an engaged genuine conversation so 
that a fusion of ideas emerge (Binding and Tapp, 2008). In keeping with 
Gadamer’s philosophy, a dialogic interaction takes place and a text develops. 
It is through this dialectic of questions and answers and the genuine open 
conversation which results, that Gadamer believed a topic could be more fully 
understood. Being present to and guided by the text and open to where the 
text takes you, is one of the goals in hermeneutic dialogue (Gadamer, 2004). 
The interview in this sense becomes reciprocal, dynamic and historical where 
a stance of openness to the meanings offered, is demonstrated (Crist and 
Tanner, 2003). Hermeneutic interviewing has been described as a unique, 
interactive, reflexive activity that is concerned with interpreting and describing 
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rich, ever day lived experience in order to achieve understanding (Walker, 
2011). 
 
The prospective nature of this study can therefore be seen as a strength. In a 
prospective study design, I could follow up on questions from previous 
interviews which are in keeping with Gadamer’s assumption that 
understanding relies on the particular historic situation (Seidman 1991; 
Gadamer, 2004). My reading of some of the early sociological theories 
(Dingwall, 1997; Gubrium and Holstein, 1997) about how the interview can 
increase understanding of the social world through language and social 
interaction, also influenced my decision to interview. The beliefs of such writers 
reflect my own in the sense that the researcher in a qualitative interview is very 
much part of the research process, viewed as a co-participant. Data is 
co-created by the researcher and the participant because language 
construction is a two way process, especially when the researcher is 
knowledgeable of the phenomena under study.  
 
Gadamer (2004) emphasised that to understand the person is to understand 
the subject matter, not to relive the experience. He reminds us that the purpose 
of the hermeneutic interview is not to replicate the experience but to create a 
new understanding of the phenomenon by both researcher and interviewee 
becoming immersed in the subject (Fleming et al., 2003). Streubert (2002) and 
Brinkmann and Kvale (2011) further purport that at an emotional and cognitive 
level, positive feelings of respect and curiosity in a reciprocal process between 
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interviewer and interviewee can lead to a deeper understanding of the topic, 
thereby generating rich data for analysis.  
 
Interviewing, therefore, has been a well-known feature of phenomenological 
research and philosophical hermeneutic interviewing in qualitative research is 
now becoming extremely popular in health care (Baillie, 1996; Vandermause 
and Fleming, 2011; Walker 2011). The qualitative interview according to 
Ritchie and Lewis (2003) requires the interviewer to have a clear logical mind, 
an ability to listen, a good memory, curiosity and an ability to establish a good 
rapport and be able to demonstrate empathy. The same elements which are 
required in a competent counsellor. Empathy is particularly relevant because 
the interviewer has access to the world of the interviewee and has the ability 
to check or clarify understanding with the individual. Kvale (1996) also 
suggested that in order to show empathy, the interviewer makes use of the 
‘self’ and becomes a research instrument.  
 
Although there has to be boundaries, there has to be a transparency of ‘self’ 
in order to allow such engagement. In addition, the values, background, prior 
knowledge and pre-understandings of the topic area regarding the researcher 
are believed to be connected to the research by influencing the responses to 
the participants as well as the generation and analysis of the rich data 
(Ashworth, 2008; Creswell, 2014). The outcome of the research is therefore 
influenced by both participant and researcher. As Ashworth points out:  
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‘There is no escape at all from the fact that the research 
interaction is a genuine human encounter and that nothing 
can be done to stop the behaviour of the researcher being 
meaningfully communicated’. (Ashworth, 1987, pg. 18) 
 
3.5.5 Reflexivity and my Role in the Interview 
Researcher ‘self-awareness’ or reflexivity is crucial in qualitative research and 
an essential element of Gadamer’s philosophy (Gadamer, 2004; Binding and 
Tapp, 2008; David and Sutton, 2011). It ensures rigour, credibility and 
trustworthiness (De Witt and Ploeg, 2006). This requires the constant 
reflection of beliefs, assumptions and prior knowledge and an insight into how 
these can affect the research (David and Sutton, 2011; Ritchie et al., 2013). 
Brinkmann and Kvale (2015) contend that acknowledging a subjective 
perspective can actually improve the findings by constructing multiple 
perspectives. Moreover, according to Byrne (2001), the experience of the 
researcher in hermeneutic studies should not be viewed negatively, it should 
be seen as a way of providing some context for the study. Ashworth (2008) 
further contends that the interviewer in qualitative research needs to be able 
to understand the talk and not be a passive recorder.  
 
That said, it would be naive and unrealistic to imply that I could remain totally 
impartial from the participants and the phenomena that I was studying. An 
important element of any study is for the researcher to remain reflexive 
throughout the whole study and this I have endeavoured to do by keeping a 
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diary of my thoughts and actions, continually questioning my decisions and 
findings and discussing the issues at supervision.  
 
3.5.6 The Relationship Between the Researcher, The Study and The 
Participants - My Clinical Role 
A key epistemological question in qualitative research concerns the 
relationship between the researcher and the researched and the influence that 
this could have on the values and the findings. On one side, there is an 
argument that the researcher can remain objective and value free. The other 
argument is that in the social world participants are not only affected by being 
studied but that the researcher cannot remain neutral and it is an interactive 
process. Value free objective research is seen as almost impossible (Ritchie 
et al., 2013).  
 
The women in this study had already decided upon having breast surgery 
following their BRCA mutation result in the cancer genetics clinic. The purpose 
of the initial breast clinic appointment was to meet their surgeon and to discuss 
surgery. This included the opportunity to see photographs of reconstruction 
and discuss surgery with the consultant nurse (researcher). Family members 
also accompany the women to the clinic.  
 
Following a referral from the cancer genetics service to the surgeon, as part 
of my role as a Consultant Nurse, I would have met the women in my study 
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approximately two to five months prior to the research interview. I therefore 
believed that a relationship had already been formed. My perception was that 
this would be an advantage. The advantages would be two-fold. For the 
participant, I believed that they would feel at ease talking to me because they 
had already met me and from a clinical perspective, I understood their BRCA 
result, having knowledge of the subject. They had volunteered to be part of my 
study, which indicated that they were interested in talking to me. Secondly, it 
would be an opportunity for the participants to contribute to and influence the 
care and service for future women and their families. For the researcher, the 
findings would be contributing to knowledge and lead to the possibility of a 
novel service. I, therefore, perceived that my relationship with them both as a 
nurse and a researcher would add value to the relationship.  
 
3.5.7 Advantages of a Dual Role 
Leslie and McAllister (2002) and Fontana and Frey (2000) emphasise the 
benefits of dual professional roles. In this case, nurse and researcher. They 
state that nurses should reclaim their ‘nursedness’ and that the benefits of this 
would allow the participants to talk about social taboos because of the intimacy 
and immediacy developed within the relationship, thus allowing such 
disclosure but always being mindful of confidentiality and doing no harm 
(Nursing and Midwifery Council, 2009). Moreover, as a trained counsellor, in 
addition to my nurse training, I believed this was advantageous in being able 
to deal with any intimate conversations confidently and effectively. 
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Furthermore, Leslie and McAllister (2002) claim that to listen empathically, 
reflect, gently probe and successfully clarify (which are all components of a 
counselling interview) can enhance, rather than hinder the research interview. 
For me, as the researcher, I anticipated and hoped that the women and the 
men in my study would want to talk about the intimate aspects of losing the 
breasts and therefore I would be able to draw upon my ‘nursedness’ and my 
counselling skills if necessary. This would also be calling upon the social, 
cultural and historical pre-understandings of both the researcher and 
participants that Gadamer so often refers to, by opening up the conversation 
in order to fully understand the topic (Binding and Tapp, 2008). That said, I did 
not know what they would actually feel or disclose to me, but I felt prepared 
for any sensitive issues that may arise.  
 
In line with Gadamer’s philosophy (2004) I, therefore, remained reflexive 
throughout the study as I did not want the interviews to become a clinical 
interview or a counselling session and I was conscious of this before I started. 
I reflected on my own pre-understandings before the interviews began, in 
addition to the pre-understandings that were generated from the review of the 
literature. I was then able to be ‘open to learn’ from the participants in my study 
(Gadamer, 2004).  
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3.5.8 Planning  
Before the interviews began, I had a few questions and a loose interview guide 
in order to meet the aims of my research. I did not want the interviews to follow 
a directive rigid format (Dahlberg et al., 2008) nor did I want to be influenced 
by what the literature had revealed as I felt this would bring assumptions into 
my approach and the interviews (Norlyk and Harder, 2010). To address this, 
as recommended by Fleming et al., (2003), I engaged with various colleagues 
at work in order to provoke my pre-understandings and my beliefs. I started 
the initial interviews with an open question. ‘Tell me about your experience of 
the BRCA gene’. Subsequent interviews involved open questions such as ‘Tell 
me about your experience of having surgery’ and ‘would you like to tell me 
about your experience so far’. I was able to listen tentatively and follow up on 
points over the course of the interviews.  
 
Through an engaged conversation, a text began to emerge and a fusion of 
ideas began to take place (Crist and Tanner, 2003). Although Brinkmann and 
Kvale (2015) argue that an interview will not slip into therapy because research 
interviewers have neither the time nor the training, I tend to disagree. Firstly, I 
do have the training and secondly, as a novice researcher, I could have 
allowed the interview to develop into a counselling session. However, 
conscious of this, I approached the interviews with the understanding that the 
aim of the research interview was very different to that of a therapeutic or 
clinical interview. This resulted from my ability to be reflexive throughout my 
decision-making and throughout this study.  
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I believe that the aim of a therapeutic interview is to bring about some form of 
‘healing’ in a psychological way and that the person is being ‘helped’, with the 
helper being the interviewer. In a research interview, however, the roles are 
reversed. The participant is the helper with the potential to increase 
knowledge, not just for the interviewer or the interviewee but also for the 
academic and the professional clinical community (Bulpitt and Martin, 2010).  
 
3.5.9 The Potential Power Imbalance in the Interview 
Due to the nature of the study, I anticipated that the participants may become 
upset talking to me about the sensitive subject but I was prepared for any 
emotion as this type of reaction is experienced in clinical practice on a regular 
basis. I was also mindful that there was further support (referral for 
counselling) that I could offer participants if necessary. More importantly, I was 
also aware that there could potentially be a power imbalance in the interview 
due to my role as a Consultant Nurse. In response, I began by explaining the 
difference in my role as a researcher and my role as a nurse and allowing the 
participants to dictate where the interviews took place and on which day and 
time; they were therefore in control. The fact that the participants had been 
approached by the research nurse and had voluntarily contacted her to agree 
to the study, further ensured that they remained in control and were not 
influenced to take part. 
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3.6 Setting, Sampling, Recruitment and Participants 
3.6.1 The Setting  
The study was based within a UK National Health Service (NHS) university 
trust in a purpose-built breast centre. Each year four thousand symptomatic 
patients are referred with breast problems. Approximately four hundred and 
fifty breast cancers are diagnosed a year. It is the main referral site for BRCA 
women and their family who elect to have surgery and there are now 
approximately one hundred patients referred per year with the BRCA mutation. 
 
3.6.2 Sampling  
In phenomenological studies, in particular, Norlyk and Harder (2010) highlight 
the wide variation in how sampling is applied. It appears that little agreement 
exists in the literature on exactly what sampling should be (Curtis et al., 2000) 
and as a result, sampling in qualitative research has become a complex issue. 
There were a number of useful texts to draw upon when considering the 
sample in this study (Mason, 2002; Silverman, 2005, 2011; Holloway and 
Wheeler, 2010; Bryman, 2012).  
 
The sample was purposive, as in many qualitative studies where the aim is 
criteria-based or to serve a purpose (Bryman, 2012). With this in mind, the 
sample were approached because they had particular characteristics, the 
BRCA mutation, which allows the deep exploration and understanding of a 
given subject (electing to have RRM). This will enable answers to be given to 
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the researcher’s questions (what is the experience of being and living with a 
mutation carrier and undergoing RRM).  Furthermore, as Dahlberg et al., 
(2008) point out, there has to be sufficient exposure to those experiencing a 
phenomenon in order to fully understand and thus husbands and family 
members were also included. The husbands and family members were 
included in addition to the women because the literature had identified a gap 
in knowledge of their experience especially their experiences of RRM. The 
knowledge gained of their experiences would help practitioner’s both 
understand and address their clinical needs, thus also help the women.  
 
3.6.3 Sampling Decisions 
As part of the decision-making process, case studies of the families was also 
a consideration. However, due to Wales being a small geographical area and 
with a prime obligation of maintaining confidentiality (thus preventing families 
with the BRCA mutation from being identified), I decided against case studies.  
In addition, I wanted to look at the experiences of the women primarily, in the 
context of their family and case studies would have focussed more on the 
family, taking the emphasis away from the experience of the women 
undergoing RRM. I decided to look at their experience as three separate 
groups. 
 
Unlike quantitative research where sampling is based on having adequate 
representation and numbers in order to be able to generalise the findings, 
  
152 
 
reduce bias or produce statistically significant findings (Silverman, 2011), 
generalisability in qualitative research is not the objective. It is therefore 
important when assessing or judging a sample in qualitative research that the 
appropriate criteria are applied (Ritchie et al., 2014). If the purpose of a 
qualitative study is to explore an experience,Brinkmann and Kvale (2015) point 
out that just one participant is enough.  
 
Prior to the study in 2011, approximately eight women with the BRCA gene 
mutation were referred yearly from the Cancer Genetics Department.  Due to 
low available numbers referred each year, it was felt that a sample size of eight 
would be appropriate given that this number was the yearly local referral rate 
and that my approach was to gain in depth understandings of their 
experiences.  Again, due to the limits of the Ph.D., the low numbers of potential 
families and following discussion with supervisors, five partners, and five 
relatives were deemed sufficient to get a glimpse of their experiences. The 
prospective nature of the study was felt to be a major strength of this approach, 
however, it was impossible due to constraints of the Ph.D., to interview all 
participants up to the eighteen-month time interval.  It was also felt that this 
may be asking too much commitment from the family.  It was therefore decided 
to interview the women at three-time points in order to gain an understanding 
of the long term effects of surgery, the partner’s pre and post- surgery and the 
relatives just once. The limits of the Ph.D. and the amount of data that would 
be generated was a major factor in the decision process and one of the 
reasons why only a sub sample of four women (the first four who came 
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forward) were interviewed at eighteen months.  The goal was to gain an in-
depth understanding of the experiences with a further plan of post-doctoral 
work to develop the findings. The eligibility criteria outlined in Figure One were 
set for the study. 
 
Figure One: Inclusion Criteria Probands Family 
 Positive genetic test result for BRCA1/2.  X 
 
 Undergoing Bilateral Mastectomy. X  
 Physically and mentally able to give 
informed consent. 
X X 
 Eighteen years of age or over. X X 
 Able to communicate.  X X 
 Willing to give informed consent. X X 
 Able to communicate in English. X X 
 Be a family member of the proband  X 
 
3.6.4 Recruitment 
Following diagnosis of the BRCA mutation and after the appointment with the 
surgeon and consultant nurse, women were approached by the research 
nurse and provided with a study information sheet. After reading about the 
study, they could telephone the research nurse who would then inform the 
researcher of the participants. The participants were then contacted by the 
researcher to discuss the study further and to agree a time and place to 
conduct the interview. A consent form was signed once any questions about 
the study had been answered and the participants were satisfied. Permission 
was then sought from the women so that their husbands and family could be 
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approached to participate in the study. When family members contacted the 
research nurse to take part in the study, the researcher was contacted and the 
family were seen after agreeing on a suitable time and a convenient place to 
conduct the interview.  
 
3.6.5 The Study Participants 
The age of the probands in the sample ranged between the ages of twenty-
three and fifty-eight years and the time since mutation results ranged from six 
to twenty-four months (see Table One). No restriction for inclusion was put on 
the elapsed time since initial results to ensure a deeper understanding and to 
include a difference in time range.  
 
Table One – Probands’ Information 
Probands BRCA 
Status 
Time Since 
Mutation 
result  
Age Occupation 
Proband 1 BRCA2  2 Years 23 Years Skilled Manual 
Proband 2 BRCA1  2 Years 36 Years Clerical 
Proband 3 BRCA1  6 Months 34 Years Skilled 
Proband 4 BRCA2  1 Year 33 Years Professional 
Proband 5 BRCA2  18 Months 40 Years Unskilled 
Proband 6 BRCA2  6 Months 45 Years Unskilled 
Proband 7 BRCA2  18 Months 58 Years Unemployed 
Proband 8 BRCA1  6 Months 35 Years Professional 
 
Seven of the probands were undergoing immediate breast reconstruction and 
six of these had an implant-based reconstruction. One proband had an implant 
and strattice (pig’s skin) reconstruction and she also preserved her NAC. One 
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proband underwent a delayed implant reconstruction twelve months after her 
initial mastectomy.  Four surgeons were involved in performing the surgery.  
 
The husbands’ ages ranged from between twenty-four years and forty-four 
years. The relatives’ ages ranged from between thirty-eight years and 
sixty-five years and included one mother, two fathers, one sister and one 
brother. The details of the sample can be seen in Tables Two and Three. 
 
Table Two – Husbands’ Information 
Husbands Age Occupation 
Husband 1 24 Years Skilled Manual  
Husband 2 37 Years Professional 
Husband 3 36 Years Professional 
Husband 4 35 Years Professional 
Husband 5 44 Years Skilled Manual 
 
Table Three – Relatives’ Information 
Relatives Relation to 
Proband 
Age Occupation 
Relative 1 Father 60 Years Skilled Manual 
Relative 2 Mother 48 Years Unskilled 
Relative 3 Father 65 Years Professional 
Relative 4 Sister 59 Years Skilled Manual 
Relative 5 Brother 38 Years Clerical 
 
3.6.6 Ethical Considerations and Approval 
I attended a full Ethics Committee Meeting in December 2011 following 
submission of all the necessary documentation requirements online to The 
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Integrated Research Application System (IRAS) and the Trust Research and 
Development Department (R&D). IRAS supported the completion of multiple 
application forms for the Wales NHS Research and Ethics Committee 
(WREC), the sponsor and the Local Health Board (R&D). I attended the 
Research Committee meeting alone and it took one hour to discuss my 
research and satisfy the Committee. It was a very positive and exciting 
experience. All their questions were addressed and the committee had no 
ethical concerns. Minor amendments were made to the information sheets and 
full ethical approval was granted in January 2012 by The South East Wales 
Ethics Committee.  
 
Annual reports have been submitted to both South East Wales Ethics 
Committee and the Trust Research and Development Department (R&D) 
since commencing the study. The Nursing and Midwifery Council (NMC, 2008) 
code of conduct for ensuring compliance with standards for conduct, 
performance and ethics were adhered to throughout this study, as was the 
Royal College of Nursing research ethics guidance for nurses (RCN, 2009). 
 
Confidentiality, anonymity and participants’ well-being were my main 
consideration throughout the study. Every effort was taken to protect the 
participants’ identity by using letters instead of names, ‘P’ for Probands, ‘H’ for 
Husbands and ‘R’ for Relatives. Having password protected access to a 
computer and following the Nursing and Midwifery Council code of 
professional practice standards for conduct, performance and ethics (NMC, 
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2009) were also ensured. All records were kept confidentially and securely 
and recordings were erased from the digital recorder as soon as they were 
saved. Participants were treated with respect and dignity and the researcher 
was honest and open throughout the study thus upholding the principles of 
research governance and ethics. The study throughout followed the ethical 
principles laid down by the Welsh Assembly Government Research 
Governance Framework (2009), Cardiff University Research Governance for 
Health and Social care in Wales (2009) and Cardiff University Research 
Governance (2010). There was a constant awareness of the potential to cause 
psychological distress from engaging in the hermeneutic circle and the back 
and forth process of partial and complete understanding. 
 
I was always mindful of the length of the interview and of the need to stop the 
interview if probands or relatives became distressed as a result of raising 
awareness. All study participants were in control and could stop the interview 
at any point. They were very keen however to continue with the interviews, 
even if they became upset. On reflection, participants were able to express 
their feelings openly in a safe and confidential environment. 
 
3.7 Analysis and Interpretation 
A number of writers have suggested methods for undertaking hermeneutic 
studies and analysis including Colaizzis, 1978; Giorgi, 1989; van Manen, 1990 
and Koch 1996, and all methods were reflected upon and considered during 
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this study. However, due to the diversity of their underlying principles, they 
were not entirely consistent with Gadamerian philosophy. Colaizzis’ (1978) 
method did not view pre-understandings as essential to understanding the 
participants. He believed that the only benefit of this was in generating 
research questions. Equally, van Manen suggested that the knowledge gained 
through pre-understandings be turned against itself thus exposing its shallow 
character (Fleming et al., 2003).  
 
 
All authors, however, indicate that when applying methods, the importance of 
analysis is to discover an approach that helps to guide an inquiry. As with most 
philosophers, therefore, Gadamer offers a guide to help researchers direct 
their research, rather than advocate a rigid procedure (Tapp, 2004). Thus for 
Gadamer, hermeneutic phenomenology had a tendency to be too dominated 
by a procedure and he advocated the use of an appropriate method rather 
than a single, right method where flexibility and modification are seen as 
acceptable (Gadamer, 2004). However, it is important for researchers to be 
explicit and transparent in the way the research is conducted. They need to 
explicate the philosophy underpinning the analysis and how analysis of the 
texts occurred, leading to the fusion of horizons. Thus, Gadamer’s three 
metaphors of understanding, the act of dialogue, the hermeneutic circle and 
the fusion of horizons were utilised (Thompson, 1990; Gadamer, 2004). 
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3.7.1 The Act of Dialogue 
The act of dialogue is aimed at understanding that which the participants 
speak about, for example, being a BRCA mutation carrier, living with the 
mutation, the decision to elect surgery and life after the surgery. A fusion of 
horizons comes about through the act of dialogue (Gadamer, 2004).  
 
3.7.2 The Hermeneutic Circle 
The hermeneutic circle considers the ‘whole’ in terms of the ‘parts’. It is a 
continuous passing to and from parts of the text to make sense of the whole 
text and in doing so, the researcher interprets the whole text. The ‘parts’ 
therefore are many and include my pre-understandings, the literature including 
the current horizon of understanding, the individual participants’ experiences 
expressed in the texts and the texts as a whole. They also include the social 
and cultural influences and past experiences’ of both the researcher and the 
participants as well as the meanings, understandings and horizons that 
develop from the interpretation of the texts.  The ‘whole’ in this sense therefore 
is the woman, her husband and the family living with the BRCA gene mutation 
and the experience of RRM. Simplistically, the researcher approaches a topic 
with preconceptions and prejudices. These are examined and revised in the 
light of what the things themselves tell us, (the participant accounts) and the 
current horizon of understanding (the literature). In light of this new 
understanding, further exploration is sought and the topic is then understood 
by ‘viewing the parts and the whole in terms of the detail and the detail in terms 
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of the whole’ (Gadamer, 2004, pg. 291). In this way, it was possible to gain a 
totality of the meaning of the experience.  
 
Thus the main aim of hermeneutic phenomenology is to reveal a ‘totality of 
meaning in all its relations’ (Gadamer, 1997; pg. 471) by going ‘beyond what 
is directly given’ (Spiegelberg, 1982; pg. 712). It seeks a deeper understanding 
of human experience by opening it up and rediscovering. Interpretive inquiry 
is therefore about being ‘struck’ by something and Gadamer (2004) believed 
that our past experiences structure how we deal with and interpret subsequent 
experiences.  
 
Interpretation and understanding go hand in hand, it should not be viewed as 
a separate task. Interpretation begins in the interview and Gadamer (2004) 
proposes that there must be a harmony between the parts and the whole. In 
this case the participants in the study and the meaning of the whole 
experience. If harmony is not achieved, then understanding will not occur.  
 
3.7.3 The Fusion of Horizons  
A fusion of horizons occurs as a result of the researcher constantly questioning 
the meaning of the text thus allowing the text to provide answers, leading to 
an interpretive dialogue between the two. In keeping with Gadamer’s 
philosophy the art of hermeneutic understanding, including analysis, should 
not follow locked steps (Dahlberg et al., 2008) but should at least demonstrate 
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congruity between the framework used for analysis and the findings of the 
study. Furthermore, the interpreter in this context carries on the conversation 
with the voices beneath the text in order to identify that which is unspoken. 
The text is constantly questioned with the aim of lifting from it what the text is 
trying to say (Gadamer, 2004).  
 
It is worth noting at this stage, that understanding others can never be totally 
achieved because understanding is constantly evolving. In addition, the whole 
analytic process using the hermeneutic circle can go on indefinitely, because 
understanding changes as time goes on. As Gadamer (2004) highlighted, 
however, to be able to understand, one has to be able to understand 
differently. 
 
The fusion of horizons leads to a new horizon of understanding and this 
process of understanding results from the encounter between the researcher 
and the topic of inquiry. Interpretation and understanding cannot be separated 
and in this way, two standpoints come together. Therefore, in keeping with 
Gadamerian philosophy, we let the other (the participants in the study) speak 
to us and we are willing to be influenced by their perspective and we learn 
(Thompson, 1990; Gadamer, 2004). Hermeneutic phenomenology, however, 
asserts that all research is value laden and that the researcher brings bias, 
prejudices (pre-understandings) and assumptions to it (Lincoln and Guba, 
1985; David and Sutton, 2011) but that these prejudices become a positive 
part of the encounter.  
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I, therefore, had to examine my own prejudices so that the text could assert its 
truth against my own pre-understandings (Gadamer, 2004). The genuine 
conversation that occurs in the interview brings the researcher closer to 
identifying their presuppositions and prejudices because of the potential to 
show up one’s own weaknesses. This I documented in a reflective diary.  
 
Pre-understandings or prejudices in this sense are not viewed negatively but 
as enlightening any new understanding (Binding and Tapp, 2008). Traditions 
and the past should not be seen as a negative but as an aid to overall 
understanding by shaping any interpretation (Gadamer, 2004). Furthermore, 
and more importantly, Gadamer believed that the historicity of an experience 
is lost if the aim is to objectify that experience by trying to repeat it or verify it. 
 
3.8 Phases of Analysis 
The following phases demonstrate the approach to analysis, this was guided 
mainly by frameworks suggested by Crotty, 1998; Crist and Tanner, 2003; 
Fleming et al., 2003 and Lindwall and von Post, 2008. 
 
3.8.1 Phase One  
The individual texts from the interview transcripts of the probands, the 
husbands and the relatives were read and re-read with an open mind and 
there was a sense of the experience emerging (Lindwall and von Post, 2008). 
  
163 
 
This phase Crotty (1998) refers to as empathic reading.  At the same time, 
the digital recordings were playing so that the two partners (researcher and 
participants) (recordings and transcripts) were working together to create a 
common understanding (Fleming et al., 2003). In this phase, there needs to 
be a continuation of openness from the researcher and an ability to see the 
participants’ point of view and what the whole text is saying. Notes were taken 
as I progressed through the transcripts, prompting questions that I could 
follow up on with subsequent interviews. Individual texts (Probands n=8, 
Husbands n=5, Relatives n=5) were examined to form a whole text by moving 
from the parts to the whole and back again (the hermeneutic circle). 
 
The first series of interviews with the probands were analysed before the 
second, third and fourth series and the cycle was repeated (Crist and Tanner, 
2003). In this phase meanings emerged from the whole text, these became 
the focus of interpretation in order to form concepts that represented the 
meaning as a whole.  
 
The interview transcripts were coded for themes by going through each 
transcript line by line. Initially, Nvivo8 Software was used to generate codes, 
but due to the enormous amount of data obtained, I found a much simpler way 
of categorising the text using Microsoft Word and a facility known as Spike. 
This method involved highlighting pieces of text that corresponded to a 
specific theme, moving it into a spike until the spike is emptied into a separate 
document. This left the original text intact allowing further categorisation, 
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whilst the selected sections of text were reflected upon by the researcher. 
Main categories then began to emerge from the themes. Mind maps of each 
participant’s story and their experiences were developed and used in the 
analysis to reflect the final three horizons (see Appendix Seven). 
 
3.8.2 Phase Two 
This phase involved interactive reading (Crotty, 1998) of the text where I 
questioned the text and the concepts that began to develop in relation to my 
pre-understandings, my research aims and the interpretation of the first 
interviews. This was done in an attempt to clarify meanings, challenge why I 
had come to that meaning and look for any inconsistencies from the previous 
interviews. Questions were asked, for example, ‘what does this text say about 
real life and the phenomenon?’ I continued to engage in the hermeneutic 
circle, moving from the parts of the text (all interview transcripts) to the whole 
as further questions transpired.  
 
This engagement with the hermeneutical circle is essential, because only 
when the whole of the text is understood can the meaning of the parts widen 
(Fleming et al., 2003). Answers to my questions began to emerge and an 
understanding of the participant’s experience began to develop. The reality of 
the text became a part of me as the reader and new meaning developed 
(Lindwall and von Post, 2008). An example of my questioning related to why 
women chose to remove their breasts rather than choosing screening. Initially, 
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the answer to that question from my pre-understandings and first stage 
analysis was that they did so to prevent breast cancer developing.  
 
On further interpretation, however, it was much deeper than that. They had 
come to that decision because of the desire to survive and only surgery could 
save them, they had a fear of leaving their children behind and they felt a deep 
sense of moral obligation whether this was as a mother or a father. Thus, 
there was a fusion of horizons between the researcher and the participants.  
 
3.8.3 Phase Three 
A number of themes and categories emerged resulting in many new initial 
horizons, this was a consequence of gaining an understanding of the 
phenomenon from all three groups. This was achieved by being open to what 
the texts were telling me through more interactive reading and looking for the 
hidden meanings or for what had not been said (Gadamer, 2004). Concepts 
then began to emerge that represented the deeper understanding and 
meaning.  
 
Quotes from the participants were identified in order to demonstrate the 
meaning and provide resonance with one’s own experience. Quotes also 
enable readers to judge the trustworthiness of the interpretations. The quotes, 
therefore, demonstrated an understanding of the interpretation and not merely 
a description of the experience (Norlyk and Harder, 2010).  It was at this stage 
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that it became necessary to identify the horizons that connected and united 
the probands and the family, this was achieved by comparing the parts to the 
whole. Therefore, the final three horizons captured the analysis of all three 
groups of participants. 
 
3.8.4 Phase Four 
In this phase the new fused horizons were synthesised with the 
pre-understandings, prejudices from the literature and my own experience 
and a new horizon of understanding developed. Norlyk and Harder (2010) 
suggest that researchers should connect the different viewpoints from the 
analysis when forming an interpretation. This was achieved by viewing the 
new horizons alongside the pre-understandings and the literature. In this way, 
the pre-understandings were either confirmed, refuted or a different 
perspective suggested. Conclusions were then made about the experiences 
and implications for practice highlighted. 
 
 3.9 Rigour in the Study 
All research demands a demonstration of trustworthiness and rigour (Koch 
2006). In qualitative research, in particular, the research process and 
truthfulness of the analytical process needs to be transparent because it 
affects the legitimacy of nursing science (de Witt and Ploeg, 2006; Porter, 
2007). Nursing research has attracted much concern and debate for many 
years (Crotty, 1996; Paley, 1996; Annells, 1999; Turner, 2003; Whitehead, 
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2004; de Witt and Ploeg, 2006; Koch, 2006; Porter, 2007) not least because 
of its definition and misinterpretation of what constitutes rigour.  
 
Rigour is defined as the ‘Goodness’ of qualitative research (Emden and 
Sandelowski, 1999, pg. 2) and ‘trustworthiness’ is recommended in trying to 
establish this ‘goodness or quality criteria’ especially when taking a 
constructivist approach’ (Guba and Lincoln 1998, pg. 210). Koch (2006) 
argues that trustworthiness is established if the reader can audit the events, 
actions and influences of the researcher. Some form of criteria of rigour is 
therefore essential to ensure high quality research methodology (Morse et al., 
2002). However, some of the previous concern centres on the fact that 
applying a generic set of criteria to establish rigour in qualitative research does 
not sufficiently take into consideration the different philosophies and 
methodologies and the inconsistencies in articulating these philosophies. 
Sandelowski and Barroso (2002)  argue against using ‘epistemic criteria’ for 
exactly that reason, preferring instead to use wise judgement and keen insight 
in recognising a trustworthy piece of work.This may then account for some of 
the criticism generated (De Witt and Ploeg, 2006). 
 
Researchers utilising Gadamerian philosophy, therefore, have to establish the 
trustworthiness of their research and the truthfulness of their analysis 
especially so because it has not been traditionally utilised in nursing research. 
However, when referring to rigour, Gadamer (2004) proposes that 
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hermeneutic experience has a rigour of its own, that of, ‘uninterrupted listening’ 
(Gadamer 2004, pg. 461). 
 
In keeping with Gadamerian philosophy, this study will demonstrate 
trustworthiness and goodness in the process of ‘uninterrupted listening’ by 
presenting the participants’ stories as true and as faithful as possible by 
accounting for every decision made throughout the research process. The 
broad set of traditional criteria for rigour used by many nurse researchers 
includes trustworthiness, auditability, credibility, confirmability and 
transferability (Fleming et al., 2003, Whitehead, 2004; Koch, 2006).  
 
However, a review of the literature shows that using generic qualitative 
research criteria of rigour for interpretive phenomenology can cause obstacles 
to the full expressions of rigour because of the philosophical inconsistencies 
mentioned earlier (de Witt and Ploeg 2006). The notion of multiple truths in 
interpretive phenomenology, for example, challenges the reader, making it 
difficult to decide which study is more rigorous than the others. There is no 
doubt, therefore, that a systematic process of accounting for the decisions 
made throughout a study underpinned by interpretive phenomenology is 
necessary and this has been a theme in the literature for many years (Crist 
and Tanner, 2003; Fleming et al., 2003; Turner, 2003).  
 
As an alternative, van Manen (1997) and Madison (1998) propose the use of 
the term expressions of rigour, rather than strict criteria of rigour, because of 
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the unique features of interpretive phenomenology. Therefore, to demonstrate 
trustworthiness in this study and to preserve the integrity and legitimacy of 
interpretive phenomenology, a proposed framework by de Witt and Ploeg 
(2006) was utilised.  
 
These expressions of rigour are balanced integration, openness, 
concreteness, resonance and actualisation (de Witt and Ploeg, 2006). The 
framework was developed and based on the work of Madison (1988) and 
reflects phenomenological schools of thought informed by Gadamerian 
philosophy. Madison (1988) argues that hermeneutic phenomenology is 
systematic and rigorous but not scientific and he justifies the bases of his set 
of criteria on what he calls persuasive (practical) reasoning.  This comes in 
the form of reasoned argumentation rather than on demonstrative (scientific) 
reasoning. This is useful for nurse researchers because it facilitates 
application to the many philosophers and philosophies with its logic of 
argumentation rather than any specific philosophical tenet (de Witt and Ploeg, 
2006). What follows, therefore, is an explanation of how the expressions of 
rigour were applied in this study and how trustworthiness was established. 
 
3.9.1 Balanced Integration  
Balanced integration in this study involved articulating the philosophical 
approach, demonstrating how it fits with the researcher and the topic. My 
epistemological and ontological standing made explicit, including the 
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underpinning philosophy of Gadamer applied throughout. (Gadamer, 2004) 
(Chapters One and Three).  A brief autobiography is also offered in Appendix 
One. Gadamer’s philosophical concepts of pre-understandings, (prejudices) 
the hermeneutic circle, and the fusion of horizons are entwined within this 
study’s methods and findings and there is a balance between the participants’ 
voices (Chapters Four, Five and Six) and the philosophical explanations. A 
range of experiences (husbands and relatives) are identified and represented 
in order to understand the whole experience (Chapters Five and Six). The 
research process is therefore reflected upon throughout my study giving the 
reader an overall understanding of the decisions made, thus demonstrating 
congruency with the philosophical tenet and promoting trustworthiness.  
 
3.9.2 Openness 
Openness is demonstrated by the overt explanation and reflection of the 
research process and the decisions made, including the rationale for my 
decisions and evidence of maintaining all ethical principles. It is recognisable 
through the systematic account of the multiple decisions made, thus providing 
an audit trail. Situating myself in the study and an introduction to the study 
(Chapter One) and extracts from my diary reflections are offered in Appendix 
Six as well as a short autobiography (Appendix One). Chapter Three includes 
a detailed explanation of the research process. Pre-understandings are 
reflected upon throughout the study (Chapters Two and Seven) and frequent 
honest open discussions took place with supervisors throughout the study.  
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An example of this openness was having a series of long conversations with 
my supervisor regarding the importance of including partners and relatives in 
the study which I consistently defended and which I believed were an 
important part of understanding the overall experience. My justification to 
include them was based on a gap in clinical practice and on the identification 
of my pre-understandings from the literature. 
 
3.9.3 Concreteness  
Concreteness addresses the research outcome and is recognisable when the 
study’s findings are written in such a way as to situate the reader in the context 
of the phenomenon, it gives the reader a real life feel of the experience by 
connection. In this study, participant voices and experiences in the form of text 
are presented in the findings chapters under the heading of Horizons starting 
with the probands, the husbands and finally the relatives. The process of 
interpreting the texts is provided (Chapters Three, Four, Five, Six and Seven). 
Frequent discussions of the findings with supervisors and presentations at 
meetings allow the reader to relate to the experiences and stimulate the 
audience, thus allowing them to judge whether the interpretations are 
congruent with the findings. An example of this was giving a presentation at a 
National breast cancer conference and having a ‘complete audience’ of both 
nurses and clinicians, with extremely positive comments because of the 
implications of the findings for clinical practice. 
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3.9.4 Resonance  
Resonance addresses the research outcome and is the experiential or felt 
effect of the findings upon the reader. Van Manen (2014) calls this the 
‘epiphany’ or the ‘sudden perception and intuitive grasp of the life meaning of 
something’ (pg. 364) is where self-understanding takes place. This is 
recognisable when the findings are presented at conferences or meetings and 
resonate with the audience. It is also evident when supervisors or BRCA 
patients themselves read the findings. It was agreed with the participants in 
this study that on completion of the final study, a summary of the work would 
be given back to them to read. Bradbury-Jones et al., (2010) support this 
method of participant feedback. Presentations at conferences and meetings 
within the university have on numerous occasions, and especially as the 
research progressed, stimulated much discussion and genuine interest with 
extremely positive feedback given. The results not only resonate with those in 
the speciality but in health care generally. 
 
3.9.5 Actualisation  
Actualisation addresses the research outcome and is where the study’s 
findings do not end when the study ends. It addresses the future realisation 
of the resonance of such findings and is recognisable when recommendations 
for practice are made and changes in practice occur. In Chapter Seven, the 
new horizon of understanding is presented and recommendations for practice 
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are made. A new way of working has been introduced in clinical practice and 
a multidisciplinary joint clinic has been established. 
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3.9.6 A Flowchart of the Summary of the Research Process  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussed the new horizons alongside the current horizon of 
understanding. A new horizon of understanding unites the participants.  
Implications for practice identified based on the new insights into the 
phenomenon. 
Identified the group of individuals to study and conducted a literature 
review to establish the current horizon of understanding and to identify 
gaps in the literature with regard to the phenomenon. Developed the 
aims of the study alongside the research questions. 
 
Chose the method of data collection and philosophical methodology 
appropriate to the aims of the study in order to explore the phenomenon, 
identified, and recruited participants. 
 
Engaged in a conversation with participants and collected accounts of 
their experience from face to face interviews at different time points. 
 
Generated texts by transcribing the accounts from the interviews and 
formed a whole text by combing all the texts. Analysed and interpreted 
the texts generating concepts to reflect understanding of the experience. 
Three new horizons of understanding developed. 
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3.9.7 Chapter Summary 
This chapter located the researcher in the study and demonstrated the 
rationale for the methodological decisions made, including the ontological and 
epistemological standing. The philosophical underpinnings of the study were 
described and the study design, participant characteristics, recruitment and 
analysis were discussed. Rigour and how trustworthiness was promoted within 
the study were given and there was a summary of the process of interpretation 
and understanding. Four phases of analysis were used to guide the discussion 
of analysis and the fusion of Horizons. The following chapters present the 
findings of the study starting with the probands, husbands and finally the 
family. 
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CHAPTER FOUR – The Findings 
 4.1 Introduction to the Findings Chapters 
This study sets out to understand what it is like to be a BRCA mutation carrier, 
live with the mutation and elect to have bilateral RRM for the woman in the 
context of her family. The following three chapters detail the findings from the 
interpretation of the experiences of the women (probands), the husbands and 
family members.  
Staying true to my methodology, findings are presented as ‘horizons’ 
(Gadamer, 2004), with three main horizons of understanding identified through 
interpretation that capture the stories and experiences of all three groups.  
These horizons are, the price of survival, the altered child trajectory and a 
separation from self. In all three chapters, each horizon of understanding is 
presented along with the sub themes that led to that horizon of understanding. 
However, I am aware that there were a number of ways in which I could 
examine and present their experiences. For example, an alternative way of 
presenting these findings would be by giving the different time points primacy, 
with chapters focussed on the period’s pre-surgery, six, twelve and eighteen 
months or by presenting all the findings under the three main horizons. I 
decided against this because of the limits of the Ph.D. and instead decided to 
capture and summarise those time points in pre-surgery and post-surgery 
experiences as not all the participants were interviewed at the different time 
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points.  The focus of my study is primarily on the woman’s experience in the 
context of her family and I felt the women’s experiences if presented under 
each horizon would have been diluted.  I, therefore, chose to study the 
experiences and present them as three separate groups.  
This first chapter examines the experiences of the eight probands and are 
interpreted through these horizons. The probands ages ranged twenty-three 
and fifty-eight years and two were sisters.  They all had children, girls and boys 
except for one proband who did not yet have any children.  Seven were 
married and one was divorced. All except one proband was employed.  The 
first horizon of understanding ’the price of survival’  is the longest horizon 
because it interprets the complex experiences and journey from first learning 
of a mutation, leading up to the surgery. This horizon will now be presented, 
followed by the ‘altered child trajectory’ and ‘a separation from self’.  
4.2 The Price of Survival - Pre-surgical Experiences 
’Surviving’ was the main priority for all participants in this study but there was 
a price to this survival.  The literature review, especially the work of Lodder et 
al., 2002; Van Dijl et al., 2008; Howard et al., 2010; Haroun et al., 2011, 
identified that women want to prevent breast cancer and survive but it did not 
offer an understanding of the price women and their families pay for this 
survival throughout the whole journey.  This study, therefore, bridges that gap 
in knowledge and includes the experiences of a long journey of acceptance 
that a gene existed within the family, the difficulties in understanding the 
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implications of a mutation including the difficulties that participants 
encountered as a result of having inherited it. The need to be tested, the 
complexities of family communication and dynamics, the shock of the results 
and the implications of the decision to elect to have RRM, for example, caused 
major changes to the participant's lives, which they were not prepared for. The 
following sections provide the reader with that journey. The experiences have 
been divided into pre and post-surgery. 
4.2.1 Getting to Grips with the Possibility of a BRCA Mutation  
The awareness of a specific breast cancer gene within families became 
evident in different ways for the probands in this study. All the probands were 
aware of a family history of breast cancer, however, none had initially heard 
about this being associated with a specific BRCA mutation and in some cases, 
individuals had no idea that family members were going for a test or indeed 
that there was a test. It all began as a general awareness when someone in 
the family became concerned about the risk and sought risk assessment and 
a test for themselves.  An identified family mutation therefore came as a major 
shock especially if there had been a lack of involvement from the start, making 
it more difficult for probands to understand all the implications.  Proband two, 
for example who was most shocked by the news of a mutation in the family, 
explained how her sister had not told anybody in the family what she was 
doing. She only came to hear about a gene because of her sister’s actions: 
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‘Finding out about the BRCA gene, I sort of stumbled across 
it, I sort of stumbled across it because my sister was err 
anxious about my nan having cancer’ (P2). 
 
Most of the probands had not initiated the process of risk assessment or 
testing themselves but had become involved because of others. As Proband 
three pointed out ‘she (cousin) started talking about this BRCA gene mutation 
and a test when my aunt died’ (P3). Another reported how as a result of her 
sister going for the test and then persuading her, she went to the clinic. ‘If it 
wasn’t for my sister I wouldn’t have gone down there’ (P5). The diagnosis of 
cancer in young female close relatives, however, had made probands much 
more conscious of their own potential risk of cancer and of their own survival. 
Proband four, for example, explained how the loss of her aunt and knowledge 
of her young cousin’s terminal diagnosis of breast cancer with an additional 
BRCA mutation, expedited and heightened her awareness: 
‘But it was only when obviously x passed away I think it was 
three years ago now this month, her daughter x who was 
thirty-two last year, her diagnosis came along and that for me 
brought it forward by a decade.  I knew that breast cancer 
would be something that I would have to consider and be 
aware of’ (P4). 
 
Indeed, for many of the probands, there was an expectation that they would 
follow the family pattern in developing either breast or ovarian cancer.  This 
depended upon what particular cancer the family member had died of.  One 
proband for example, because of the family pattern of breast cancer explained 
how ‘she knew breast cancer would be coming her way’ (P4). Another believed 
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it inevitable that she would get it because it had come down through the female 
generations. ‘I was bound to be in line’ (P8).  
The focus of concern, however, was the type of cancer which they knew was 
in the family and initially, they did not link this to the wider risk of a BRCA 
mutation with both breast and ovarian cancer so this posed an additional shock 
with more difficult decisions to make. Despite having genetic counselling about 
risk, it was surprising to see that for many of the probands, the shock about a 
BRCA gene was related to the sudden connection being made between the 
mutation and the risk to the breasts.  Thus ovarian, rather than breast cancer, 
was the main fear if family members had died of ovarian cancer and three of 
the probands had lost relatives to ovarian cancer. Indeed, five of the eight 
probands had already had their ovaries removed following their BRCA result 
and before breast surgery, reducing their risk of ovarian cancer but many 
probands had not connected a BRCA mutation to the risk of breast and ovarian 
cancer proband two, for example, had never worried about her breasts:  
‘I don’t think I ever really connected breast cancer and ovarian 
cancer as being together so I’d never, ever had an issue with 
thinking about my breasts and would never have even 
crossed my mind that that needed to be looked at’ (P2). 
 
Other probands soon realised that the risk of breast cancer was higher than 
for ovarian cancer which they were unprepared for and which caused 
additional fear and shock because they now had more to worry about and the 
decisions to be made, were much more difficult.  Two probands explain: 
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‘And I felt fine about it because I just thought well umm I am 
going to have a hysterectomy anyway, and although it 
sounds strange to say, I wasn’t as worried about breast 
cancer at that point because my cousin was very much 
worried about breast cancer because of her mum and I was 
much worried about ovarian because of my mum. But you 
know, as I have sort of found out information about the breast 
cancer, it become apparent that actually, that is, you know, 
something that is more likely to happen than the ovarian’ 
(P3). 
 
‘So the biggest, I think the biggest shock for us really is the 
percentage of getting it (breast cancer) was quite a lot higher 
than I’d thought, so that was quite a shock, you know it’s not 
like you’re saying oh you’ve only got a 15-20% more, your risk 
is so much higher that that was quite a shock and although 
there was a thought around, I don’t think I ever really 
connected breast cancer and ovarian cancer’ (P7). 
 
Even in families where there was more awareness of a possible genetic link 
and reports of more open communication, there were still difficulties 
experienced concerning risk and the breasts in particular. Proband three, for 
example, had some awareness that there may be a genetic link and promised 
her mother that she would have a hysterectomy after her family was 
completed. Her mother died of ovarian cancer and had the foresight to provide 
a sample of her blood when she was alive in case a test ever became 
available. However, despite this communication and planning with her mother, 
proband three like many others, explained how it was all ‘a bit of a taboo’ and 
therefore hard to discuss with anybody else in the wider family.  Why was this 
so difficult to discuss? It was difficult because it concerned the breasts, which 
were seen as taboo and which had wider implications and consequences for 
the whole family.  Proband three explained how difficult it was: 
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‘And whilst she was alive she um sent some of her DNA umm 
to be tested and to set me up with genetic counselling umm 
and so after she died, I saw the genetic counsellor and they 
went through umm our family history and umm said that they 
would test my DNA against my mum’s and do a test basically. 
And then with the breasts it different really because it affects 
so many more people you sort of feel and it’s hard for my 
family. I talked to my cousin about it a lot but not many other 
people sort of ask me about it sort of family wise because I 
think they all see it as a bit of a taboo’ (P3). 
 
4.2.2 Conflict Within the Family About How to Respond  
Many probands highlighted family communication difficulties with knowledge 
of a mutation, for example, not all family members, supported the probands’ 
decisions to seek genetic testing. Despite close relatives having had breast 
cancer themselves, some probands were discouraged from starting the 
process which would lead to a test or surgery, for example, their family viewed 
it as ‘meddling’ or ‘potching with yourself’ (P5). Family members could not 
understand why some probands would want to start a process that could lead 
to the loss of their breasts when they did not have cancer.  Family members 
who had to deal with their own cancer diagnosis and surgery were identified 
as being particularly reticent. As a result, initially, there was an unwillingness 
by some family members to give their blood in order for a mutation to be 
identified.  This caused problems and tension within family relationships with 
some probands having to fight for and justify their decision. For example, it 
took some time before the mother of two of the probands agreed to give a 
sample of her blood so that they could have the test. Proband six used her 
need to survive to convince her mother:  
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‘No, my mother’s answer was stop potching with yourself 
when there’s nothing wrong with you, stop meddling. I’m like 
well because I value my family and I’ve got a new grandson 
and I want to be here for them.  I said I don’t want to die young 
if I can prevent it.’ Yes and they (Mother and sister) wouldn’t 
give it (blood) in the beginning, I’d forgotten about that, neither 
of them would give it and I said well still, I’m still going to go 
down for the counselling and I was going there for a long time 
before . For some unknown reason, my mother decided to 
give it and she said I will give it if you really want me to’ (P6). 
 
Why would parents not want to help prevent their children from getting cancer?  
It was too painful for some parents to acknowledge that they had passed on a 
mutation. In justifying their mother’s initial reaction to testing, one proband 
believed that her mother felt guilty and responsible thus wanting to ignore it. 
Proband five explained: 
‘I dunno, my mother blamed herself type of thing, obviously 
which you do, don’t you, because she passed it out through 
the genes and um she sort of wasn’t happy in the beginning 
for us to go for Genetic testing.  She said like things like that 
should be left alone’ (P5). 
 
4.2.3 Responsibilities, Obligations and Needing to Know 
Once it was evident, however, that a BRCA mutation existed within their family, 
probands felt an obligation and a responsibility to act upon it and various 
events contributed to the difficult decision to be tested. The death of a relative 
from a younger generation (P3, P4, P5 and P6), a memory of a close relative 
suffering at the end of their life (P2, P8), the recognition of the sheer number 
of women diagnosed in the family (P1, P7) or a need to know for their children’s 
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sake in order to be able to take care of them (all), prompted probands to seek 
testing.  A close family diagnosis increased the need to know for two probands 
whose mother and sister were diagnosed within weeks of each other. Their 
fear increased and the diagnosis had a catastrophic effect on the whole family 
thus initiating the test for the two probands. The fear of breast cancer was very 
vivid for one proband who believed she was next: 
‘mum had her results during July of 09 and was told she had 
breast cancer which was like, devastated the whole family 
because up until then my mother had never had any previous 
history of illness and we were all fit and healthy. That hit us 
for six for a start, two weeks later my sister was diagnosed 
with breast cancer so not only one but two within weeks, we 
were all just, didn’t know what to do with ourselves and then 
all of sudden you’re lying in bed and I couldn’t sleep thinking 
of them, thinking oh my god if it’s mother, my sister, what 
about me, what about me’ (P6). 
 
There were a range of rationalisations therefore for the decision to have the 
test and the subsequent decision to have RRM.   Most probands had a 
constant fear of cancer but it was more than avoiding cancer, they wanted to 
survive and they believed they had an opportunity and a responsibility to do 
so. As proband two explained ‘Someone and something has given me this, so 
why would I ignore it’ (pg, 2). In addition, during data collection in May 2013, 
Angelina Jolie disclosed that she was BRCA positive. The probands were able 
to relate the meaning of being BRCA positive to her, making it less of a stigma.  
Some felt she had also sent out a message to the world that it was the right 
thing to do as a responsible mother and that even for famous people, there 
was an obligation and a price to survival, having the test and removing healthy 
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breasts.  This famous disclosure had a range of impacts on the probands. 
Most probands thought she was brave in having told the world about her gene 
status and subsequent RRM. This had made it easier for probands to talk to 
people and explain their own story by normalising it.  Proband eight explained:  
‘Well it made it easier to talk to people about it, you know, you 
say well you know I’ve got what Angelina Jolie’s got so I  think 
it was very brave of her. Well, there’s somebody who’s 
famous, it can happen to anyone, yeah, precisely’ (P8). 
 
However, some probands were angry about her disclosure because they felt 
she was giving false hope to women who would have expected to look like her. 
They also felt that she was being put on a pedestal for what she was doing. 
Proband five was particularly angry: 
‘Oh I just thought it was a bit, it didn’t affect me at all, I just 
thought it was sad that they put it all over the press, you know 
she was a martyr, she’s this she’s that, I mean she’s not the 
only woman in the world who’s had it done is she, you know. 
I was a bit angry really I think because they were saying like 
she was a martyr because she’d had it done you know’ (P5,  
6 months). 
4.2.4 The Price: Divisions Within the Family 
The gene testing and the disclosure of results caused many rifts within families 
because of collusion, silence and secrecy.  The majority of probands explained 
how communication about a gene was complex within the family. This was 
because of the secrecy of the topic and beliefs and rules within the family 
regarding who is permitted to know and who must be protected from this 
knowledge. Proband seven, for example, explained how a gene had never 
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been discussed properly in the family because she had not revealed that she 
had gone for a test. Her grandmother had not been tested but it was obvious 
that her grandmother had passed it down the generations to her mother, her 
aunt and then onto her.  The secrecy and collusion was because nobody 
wanted to upset her grandmother or make her feel guilty. Proband seven 
explained the complex situation: 
‘I’m not supposed to know that my gran, I’m not supposed to 
know that my gran has the gene, she’s never formally told me 
that and she’s never told that to my aunt, Yeah and so she 
told, it’s kind of all a bit hush hush, we don’t discuss it with 
Gran although I think now it’s fairly obvious that gran has got 
it but we don’t actually say that because I think she was upset 
about the concept that she might have passed it down to my 
mum and also to me, which is ultimately what has happened 
isn’t it.  But there’s nothing, as you say there’s nothing you 
can do about it’ (P7). 
 
Many other probands explained the complexities within the family. They gave 
accounts of individuals having a test and the wider impact this had within the 
family. The issue of testing for one proband, for example, resulted from a 
forced disclosure from her sister. Her sister had secretly gone for the test and 
subsequently revealed that she did not have the mutation.  As a consequence 
of her sister’s actions, proband two and her brother felt they had almost been 
forced to consider the test themselves without any discussion, forewarning or 
individual control. The resulting impact of that one test had devastated the 
whole family because of the wider impact the results had on them all. The 
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decision to seek testing was seen as a family decision and not an individual 
one to be taken.  Proband two justified her anger at having no control: 
‘And this is the thing, we feel, well me and my brother 
discussed this and we said it is very canny that x has pushed 
for this and went into this with her eyes open and requested it 
through her GP and everything, and we have been sort of, it’s 
been  forced upon us, we have, in a way’. This was a family 
decision to proceed with this test. My sister should have never 
embarked upon it on her own and in isolation.  She should 
have discussed this with us all because it has impacted on all 
of us’ (P2). 
 
Proband two continued to explain the family difficulties about the issues of who 
could be told and who had control over this information. Similar to other 
probands, it was expected by some individuals in the family that a gene result 
would be kept secret from other family members but this did not feel 
comfortable or right for some of the probands, causing much distress. Proband 
two for example despite resistance, morally, could not keep it from her father: 
‘But I felt disloyal because I was holding something about my 
dad, and him and his family because my sister didn’t want him 
to know. He has a right to know. And I found that difficult’ (P2). 
 
Thus, she explained the ‘mess’ and how unpleasant it had all become and how 
the family had been divided. It, therefore, took a long time after the positive 
test results to pluck up the courage to go and tell her father that both she and 
her brother were positive for a BRCA mutation.  Like many of the probands, 
she did not want family members to feel guilty about passing on a mutation. 
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Furthermore, her father would not have known that he had passed the 
mutation on because he had not been for the test himself. It was also a ‘mess’ 
because she now had to think about acting upon her own result which brought 
many difficulties in itself. She explains: 
‘So I think around the end of February I took the courage to 
go and tell my parents because it meant that I had to start 
making some decisions about myself which was awful, it was 
a dreadful mess, only because I am more protective of how 
they are going to feel because it is always about well it’s my 
fault I gave it to you, but my answer back to my dad was you 
didn’t ask for it either so why are you blaming yourself for’  
(P2). 
 
Why was there so much secrecy within the family?  Issues of secrecy and who 
to tell were reported by all probands and a range of reasons were given to 
justify it. For example, probands wanted to protect parents or siblings from 
worrying about them. Indeed, in some cases going for a test and the decisions 
they had made were kept a secret right up until the time of surgery. Probands 
also needed to be sure of their decisions. Proband one, in particular, was 
scared to tell her family, especially her siblings, because it would highlight that 
they too may have inherited the mutation and they did not want to know. 
Proband one was, therefore, trying to avoid a division in the family: 
‘But um I thought it would be better that way because save 
them like obviously save them worrying all year bout my 
decisions. I wanted to make sure I knew what I was doing’. I 
didn’t actually tell my family, I was scared to tell my family, so 
I actually left it the whole year and I literally told them about 3 
weeks ago (laughs) um cause I was scared, I was like, okay 
in myself and my husband knew ,and like two friends but I was 
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just afraid to tell my family because I didn’t want to upset my 
brother and sister because obviously, it would come to them 
that they might have it and they would have to go for the test’ 
(P1). 
 
4.2.5 The Price: The Unexpected Impact and Implications of the Result  
Although most of the probands expected or prepared themselves for a positive 
mutation result, some had not. Three probands, two of whom had inherited a 
mutation from their father, were shocked, scared and devastated on hearing 
their result.  Why were some probands more shocked, scared or devastated 
about the results than others? It was because they had not be involved from 
the start, had not realised the implications of the test or understood the 
significance of a mutation.  Proband four, for example, expressed the fear that 
she may already have breast cancer ‘I’m panicking in case it’s already there 
now’ (P4). Proband five she did not expect her mutation result, believing it was 
down to luck. ‘I’m always the one who is okay’ (P5) and proband two who did 
not understand that her father could pass it on, believed ‘It’s just one of those 
freak of nature things that has happened’ (P2). 
 
Indeed, proband two had given little attention to the prospect that she may 
have a mutation. Like many of the probands who had not realised the full 
implications, she reflected on her naive decision to be tested:  
‘I don’t think I realised what I was getting myself into at all, I 
just thought oh well if x is doing it I will need to do it, thinking 
it will never happen to me’ (P2). 
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Following her result, like many of the participants, proband two was shocked 
and traumatised, questioning why she had the gene and initially feeling 
responsible for having inherited it.  Coupled with the shock and the unforeseen 
effects of the result, in an attempt to make sense of it all, she subsequently felt 
a sense of failure in preventing it from occurring: 
‘And I think maybe in a way I saw it as failure. Failing, that I’ve 
actually got this thing, this BRCA thing, you think it will never 
happen to you, why did it happen to me and also that I just felt 
so unwell you know, and I normally bounce back after things 
but this did hit me for six in terms of feeling rotten’ (P2). 
 
4.2.6 The Price: Living with and Making Sense of Being BRCA Positive 
Having embarked upon a journey therefore that led to a test and a positive 
mutation, probands now had to make sense of it all, deal with the result and 
its implications and live with the fear, which was life changing for them. For 
some, cancer was already an inevitability especially in families that had 
experienced the death of a close family member and so having a specific 
mutation, did not have the same impact as for those who had not witnessed 
death.  Some probands, for example, were expecting to develop breast cancer 
without an identified gene. Proband eight explained why: 
‘Yeah, before we even knew about the BRCA gene I always 
thought I’d be the one being the eldest, somehow, that I would 
get it but of course, my little sister got it instead.But when 
you’ve lived with cancer and it’s been in the family for years 
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and years, it’s not as, it’s a horrible way to die but it’s not as 
frightening as somebody that’s had nothing to do with it and 
you mention the word cancer and they like nearly drop you 
know. Sounds funny but a lot of my family have died of cancer, 
a lot of them and…’ (P8). 
 
However, for the majority, a BRCA mutation was more significant confirming 
the certainty of their bodies being invaded by cancer, which increased their 
fear.  Indeed, some probands considered that they may already have cancer.  
As proband four explained ‘breast cancer felt like it was imminent like it was 
around the corner if not there already, but it just felt inevitable, and with X 
getting it…’ (P4).  For many probands, despite knowing that the risk of breast 
cancer with a mutation was up to an 85% lifetime risk for example and despite 
reassurance from professionals that it may never occur, all probands feared 
that it was now a confirmed definite. Two probands explain: 
‘Yeah, I know that’s like not a fact, but to me, that’s how I felt, 
so as soon as I found out I just said look, I know now that I’m 
going to have cancer one day so but like, but doctors would 
say or you know there’s nothing that to say your gonna have 
it, you might have it when your 70, you might never have it’ 
(P1). 
 
‘I think my family history had always pointed in that direction 
but getting the news that I had the gene just confirmed that 
and cemented my opinion that I was going to get it (breast 
cancer) one day. When you look at the science and the 
genetic risk then yeah, I couldn’t be definite about that at all 
and I know that, but it’s just that kind of acceptance in my 
head’ (P4). 
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Despite the belief and inevitability of getting breast cancer and their individual 
understanding of having a mutation, probands also gave their rationalisations 
for expecting to be BRCA positive. The majority of probands for example who 
had expected to have a mutation believed it was because they resembled their 
mother and because of the number of women with cancer in the family. Thus, 
as well as inheriting other traits, they would also inherit a BRCA gene. They 
connected the same physical and personality traits of family members with the 
likelihood of testing positive. Two probands were convinced they had it and 
explained why:  
‘but I was fairly certain in my mind that I had it because I’m so 
similar to my mother that, I know it doesn’t necessarily you 
know, you’re 50% your mother, 50% your father or whatever 
but the reality is I look the spit of my mother, I am. 
Mannerisms, everything is my mother so I was convinced that 
I had the gene’ (P7). 
 
‘I don’t know what it was, I think I knew I was going to have it 
because what I had seen with my mother as well, and me and 
my mother, because we are so close and alike I just thought 
if my mother has it, then I got to have it. ‘I think it was 
something I always, cause my mother and her mother, I think 
it was 4 or 5 other women in the family had had it (breast 
cancer) and think it was something I always thought I knew’ 
(P1). 
 
These rationalisations of risk also extended to their children and future 
generations. Proband seven, for example, was able to identify which of her 
children she believed she needed to worry about based on both the physical 
and personality traits she associated with her mother and the genetic pattern 
of inheritance within the family:  
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‘I mean I look at the kids and I think x is so much like my 
husband, it doesn’t really matter, you know, but x is the 
spitting image of my mother, absolutely spitting image, 
personality and everything and I think oh I hope he doesn’t 
have it. Yes, in my head that’s how I think that’s the worst 
thing is that the kids could have it’ (P7). 
 
However, not all the probands could rationalise the positive mutation by linking 
it with their family resemblance or family history. Proband six unlike her sister 
who believed she was always lucky, believed she was always unlucky.  She 
thought this view would help prepare her, but the result had much more of a 
negative effect than she anticipated:  
‘Yeah, I prepared myself in as much as if anything ever goes 
wrong in this life, in this family, it’s normally me. Like 
hysterectomies, three of us had it done within weeks, whose 
went wrong, mine, things like that and I’d sort of prepared 
myself to think well it is me and I will be okay about it, but 
when you hear it, it’s different’ (P6). 
 
Most probands were empowered and forewarned with the knowledge of a 
BRCA mutation, enabling them to be pro-active and take control, even if the 
price to pay was the removal of their healthy breasts. Proband four explained 
the benefits of knowing: 
‘I felt as though I’d, I guess because if you know you’ve got 
the gene you know what your risks are and so, you’ve got a 
relatively good idea and I’m not somebody really who sits 
there panicking over, oh my god what if this happens or what 
if that happens, I kind of feel that you just deal with the 
problems that arise when they arise and there’s nothing else 
you can do about it otherwise. So, I felt as though well at least 
I’ve been forewarned which is more of an empowering 
position to be in’ (P4). 
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Interestingly, unlike the other probands, one proband felt fortunate to have a 
mutation because she believed she would be safer, thus enabling her to 
receive superior care compared to those who had chosen other risk 
management strategies: 
‘I said that I wasn’t actually convinced that if I didn’t have the 
gene whether that was a positive outcome for me because I 
very much saw it that if I had the gene something could be 
done about it, I would then come under the care of people who 
would look at it, would look after me and it would be something 
that I would actually get preferential treatment over somebody 
else who might just be on screening’ (P4). 
 
This ability to be proactive was echoed by many other probands, who unlike 
some family members were lucky to have a choice in doing something about 
their risk. This had not been possible for some family members because they 
had already died and it was at the expense of these family members, that it 
was possible to prevent the same from happening to themselves.  Proband 
eight explained: 
‘It sounds strange, but it was bad that I have got the gene but 
good that I had the opportunity to do something about it. I feel 
lucky that they’ve found, but at my sister’s expense, that they 
found out that we’ve got the BRCA gene to give me the choice’ 
(P8). 
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4.2.7 The Price: Disposing of Dangerous Breasts  
In acknowledging some of the benefits of being BRCA positive, all probands 
now had a different view of their bodies, in particular, their breasts and what 
they represented.   Whereas most liked their breasts before the BRCA result, 
they used different metaphors to explain how they felt after the result. They 
reported a need to dispose of their breasts because they were dangerous, Two 
probands explain: 
‘Because like I don’t know, it’s just like monsters and aliens 
inside you, just wanna like get rid, don’t you’ (P5). 
 
‘Mmm, they are my time bombs.  They used to be my big 
voluptuous chest, they’re now my time bombs, I want them 
gone’ (P6). 
 
However, despite the need to dispose of their breasts, the majority of the 
probands were concerned about what people would think about their body 
looking so different.  Many people, for example, had already started to judge 
them about their decision, especially if they were very young.  It was important 
to probands for people to understand the preventative nature of their surgery 
and as such, they felt a need to justify their decision. The majority of probands, 
for example, did not want people to think that they were having surgery and 
reconstruction for breast enhancement because that would be for a different 
reason. Many were frightened that they would be judged and felt embarrassed.  
Two probands explain: 
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‘Yeah, and do you know what I’m more frightened of as well, 
that somebody thinks I’ve had a boob job for vanity purposes’ 
(P2). 
 
‘I don’t want people sat there thinking has she had a boob job’ 
(P4). 
 
4.3 The Price - No Choice, Surgery is the Only Option 
The fear of cancer and not surviving dominated the experiences of all the 
participants but the price to pay for their survival was the need to elect to have 
RRM.  Despite the understanding that the risk was not 100% reduced and the 
availability of alternative options such as surveillance programmes, RRM, 
although a difficult decision, was seen as the best and only option for 
preventing breast cancer and thus death for all of the probands. All of the 
probands felt that they had no choice because they wanted to survive.  Two 
probands explain why:  
‘The knowing that I’m not going to die of breast cancer or the 
risk is minimalized to such a low % by having surgery...’ (P6, 
pre-surgery). 
 
‘Getting cancer? I have always, since my mother I was only 
young like very young but I’ve always worried so when I found 
out about the gene it was just like I’m definitely going to have 
it. Don’t you know something, I felt like I knew that I was going 
to have cancer and that’s why I feel like I have to do what I’m 
doing tomorrow (having surgery) because deep down inside I 
feel like she was like only 31, her mother was 34 and I feel like 
obviously, I’m going to be young having it, so that’s why I want 
to do this now’ (P1, pre-surgery). 
 
  
197 
 
Most probands were, therefore, determined to proceed with surgery despite 
friends, family or professionals questioning their decision, trying to persuade 
them against it or suggesting that they wait until they were older.  Proband one 
was determined to go ahead with surgery despite her young age and the 
resistance: 
‘But yeah, my age, people like the genetic counsellor ‘do you 
want to wait until you’re older’? And then down here, you 
might not have cancer till you’re into your 70’s and I was like 
but I’m still going to have it’ (P1, surgery). 
 
When questioned on why and how probands came to the decision of surgery, 
many reasons were given for choosing surgery over other options and most 
provided detailed accounts of losing close young family members to cancer. 
Proband eight reflected on the terrible distress of watching her sister die of 
breast cancer. Thus, like many of the probands, although she did not want to 
have her breasts removed, she felt she had no choice and this experience had 
convinced her to elect to have surgery:  
‘What made up my mind that perhaps might not have made 
me so definite is I was watching my sister dying of it and the 
state that she was in. Quite honestly it was terrible’ (P8). 
 
Most probands, therefore, believed that they had been given a great 
opportunity to ensure survival, which must be taken. Surgery would enable 
them to carry on living their normal lives, albeit at the price of losing their 
breasts, which initially was a secondary consideration. Indeed, all probands 
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believed that the decision and the opportunity to elect to have RRM was going 
to save them and they were grateful to have that option. RRM would also 
prevent them from living with a constant fear of breast cancer occurring.  Two 
probands explain why it had to be surgery: 
‘So, my way of thinking is life’s for living, you’ve been given a 
second chance in a way, why would you want to waste it’ (P2).  
 
‘I’m glad that we have found out now and that there is the 
surgery about, you know, to fix it. I do see it as lifesaving, 
yeah. I mean can you imagine if they had this years ago and 
they say oh yes you’ve got the BRCA2 gene and you’d have 
to live with the thought of that every day, constantly on your 
mind, so yeah it’s a relief’ (P5). 
 
However, having these opportunities to be proactive and secure their own 
survival at the expense of family members who had not survived, caused many 
probands to feel sadness and guilt:  
‘I felt terrible guilt that what she had been through had meant 
that I was able to dodge it and it was unfair that it was 
something that she couldn’t dodge’ (P4). 
 
4.3.1 The Price: A Visibly Altered Body 
As time elapsed and the reality of surgery approached, despite the perceived 
survival benefit, the decision of RRM was far more difficult for probands 
compared to removing their ovaries.  If probands had completed their family, 
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removing the risk of ovarian cancer was a much easier decision.  As proband 
two explained: 
‘I didn’t want more kids that’s one thing, so that was a no 
brainer.  And this is why the bottom half was much easier to 
make a decision on. But that was easier because I thought 
right I don’t want any more children’ (P2). 
 
Why was this an easier option especially in view of the known menopausal 
symptoms experienced following oopherectomy? Even though many 
probands experienced menopausal symptoms following RRSO, there was no 
visible evidence to the body of having had the ovaries removed compared with 
breast surgery, making it easier for the probands to accept and live with.  
Proband eight explained why:  
‘Yeah, or I didn’t mind having a hysterectomy because you 
can’t see it so that didn’t bother me’ (P8). 
 
Breast surgery, on the other hand, was much more visible, perceived as a 
bigger operation psychologically and would result in a changed visible body.  
More anxiety was experienced by all probands about the expected outward 
appearance because people would be able to see what had been done to their 
body. Indeed, it was this fact that had been a dilemma, making it more difficult 
for some probands to decide to proceed with surgery despite believing it was 
the right thing to do. It was also more difficult to accept if breast cancer risk 
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had not been their main fear.  Proband three was particularly worried about 
living with the changes to her body: 
‘It was you know a no brainer situation, you know. I had to do 
it (have ovarian surgery) and that’s all there is to it. It’s harder 
to make the decision about the breast cancer because my 
mum didn’t have breast cancer and because it’s an outward 
thing. And time to recover and you know all of those sorts of 
things but I don’t want to choose to have this operation and 
then feel sad that I don’t, I don’t feel like I can you know, sort 
of be pleased with my body’ (P3). 
 
4.3.2 The Price: No Longer My Whole Self 
Probands wanted to survive, but they also wanted to remain looking like a 
woman.  For the majority of probands, their breasts were very important and 
defined who they were, representing being ‘whole’ women.  All probands 
wanted breast reconstruction in order to remain feminine, whole and womanly 
and it was an expectation that breast reconstruction would enable them to do 
so, looking like a woman should.  Pre-surgery all probands were given an 
opportunity to see realistic photographs of the surgical outcome and discuss 
the operation.  All but one proband was either shocked, horrified or devastated 
at these images of the cosmetic result of breast loss, even with reconstruction 
because it was not what was expected.  The images looked so different to 
normal breasts and did not resemble ‘themselves’.  Two probands share their 
expectations and devastation after seeing the photographs:  
‘What! I really, this is what I expected, scar underneath, pop it 
all out, pop something in and do it up. But we thought cosmetic 
  
201 
 
and preventative was one and the same thing but they’re not. 
O they were shocking, they were shocking’ (P6). 
 
‘In the beginning, before I seen the photos I thought oh yeah 
you know, you’ll have a nice lovely looking pair but I don’t 
know I just haven’t got any expectations now. Ooh, I don’t like 
the look of them, I thought, Oh fuck, look at that, really when 
I saw the photos. ‘In the beginning, before I seen the photos I 
thought oh yeah you know, you’ll have a nice lovely looking 
pair but I don’t know I just haven’t got any expectations now.  
Ooh, I don’t like the look of them, I thought, oh fuck, look at 
that, really when I saw the photos. I was gutted. I thought, 
Yeah, scoop it out or something you know and I don’t know, 
and just put a bit back in. Where I got that from I don’t know, 
but that was I was thinking’ (P5). 
 
Most of the probands initially thought that after reconstruction, the breasts 
would look normal, possibly like women who have plastic surgery and they 
expected minimal evidence of surgery.  The majority of probands were 
shocked to see the extent of the scars and the final shape of the breasts.  All 
probands wanted an acceptable cosmetic result in order to be able to live with 
themselves. Thus, although they were very shocked, they were grateful to see 
the photographs to help prepare them for the cosmetic result. Two probands 
explain why:  
‘I didn’t realise it was so ugly. I thought that they could rebuild 
them with all the cosmetic, you know with all the plastic 
surgery around I thought that I could have them rebuilt back 
to normal, except for perhaps little scars’ (P8). 
 
‘Yeah, so I think it’s really good because I think you know, if 
you didn’t show those pictures you would be like oh shit, what 
the hell is that’ (P2). 
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Looking normal was therefore very important to all of the probands but many 
were distressed and viewed the surgical results as mutilating because there 
were no nipples on the women in the photographs. This was one probands 
reaction on first seeing the photographs without nipples: 
 
‘One thing that shocked, I think probably increased my shock 
and upset was I think the surgeon's results are very extreme 
surgery, isn’t it, or in my mind, it is because of losing your 
nipples’ (P7). 
 
These reactions led me to the question of why they were so shocked and what 
was it that they were expecting?   The pictures of reconstruction on the internet 
were very different because the women in these images had kept their nipples. 
The perception of plastic surgery had also strongly influenced their initial 
expectations.  For example, initially, some of the probands thought that the 
operation was a quick, relatively small procedure that gave an opportunity to 
improve their original breast shape, being more of a cosmetic procedure.  This 
is precisely what proband seven was expecting:  
‘I’m trying to view it, the breast side of things, as a really 
positive thing and that hopefully I get a fantastic pair of boobs 
and I come from having always had big boobs, of having to 
have enormous bras with ridiculously wide straps on  my back 
and never wearing a backless top to now I’ll be able to wear 
backless tops because I’ll have a pair of, okay they’ll be false, 
but you can’t see that in a top and actually it’s not a bad thing, 
they don’t flop all over the place when you take your bra off’ 
(P7). 
 
  
203 
 
However, although acknowledging the need to see the photographs, after 
seeing them, the reality of the surgery had an impact that was unforeseen with 
many now reporting much anxiety about what they were going to look like.  
Why was this so important to them when surviving was the main reason for 
surgery? The potential impact on their femininity and identity was just as 
important as the need to survive, and this suddenly became real for them.  Two 
probands explained why: 
‘We need to see pictures so that we are going to be sort of 
happy to live with the cosmetic result. Even though you know 
it is only vanity but it’s your femininity as well isn’t it you know. 
And things like that do bother me and ah you want to, still want 
to feel like you can be feminine Umm I think umm the only 
thing I would say was that when I saw the pictures Umm I did 
find it quite a shock and umm (thinks) even though I do 
recognise that I shouldn’t have done, because I knew what it 
was going to look like, it wasn’t that, it’s just that it was the 
reality hitting home’ (P3). 
 
‘So I don’t know, I just always think what are they are gonna 
look like after, and there’s not gonna be any feeling in them, 
and to touch them and think oh I’m not going to have that. The 
scarring and I know I’m not going to be left with any nipple and 
things like I worry about all of that’ (P5). 
 
4.3.3 The Price: Being without Nipples 
The issue of losing the nipples, therefore, became a major dilemma for the 
probands.  They all believed that they had no choice but to lose their nipples 
in order to maximise the reduction in risk, but removing the nipples was going 
to be a huge loss for them.  The majority of probands did not want to lose their 
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nipples but equally, they did not want to worry about breast cancer developing 
later.  One proband expressed the dilemma: 
‘I wouldn’t get rid of them (nipples) if I had a choice, but I 
haven’t got the choice so’ (P8). 
 
Why were the nipples so important?  Having nipples was seen as ‘normal’ for 
women and represented their ‘breasts’.  They represented the look of 
femininity and womanliness.  Despite believing that it was the right thing to do, 
the thought of waking up after the operation without nipples frightened many 
probands because they would not look like ‘normal women’.  The nipples were 
seen as the normal representation of a breast.  Two Probands explain their 
concerns: 
‘I am going to be scared not having the nipples which has 
scared me the most, um but like I say, I know I am doing the 
right thing even though  it’s going to be hard, I know I have 
done it for the right  reasons Just the thought of like, like I have 
never liked my boobs, they not very attractive I’ve never liked 
my own boobs but um just the nipples is what like you look 
normal in clothes but when you take your bra off not having 
any nipples it will feel, it won’t look right ,it will just  be  like the 
scars but I obviously know like that I can have reconstructive 
nipples like afterwards’ Yeah, like what I was scared of was 
waking up after the operation and just not seeing any, I don’t 
know why, but it was just the nipples which was’ (P1). 
 
 
‘My biggest thing is how I am going to look. You know if I look 
at it clinically, will I feel like a woman not having any ovaries, 
fallopian tubes or real breasts’ (P2). 
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Indeed, one proband felt so concerned about life without her nipples, that 
despite knowing the risks, she chose to preserve them. She was not able to 
imagine living without her nipples especially after seeing a patient volunteer 
who had her nipples removed.  Consequently, she was willing to live with the 
additional risk of getting breast cancer in order to maintain her femininity, 
identity and ultimately her happiness:  
‘The scars didn’t look as bad as I thought but I did think it 
looked odd that she didn’t have nipples and that’s been my 
main concern because I can cope with the plastic appearance 
of implants but I think not having a nipple would, is the thing I 
can’t cope with. ‘I’ve made the decision to keep my nipples 
because I kind of decided that you have to have an element 
of risk in life, I think we’ve talked about this before didn’t we, 
you have to have an element of risk and I think that’s, that 
additional risk would mean I would be happier with myself and 
I have to still live with myself going forward and have to look 
at myself in the mirror and I think that, at this stage would be 
too much of a shock for my system, not to say maybe in five 
years’ time when nipple reconstruction hasn’t improved again 
I might make the decision that actually I’ll take them off and I’ll 
have prosthetics or I’ll have it reconstructed, I don’t even know 
if that’s an option.  But at this stage, that’s too much for my 
brain to deal with’ (P7). 
 
The expected impact of the loss of the nipples and the breasts, however, very 
much depended on the significance of the breasts and the meaning attached 
to them.  If for example, breasts did not define who the proband was, it was 
perceived to be less frightening.   Only one proband explained how her breasts 
did not define her or her body image, her partner was very supportive which 
she believed made it less likely that she would be negatively affected:  
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‘So, in which case it wasn’t scary because I kind of thought, 
and ultimately perhaps mixed in with my own feelings on my 
body image, that it’s just flesh, it’s something that I knew 
wasn’t going to, or I hope still isn’t going to massively affect 
me because I don’t hold great store in these in defining me, 
I’m not somebody who gets my cleavage out or wears low 
tops so I don’t know how much things are going to change for 
me in that sense. It’s only recently I’ve thought about it as well 
in terms of I’m in a strong relationship where x has had his 
health issues and I know that it’s only made us stronger and 
so I’m, you know it’s now that tables are turning slightly. I don’t 
know whether my decision would have been different and I 
would have felt differently if I was single, it’s only recently I’ve 
thought about it in that way. I don’t know whether I’d have had 
different body image issues if I didn’t know that there’s 
somebody at home who is going to be supportive’ (P4). 
 
Was this the same for women who were single?  One proband who was single 
had to wait for a delayed breast reconstruction because of other medical 
problems but she needed her breasts in order to feel feminine and to secure 
a relationship.  She talked about how a ‘flat chest’ is not regarded as feminine 
and was concerned about being ‘dead flat’, as this would restrict the clothes 
she could wear that made her feel more feminine.  She, therefore, anticipated   
that the wait for reconstruction would be very difficult for her:  
‘Well, they’re (my breasts) quite important because I’m still 
single. I think the most stressful bit will be waiting for the 
reconstruction. It’s just not feminine is It.? No, I wouldn’t want 
dead flat because I know the problems you get with that and 
you’re restricted by what you can wear, you can’t wear a bikini 
and stuff like that, which I still do’ (P8). 
  
Like the majority of probands, her breasts did define who she was and the 
anticipated loss of her breasts and her nipple, in particular, was also a major 
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concern.  She was anxious about the effect that all this could have on a 
potential partner because she feared it would scare him away:  
‘I think they’d (men) run a mile if I met somebody because 
they look so horrible. You never know, even at my age, that’s 
the main thing really is that I’m still single and if I did get a new 
partner what would they you know, think? And when would 
you tell them and you know, it’s that more than anything, it 
was the length of scars and it, and also what to me is 
important is that they disregard your nipple, they can’t sew it 
back on’ (P8). 
 
Despite probands acknowledging that the purpose of RRM was to survive, the 
cosmetic result was far more important than they initially disclosed.  Some 
probands, for example, had tried to convince themselves that the surgery was 
not being done for cosmetic benefits but they still hoped that the result would 
be better than the photographs had portrayed.  Proband five explained this 
dual importance: 
‘Even though the surgery is to reduce the risk of breast 
cancer, the cosmetic result is still very important. When 
people say it doesn’t matter what they look like, it does. You 
think to yourself I don’t care, I’m having it done because of the 
risk-reducing bit and whatever but it does, it does matter. I 
think you look at those pictures right but you think no, mine 
will probably look better than that, I don’t know, you look at 
those pictures and you think no and you still go ahead with it, 
don’t you. It wasn’t for cosmetic reasons anyway so, but still, 
once you have it done, you know it’s still a bit of a shocker 
then when you see the result’ (P5). 
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4.3.4 The Price: Loss of Intimacy 
Although the majority of their husbands were supportive of their decision to 
remove both breasts, most probands did not know what their husbands 
thought about the actual loss of breasts and the effect it could have on their 
relationship.   As one proband claimed ‘he just doesn’t want to talk about it’ 
(P7).  The effect on intimacy especially caused concern because the majority 
did not discuss it as a couple and they had to guess what their husbands would 
think.  Proband five, for example, was curious to know what her husband 
thought: 
‘I don’t know because he’s not very open with me, so he 
wouldn’t so much tell me but probably you know, if you’ve got 
on the phone to him he might say it to you, but not to me 
because like men are really deep in there, you know, so’ (P5). 
 
Therefore, in addition to their own concern about how they would look, all the 
probands worried pre-surgery about how their husbands would feel about the 
change in their physical appearance, if they would be less attracted sexually 
to them and if they would be compared with other women. Proband three 
explained: 
‘It’s more about him as well as me you know and when he 
looks at other women, will he think of gosh you know, I haven’t 
got such a feminine partner any more, you know all those 
things…’ (P3). 
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Probands talked openly and honestly about their anxieties of how their 
husbands would cope without their breasts because they were very much part 
of their sex life and it was difficult to ‘read’ their husbands. For example, one 
proband described her husband as ‘deep’ (P5). Others justified their lack of 
discussion as ‘he didn’t want to upset me’ (P4). Proband two was frightened 
that her husband would not be able to accept the breast loss: 
‘Yeah, he (husband) has really been my biggest issue, he has 
been my biggest fear in all of this because I am constantly 
thinking what is he thinking, what is he feeling.  How is he 
going to cope’ (P2). 
 
Why was he her biggest fear?  One of her main concerns was that her husband 
was only able to accept the RRM if he thought of it as a breast enhancement 
and this attitude concerned her because he was avoiding the real issues of 
her losing her own breasts, suggesting that he was not coping 
‘He said so let’s think of it this way, you’re going in for a boob 
job’ (P2). 
 
All probands and their parents were concerned about the effect of RRM on 
intimacy after surgery and were concerned that it may lead to sexual problems 
in the marriage and have the potential to end the marriage.  Thus, in order for 
one proband to prepare herself for the changes which she perceived to be 
inevitable, pre-surgery she initially stopped including her breasts intimately 
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and then went on to stop having sex completely.  The difficulties experienced 
were explained by two probands who were preparing themselves for the loss: 
‘Right, my sex life has gone out of the window. I can’t explain 
it, it’s, I think, we’re all human and I think well they’re going to 
be gone soon so if I don’t involve them in a sex life now I’m 
not going to miss them Right, so it’s like I put them totally out 
of bounds and fair play to my husband he was like right okay, 
because let’s be fair they’re part of your sex pattern. I totally 
cut them out, I was like don’t touch them, don’t bother with 
them, I even stopped having sex, right, and it affected my sex 
life totally’ (P6). 
 
‘And like my parents were worried about my husband’s 
reaction like, um how will he um cope after it cause she said 
people break up and it’s an intense thing and she said life isn’t 
the same after it she said you will never look at yourself the 
same and he may not look at you the same’ (P1). 
 
4.3.5 The Price: Living with the Consequences of their Decision 
The decision to remove healthy breasts had therefore prompted different 
reactions from people, many negative.  Most of the probands were questioned 
about their decision because of how they would look, even by those who had 
a previous breast cancer.  This surprised many of the probands because they 
thought these individuals would understand the reason for their decision. 
Proband four shared a story about a difficult conversation with a work 
colleague who could not understand her decision: 
‘one girl in particular who was a couple of years older than me 
but she’d had breast cancer a couple of years ago, she turned 
to me and said why are you doing that, you know you haven’t 
got cancer why are you doing this to yourself’ (P4). 
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The majority of probands were under the age of forty and were being 
additionally judged because of their age.  This was a consistent finding in their 
stories and experiences.  Proband one like many, found it extremely stressful 
trying to convince people that it was the right decision for her.  She constantly 
had to justify why her young age did not matter: 
‘Then I got, felt like I was getting judged because of my age 
but still to me if I carry the gene, age doesn’t matter to me 
because if you got it, it could happen at any time can’t it’? Well, 
it’s just the age people would say you don’t need to do 
anything rash because obviously, I was, how old was. I was 
23, I was 22 at the time um, I’m 23 now 24 in a couple of 
months. I was worried about their reaction because it was 
something they were like or don’t do that yet you know you’re 
too young but inside I knew I had to do it’ (P1). 
 
Why was there so much resistance to their decisions from colleagues, family, 
and friends?  Many people disagreed with the probands’ decision to remove 
their healthy breasts because of the unnecessary effects on the body, 
comparing it to the removal of other body parts. Many people could not 
understand their decision because there was nothing wrong with them and 
they did not have cancer. Proband three explained why she had to do it but 
also the resistance she experienced:  
‘Before I had the operation people did say to me well you can’t 
go around chopping parts of your body off and things like that. 
But I was just so clear that it was the right thing to do for me 
so I kind of thought well it doesn’t really matter if that’s what 
other people think, I’ve just got to do this for myself. I think 
that is definitely a consideration that you think people might 
think you are being drastic…’ (P3). 
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Why did RRM attract so much resistance from family members?  In particular, 
fathers worried about electing to have RRM so young and the effect on their 
daughter’s body and relationships. Parents believed the loss would be 
significant.  Proband three relayed her father’s reaction to her decision: 
‘And he (father) thinks, I think umm, you know I am still a 
young person, you know, he doesn’t want it, it’s all for me, it’s 
not because he’s being horrible or anything (laughs) I think, 
you know, to begin with, I think he was just like well, you know 
this is very drastic. He could understand the hysterectomy but 
this is very drastic, you know’ (P3). 
 
4.3.6 The Price: Marital Conflict 
As a consequence of the resistance from family, probands talked about the 
length of time it took to decide on breast surgery and how the decision was 
made more difficult when there was a lack of support or communication from 
their husbands and the wider family.  The majority of probands had full support 
from their husbands, who were able to contribute to their decision.  Some 
probands however experienced conflict. One proband experienced many 
problems in her marriage as a result of the decision to elect to have RRM.  Her 
husband did not want her to have the surgery and thus could not contribute to 
the decision. She shared his response for example to their initial discussion 
on RRM, ‘I think you should stay on screening’ (P2). Proband two explained 
the marital conflict: 
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‘My husband has been my biggest stumbling block since I 
have had this Ummm and I think he thinks that there is nothing 
wrong at the moment so why do anything about it. You know 
if it’s clear now, why you are doing that. Umm, I think he is in 
denial, he finds it extremely difficult to communicate and we 
have had, recently we have had some, very, not nice 
conversations about it, because I am saying you can’t go 
through life and not have any feeling or an opinion.  Your 
opinion can’t be the statistics are this and therefore you do 
this. There’s got to be some emotion and some feeling and 
you have to talk about it, otherwise, it won’t go away’ (P2). 
 
As a consequence of this conflict and difference in views about RRM, there 
were tensions and problems in the marriage which persisted and which made 
her whole experience more distressing.  She shared her sadness:  
‘It’s very difficult. You feel like lonely and isolated in your own 
life and marriage and home. There were times when I really 
didn’t want to go home; I used to sit in here until 8-9 o’clock. 
You just think I just don’t want to go home; I can’t talk to him 
so what’s the point’ (P2). 
 
4.3.7 The Price: The Fight for Surgery 
Despite the difficult decision to elect to have RRM and the journey leading up 
to surgery, it was difficult for some probands to have access to it.  For example, 
two probands had to move hospital and change consultant in order to have 
the surgery.  The first surgeon seen was not keen to perform surgery and tried 
to persuade them to have screening. They had to fight for surgery and were 
made to feel guilty because they did not have cancer.   Proband five explained: 
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‘It’s like you feel guilty.  I dunno, for going there because there 
isn’t anything wrong with you and you, they (the first surgeon) 
make you feel like if there’s nothing wrong with you, why do 
you want to do it type of thing. Yeah, it’s like she (first surgeon) 
was going why don’t you just have the mammograms and 
whatever you know, it’s not, they like sort of tell you, obviously 
it’s not going to be like a boob job type of thing, and you know, 
I knew that before I went down there. I knew it was 
reconstruction. I think they are testing you. I think they think 
you know are you going to have these, perhaps you think you 
are going to have these lovely boobs when this finishes and it 
aint like that’ (P5). 
 
Why did women have to fight for surgery when they were proven to have a 
mutation and guidelines had suggested that it should be offered?  The reason 
for this reluctance was the psychological effects that breast loss could 
potentially have on the women, with little understanding of its long-term 
consequences. These probands had, therefore, waited a long time for the 
surgery because they had to move hospital and find a surgeon who was willing 
to perform the surgery. This experience had exacerbated their anxiety and 
they were angry at the unacceptable waiting time for surgery.  The long waiting 
time was echoed by many of the probands and there was a general feeling 
that women electing to have RRM were not a priority. Proband six was very 
angry:  
‘Treated differently, you feel like umm, I totally understand that 
people with breast cancer have got to be seen before me but 
when you’re in the position you also feel, excuse me, I’m still 
here and I’m still waiting and there’s always going to be people 
diagnosed daily with breast cancer so when do I fit in’ (P6). 
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4.4 The Altered Child’s Trajectory 
The literature review identified the moral obligations of parents to children once 
a mutation is identified within the family.  Work by authors such Liede et al., 
2000; Lodder et al., 2001, Hallowell et al., 2005,  d’Agincourt-Canning, 2006a,  
and McEwan., 2011, remind us of such obligation to be tested and 
complexities when considering children.  This thesis, however, offers an 
understanding of how parents viewed the child's trajectory as altered as a 
result of disclosure, of living with risk and living with a mother who has elected 
to have risk-reducing surgery.   In this study, probands, husbands, and 
relatives in addition to feeling a moral obligation to their children to do the right 
thing, were extremely concerned about their children's future.  Parents feeling 
the most responsible for the inheritance of a mutation, believing that people 
would now treat and view their children differently.  As a consequence, they 
experienced guilt and fear and this thesis provides an explanation for that guilt 
and fear. The horizon of the altered child's trajectory, therefore, resulted from 
an interpretation of the fears and concerns that the participants now believed 
were facing their children and future generations by introducing risk into their 
lives, including having surgery. It also resulted from the potential of getting 
cancer and the possibility of their children being without a mother, thus how 
children's lives would be altered. This next section will focus on the probands 
experiences of concern for their children and how the interpretation evolved 
leading to an ‘altered child's trajectory’.  It will demonstrate the attempt made 
by the probands to preserve the normal child trajectory. 
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4.4.1 The Kids Sake - Cancer Free Worry 
Before embarking on a  mutation test, surprisingly, probands reported that the 
initial focus and the importance of their need to know was for their children’s 
sake, rather than for themselves.  They talked of a moral obligation as a mother 
to be tested and to be pro-active, for their children's sake.  This concern for 
their children was echoed by the majority of probands who were afraid of not 
surviving or being able to care for their children as this would alter their child's 
life trajectory.  Two probands explain:  
‘Um, and I was quite paranoid, I kept thinking any symptom, 
this could be cancer because I knew I could have been 
carrying the gene, any little thing was like setting my mind off 
thinking or it’s something you know, is seriously wrong with 
me. I was back and forth to the doctors just quite paranoid 
really thinking or this could be cancer so I needed to know if I 
carried it or not and I wanted to be able to then do something 
about it cause I got two kids as well and I wanted to be able 
to say to them if anything does happen, mammy done 
everything she could to try and stop it so’ (P1). 
 
‘you know, and feeling that for our children and x knows that 
I’ve always like thought that I’ll never see, even when we were 
younger I used to say well I’ll be the first to die, you know. I 
just always used to think I’ll never see them get married, you 
know which is awful isn’t it’ (P3). 
 
The genetic test and subsequent surgery was therefore seen by the majority 
of probands as a means of preventing their death for their children's sake.  It 
was also seen as the right way to behave and the right thing to do as a result 
of being armed with the knowledge.  Proband six strongly believed that having 
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the test and surgery would save her life and the lives of others and she urged 
other women with children to do the same: 
‘I would say to people that have cancer in their family, is for 
immediate family to go down the same route, to go to the 
genetics, get themselves tested, have this (surgery) as an 
option because there is help out there, don’t hide in the corner 
and wait to die, because that’s what you could be doing if you 
don’t go. So in my experience, it’s better to get yourself looked 
at’ (P6, 12 months). 
 
As with the decision to be tested, probands believed they also had a moral 
obligation to make the decision to elect surgery for their children’s sake. 
Throughout their stories, probands gave various accounts of their decision to 
have RRM and their moral obligation to protect their children as a mother. 
Proband one, for example, reflected on the day she received the test result 
and thought about RRM, she thought ‘I’ve got to do it for my kids’ (P1).  Why 
did probands believe that they had to do it for their children and not themselves 
and only RRM would allow them to be there for their children? 
Probands believed that surgery would prevent breast cancer from occurring 
rather than waiting for cancer to develop which they all believed was inevitable.  
They feared cancer could be missed on screening mammography. Two 
probands had experience of cancer being missed on both their mothers’ and 
their sisters’ mammograms.   As for all probands, they wanted to avoid breast 
cancer and treatment at all costs, to protect their children.   Proband six 
explained why it had to be surgery: 
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‘So, I thought no I can have a mammogram and still end up 
with breast cancer and chemotherapy like my sister, so no, 
let’s do the preventative like. I said well they’ve offered us 
preventative surgery or regular mammograms but because 
my mother and sister had misdiagnoses, in the beginning, the 
mammograms missed the cancers. I don’t trust 
mammograms’ (P6). 
 
They were electing RRM for their children's sake because  it was the means 
of preventing any chemotherapy or distressing treatment that the children 
would have to witness, in addition to the  possibility that the probands could 
die.  For example, RRM they believed, would prevent their children from 
having any psychological suffering, allowing them to have a cancer worry free, 
childhood.  They did not want to burden them with this worry.  What suffering 
were they trying to prevent?  If breast cancer did occur, their children would 
have to witness the distressing effects of the treatment such as vomiting from 
having chemotherapy and the stigma associated with hair loss, thus a 
disruption to normal family life.  They wanted to prevent that from happening 
because of the perceived long lasting psychological effects. Proband two 
reflected on the effects of cancer treatment on her son at the age of five when 
her mother-in-law had breast cancer and the need to protect him: 
‘Umm, I don’t want them to see me go through lots of surgery 
with chemotherapy and losing my hair.  My son was five when 
my mother in law had breast cancer and lost her hair and he 
talks about it now so it is obviously buried in his head. I don’t 
want to put that risk in their lives; I don’t want them to go 
through it’ (P2). 
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4.4.2 Preserving the Childs Trajectory - Maintaining a Normal Childhood 
Maintaining a normal childhood for their children by excluding any risk or 
stigma attached to having cancer and undergoing treatment was poignant for 
many of the probands but particularly proband one, who explained what it was 
like for her as a child whose mother was undergoing treatment.  She had vivid 
memories of how disruptive this was on family life. She wanted to prevent that 
happening to her children at all costs: 
‘I said to my mother if you could go back in time and like ,if my 
father would have had the choice, would he have wanted you 
to prevent this so obviously he wouldn’t have had to go 
through and my mother wouldn’t have to and us kids cause it 
was hard and I just can remember being a kid and I don’t 
wanna do that, I would rather them see me like this for the 
next couple of months, getting over it than going through the 
chemo and we were going to like people’s houses and we 
weren’t seeing, you know, when she was going for chemo and 
everything, we were out of the house a lot and I would rather 
do this now’ (P1). 
 
Probands were also concerned about their children’s risk of cancer.  Why were 
so worried about their children's own risk of cancer especially being so young 
or yet to be born?  Probands soon realised that their children, both girls and 
boys had the same 50% chance of inheriting the gene which they perceived 
as extremely high.  This meant that in addition to worries about possible cancer 
treatments if they themselves were to get breast cancer, they were now faced 
with fears about their children having a positive mutation and getting cancer. 
This fear had now changed their child’s life trajectory.  For proband two this 
was her main concern: 
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‘I think like I say, you don’t think it’s you, so my first reaction 
when I was told was what about my children because this 50% 
thing obviously because it’s your genes, was more of an issue 
at the time for me’ (P2). 
 
Thus, all probands were extremely anxious and frightened about passing a 
gene to their children and to future generations.  They were particularly scared 
that once the children knew, they would feel differently about themselves, be 
seen as different by others and be burdened with the need to make major 
decisions about having a test and having children of their own.  Proband six 
explained the extra worries she now had: 
‘The worry, it’s not just about myself, I’ve got a daughter and 
a grandson and a son who wants children, it’s about them as 
well’ (P6). 
 
However, most of these concerns and fears were gender specific, with a focus 
on girls and their future risk and decision-making.  Their fear concerned their 
daughters, specifically the decision of electing to have RRM which consumed 
the majority of probands.  Probands experienced fear and sadness when 
thinking about their daughters because of the implications for their breasts. 
This meant that they could not relax and enjoy their children growing up.  Two 
probands share their fears: 
‘And then you’ve got to think about your own kids, that’s the 
biggest thing for me and I think oh my god I’d hate her to go 
through all this so what I’m really, really frightened of is 
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watching my daughter even contemplate going through it. I 
look at her and I just want to cry because she’s got to make 
these decisions one day and I find it so hard’ (P2). 
 
‘Yeah, just the way, if I’m in the bath and she walks in trying 
to cover myself, trying to dress, trying to make these stupid 
decisions which you know and I think oh my god, I’d hate her 
to go through all this’ (P5, eighteen months). 
 
 
The process of testing, disclosing a mutation in the family, decision-making, 
and fears about RRM for all probands had now shifted to concern for their 
children.  All these factors had changed their children's life trajectory. Their 
anxieties related to the timing of telling their children, but mainly to the decision 
of electing to have breast surgery, including the effect it could have on the way 
they and others would perceive them. Proband four who did not yet have 
children was already worrying for example about dealing with a daughter who 
asks for advice, concerned about the amount of pressure that her daughter 
would be under and  the effect it could have on her daughter’s future life and 
relationships: 
‘Yeah, I’ve got a risk in life, for life, it’s easier for me at the 
moment as well because I don’t have children, when children 
come along that, and that’s made me worry as well about the 
relationship I’m in because I’m very comfortable and confident 
but if a twenty year old daughter of mine, you know at what 
point do you tell  them, at what point do they decide I can’t do 
this yet mum, you know no boy will look at me and at what 
age, it puts a pressure on them and you think oh we didn’t get 
together until I was thirty but it could be that, you know at thirty 
the risks are still high and if they’re still single as I was at thirty 
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and career wise as well, I don’t know it will affect their career 
so there are all those kind of things to worry about’ (P4). 
 
4.4.3 Hope for Future Developments in Medicine 
In order to manage the worry and fear which persisted up to the 
eighteen-month interviews, about their children's altered life trajectory, many 
probands wanted to believe that their children had inherited their husband's 
genes or hoped for alternative future treatments that either replaced the need 
for surgery or could stop the gene from being passed on.  Proband two could 
only deal with it all by thinking this way: 
‘And then you’ve got to think about your own kids, that’s the 
biggest thing for me.  I’ve said at the moment we cannot 
control it and in my head I’m saying she hasn’t got my genes, 
she’s got his and that’s what makes me get through it but now 
and again something will click and I’ll think oh my god and I’m 
looking at her thinking.  You know there might be a pill to fix 
the faulty gene’ (P2, eighteen months). 
 
These concerns for their daughters were echoed by all of the probands.  Why 
was this the case when their daughters may make different choices or may not 
have a mutation?  It was because of the devastating effects of surgery on the 
body and potential relationships. Many hoped that there would be an 
alternative to surgery for their daughters and future generations because of 
their own experience and effects to the body.  One proband relayed a difficult 
conversation that she had when her daughter had already started to worry 
about her own risk instead of enjoying her youth: 
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‘Yes because she (daughter) said to me today, what could I 
do and I said perhaps like things will be different and it’ll just 
be like a little tablet she can take when it comes to, but she 
said what would you do and I said I don’t know, I don’t think I 
would have done it(had surgery) if I had the choice again. Had 
I known now, I would have felt like this, it’s just physically, I 
am absolutely drained’ (P5, 6 months). 
 
4.5 A Separation from Self - Post Surgical Experiences 
The final horizon of understanding, ‘a separation of self’ resulted from the 
interpretation of the experiences following surgery including a separation from 
the fear of breast cancer.  The literature review had identified that body image, 
sexuality including femininity and identity are impacted as a result of RRM 
(Hatcher and Fallowfield, 2003, van Oostrum et al., 2003, Brandberg et al., 
2012; Gopie et al., 2013).  In particular, the latest studies by McEwan, 2011 
and Hallowell et al., 2012 identify the consequences of such surgery and offer 
useful insight into the experiences.  However, the latest studies also focus on 
the experience of undergoing RRSO and include women with breast cancer, 
whereas the focus of this study is BRCA positive women and RRM.  Thus, the 
interpretation of the experiences of the eight probands in this study, offer 
insight and a contribution to existing knowledge  as  to the reasons why women 
experience such impact, which led to the expanded horizon of understanding. 
The next section, therefore, presents both the positive and negative effects of 
electing RRM through the interpretation of the probands experience leading to 
the third horizon of understanding ‘a separation of self’ and the expanded 
horizon of understanding that of ‘disembodiment’. 
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4.5.1 Separation - The Fear Has Gone 
In support of many of the studies identified in the literature (McGaughey, 2006; 
Hallowell et al., 2012; Hagen et al., 2014; Glassey et al 2016), all probands 
felt a great sense of relief post-surgery because the risk and fear of breast 
cancer had gone.  This was an immediate effect especially if no cancer had 
been found, they, therefore, experienced a separation from the fear.  One 
proband, for example, explained how she now ‘never gives it a second thought’ 
(P4). Another commented on how the ‘risk has gone and so I never think about 
it’ (P2) and a third made the point ‘Great, I have got nothing to worry about 
now’ (P8).  Proband three explained the overwhelming resolution of fear when 
she woke up from surgery and the enormous amount of relief knowing that no 
cancer had been found: 
‘Fear has totally gone, in like a massive way, in a way that, 
because I remember friends saying to me oh you’ll have such 
relief when you’ve done it and I must admit at the time I 
thought I’m sure I will feel relief but I think I will feel scared 
about what’s happened to my body. But actually, when I woke 
up I just felt such relief and no fear about what had happened 
to my body, it was quite sort of empowering really I just 
thought oh you know, no cancer now’ (P3 6 months). 
 
‘And felt a huge sense of relief afterwards, huge. And to know 
that it had all come back clear, and x had her mastectomy and 
reconstruction in early November/late October but it didn’t 
come back clear.  Umm so it came back, first of all, they said 
that they that there was pre-cancerous cells, and then they 
actually called her in to say they had found a tumour in the 
nipple duct’ (P3, twelve months). 
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This resolution of fear continued for all probands and was evident at eighteen 
months post-surgery.  It was a huge and difficult decision to elect to have RRM 
but many probands had feared cancer for such a long time and had now been 
separated from the fear.  They had elected such surgery in order to be freed 
from this fear of cancer.  Proband five explained: 
‘I don’t even think about the fear any more. I think of all that 
I’ve done and to me, that has eradicated that because I 
haven’t gone through all that to have fear so that’s gone. Oh 
god, yes for me it has, yeah, I don’t even think about that’ (P5, 
18 months). 
 
4.5.2 Separation - No Return to Normality 
Although the fear of cancer had gone, the majority of probands expected to 
recover from surgery more quickly than they did and return to normal life.  They 
underestimated the pain and the length of time necessary for recovery. This 
delay in recovery occurred for a number of reasons. If there were 
complications with infection (P2, P4, P5, P6, P7, P8) or probands were 
dissatisfied with the cosmetic result (P2, P4, P5, P6, P8), or needed further 
surgery, this delayed a return to normal life.  One proband, for example, lost 
both of her implants due to infection and this further delayed recovery.  For all 
probands, it was important to get back to work and to normality but many were 
experiencing and dealing with complications over a year post-surgery and 
waiting for more surgery.  Proband four explained her problems: 
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‘The infection I had, actually that put me back in hospital for 
10 days and that was more painful than any surgery I have 
had. Well I guess over the last twelve months it’s hard to 
ignore the fact that the implants had to come out, so it’s a year 
on, I hoped at the time when I was making the decision 
originally that it would be one operation all done and dusted, 
twelve months on I would be you know, kind of well and truly 
over it and moving on whereas at the moment now I’m still 
waiting for my final operation. So, the cycle isn’t complete yet, 
so the downsides have been that yes it hasn’t quite been the 
smooth process that I’d planned. and the other side of the coin 
in that period after the implants had to be removed I had 
something like three or four months with nothing at all, with 
completely flat, no implants in and I found that quite liberating 
and its only kind of just served to remind me that I’m quite 
comfortable in my skin, it was definitely the right decision for 
me’ (P4, twelve months). 
 
The majority of probands also experienced the surgery itself as much more 
painful than expected and there were a number of unexpected physical effects 
even after six months, which prevented them from returning to normal.  Many 
experienced a lack of strength and mobility in their arms for example and also 
expected the recovery to be as quick as the ovarian surgery.  It was therefore 
frustrating and a big shock when they were not as active or could not do their 
usual activities. Two probands explain: 
‘I can’t put any weight on my arms; I couldn’t get up from that 
position if I tried.  I noticed through physical things when I try 
to do something the lack of strength or the pull or the aching 
because of, because I use my arms a lot but I don’t sit and 
think look at the state of me or nothing like that’ (P6, six 
months). 
 
‘I probably under estimated the amount of pain and the 
mobility if that makes any sense, because from the surgery I 
had before(hysterectomy) within two weeks I felt fine, I was 
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up and about driving and things but this time after five weeks 
I still wasn’t driving, which for me is a massive shock because 
I’m so active but in my mind and physically I knew I couldn’t 
do it because it was too much pain and I’m not sure, because 
I’ve researched it as well post op, whether the pain I was 
getting was due to the muscles because they were tight or 
whether it was the surgery and probably a bit of both. It hurts 
all the time and it’s the weirdest feeling because it feels heavy; 
it feels really, really heavy’ (P2, six months). 
 
Indeed, the pain, the fatigue and the effect on their lives continued for most 
probands beyond twelve months and this emphasised what an ordeal it had 
been for them.  It also emphasised that they had not realised the enormity of 
the surgery or had not prepared themselves for it.  Furthermore, despite all the 
physical and emotional effects experienced following surgery, many of the 
probands soon realised that they had returned to work too soon.  On reflection, 
they had not given themselves enough time to come to terms with what had 
happened. Thus, for many probands, this long process was continuing as 
there were still outstanding operations to complete their reconstruction which 
some family, friends and work colleagues did not appreciate.  Two probands 
explain their experiences and the unexpected consequences of surgery: 
‘I think I under estimated it, yeah, I think I did and also 
because it’s been longer than I thought it would be. I think in 
hindsight it was a stupid thing to do because I didn’t give 
myself the opportunity or the time to come to terms with what 
went on.  Because as soon as my butt was sitting on that 
chair, because I was back in work and I feel that, not that I 
want anyone to feel sorry for me because I’m not like that or I 
don’t want people saying are you okay, because I’m not like 
that either but I feel as if, not just work but my family, have 
certainly oh well she’s back to herself, where behind closed 
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doors, they don’t appreciate what I’ve still got to go through’ 
(P2, six months). 
 
‘I think I was completely and utterly naïve in terms of the pain 
and I am not a very patient person and so it’s about a year of 
your life really and I don’t think I really appreciated the level of 
pain, how rubbish I feel at points, not all the time but how all-
encompassing it was going to be’ (P7, twelve months). 
 
4.5.3 Separation - Regret and Loss of a Former Self 
Despite the long recovery and emotional effects, seven of the eight probands 
had no regrets about having elected RRM and believed it was the right 
decision.  Proband one was particularly sure:  
‘I am so glad I done it; it was definitely the right decision 
(laughs).  Like my mother was saying, everyone was saying, 
any regrets?  I said no I will do it all again tomorrow if I had to, 
for me it was like 150% the right thing to do’ (P1). 
  
For one proband, however, there was a deep sense of regret in electing RRM. 
The drastic changes to her body and the way she now looked, made her 
question if it was worth doing.  It had affected her intimate relationship with her 
husband and she wanted to hide away.  Proband five believed that screening 
would have been the better choice because she now found her body repulsive: 
‘I’d say about two or three months ago I was sorry I had it 
done, I kept looking at them and thinking oh my god they’re 
gross and whatever.  He can’t touch.  No, no. He wouldn’t 
want to anyway, the way they look.  He doesn’t say anything 
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but.  Yeah, I wouldn’t let him touch them. I don’t like him 
looking at them, no they are disgusting. Yes disgusting, they 
are, honestly, they are.  I wouldn’t have had it done if I had 
known I would feel like this, would put up with the risk and just 
be tested regularly. Yes I wish I’d done that to be honest with 
you (chosen screening) rather than go through with all this 
because life is so short and you don’t realise how short life is 
and then you think you’re putting yourself through all this and 
I don’t know, is it worth it’ (P5, twelve months). 
 
Why did she find her body so disgusting?  Despite seeing the photographs, 
like many probands, she was expecting ‘proper’ breasts.   Instead, she felt she 
‘looked like a man’, masculine, not feminine and this was not regarded as 
normal.  To be a woman was to have breasts that both looked and felt like 
breasts.  These expectations were echoed by many probands. Proband two 
for example, similarly believed she was ‘looking like a boy’ because she had 
no nipples and her breasts were flatter. Proband five explained why she 
thought she looked like a man and what she was expecting: 
‘I didn’t think it met my expectations after I had it done 
because you know what it’s like, I think you have this picture 
in your mind, you’re going to have proper boobs and it’s not, 
it’s basically not like that is it. Because there was no nipples 
and I thought it looked a bit like, like a man’ (P5). 
 
4.5.4 Separation - No Longer a Feminine Body  
Looking feminine and like a woman should look was important for all the 
probands who were still relying on reconstruction to replace their breasts and 
make them feel feminine.  However, this was not the case and many probands 
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hated the way they looked. As a consequence, the majority now avoided 
looking at themselves and did not allow their husbands to see them undressed. 
Thus, many probands tried to disguise their bodies by wearing clothes that 
were different to what they were used to. Proband five particularly hated her 
body: 
‘I just don’t look at them; I try not to look at them because I 
think if I looked at them too much that would bother me. I’d 
probably cry because of the way they look.  Yeah, obviously 
miss the way they look because they obviously looked better 
before didn’t they. Oh my god, I hate my body. I don’t know, I 
didn’t mind. I suppose you dress differently. I think I hide under 
baggy clothes and stuff now. Oh my god, I hate the way they 
look. It’s just their totally shapeless and there’s like, I mean 
I’ve got that much hanging skin underneath so there’s more 
hanging skin than there is boob, too be honest’ (P5, twelve 
months). 
 
The efforts to hide their body and maintain different disguises was exhausting 
for many probands especially if they had not told their children.  One proband, 
for example, whose husband had insisted on not telling their children about 
the surgery, was constantly under pressure to hide away because of the 
shame she felt and she did not want to upset her children. Proband two 
explained why it was so difficult for her: 
‘So, I, as much as I disagree, it was easier to agree (not to tell 
the children). The frustrating thing about it is for me with it, is 
getting changed and bathing because my son walks in and 
out and all sorts right and last night he unlocked the door and 
came in the bathroom and in the mornings, we’ve always 
done it, the kids get up in the morning and come into our 
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bedroom, in our bed and watch TV. I find it difficult now 
because all my clothes, his are in a separate room, his 
clothes, he sleeps in our room, all my clothes, everything are 
in my bedroom and I’m trying to get out of the bath, across the 
landing and I’m like this with the towel and I’m finding that that 
pissed me off this morning really bad because the kids were 
in bed, in our bed, I get out the bath and I’ve got to adjust a 
towel around me and I’m trying to hide’ (P2, six months). 
 
Although seven of the probands had no regrets about RRM, many of these 
probands were also ‘unhappy’ with their body despite reconstruction.  One 
proband who was advised to undergo a delayed reconstruction equally found 
her mastectomy scars ‘horrible’ (P8).  Why did she think they were they so 
horrible?  The scars were uneven and looked ‘unfeminine’ because they were 
‘flat’.  This had adversely affected her confidence resulting in a total life change 
in which she became totally housebound: 
‘After I had the mastectomy, it made a bigger difference than 
I thought and I didn’t go out, I haven’t been out because I don’t 
have any confidence. I haven’t gone out and I used to go out 
quite often with my sister, which I am going to do again once 
things are finished. Even sunbathing out the back, because of 
the lumps, it is just horrible. It’s just not feminine is it’ (P8, six 
months). 
 
Why did the mastectomy scars affect proband eight so much and result in her 
being housebound?  Whilst waiting for her reconstruction, a flat uneven chest 
made her look like neither man nor woman.  This was unattractive, making her 
too conscious to go out, scared of what people would think.  She felt and 
looked different, she explains: 
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‘It’s ugly. You look like a man, don’t you? I don’t feel female 
any more if that makes sense? I was very conscious of it, that 
I looked like a transvestite or something’ (P8, twelve months). 
 
4.5.5 Separation from Self - Disembodied 
Looking ‘normal’ and feeling normal like a ‘real woman’ should was crucial for 
all the probands in terms of ‘being women’ and maintaining a sense of self. 
However, the majority were devastated about the way they looked because 
they did not feel themselves. This was because their bodies had drastically 
changed, they had many scars,they had no feeling in the reconstructed 
breasts and their breasts looked unreal.  It had therefore been a major life-
changing event with many experiencing that the loss of their natural breasts 
had split them in two, separated them from their whole self and their husbands, 
as though they had been disembodied.  Proband two explained: 
‘But I don’t like what I see, yeah just looking and thinking what 
can I wear to hide this today. I just see scars and ‘broken’, I 
don’t know, especially because I’ve got so much surgery I just 
look, like dot to dot and I just feel as if, I don’t know. He always 
says to me it doesn’t matter, you’re still you, he’s said that 
from day one in fairness to him and he doesn’t matter you’ve 
haven’t got them, it’s fine.  But I think deep down it does, with 
him and I think that makes me think differently about myself. 
Yeah, I think it just looks a bit, I don’t know what the word is, 
‘broken’ I guess. Whereas before you would have had feeling 
in your chest but I’ve got no feeling in my chest, I’ve got 
nothing there. Not real, it doesn’t feel real’ (P2, twelve 
months). 
 
The majority of probands therefore looked and felt very different about 
themselves and their bodies, which did not significantly improve over time.  
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Many continued to avoid looking at themselves in mirrors or avoided taking off 
their clothes because it was too traumatic, reminding them of the intact body 
they once had.  It also reiterated the drastic life changing effects on their body 
and the loss of who they once were.  Proband six explained: 
‘You look at yourself differently. I often stand there, you know 
through the stages and look in the mirror to have a look, and 
they’re obviously not as pretty as a normal breast would be 
out of clothes, I look at myself and think oh, don’t look in the 
mirror. I tend to look and then look away, but not just because 
I don’t know, it makes you look at yourself differently. You 
sometimes feel the same and yet you look different and I think 
people need to be prepared for that.  It’s not a pretty picture 
then, it isn’t’ (P6, six months). 
 
Consequently, as a result of this drastic change to the body and the way 
probands now felt about themselves, there had been major life changing 
consequences, especially for relationships.  Proband six explained the effects 
on her relationship: 
‘Because everything is different. My feelings are different, my 
body is different and everything is different for the two of us’ 
(P6, twelve months). 
 
Why did probands feel so different about themselves and why had 
relationships changed?  It was difficult for most of the probands to accept the 
reconstructed breasts as ‘their breasts’ or refer to them as ‘my breasts’ 
because the breasts did not move like their real breasts, look like real breasts 
or behave like real breasts for example even with time, the sensation was still 
altered which affected their relationships.  The majority felt disconnected from 
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their breasts, disembodied, as they tried to accept a new self.  Proband four 
explained how she viewed herself: 
‘It’s weird because when I talk about them its ‘these don’t 
move’, but I haven’t thought about it in the sense of these are 
mine, it is just this is me now. More sensation has come back 
and so that makes it easier. They still feel numb in certain 
places. I have knocked into things and not realised which is 
fine because it doesn’t hurt but I realise when I am about to 
knock a chair over or something. I couldn’t feel them. They 
don’t fully feel like me’ (P4, eighteen months). 
 
The probands did not feel ‘themselves’ anymore because the drastic change 
in shape, size and sensation of their breasts especially when they were 
undressed, was not who they once were and reminded them of what they had 
lost.  Proband six explained why: 
‘It doesn’t feel like me anymore because I was voluptuous, I 
was a big girl and now I haven’t got any and I feel a little bit 
that I’m unfeminine because of my shape. Not so much in 
clothes, in clothes, I can handle it but out of clothes because 
they’re behind that pectoral muscle, if you bend or make a 
movement they distort so badly that that’s when I don’t like 
looking at them’ (P6, twelve months). 
 
4.5.6 Separation from The Intimacy 
The most drastic changes in relationships involved the lack of intimacy and 
probands were willing and needed to discuss how their sex life had been 
negatively affected.  The majority of probands complained that there was no 
feeling for them in the breast thus could not get aroused or feel any pleasure. 
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Their breasts did not feel natural to those who touched them, making probands 
self-conscious and embarrassed.  The implants also felt firm which meant that 
their husbands found it difficult to touch them, often avoiding their breasts. 
Many probands, therefore, continued to cover themselves up or avoid 
intimacy. Proband two explained:  
‘And if you touch it it’s really, really strange because there’s 
no feeling there. I think he struggles that I avoid, if we are 
intimate I’ve always got a vest on, he finds that really hard. He 
doesn’t touch at all. He doesn’t even touch me. Because he’s 
never tried, so I don’t think he can. I think he thinks it’s horrible 
but he won’t tell me that. He won’t say that to me, but I know 
that’ (P2, twelve months). 
 
Wanting to look and feel womanly, feminine and attractive especially during 
intimacy was essential for all the probands but many probands avoided sex 
because they did not feel attractive and were ashamed.  Even for the minority 
of probands who did not have any complications with the surgery, who were 
pleased with the outward appearance of the breasts and who did have sex 
post-surgery, it was still very difficult for them to feel feminine and attractive.  
Why was this the case?   There appeared to be a mismatch between what 
they saw in terms of an acceptable breast shape and what they felt. It is 
proposed that these women, like those who avoided sex felt this way about 
themselves due to feeling ‘disembodied’. Proband three for example, despite 
being pleased cosmetically, still did not feel like a woman: 
‘As time’s gone on we’ve found, you know I’ve been totally 
happy with the reconstruction, really happy with the scarring 
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and everything else but I have found it difficult from a womanly 
perspective and that is something that I think, you know 
initially so relieved to get over the operation, so pleased about 
the cosmetic result and things but actually you know as time 
goes on and your mind settles I do find it hard to feel womanly 
which is odd because from the outside nobody can tell 
anything different but I think just psychologically I do find that 
quite hard. Yes I think it’s just feeling like a woman, it’s hard 
you know, sexual relationships is hard and because there’s 
not much feeling, you know at the end of the day, it’s hard. I 
don’t really feel attractive you know, even though I’ve got a 
much better cleavage than I had before’ (P3, eighteen 
months). 
 
Indeed, as a result of many probands feeling this way, some reported taking 
anti-depressants in order to cope with the effect that RRM and reconstruction 
had on their sex life.  The anxieties that probands had pre-surgery about their 
husbands finding them less feminine and less attractive were still vivid.  Many 
probands believed that the lack of sex in their lives was because their 
husbands were struggling to adjust to their bodies.  For one proband this had 
a major psychological effect which continued long term.  She explains: 
‘I look for reassurance, I just look to see if that’s what does 
put my husband off(sex) or not and he says I love you anyway, 
but I look for reassurance. I tend to cover up a lot more, 
clothing wise. I have, I had to go on Citalopram. I’m still on 
citalopram but I think without that I would be low, I do need a 
lift still. It has taken the stuffing out of me basically’ (P6, six 
months). 
 
‘Well I didn’t really know how I would feel, I was hoping I would 
feel better for it which I said I do because we eradicated the 
fact that I shouldn’t have cancer now. I didn’t know how I was 
going to feel, I suppose okay, the only thing I would say is 
affected in my life is my sex life as I told you before’ (P6, 
twelve months). 
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Wanting to discuss their sex life and warning women about the long-term effect 
on the sexual relationship was something that many of the probands felt 
strongly about and requested that it be an integral part of the pre-surgical 
information.   Proband five explained the significant effect the surgery had on 
her sex life even after eighteen months and why women should be forewarned: 
‘I think perhaps you should bring into your talk beforehand the 
fact that it does affect your sex life because obviously it’s a 
sexual organ and it’ll be gone, never to be replaced, it’s not 
just gone for a day, it’s gone for life and it’s a big effect on your 
life, perhaps you should mention that to people’ (P5, eighteen 
months). 
 
Many of the probands, therefore, felt different, very unattractive and 
unfeminine. In order to try and accommodate these drastic changes to their 
body and to appear more sexual to their husbands, some probands adopted 
various strategies to try and look more feminine.  Proband four, for example, 
wore pretty underwear to disguise the results of the reconstructed breasts: 
‘Just keeping a little bit of the ugly away. Although I don’t think 
of it as ugly but they are not attractive. It’s not to say the ones 
I had before were that brilliant either but just keeping away the 
scars and just wearing a nice pretty little cami top or 
something like that it actually helps to bring back a lot more of 
the feminine, sexy back into the relationship’ (P4, eighteen 
months). 
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4.5.7 Separation - Nipples to Preserve and Restore Femininity 
To improve the way they looked and to feel more feminine, probands chose to 
preserve the nipple (P7) or to have a nipple reconstruction with the areolar 
complex tattooed (P1, P3, P6).   Why did the nipple make so much difference? 
Nipples helped to make the breasts look more real, like they should look.  They 
also differentiated probands from looking male and masculine, a factor which 
was extremely important to them.  Nipples also helped take the attention away 
from the scarring and the fact they looked unnatural.  Two probands explain: 
‘I’m thrilled to bits, I’m so happy with it as well. I didn’t know 
whether I felt like I needed them done, but I’m glad now., I’ve 
always been happy from day one so it’s just like the finishing 
touch I just can’t believe how real they now look’ (P1, six 
months). 
 
‘Because I’ve had the nipples tattooed on haven’t I, so that 
made me feel a bit better immediately because you had a 
focus, you looked before a big bump, now you look and 
there’s a centre of attention. I think it makes them more 
realistic’ (P6, twelve months). 
 
Indeed, some probands who were frightened about losing their nipples 
pre-surgery were able to get on with their lives, feeling more  ‘normal’ after 
having the nipples reconstructed and tattooed.  The husbands of these 
probands were also very pleased with the nipple surgery and tattooing which 
was important for the probands, who very much considered what their 
husbands thought of their bodies.  Proband one explained: 
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‘Marvellous, it’s like everything was normal like, even from, he 
was brilliant, he always has been but as soon as I was back 
to normal in myself, everything else went back to normal. 
Yeah, completely part of me, I think he feels the same, well I 
don’t, I think he’s really happy and you know when I had the 
nipples he was thrilled, they were amazing, you know they 
couldn’t have done a better job if they tried’ (P1, eighteen 
months). 
 
However, having just a nipple reconstruction without the tattooing did not have 
the same effect because this still made the probands still feel masculine.  The 
tattooing of the areolar therefore completed the process and made the breast 
look more female and thus the probands feel more feminine.  Proband three 
explained the difference an areolar made to her femininity: 
‘This is good and it has now all come together. It just shows 
how important the tattooing is, just a nipple on its own made 
me feel in some way masculine because men have pecs, the 
nipple maybe you don’t see, it’s the areola. I don’t really know 
why psychologically I felt it because obviously, I had 
something, I had a nipple whereas previously I hadn’t had a 
nipple but I just felt a bit manly, I couldn’t really put my finger 
on why and I thought that’s really strange because I was so 
excited about having nipples and it wasn’t like I was unhappy 
with anything because the result was great but I just didn’t feel 
very womanly for some reason’ (P3, eighteen months). 
 
The effect of seeing nipples made a huge difference to the way probands were 
able to live their lives.  As predicted pre-surgery, many probands confirmed 
the positive difference having nipples would make.  Proband seven, who was 
the only proband to preserve her nipples, reflected on her decision and the 
result.  It had helped her to cope by disguising the scarring from the outset.  
She believed that her breasts looked more normal with her own nipples: 
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‘Yes, I’m really happy about it. I think it was the right decision 
for me at the time and actually I, yes, I think so and I think it’s 
helped disguise the scars as well because they’re obviously a 
bit darker the scar just doesn’t look red and you can’t see the 
scar at all.  So, I think visually it’s helped and I think it’s helped 
me cope with it all. They look to me like normal breasts’ (P7, 
twelve months). 
 
However, there was a difference in seeing a nipple and feeling sensations in 
the nipple, which remained a challenge.  Because there was now no sensation 
even in the normal nipple, coupled with the reconstruction, proband eight like 
many other probands also felt disconnected from her breasts: 
‘The nipple area I can’t feel anything, it’s literally just the 
sensation of the bag pushing on the inside so that’s strange 
and I suppose I’m never going to, that’s not ever going to 
come back, is it. There’s nothing there. It is a bit weird that 
you can’t feel anything and that’s a bit odd really’ (P8, twelve 
months). 
 
4.5.8 Separation - Still Not Me! 
Despite the efforts that probands made to look and feel more feminine, many 
were still experiencing problems with the way they looked and felt about 
themselves and their bodies at eighteen months.  Some probands who had 
completed their surgery and thus were living with the final cosmetic result were 
now very different people.  Proband two, for example, who was extremely 
self-conscious believed the reconstructed breasts were not part of who she 
once was and she shared her experience of how much she missed her own 
breasts:  
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‘I don’t know, I think they’re just part of you(your own breasts) 
and you don’t realise until they’ve gone, I didn’t realise and I 
don’t think I’ll ever be the same, I don’t think I was very open 
anyway if that makes sense, I wasn’t one to walk around my 
house or with my friends and just strip off, I was never like 
that. This has just pushed me completely over the other side 
you know. I feel extremely conscious because I don’t like the 
look of them’ (P2, eighteen months). 
 
Indeed, those probands still waiting for further surgery could not move on with 
their lives until it had been completed because they hoped it would make them 
feel more like themselves.  As a consequence, probands continued to be very 
self-conscious about their bodies.  Proband seven, for example, who was 
obsessed about her appearance needed to have her reconstruction finished 
in order to feel and be herself: 
‘Well I’m so fanatical about my appearance, not that you’d 
know it looking at me at the moment but I’m very self-
conscious about my weight, always have been, very self-
conscious about my stomach even down to like my 
appendicitis scar which hasn’t healed particularly well, I’ve got 
a lot of loose skin on my tummy and to not have any breasts 
and I’ve always had very large breasts for my size so I’ve 
normally been, I’ve always been about a double D or an E, 
possibly going up to an F at some points. So, at the moment, 
I’ve got a very small chest for me at the moment so I can’t wait 
for them to be finished’ (P7, twelve months). 
 
The difference in the way probands perceived their bodies was not only related 
to the physical aspects of the surgery, but to the whole process they had 
endured. This included the inheritance of the gene, the constant fear of cancer, 
electing to have the surgery, the worry about children and the process of 
coming to terms with everything. Most probands felt that they had now 
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changed as a person. They had become far more concerned and anxious 
about their family and the whole journey had been traumatic and all 
consuming. Proband three reflected on the journey: 
‘I still think that when you are in a big worry sort of mode and 
this has been going on for years because of Mum and x and 
then all the decisions around this, I think it changes you to a 
point. It makes you more serious and worry about the people 
that you love, you just want to protect everybody and I think 
that now I have done everything, I would like to get back to a 
point where I am, sometimes I think I just feel a bit low but not 
because I am depressed I think it is just the amount that has 
happened. That has been over a period of 13 years and it 
hasn’t all been hard but there has been a lot of difficulties and 
I would like to feel a bit more lifted and I think that will come 
now that everything is moving on’ (P3, eighteen months). 
 
4.5.9 Help to Restore Self 
As a result of all these changes to their bodies, all probands expressed a need 
for support, information and psychological support from the professionals both 
before and following surgery.  Some probands did receive support from their 
family and friends with physical activities such as shopping and house work, 
but in other families where there was tension about their decision to proceed 
with surgery, little physical or psychological support was received.  Proband 
six explained: 
‘They (family) don’t ask really, no.  Even though they’ve been 
through it, like I say we’ve always been there for them, there’s 
us we’ve had cancer, there’s you, you haven’t and you’ve 
done this of your own accord, so they don’t really ask us how 
we are’ (P6, twelve months). 
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What Psychological support was needed by probands and why did they feel 
this was necessary?  Access to counselling and information was deemed 
important especially post-surgery, including access for their husbands who 
many probands felt were not coping.  Many of the probands recognised that 
their husbands did not have anybody to discuss the whole experience with, 
especially any intimate problems, especially if their husbands had been sworn 
to secrecy.  In particular, probands worried about how their husbands were 
coping with the loss of their breasts, especially when parents had also shown 
concern that the relationship may not survive.  One proband explains: 
‘with him, I do worry about him because he does keep himself 
to himself and I do worry he’s not telling me everything he’s 
feeling, cause my family were worried that he may not feel the 
same cause my mother has seen herself being down in that 
in that, men don’t stay with their wives after stuff like that. But 
I worry that he hasn’t had enough people to talk to or get 
support from throughout the journey of it all’ (P1, twelve 
months). 
 
Furthermore, because many probands had experienced a separation from self 
thus feeling less feminine and disembodied, the need for  counselling and 
support for themselves was also highlighted.  Why did they feel counselling 
was necessary?  All probands needed to be prepared by professionals for the 
effects of RRM on their sexual relationship in particular and be able to discuss 
their concerns pre-surgery.  The sexual aspect of their lives pre and 
post-surgery was not discussed and more preparation about the potential 
sexual difficulties with the ongoing support post-surgery to deal with the 
  
244 
 
relationship issues was necessary.  Proband six who needed that support 
particularly made the point: 
‘Nobody tells you that bit, nobody tells you what’s going to 
happen after. there’s fantastic support all the way up, yeah, 
and you get told what’s going to happen, when you’re going 
to do it but as soon as you have the operation in terms of how 
you’re going to feel sexually or physically, who tells you that 
bit’ (P6, twelve months). 
 
As many of the probands were shocked and devastated with the cosmetic 
results, on reflection, they believed that an opportunity to see a patient 
volunteer who had undergone the surgery would have helped them 
psychologically by setting realistic expectations and easing the blow.  They 
particularly wanted to see the final cosmetic result of a range of real people 
who had been through the same experience, but who had different surgical 
outcomes, both good and bad.  Others also believed that having this 
opportunity may even challenge decisions, questioning whether the technique 
is the right one, or indeed whether surgery is the right decision. Some 
probands, for example, may not have gone ahead with surgery and may have 
taken a different path had they seen the results on a real person. Two 
probands explain: 
‘I think having more access to people who’ve had it done and 
seeing a range of what it looks like would help because it 
helps your understandings and shapes your expectations for 
the op’ (P7, six months). 
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‘You know you should ask people like me and x to show the 
results, instead of photos, ask us to show the results, real 
people.  Because I don’t know, perhaps like me, they might 
think do I really want to put myself through that. You don’t 
know, do you? I think perhaps if I’d seen the real thing I would 
not have gone through with it’ (P5, twelve months). 
 
Probands again reflected and acknowledged the importance of having the 
opportunity to see the photographs pre-surgery and the chance to discuss their 
options.  For all probands, they had benefitted because this had given them 
some idea what would be happening to their body and gave them an 
opportunity to change their minds.  Proband three, for example, after seeing 
the photographs and having the opportunity to go over the implications of 
reconstruction, soon realised that she was not ready for the surgery:  
‘I think us talking it through, has made my mind set slightly 
different as well and just sort of thinking you know because 
obviously when I last saw you I was thinking yes lets go for 
the summer and then after seeing the photos and talking to 
my cousin, and thinking, and talking to my husband obviously, 
I just thought right actually you need more time, if time is on 
our side, but just when, so that our minds are ready for it and 
also what type of operation’ (P3). 
 
In contrast, the disadvantages of not seeing any photographs were also 
highlighted.  One proband for example, who was fortunate to elect to have a 
new procedure, with an implant based reconstruction and pigs skin (strattice), 
did not see any photographs because of its novel technique.  Although she 
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had a plastic surgeon involved in her surgery, she had little understanding of 
what to expect and little idea of how she was likely to look and feel: 
‘I don’t think I really saw any photographs in x, he drew 
pictures so I could understand it but I didn’t see any 
photographs other than I was being reassured I would have 
that natural droop, that was kind of all the reassurance that I 
had, that was it. What I’m still, what I struggle with sometimes 
is if I’m getting a pain or a feeling or a sensation and I think 
oh gosh what’s going on now, here we go, I think for me I 
would have liked an even more detailed understanding of 
what they did, to understand, for quite a while it was pulling in 
some places and I was feeling that really quite, actually 
physically unbearable, I didn’t like the sensation it was really 
horrible’ (P7, six months). 
 
However, seeing the photographs was only part preparation for the extreme 
changes to their bodies.  All probands, therefore, talked about the need for 
ongoing support, more consultations especially if there were complications 
with the surgery or a need for more surgery and counselling to adjust to their 
bodies.  Ongoing support from women who had personal experience of such 
surgery or from support groups was also identified as being beneficial to 
restoring self.  Two probands suggest what could help them and others:  
‘Yes, but you need more consultations and not be too far apart 
because what I’m finding is the consultations are so far apart 
you forget what you’ve asked, you forget the information, you 
kind of want them a lot closer. So, you want a couple of weeks 
to mull something over and then go back, not go back six to 
nine months after, there’s too long in between’ (P7, twelve 
months). 
 
‘I don’t know, perhaps a little bit of counselling after maybe, 
you know.  Sort of like, like some ladies who’ve had it done 
meet up and then discuss. Yeah, like a support group or 
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something like that. It would be nice for people to know what 
they’ve been through’ (P5, twelve months). 
 
4.6 Conclusion of Probands Findings 
The probands’ stories were powerful accounts of the impact of the inherited 
BRCA mutation and RRM.  Although their fear of breast cancer had resolved, 
the fear was now for their children, who they saw as having an altered child 
trajectory.   As a result of RRM, despite reconstruction of the breast and nipple, 
all probands experienced an alteration in themselves as a person and a drastic 
change in their bodies as women with one proband experiencing deep regret 
in having elected to have RRM.  Thus, by electing to have RRM and losing 
their breasts, probands experienced a ‘separation from self’, their whole self, 
as a result of ‘disembodiment’ which did not improve significantly over time 
and for which they required support and counselling long term.  This new fused 
horizon of understanding, that of ‘disembodiment’ offers a new contribution to 
existing knowledge by offering an explanation as to why women experience 
such negative effects on identity, femininity and sexuality and feel separated 
from their whole selves.  These findings have implications for practice and the 
wider breast care community and thus, identifying the symbolic significance 
and functionality of the breasts for women with a BRCA mutation who elect to 
have RRM, is essential. The next chapter presents the experiences of the 
husbands. 
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CHAPTER FIVE – The Husbands’ Experiences 
5.1 Introduction 
This chapter explores and interprets the experiences of the five husbands in 
this study.  The men were aged between twenty-four and forty-six years and 
they were all in full time employment except for one who had left the Army. 
Two were professionals, two were manual workers and one was ex-military. 
All but one of the men had children.  The men were interviewed either in their 
own homes or in the breast centre and they were interviewed just once before 
and once post-surgery due to time constraints.  It was felt that at twelve 
months, they would have had enough exposure to the lived experience that 
would enable them to tell their stories and increase knowledge.  
 
The probands who took part in this study had asked their husbands to consider 
the study and contact the research nurse if they wanted to participate.  Five 
husbands came forward.  This chapter interprets the experience of living with 
a BRCA mutation and surgery from the husbands’ perspectives.  Three 
horizons of understanding found in the experiences of the probands unite the 
experiences of the husbands and the family members, the price of survival, 
the altered child's trajectory and a separation from themselves.  Each horizon 
will be presented alongside the interpretation of their stories which led to that 
horizon of understanding.  The price of survival will be presented first, followed 
by a separation from themselves and the altered child's trajectory.  The 
pre-surgical experience will be followed by the post-experience. 
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5.2 The Price of Survival - Pre-Surgical Experiences 
The Survival of their wives and their children was the main focus of the 
experiences of the husbands in this study.  However, there was a price to this 
survival which included the long journey of discovering and making sense of a 
mutation in the family, the difficult decision of testing and the decision to elect 
to have risk-reducing mastectomy, concern about the effects of RRM on the 
relationship and living with ongoing concerns about their children. The next 
sections provide the reader with that journey.    
 
5.2.1 The Price - Finding Out About a Gene in the Family 
The husbands in this study only became aware of a BRCA gene mutation once 
the probands had attended the clinic to discuss their risk, this was the result 
of other family members initiating a test.   Although family history was a term 
they were familiar with, the link with an actual gene that caused breast and 
ovarian cancer was all new information that shocked them and took some time 
to comprehend.  They were aware of young family members dying of breast 
or ovarian disease and that cancer was in the family but many husbands had 
not attended the genetic clinic appointments with their wives thus the full 
implications of a BRCA gene, for example, the cancer risk and the surgical 
options, was difficult to understand even after time had elapsed.  As husband 
five explained: 
‘It is in the family; a lot of her family have passed away very 
young through cancer you know’. Well I heard of breast 
cancer but I never heard of like the BRCA gene sort of thing 
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before, I couldn’t understand a lot of that; I still don’t 
understand a lot of it now’ (H5). 
 
Why was this so difficult to understand?   Although some of the family had 
been seen by a genetic counsellor and verbal information had been given, the 
majority of husbands were not aware of the availability of a particular test for 
a BRCA gene and it had all happened very quickly for some of them.  Many 
were gathering information from their wives or were directed by family events, 
for example, it was only after the death of his wife’s young cousin that a test 
for a BRCA mutation became apparent to husband four: 
‘I’ve known about, my nan died of breast cancer, I know, I’ve 
heard of, I didn’t know about the BRCA gene or what it was 
called but I’ve heard of families where the risk of breast cancer 
is really high, in media and stuff but I didn’t know that there 
was, you know the gene testing going on and things like that 
until her cousin’ (H4). 
 
For others, if a close family relative had died young of breast or ovarian cancer, 
there was some thought given to the possibility of a link to this and the next 
generation.  Husband three had some suspicion of a family link because his 
mother in law had ovarian cancer and died: 
‘Unfortunately, her mum died of ovarian cancer when we’d 
been together for three or four years and you know without 
knowing the science behind it that did; it did seem quite 
obvious to us that there would seem to be some kind of link 
even though we couldn’t really prove it’ (H3). 
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As the husbands gathered and received more information from their wives, 
they reflected on the family history and became much more aware of the 
increased chances of getting breast and ovarian cancer with a positive BRCA 
test result.  They then became extremely worried about their wives’ survival 
because of this high risk and the link with cancer.  There was a price to pay 
however for acting upon the genetic information and ensuring survival. By 
embarking on the journey to find out if a mutation existed in the family, this led 
to many anxieties with difficult decisions to make.  These anxieties included 
the BRCA gene itself, a decision to be tested, a potential positive result, the 
possibility of surgery with loss of the breasts and the risks for their children.  
For all husbands, this information was overwhelming and the majority needed 
more than a verbal explanation.  One husband was so shocked, he did not 
understand the full implications, ‘what it all means’ and could not take 
everything in when he first learnt of a mutation in the family:  
‘So, I suppose you know going back to the day when we first 
got the news, umm, there was that initial ok I understand what 
you have just told me but don’t understand what it means so 
in a way, where’s the leaflet’ (H2). 
 
Husbands needed more information and time to assimilate the information 
because the majority wanted to be able to support their wives.  What did they 
need to know?  They needed to understand for themselves the implications of 
the test and the result.  They needed to discuss and understand the actual 
risks, they needed to discuss and assess the urgency of the test or indeed, 
decide if their wives should have the test. However, this was difficult for the 
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husbands if their wives did not want to disclose their risk information more 
widely or if they did not have the necessary information.  This secrecy caused 
many problems because there was nobody for them to talk to or find answers 
to their questions.  One husband was really struggling to help his wife: 
‘It has been hard like but you have nobody to talk to them and 
explain/ask questions and different things so it just been kept 
close between us like so it been a bit hard at times and 
obviously she been stressed about it and what do I do and all 
that, but I can only give so many answers like and that’s, it 
been awkward at times like, and that’ (H1). 
 
5.2.2 The Price – Having the Test and Understanding the Implications  
Once the husbands gained more information, with time, the risk of cancer and 
some of the implications were beginning to be realised but the test became a 
real concern because they feared it may be positive. However, all of the 
husbands concluded that their wives should have the test.  They gave various 
reasons for their decision, for example, if a young family member had died of 
cancer or if the probands themselves were pushing to have the test, the 
husbands were strongly influenced.  For one husband whose wife’s cousin 
had recently elected to have RRM and was found to have the early stages of 
breast cancer, this also reinforced his decision making him more anxious that 
his wife would get cancer.  He wanted the test to be done immediately:  
‘But I think what really kind of brought it into really sharp 
contrast was her cousin when they did the double mastectomy 
they found pre-cancerous cells in her milk ducts and her 
cousin is quite a bit younger than her as well, she’s only 
twenty-nine so I think that really, so I think that was really the 
thing that completely swung it you know, I think we went from 
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an initial reaction of you know, breast cancer is quite treatable, 
it’s quite curable, it’s not guaranteed that you’d get it, if you do 
you can deal with it, to lets have the test now’ (H3). 
 
Although there was a desire for their wives to have the test and know the 
results, some acknowledged that the implications of having the test had still 
not been fully considered or understood, for various reasons.  One husband, 
for example, needed to know the test result before he could think about the 
next step.  He encouraged his wife to have the test despite his wife not being 
sure about it.  In hindsight, he reflected that this may not have been the best 
approach because they now had to consider the bigger picture of the surgery.   
Husband two explained:  
‘Umm, and she wasn’t sure whether she should have the test 
because she wasn’t sure what she would do with the result if 
she got it. Yeah I’m a, I’m quite a practical person by nature, 
so my stance on that sort of thing and I think I said this to her 
at the time, why don’t you just have the tests and then figure 
out what you do with the result once you got it, there is no 
point trying to figure out what you would do with the result if 
you don’t know what the result, In hindsight maybe that wasn’t 
helpful, I don’t know, umm but from a practical sense, that to 
me made sense’ (H2). 
 
Other husbands did not have time to think about the implications because the 
decision to be tested, the timing of the test and the urgency of having it done 
depended on how anxious their wives were and what was happening in the 
family.  For some husbands, therefore, the gene test came about too quickly 
because their wives had initiated it and there had been little time to think about 
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it. Husband four who was distracted with his own health problems, was 
suddenly faced with the whole process of testing before he had time to think:  
‘I suppose it all came about a bit quick ‘I wasn’t really thinking 
of the gene testing and family history and it seemed to, 
because there was so many things going on with my own 
health at the time I wasn’t paying so much attention to it.X got 
to be tested first because that’s where it’s coming from sort of 
thing, so it was put off for a couple of months but still on a 
back burner so to speak and then it came.’ But yes, with the 
age of X getting it so young and then the gene testing, that 
came about pretty quick from when she was diagnosed and 
then getting tested and then her sister getting tested, then her 
dad getting tested and then you know all the way down to X’ 
(H4). 
 
One way of helping the husbands understand some of the implications of the 
BRCA gene was Angelina Jolies’ disclosure that she was BRCA positive and 
that she had elected to have RRM. Her disclosure had helped the majority of 
husbands because it had raised awareness, they could now relate to it and 
they could talk about it. Husband five who had never witnessed cancer in his 
own family was comforted by the Angelina Jolie story.  Her story had raised 
his awareness:  
‘Well it’s definitely opened my eyes up to it because like I’d 
never really known anyone who’s had breast cancer or 
anything you know, so I’ve never had to witness anything and 
then with Angelina Jolie in the news, it really helped…’ (H5, 
six months). 
 
Why had this helped them? Most husbands had difficulty in telling people 
about the gene and the surgery, not only because it was a private matter and 
they had been sworn to secrecy but because they had to understand it first for 
  
255 
 
themselves. Having celebrities and public figures like Angelina Jolie and 
Sharon Osbourne as examples of people having the same gene and surgery 
made it easier to explain to people and normalise it, especially when they were 
nervous about telling people.  These husbands also saw Angelina Jolie as a 
role model in having a BRCA mutation, thus it was more acceptable and 
reassuring for their wives to have the gene and the surgery knowing that 
celebrities also had it.  Two husbands share their experiences of how the 
celebrities’ disclosure had helped them:  
‘I think in terms of being apprehensive about telling people, I 
think that crossed my mind, yes definitely but I think if you can 
explain it and having the Angelina Jolie story is something to 
help you explain, I think is great, to be honest’ (H3). 
 
‘whereas Angelina Jolie is a global superstar and doesn’t 
need the publicity so I think in that respect it’s been very, very 
good and very useful and she’s obviously such a glamorous 
sort of Yeah, yeah, married to one of the heart throbs of 
Hollywood so you know it’s, almost I suppose to some extent 
a perfect role model in terms of other people sort of seeing 
what can be done and that somebody and that it can affect 
somebody like that and then I think there have been a couple 
of others, I think Sharon Osborne has had the surgery as well’ 
(H4). 
 
5.2.3 The Price - The Meaning of Being BRCA Positive 
The majority of husbands had considered the strong probability that their wives 
would be carrying a BRCA mutation once tested.  This was influenced by how 
much their wives had convinced them that they would carry it and by reflecting 
upon the number of female relatives already diagnosed with breast cancer. 
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For example, if there had been many female deaths within the family, there 
was an expectation that their wives would have the mutation.  Two husbands 
explain how they came to that conclusion: 
‘We, therefore, decided that we would find out whether she 
had the BRCA gene and again even though it seemed, you 
know, like a 50/50 chance, I think we both kind of thought that 
she would have it because it did seem to pass down the 
female side of her family and sure enough that was how it 
panned out’ (H3). 
 
‘I think in the back of her mind she always knew, because her 
mother’s mother I think it was, died of cancer, obviously the 
gran, the mother’s sister’s daughter died two or three years 
ago, from cancer, at a young age forty-two, forty-four. X father 
is a twin, his twin brother died of cancer only six, seven years 
ago, you know, so it is. It is in the family, it’s really scary’ (H5). 
 
In addition, following the test results, although the risk and the likelihood of 
getting breast cancer with a mutation was explained to the husbands in 
percentages and in terms of a lifetime risk, the majority believed that cancer 
was inevitable and again, this perceived risk was associated with the number 
of relatives who had already died.  Husband three gave his reasoning:  
‘65% to 85% but we felt it would be 85% and part of the reason 
I think we felt that was because x auntie had died of breast 
cancer as well, which is her mum’s sister and at the same time 
as finding out that x had the BRCA gene, she was very close 
to her cousin, her auntie’s daughter and they had both lost 
their mums, and were very close’ (H3). 
 
All these husbands were not just fearful of the risk of getting breast cancer but 
were constantly anxious about their wives’ dying, perpetuated by their wives’ 
  
257 
 
anxiety and strong beliefs about getting cancer and dying.  In fact, the fear of 
cancer, in general, was very vivid in all the husbands’ experiences.  Two share 
their fears of losing their wives: 
‘Really high and I’m still worried that she still might get 
something, because, although you’re saying it’s like the breast 
cancer and the ovaries or whatever, is it if you remove them’ 
things which will lower it, is there still a chance she’s going to 
get it anywhere else, I don’t even know them questions you 
know’ (H5). 
 
‘It was more like, with her it was more of a worry of when am 
I going to have it like. With her and her side of her family, it 
was all coming down in generations and coz her sister 
obviously didn’t want to be tested, it was like, is it going to 
miss her like and get me  and I was like so you really think it’s 
going to happen, like you know so I was like, to me at first, I 
thought she was thinking oh she’s going to have it in the next 
couple of years like which was a bit like what am I going to do 
if I lose her?’ (H1). 
 
Thus, for the majority of husbands, a mutation was more frightening than 
having a strong family history because it meant it was more serious, the risk 
of getting cancer was almost inevitable and importantly, they were likely to 
lose their wives.  Husband five was very frightened: 
‘Well, it was quite frightening to be honest with you because 
just my, lucky enough we’ve never had it in my family at all so 
I don’t really understand much about cancer apart from what 
you hear on the news and the telly and everywhere else. But 
the minute you find that something like that (BRCA gene) is 
involved in your family, then it’s quite frightening because the 
last thing you want to do is lose your wife’ (H5). 
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Indeed, the BRCA mutation result devastated some of the husbands despite 
being aware of the strong family history and the probabilities of testing positive.  
One husband for example, although he had encouraged his wife to have the 
test, like many of the husbands, he had not thought about the implications of 
a positive result.  Thus, it was too painful for him to believe the result hoping 
that a mistake had been made when his wife was given the result.  His disbelief 
was evident: 
‘And sort of, you know, are you sure you know.  Could this 
have been misdiagnosed you know, again with the greatest 
respect to your colleagues, you hear these odd stories about 
people who go in to have the right kidney taken out and the 
left comes out instead and you think well could there have 
been a mistake’ (H2). 
 
Thus, although having the test made sense to the husbands, the result of a 
positive mutation had a significant impact on the husbands for a number of 
reasons.  It meant having to make decisions about surgery, a need to consider 
future generations and a constant worry about their own children’s risk. Their 
experiences involved a constant fear of the probands’ not surviving.  
Therefore, even though many had expected the result of the test, they 
experienced considerable negative impact and devastation.  For example, one 
experienced 'a feeling of isolation' (H2), another was constantly feeling 'quite 
upset', whilst others were pre-occupied with thoughts about the test result 'five 
days a week' (H3), 'it was on my mind, playing all the time' (H1).  
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These negative experiences mainly related to the significant risk of both breast 
and ovarian cancer, which threatened their future and importantly their wives’ 
survival.  For example, the impact of knowing his wife had the BRCA mutation 
and was at risk of two potentially life-threatening cancers frightened husband 
three who shared what it meant to him to have a long life together: 
 
‘In terms of how it impacts on me, obviously being supportive 
of her  and wanting for us to be married for a very long time is 
the key driver behind everything really and you know, I think 
it’s very difficult because part of you sort of thinks, I think 
particularly when you first hear about the BRCA1  gene and 
you hear about your kind of the percentage probabilities of 
different types of cancer, ovarian and breast, you realise that 
you know you’re not being dealt a particularly great hand’ 
(H3). 
  
The pre-occupation with the results and the negative effects on their day to 
day life was like having ‘the sword of Damocles hanging over them’ both in 
terms of the fear of getting breast cancer and the long wait for surgery.  Most 
husbands were consumed by the result which affected everything they did.  
Husband two explains: 
‘You know there is not a day that goes by and probably not an 
hour that goes by without this being there, you know this is 
the sword of Damocles that is there from the moment we 
awake to the moment we go to sleep’ (H2). 
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5.2.4 The Price - Strategies for Getting Through the Day 
To deal with the gene result, all of the husbands were trying strategies to keep 
themselves healthy and well.  These behaviours included blocking negative 
thoughts out by distracting themselves or some focussed on their own health 
and getting fit.  The test result had made some much more aware of the need 
to stay fit and healthy for their wives’ sake.    For others, it was too painful to 
think about any of the implications and so they tried to ignore it.  Two husbands 
adopt different strategies to deal with the situation: 
 
‘Okay, so first it’s been about 2 years since the diagnosis was 
first derived, it’s been a strange experience. I suppose umm 
lots of conflicting emotions umm at one end of the scale, we 
effectively have been able to block it out, probably incorrectly 
but nevertheless, we are busy people day to day there are so 
many things to do, it’s quite easy to just fill your day with stuff 
that blocks this problem out’ (H2). 
 
‘Well I suppose it depends on the circumstance you know, I 
think what it has done is given me quite a clear insight that in 
my own personal sort of health is you know, really important 
and that there’s no point her going through all of this if I go 
and keel over with a heart attack so I think you know, I’ve been 
really a bit more involved with the gym and football and stuff 
so I think that’s a good release for me that I think’ (H3). 
 
5.3 The Price - Losing the Breasts 
In order for their wives to survive, the husbands believed that screening with 
mammography could detect cancer, but not prevent it or prevent their wives 
from dying.  Thus, the majority believed that although the loss of the breasts 
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with all the implications, was a price to pay, RRM was the only option in 
maximising their survival.  Primarily it was their wives who had made the 
decision about surgery, but some husbands had strongly influenced or 
encouraged their wives because they were so frightened of them dying and 
because they would not have forgiven themselves if cancer did occur later in 
life when they had this opportunity to prevent it.  Two husbands explain why it 
had to be surgery:  
 
‘That’s exactly the right decision (surgery) and I think you 
know, I also think that if we were to not have the operation 
and to find ourselves five or ten years down the line and her 
getting it I think we’d never forgive ourselves because you 
know we need to be there for each other, for our children and 
you know it’s, it could be that almost, potentially it could be 
almost the best case scenario that you’d end up having this 
operation reactively rather than proactively. Anyway, so that 
is, you know, when you kind of weigh it all up then it just, you 
know it didn’t seem as though there was an alternative really 
to us’ (H3). 
 
‘Oh yes, well to be honest I virtually pushed X all the way you 
know, I think I most probably made 90% of the decisions for 
her because you know I don’t want to lose her, her mother 
decided that she was going to keep hers you know, so she 
said she’s coming up to 70 years of age now so it didn’t make 
a difference whether she passed away or not. It’s quite a 
brave thing to say to be honest with you but I just want to hold 
on to my wife a bit longer’ (H5). 
  
The majority of husbands, therefore, believed that surgery was a chance to be 
proactive rather than reactive.  They believed that they had been given a better 
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chance of surviving than other family members and should take that 
opportunity.  Husband three shared the long-term benefits of this decision: 
‘I’m trying to very much see it is as a positive because it gives 
us an opportunity that perhaps people have not had in the 
past, you know, people have obviously developed cancer of 
different forms and not had the opportunity to have proactive 
surgery that you know, so, it doesn’t always feel like it but I 
think we’ve tried to be really glass half full about it and so it’s 
been something that we’re really trying to embrace as being 
an opportunity and although it means obviously a difficult next 
few weeks, hopefully, it will make for a much more beneficial 
time in years to come’ (H3). 
 
5.3 1 The Price - Physical and Emotional Impacts of the Decision 
Although surgery was the right decision, it was still a very difficult decision and 
their experiences leading up to the decision of electing surgery was very 
intense for all of the husbands. However, the majority were able to contribute 
to their wives’ decision-making even if they questioned the timing of it.  For 
example, some husbands wanted their wives to go ahead with surgery 
immediately but others wanted their wives to wait until they were older.  Why 
did age matter to them?  They were concerned that losing the breasts so 
young would have greater consequences on their sex life and their 
relationship.  One husband explains: 
‘She had to do something about it, and I was like give it a 
couple of years but she was adamant that sooner is better 
kind of like. At first, I was a bit like you know, do you think it’s 
a bit soon and you’re so young? Do we have them off and all 
that like, because she is so young and I am like. I was like 
what is it going to be like without them and all that. It was just, 
is it going to be the right option, is it going to be the sensible 
thing to do or is it going to push us apart’ (H1). 
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Indeed, for this reason, the decision about RRM was far more difficult than the 
decision to have the ovaries removed.   For example, one husband who 
agreed to his wife's ovarian surgery, was not able to contribute at all to his 
wife's decision about RRM, why was this the case?   He did not think it was 
the right decision for them and he explains why: 
‘I said to her, I am not going to advise you because I can’t, I 
am not the right person to, so you will at some point come to 
me for advice and I’m afraid I won’t be able to give it.  I will 
give support but not advice and I’m not sure we are ready for 
this’ (H2). 
 
Why was the removal of the ovaries an easier decision and more acceptable? 
The breast surgery was far more difficult than the decision to elect 
risk-reducing ovarian surgery because of the visible effect of breast loss on 
appearance. In fact, all of the husbands were concerned about the effect that 
the breast loss would have on their wives’ psychological state especially if their 
wives were very conscious of their body appearance. Two husbands explain 
their concerns:  
‘obviously, we had a decision to make about whether we sort 
of followed that through with a mastectomy and that I think 
was a harder decision because the hysterectomy is kind of, 
whilst obviously it’s a serious operation, there’s no kind of 
outward appearance’ (H3). 
 
‘I think the one with the breasts is more, not so much a worry 
for me, but for x, because women like their figures and she 
does cry a lot and then saying’ what am I going to look like 
and this, that and the other’ (H5). 
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Thus, although RRM was believed to be maximising their wives’ survival, some 
husbands felt that RRM was mutilating and were initially reluctant about it 
because of the drastic effects and deformity to the body. Why was the surgery 
viewed as producing a deformity?  The husbands acknowledged the 
importance of the breasts for a woman’s femininity, sexuality, and identity, 
acknowledging that the decision was difficult for them and their wives because 
their wives would look different to other women.  Two husbands explain why 
they were concerned: 
‘Why would you do that to yourself basically, why would you 
kind of I suppose, kind of deform your body that was the initial 
reaction’ (H4). 
 
‘Because I think a woman’s breasts are a very visible part of 
their persona, their femininity, I think you know they are just a 
very overt physical sign of somebody’s I suppose their being, 
their sexuality, their femininity, everything you know and I 
think that you know, I daresay in a jumper or in a dress or 
something like that then you know, it may not be particularly 
evident to the untrained eye I’m sure’ (H3, twelve months). 
 
5.3.2 The Price - Undergoing Breast Reconstruction 
The husbands understood the need to have a reconstruction to maintain their 
womanhood. They expected and relied upon reconstruction to maintain this 
femininity and restore who their wives were before the surgery:  
‘I just feel desperately sorry for her. So, yes, it’s a dreadful 
situation for her, for all of us, there is a route out of it which is 
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the, I think it’s the reconstruction. It’s difficult for a man but for 
a woman to have your breasts removed, I just can’t imagine 
anything worse because it’s kind of who you are’ (H2). 
 
Why were the husbands so reliant on breast reconstruction to fix everything? 
The cosmetic result of the surgery was also very important to all the husbands 
and they were very honest about their concerns.  They were expecting breasts 
that resembled their wives own breasts.  However, the photographic images 
they had seen of the proposed surgery and reconstruction were very different 
to their expectations, especially seeing breasts without nipples. Although 
acknowledging that they needed to see photographs in order to prepare them 
for the devastating outcomes, the images were shocking (H2, H3, H4) and 
graphic (H4, H1).  Husband four was overwhelmed and shocked when he saw 
the results:  
‘The one thing that, I didn’t know what they would like 
afterwards and so we saw photos beforehand, Yeah and it’s 
a big operation and it’s not what I thought, It was a bit like 
woah, but it didn’t last long. Just taken aback, I can imagine 
some blokes being, oh fuck sort of thing, massively so I think 
when a male thinks yeah implants, he’s not thinking what the 
actual thing is, I didn’t realise the nipple is gone. Yeah, I 
suppose so, and you know the scarring is big and some of it 
looked quite graphic, I can see some, for me, it’s not really a 
problem I honestly don’t think but I can imagine some men 
might have a real sort of problem with it because it is fairly big. 
Yes, I think that’s really important, to get the photos in your 
head straightway, really straightaway so that you can prep 
yourself’ (H4). 
 
Why were the photographs so shocking and devastating?  The majority of 
husbands felt that the images did not resemble normal breasts and they could 
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understand why women or their husbands would choose not to have the 
surgery.  Husband four explains why the images would affect most men: 
‘I just think, you know we saw some photos of what it looks 
like afterwards and it just, they’re just lumps of flesh, and we 
were both of the same sort of attitude. I can understand 
women who don’t want to have it done, I really can, especially 
if they’re more concerned about their looks and I don’t mean 
that in a vanity sort of way and especially if they’re, I can 
imagine it would be difficult if they were single, I mean if you’re 
not with a partner, your life partner so to speak, you’d be 
thinking that’s going to put men off and all the rest of it and if 
you’re strong enough to think well it’ll be alright, I’ll just see if 
I get cancer, I’ll deal with it then, if you can live like that and 
just have the tests every six months to a year, then all power 
to you but I know I couldn’t live like that and I don’t think she 
could either, everyone’s different’  (H4). 
 
5.3.3 The Price - Uncertainties about Changes to the Body 
After seeing the photographs, therefore, husbands were very concerned about 
how their wives’ bodies would change and how they would react, so much so 
that one husband had asked himself ‘am I going to accept it?’ (H1).  Others 
tried to imagine how the new breasts would actually look compared to the 
images in the photographs.  They were not convinced that the photographs 
were a true representation of the final result, hoping that they would be better. 
Husband three tried to imagine how different his wife would look: 
‘She will look different, it’s hard to imagine, she said they are 
going to be firmer and higher but  you just see pictures and 
see people and it’s what will it really look like, I don’t know’ 
(H3). 
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Thus pre-surgery, all the husbands were concerned about the effect that RRM 
would have on their relationship, especially their sex life.  They were 
concerned that the changes to the body would change their wives and their 
normal life, making their wives very self-conscious and less likely to want any 
intimate contact: 
‘With sex l, well its, is it going to be the same obviously, like 
before everything was fine.  That it’s going to be ok? is it going 
to be the same or is it going to be more, I want to keep my top 
on or I feel uncomfortable.  Is that going to push me away or 
will things be fine, you know’ (H1). 
 
All husbands therefore expressed concerns about the long-term impact of 
RRM on them and their wives.  What long term effects were they worried 
about?  They all recognised for example that breasts are an integral part of a 
woman’s body and the photographs of reconstruction did not resemble ‘normal 
breasts’.  Husband three was concerned therefore that if his wife disliked her 
body, this would affect her mental state long term:  
‘Well I know that a wife who is healthy in body you know and 
you know fundamentally it is something we’ll deal with 
because in years to come we’ll look back on this as just 
another thing that we’ve gone through I’m sure of that but I 
think my concern is obviously just, yeah, for the operation 
itself obviously for her physical wellbeing but then in the future 
for her mental wellbeing’ (H3). 
 
Like many of the husbands, he wanted to maintain his wife’s confidence 
because that was part of who she was and in many ways, he was envious of 
and applauded the gift she had.  He was afraid of the surgery changing her as 
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a person. Other husbands were also concerned about how their wives would 
feel about and view their body, but the majority believed that if the cosmetic 
result was acceptable and their wives were pleased with their body, then 
everything else would take care of itself.  Two husbands explain:  
‘The cosmetic result, I think if she’s happy with that it’ll be all 
over, you know, I think it’ll be all over. She won’t think anything 
of it again you know. I think she’ll be fine, to be honest with 
you like, as long as she’s happy with the outcome after you 
know, I think she’ll be over the moon to be honest with you 
because it’s something that she’s always wanted, you know.  
Because she’s never liked her breasts anyway, you know, so 
she, I wouldn’t care if she didn’t have anything at all, to be 
honest with you, it would never bother me at all. Yes, as long 
as she’s happy with her appearance that’s all I’m bothered 
about, you know’ (H5). 
 
‘I just think that you know, confidence is huge because if you 
don’t have a lot of confidence then you sort of become 
withdrawn and potentially go into your shell, don’t you? she’s 
a very bubbly person, she’s got lots of friends, she mixes well 
with people, you know you put her in a room with people that 
she doesn’t know and she’ll hit if off with people, it’s a gift, to 
be honest that I don’t have and I would hate to see her lose 
that because I think that’s part of who she is’ (H3). 
 
5.3.4 The Price - Turning the Family Upside Down 
In addition to the concern about physical appearance and psychological well 
being, there were also practical considerations and uncertainty about the 
recovery and how much disruption would be caused to family life.  For 
example, there were uncertainties about how much help would be required 
and how long recovery would take. Husband one was particularly anxious 
because of his small children: 
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‘We have got two kids as well? Obviously how long is she 
going to be off for and not be able to do things and stuff like 
that’ (H1). 
 
However, once a decision had been made to elect for RRM, husbands wanted 
to get on with it and with their lives. The wait for surgery varied, but it was at 
least five to six months after their initial clinic consultation and some operation 
dates had been cancelled.  The wait was extremely traumatic and disruptive 
to family life because they had planned everything around the date.  Husbands 
were also scared that their wives would develop cancer during that time.  For 
others who did not yet have a date, life was on hold. They found it difficult to 
see a future until the surgery had been done.  Two husbands explain the 
effects of having to wait:  
‘Awful, I think the waiting is the worse, The waiting is definitely 
stressful, I think it’s a, I can’t think of a better word than 
stressful but it’s kind of, in some ways because it’s always 
looming, it can almost become unbearable and you just’ 
something that’s kind of been the hardest bit has been the 
waiting and that’s what I think the tunnel vision approach has 
kind of been the right thing for us and therefore that we just 
can’t wait to be out the other side and I think then you kind of 
cope with it in your own way from there. Whereas I think for 
me I need to see past the operation to the future’ (H3). 
 
‘Because that’s another thing, sort of date wise because I said 
the whole year is on hold at the moment because we like to 
go on holidays every year and at the moment we haven’t 
booked anything at all because they’re saying it could be 
middle to the end of summer, you know what I mean so’ (H5). 
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5.4 A Separation from Themselves - Post-Surgical Experience  
As with the probands experiences, the initial focus of the husbands’ 
experiences post-surgery was the reduced fear of cancer, but their main focus 
was the effects of RRM on their wives’ bodies and their relationships and the 
ongoing concern for their children, who they now believed had an altered child 
trajectory.  The focus on their wives bodies included the effects of RRM on 
their sex life, on how their wives now perceived themselves and how they 
believed that their wives had changed.  These experiences dominated the 
post-surgery journey.  The following section takes the reader through that 
journey. 
5.5.1 Separation - The Fear Has Gone  
Post-surgery, the majority of husbands (H1, H3, H4, H5) were very relieved at 
not having to worry about the fear of cancer.  Indeed, the fear of their wives 
dying from cancer had resolved for all the husbands. Two husbands share 
their experiences of the relief: 
‘Which as I say everyone is completely different and entitled 
to their own view, but I think that being out the other side now, 
it might have been a hard couple of years but it doesn’t half 
feel good to think that’s not a worry for us’ (H3, twelve 
months). 
 
‘It’s been something that we’ve put behind us and put some 
real fears to bed as well’ (H4, twelve months). 
 
Despite some of the uncertainties before surgery and any reluctance about the 
decision, all the husbands believed that for the benefits of the resolution of fear 
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alone, it was the right decision to elect for RRM and reconstruction. Without 
hesitation, one husband explains: 
‘It’s definitely, 110%, it was the right decision to… Oh yeah, 
yeah, without a doubt, especially with regards to what’s 
happened to her cousin at the moment, you know: So yeah, 
definitely it was the right decision, there’s no hesitation about 
that’ (H4, twelve months). 
 
 All the husbands, however, recognised that it was still a difficult decision to 
make, having the utmost admiration for their wives. The majority, for example, 
commended their wives for being ‘very brave’.  Why did they think it was 
brave? Most believed that their wives had sacrificed their femininity and 
identity for the sake of their family and it acknowledged that it was not an easy 
operation to undergo.  One husband expresses his gratitude: 
‘I think she’s every bit as beautiful now as she was when she 
had the operation so, in fact in many ways more so because 
I actually, I think what she’s done for our family is so brave 
really …’ (H3, twelve months). 
 
5.5.2 Separation - Not Who They Were? 
However, despite being prepared for the cosmetic appearance, the majority of 
husbands were still very shocked at first seeing the changes to their wives 
bodies and surprised about the effect it had on them. Why were they so 
shocked?  It made them realise the extent of the surgery and that their wives 
did not look like themselves.  Most of the husbands took time adjusting to the 
new look of the breasts and their wives bodies because of the severe bruising, 
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the stitches and they looked so different.  Two husbands share why they were 
so shocked at what they saw: 
‘Probably a bit of the shock, I didn’t really realise how taken 
aback I’d be by it when you see them’ (H4, twelve months). 
 
One of the things that I think was difficult was seeing how she 
looked immediately after the operation, because that was you 
know, I guess like with any operation there were stitches and 
bruising and you know that looked really, really painful and 
really I suppose shocking in a way’ (H3, twelve months). 
 
 
As time elapsed, the look of their wives’ reconstructed breasts became more 
acceptable to them. If nipple reconstruction and nipple tattooing had been 
completed, for example, some husbands were even more pleased because 
the breasts started to resemble normal breasts.  However, this depended on 
how the appearance was viewed by their wives and the stage of the surgery. 
At twelve months, for example, the scars had settled, some of their wives had 
nipple reconstruction and the cosmetic result was better than some were 
expecting. Two husbands were pleasantly surprised: 
‘Didn’t know what to expect, I thought it was going to be scars 
and looking a bit awful but when I looked at them I was, that’s 
pretty good that is, quite impressed’ (H1, twelve months). 
 
‘I think the result as it stands today is fantastic, you know I 
genuinely think that x could be in a changing room and 
somebody could catch sight of her and not realise that 
anything has happened operation wise.  So that’s an 
incredible testament to the process I suppose and the surgery 
and the aftercare, I think having the nipples tattooed in the 
end has actually made an incredible difference as well 
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because although previously you know, the shape was good 
but there were scars, actually the tattoos have covered up 
most of the scars as well so I think you know, the physical 
appearance is incredible’ (H3, twelve months). 
 
However, some husbands were struggling to come to terms with the ‘new 
breasts’ at twelve months because they were still so shocking and looked so 
different to normal breasts.  They were finding it difficult to accept the new 
breasts and they had to adjust slowly because it was such a drastic change to 
the body and to how their wives once looked.  In trying to find strategies that 
enabled them to cope with the drastic changes, they had to keep reminding 
themselves of why the operation was being done, to prevent cancer and 
maximise survival.  For those husbands who could think in this way, it was far 
easier to accept but those who could not rationalise it in this way found it more 
difficult to accept. Husband four explains why he was struggling to get used to 
the way his wife now looked: 
‘I knew what they were going to look like from pictures so, you 
know wasn’t expecting breasts again, you know, get that idea 
out of your head straightaway. It was quite, it’s still, and you 
know it does knock you back a bit when you see them but it’s 
just a case of getting used to seeing them. I don’t know, they 
still, yeah, they still kind of surprise me a bit. I mean with time 
I’m going to get used to them and I’m still all for her having 
them done: It’s not something that’s that easy to get used to 
because it’s something so physical, the only way that I could 
sort of compare it to is if you lost a limb and do you know if 
you look at someone with like a false limb and then all of a 
sudden you can find yourself sort of staring just because 
you’re not used to it and you’re taken aback by it.  So there is 
that element of it still’ (H4, twelve months). 
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5.5.3 Separation - No Return to Normal 
In addition to affecting the final appearance of the breasts, if the wives had 
complications post-surgery, this made the experience far more difficult for the 
husbands.   Many of their wives, for example, were experiencing pain or 
infection with six of the eight experiencing complications. This meant that there 
was a long delay in recovery and they could not move on with their lives. 
Husband four was just one of many who was frustrated and annoyed: 
‘Shit happens, I mean it was really annoying and really hard 
to see her in quite a lot of pain and with my own experiences 
of pain on a day to day basis with breathing exercises, she 
couldn’t do that because she couldn’t breathe properly so it 
was quite hard to try and help her with it.  But what can you, 
you know it’s not really preventable, it’s just something that 
happens with surgery. You know it’s really delayed us with 
stuff and life but there’s nothing that can be done’ (H4, twelve 
months). 
 
Why were they so annoyed?  They had to wait and be patient and it was out 
of their control.  This delay also meant that life was on hold because there 
were more operations to follow and the journey was still not over.  For all the 
husbands, the whole process had taken far longer than expected and had not 
gone to their plan.  Many did not expect the number of complications and life 
had been turned upside down.  Two husbands explain: 
‘Well yeah, no not really, not until she’s had her final surgery 
and then we can try and get into a groove of what our life is 
going to be like.  It’s been so up and down, what with myself 
and with her, yeah it’s a bit annoying in a way, like I say it’s 
annoying in a way that it hasn’t gone, it’s been so up and down 
with her and we can’t move on and we’ve got operations 
hanging over our head and so I mean once this last one is out 
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of the way and hopefully she heals up fine and we can move 
on’ (H4, twelve months). 
 
‘I really wasn’t expecting the surgery to have the 
complications that we’ve had. I don’t know why I think you just 
sort of think yeah everything will be fine then, it will be done 
and then bobs your uncle it’s all sorted in a month or so, so I 
wasn’t really expecting all the problems’ (H5, twelve months). 
 
5.5.4 Separated - Not in Unity  
The surgery, complications and delayed recovery had taken its toll on many of 
the husbands but the majority were in unity and able to work together.  This   
long process, however, was more difficult if there were problems in the 
marriage before the surgery, or as a result of the surgery.  One husband, for 
example, who was not ready for his wife to have the surgery and who had 
problems in his marriage before the surgery, explained how the experience of 
surgery was the last straw, causing more divisions in their relationship: 
‘So, I think, we were close to the edge anyway, the surgery 
has taken us over the edge so you can’t just blame the 
surgery, it’s everything that takes you up to that cliff edge 
rather than the thing that takes you over it.  So it’s just the 
combination of all of that’ (H2, twelve months). 
  
What had taken them over the edge and why were they so close to the edge? 
The journey of discovering a BRCA mutation and surgery for husband two had 
been extremely difficult, exacerbated by insensitivities of other family 
members who were invading their lives by expecting support for their own 
ongoing problems.   He felt this intrusion on top of the surgery, had put him 
  
276 
 
and his wife under extra pressure and had put a strain on their marriage.  He 
shared his frustration: 
‘There is too much invasion, that perhaps too strong a word, 
intrusion, there’s too much intrusion from other people 
needing stuff. People come and take whatever they need and 
we get what’s left and it’s not enough’ (H2, twelve months). 
 
He also expressed the personal price of the experience, the experience of 
much sadness and his struggle to live a normal life with his wife.  Even after 
twelve months, he was just existing, rather than living a happy life: 
‘For me it’s, I suppose it’s, I suppose I’m just trying to find a 
way of maintaining sanity amongst the status quo, so it’s not 
a great existence but you just deal with it and you carry on. 
It’s a struggle I think is the short answer, it hasn’t got easier 
over the last twelve months, there are still the same basket of 
challenges that there was twelve months ago and none of 
them have really moved forward I don’t think so, we spend 
most of our time doing what we need to do on a day to day 
basis without really resolving any of the more challenging 
issues. They just tick along in the background’ (H2, twelve 
months). 
 
Furthermore, he felt strongly that input from the professionals was essential in 
order to prepare and guide families in dealing with such a difficult journey with 
potential family conflict.  Whereas the surgery should have been the end of the 
long difficult journey for husbands and wives and an opportunity to move on, 
husband two believed it was the beginning of the process:  
‘It’s, you know it’s not an easy journey to go through, I think if 
there’s a learning from all of this it’s preparing the family as 
well as the patient so more guidance from professional people 
to the parents to say you’ve got to give her space here, 
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whatever other issues you might have take them somewhere 
else because your daughter is no longer the person who can 
do this for you.  She now needs to focus on her. If she’d had 
something more sinister, so if she’d had a heart attack or 
something or if she’d actually had cancer then maybe it would 
have been different.  But there is this impression that oh well 
she’s had the surgery therefore it’s done and it’s not done, the 
surgery is the start not the end of this process But if there’s 
something that the medical profession could do at the outset 
which helps prepare the wider family for all of this’  (H2, twelve 
months). 
 
The wider family conflicts on top of what they were trying to deal with had not 
been helpful for them as a couple or his wife personally. He was concerned 
about everything she had to cope with and how devastating it had been, she 
had drastically changed: 
‘you know she was not in a great place before all this 
happened and you know, her going through what she’s gone 
through would be challenging on its own, when you overlay all 
the other stuff it’s, I don’t want to sound like I’m over 
exaggerating here but I think it’s basically destroyed her as a 
person’ (H2, twelve months). 
 
Husband two, therefore, felt strongly that continued support after the surgery 
was necessary because of the trauma of the whole journey.  One suggestion 
was that the professionals need to put a care pathway in place for men and 
families in order to help the marriage survive:  
‘Yes, it’s been hell, there’s no doubt about that, I think one of 
the points that you made right at the start is there is no, there 
is no patient pathway or patient journey for the man in this, 
other than the steps that you personally have taken because 
you’ve seen a gap in the NHS provision. So that doesn’t exist 
and I think there are knock on effects because that doesn’t 
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exist, there will be marriages that fail because of this’ (H2, 
twelve months). 
5.5.5 Separation from her Self 
For the majority of husbands, ‘getting back to normal’ was judged in terms of 
the intimate side of their relationship.  Despite the wives concerns pre-surgery 
that their husbands would not find them attractive or desirable, husbands still 
felt attracted to their wives sexually and there was no change in the way they 
felt about their wives.  Husband three explained: 
‘No, no, it’s changed nothing, if anything I suppose it’s made 
me feel more protective of her I suppose which, yeah it 
certainly hasn’t had any negative ramifications in terms of how 
I feel about her sexually’ (H3, twelve months). 
 
One husband even acknowledged that his wife had made efforts to be intimate 
because she understood that he had sexual needs.  Despite it being difficult 
the first time they had sex, he explained how his sexual life was  getting back 
to normal: 
‘I don’t think it’s changed it to be honest with you, at first just 
obviously adapting to it but then everything is so back to 
normal it’s like, you wouldn’t think she’d had anything done 
like. Everything has just carried on as normal. It was a little 
difficult at first but was easily overcome. No, at first it was a 
big thing like, you know when it came to sex and things but 
then once you get over, then everything was fine. But she was 
kind of accepting too, understanding then that I’ve got kind of 
needs’ (H1) 
 
For the majority of husbands, however, sexual intercourse occurred far less 
often and for some, was non-existent, especially if their wives were unhappy 
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with their bodies. The husbands believed the reason for this lack of intimacy 
was because their wives were ‘self-conscious’ about the way they looked, still 
covering themselves up and hiding away with embarrassment, even after a 
year had passed: 
‘I don’t see them that often, she keeps them covered up, 
although she is getting better, she does it on purpose I know, 
they’re like rocks, I mean, but I know with time she’ll get more 
comfortable’ (H4, twelve months). 
 
Others believed that the problems with intimacy and having sex was a result 
of their wives feeling different and not themselves, emotionally and physically 
disconnected from their body.   Husband two explained: 
‘Yeah, you know we’ve had sex a couple of times since the 
operation but there isn’t that emotional connection. I think it’s 
her body, you know she doesn’t like the way she looks, I think 
the operation has killed off any sort of sexual appetite 
perhaps, she has become more withdrawn in herself, so she 
is less, if willing is the right word, she seems to not want an 
intimate relationship any more’ (H2, twelve months). 
 
5.5.6 Sex Talk - A Need to Reunite 
Having support before and after surgery was welcomed by most of the 
husbands and seen as extremely important. They wanted the opportunity to 
talk about their feelings, especially the sexual issues, with people who have 
been in similar situations. Various other suggestions for the support they 
required were also given for example, in addition to access to the specialists 
within the team who could understand what they were going through, many of 
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the husbands wanted access to a support network.  Two husbands give their 
views: 
‘You know, someone to talk to about it, someone who gives 
you a bit of understanding and someone else, you know, to 
talk to mainly about it, like I have really felt like talking to 
people like, and your feelings of like you know ,the sexual 
issues and that and different stuff like that and obviously you 
have times when you are down and think about it and you 
have nobody to talk to like and it’s like we talk to each other 
but you can only talk so much about it like to each other. A 
male preferably because it is easier to talk male to male’ (H1, 
six, twelve months). 
 
‘But umm, if there was some kind of support network, it 
wouldn’t appeal to everyone but for me, it would have helped’ 
(H2, twelve months). 
 
5.6 The Altered Child’s Trajectory 
5.6.1 Maintaining A Normal Child Trajectory 
Concern about children and future generations was a focus for the husbands 
as well as their wives.  Although the fear had resolved regarding their wives, it 
was now for their children.  The heritability of the gene was seen as an ongoing 
problem for many of the husbands because of the risk for their children and a 
there was a desire to maintain a normal childhood. All the husbands for 
example now feared for their children, in particular, they had anxiety about 
their daughters’ risk because of the need to have the breasts removed.  Many 
were totally pre-occupied with and extremely concerned about their daughter's 
risk and believed they now had a different life trajectory, a life of uncertainty, 
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worry and difficult decisions.  For example, despite the fact that she was only 
eight years old, one husband believed the risk and potential surgery would ruin 
his daughter's life. This constant worry invaded his whole existence:  
‘It even invades the dreams, it’s there all the time, and it’s not 
just with x…, it’s obviously with my daughter now and her risk’. 
‘Umm, you know my daughter is eight soon, umm, at what age 
do I destroy her life by telling her that she might have this 
problem. I have no idea how to answer that question’ (H2). 
 
5.6.2 Introducing Fear into the Children’s Lives? 
Many of the husbands were constantly pre-occupied and afraid of telling their 
children. They did not want to alarm them, yet at the same time, they believed 
they had a responsibility. They felt responsibility as a parent to tell their 
children about the BRCA mutation, especially their daughters, but they felt it 
would change their life trajectory, their care free attitude and their potential 
relationships.  It would also change the way people viewed them.  Not only did 
they struggle with identifying the best time in the life trajectory to tell their 
children, but how to tell them.  They were also fearful that they would get 
cancer.  One husband was so afraid of his daughter finding a breast lump 
before they had actually told her. He shared all his fears: 
‘and we still have my daughter and we need to find a way of 
telling her about this when she’s old enough to understand, in 
a way which is not going to terrify her and I don’t have the 
answer to that at the moment but that’s at the back of my mind 
all day every day’ (H2). 
 
‘Do we wait until she is married then her husband might say 
well you knew about this before we got married, why didn’t 
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you tell me. You know, are we going to wake up one day and 
she finds a lump at the age of 10?’ (H2). 
 
This fear caused many problems in the marriage because he felt so upset and 
responsible about the risks to his children and the issues that the mutation 
now brought.  He started to question their decision to have had children and 
he explained why:  
‘I think if we had known about this gene before we had 
children then we might not have had children, simply because 
you don’t want to pass on the gene’ (H2). 
 
Major concerns were echoed by many other husbands, the thought of their 
children taking a test, having a mutation, their daughters electing to have 
surgery or importantly their children dying as a result of getting cancer, filled 
them with fear.  Husband five explained:  
‘My daughter now, well she will have to be tested and my son 
as well so, it’s quite scary, to be honest. That’s my biggest 
concern, if anything god forbid ever happens to her you know, 
that I lose my daughter through breast cancer Yeah because 
we’ve seen it in the family on x side now and x cousin, years 
ago, she died of it, forty-two, you know’ (H5). 
 
However, the fear for their sons did not appear to be as strong. Although all 
their children had an equal chance of inheriting a BRCA mutation, husbands 
focused on their daughters because they believed it was less likely that their 
sons would have it.  Why was this the case?  They were less fearful about the 
consequences for their sons because they did not have the double risk of 
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ovarian and breast cancer and they would not need such radical surgery as 
breast removal.  Husband three explained why he had far less concern about 
his boys:  
‘also, although I know that the BRCA gene can be passed 
down to the boys I suppose to some extent, firstly there’s no 
guarantee that it will have been and secondly, as boys, they’re 
prone to obviously different things – they don’t have ovaries. 
I suppose that is something that maybe at some stage we’ll 
need to consider whether we go down similar routes with them 
in terms of genetic testing and seeing whether we need to kind 
of have them screened for maybe, I’m not sure’ (H3). 
 
Some of the older children had been given limited information about the 
mutation and the surgery but other children had not been told.  Despite his 
wife not agreeing with him, one husband did not want to tell his children, 
causing extra strains in his relationship.  He rationalised his decision because 
he believed this could mean they would get bullied.  However, his main reason 
was that it would ruin their lives by changing the way they would see 
themselves and the way other people would see them. He had personal 
experience to base his decision upon.  He shared his own story: 
‘We have made a decision that we are not going to tell the 
children what surgery she is having. She will obviously tell 
them she is going into hospital umm I don’t think the kids need 
to know so we have decided we are not going to tell them 
necessarily.  Umm, I think back to when I was about thirteen 
or fourteen, umm children could be very cruel’ (H2). 
 
  
284 
 
Indeed, for some of the husbands, the concerns and fears for their children 
were still evident at twelve months and revolved around their risk of getting 
cancer and not surviving.  Husband five feared losing his whole family:  
‘That’s my biggest worry out of the whole lot since she has 
gone through it, I know obviously she’s a lot older than my 
daughter obviously and I already understand a lot more and 
sort of she’s done it, by the time well, we haven’t done our 
time exactly but you know it’s not nice sort of getting prepared 
for my daughter to see what the test will be. Well that’s was 
my biggest fear before I pass away, do I end up losing my 
wife, my daughter, my son before me, and you know’ (H5, 
twelve months). 
 
Thus for all the husbands, their initial fear of losing their wives had resolved, 
but for many, the fear had now transferred to their children, making life 
uncertain.   Husband two summed it up: 
‘Yeah, has life got better no, has the fear gone, it’s moved, so 
the fear is now for the children rather than for her’ (H2, twelve 
months). 
 
5.7 Summary 
Finding a BRCA mutation in the family with all its implications had been a major 
life event for all of the husbands.  Following news of their wives’ positive result, 
there was a preoccupation and a negative impact for the majority of husbands 
even if they anticipated the result, especially in families where there were 
complex relationships.  There was an overriding fear of losing their wives and 
their children to cancer. Although it was a very difficult decision, the majority 
of husbands believed that RRM was the only option to maximise survival but 
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they all acknowledged concerns about the effects of surgery on their wives 
and potentially, their children’s psychological health including their own 
relationships and their future children's relationships.  
 
The majority of husbands took time to adjust to their wives new reconstructed 
breasts because their wives looked so different and felt so different.  Even with 
time, the appearance of the breasts for many of the wives did not improve and 
thus husbands were also living with the consequences of their wives 
‘separation from themselves’ and feeling ‘disembodied’.  As a result, some 
husbands reported negative changes to their relationship and intimacy long-
term for which they required help and support. 
  
Post-surgery the fear of cancer they experienced for their wives had resolved 
but had transferred to their children.  This fear, primarily for their daughters 
concerned the implication of breast loss but also included the fear of losing 
their children with cancer and the fear of how their life trajectory had changed.  
These findings have important implications for clinical practice and will be 
discussed in the last chapter.   
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CHAPTER SIX – The Family Members 
6.1 Introduction 
This chapter provides the analysis and interpretation of the five family 
members who took part in the study. Due to time constraints and the overall 
aim of the study to understand the probands’ experience in the context of their 
family, they were interviewed just once.  The interviews took place in their own 
homes either before or following the probands surgery and after their own 
genetic test. Of the family members interviewed, two were fathers of the 
probands who also had a BRCA mutation; one brother carried the mutation 
and one sister did not.  One mother had breast cancer at the age of thirty-one 
a mutation was later identified.  
 
The family members had agreed to be interviewed once they had been 
approached by the probands and this particular sample came forward offering 
a wide range of experiences.  The age of the relatives ranged from thirty-six 
to sixty-five years.  The two fathers had retired; the mother was in full time 
employment as was the brother and the sister.  One father of the probands 
and her brother were part of this study.  All the family members were therefore 
in some way, living with a BRCA mutation. In considering the ‘parts in terms 
of the whole’, three horizons of understanding united their experiences and 
those of the probands and the husbands. These are the price of survival, a 
separation of themselves, and the altered child’s trajectory.  Each of the 
horizons will be presented alongside the themes that led to those horizons.  
  
287 
 
The price of survival will be followed by a separation from themselves and 
finally, the altered child trajectory. 
 
6.2 The Price of Survival 
6.2.1 The Price - Being on The Alert 
Preventing or surviving cancer was the main concern for the relatives as it was 
for the probands and the husbands in this study.  All the relatives had been 
aware of living with a family history of breast cancer, indeed one relative had 
been treated for it, but none had ever heard of a specific gene.  For the female 
members, there had been a constant message to the girls in the family ‘to be 
careful’ and ‘examine themselves regularly’ (R4).  Relative four, for example, 
had always been alerted of the family history by her mother who believed she 
and her sisters had to be on ‘their guard’: 
‘She would say to us (mum) you have to watch yourself, girls, 
you have to be careful there’s something in our family. You 
know mum never knew anything about genetics or whatever 
she just yes, she just said there’s something in the family 
because there’d been a history so I guess that’s where it 
started’ (R4). 
 
On their guard for what? There was a general feeling that a link existed 
between the number of cases of cancer in the family and the number who had 
died, but nobody knew what the link was.  This coupled with a few cancer 
scares themselves or a personal diagnosis of cancer made the female 
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relatives much more aware of their risk.  One relative who had a cancer scare 
remembers it vividly: 
‘And I mean I’ve always been very aware, when I was thirty, 
thirty I think maybe thirty-one I had a lump in the breast so 
they checked it out and they said it doesn’t look malignant but 
I had a, I had my second baby and I had to stop breast feeding 
her for them to remove the lump because they weren’t sure. 
Again I don’t know if that was something to do with the history 
that they were extra careful, but it was nothing, but I mean the 
awareness has always been there’ (R4). 
 
Although relatives could see a pattern emerging within the family by the 
number of cases of breast cancer amongst the females, the implications of this 
with an additional BRCA mutation had only became apparent when other 
members of the family had been tested or had breast cancer.  Male relatives 
like all of the participants initially had never heard of a BRCA mutation.  There 
was much secrecy about cancer which was only ever ‘whispered’ about in the 
family.  Two relatives share how it all unfolded and they came to know:  
‘Nothing, nothing before, I think x and the other cousin, her 
other cousin x, were both very interested in this following x 
experience of breast cancer and it was through them that we 
came to hear about it. Probably my father’s sister, his oldest 
sister x, born 1920, she had breast cancer in her early thirties 
which was 1950 something when I was born.  So this was 
something that was always whispered about in the family, I 
wasn’t party to it but it came to the front then when my sister 
had breast cancer, the first time, she was probably in her early 
forties. It was only then when the younger of my niece’s, x, 
found a lump a few years ago that the genetics people took 
an interest in the case and it’s only since then that we’ve come 
to know about the BRCA gene’ (R3). 
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‘I thought oh gosh this is a big thing, you know and out of the 
blue then they rang me and said oh you know can we have a 
meeting she said, we’ve got some news for you.  So right okay 
then, so she came along to the house, she done another 
blood test and she said look she said, we’ve had this new 
testing, it’s literally just in from America and she said we do 
this gene testing now and it’s more or less instant she said, 
we’ll have a result for you now within a few weeks. So we done 
that, a couple of weeks later and this, BRCA2 gene was 
mentioned’ (R2). 
 
Thus, the full details of inheritance and the implications of a specific mutation 
were not fully understood by any of the relatives, for example, the knowledge 
that each person had a one in two chances of inheriting it.  One relative had 
her own understanding of the inheritance chances: 
‘Well I wasn’t aware of the 50/50 so it was kind of x was 
positive, x was positive and I think in the back of my mind it 
was somebody’s got to be negative, you know and I wasn’t 
quite aware that it was absolutely straight 50/50 you know, 
everybody had exactly the same chance of having the gene 
or not’ (R4). 
6.2.2 The Price - It’s A Female Thing 
All relatives had limited understanding of the implications of being BRCA 
positive.  The male relatives, in particular, were generally less well informed 
for example, they thought it was only females that were at risk or should be 
concerned about inheriting a BRCA mutation because of the risk to the female 
organs.  As a consequence, they paid little attention to their own risk or 
potential consequences of having inherited it. Relative five, like others, 
believed that being healthy put him at less risk: 
‘I just thought well it’s a female thing, you know touch wood I’ve 
always been healthy, I’ll be fine, you know, I thought I’d be negative. 
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I haven’t really looked, I think when I went for the test I had a quick 
google, that was it so I didn’t look at anything about it and’ (R5). 
 
Initially, therefore the men in this study did not think that they would need to 
be tested and just ignored what was going on in the wider family because it 
had no personal consequences for them and they had no idea of the full 
implications.  Two relatives explain:  
‘No, if I was honest I probably just put it to the back of my mind 
and thought well personally I’m not going to get tested’ (R5). 
 
‘I didn’t realise what it was, the implications of it so I didn’t 
really know much about it at all’ (R1). 
  
The secrecy within the family also made it more difficult for them to gather 
information for example, for one relative neither he nor his wife were aware 
that one of his daughters had already been for the gene test and tested 
negative and another daughter was waiting on results.  It was only when one 
of his daughters came to tell him her result, did he realise what was happening. 
He explained how he came to know: 
‘I obviously know my mother’s family history and she had 
cancer and her sisters and her mother but we didn’t, we 
weren’t even aware that there was a BRCA Gene.  So, x came 
in and told us she had news, umm and then consequently we 
found out that our eldest daughter went for tests’ (R1). 
 
In terms of their own mutation test and result, some relatives were shocked 
and yet numb when they were first told because they had expected to test 
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negative. They did not feel sadness or fear about their own positive results, 
the men rationalised that nothing had changed for them because nothing could 
be done. They took the view that there was no screening, no surgery and 
cancer was common.  Relative threes’ concern was always for his daughter:  
‘So the actual day, going in for the result I was surprised at my 
reaction, I thought that I was a little bit stronger but no, I felt myself 
quite wobbly going in, certainly a bit shocked coming out.  A few 
days of feeling uncomfortable but then the realisation well nothing 
has changed, this doesn’t make any difference to me but it’s X now 
she’s got that 50/50 chance’ (R3). 
 
Why were the men so concerned about their daughters rather than for 
themselves?  The men took the view that their odds of surviving had not 
changed by having a mutation. All the men had, therefore, accepted their 
mutation result, taking a fatalistic view and rationalised that they had no control 
over it or its implications.  In addition, they believed that a mutation did not 
have the same consequences or gender implications, whereas it did for the 
females, breast loss with all its implications. This was the main concern for all 
of the relatives. Two relatives were very blasé about their own risk:  
‘There’s more, you know we’re all going to die of something, like 2.7 
people are affected by cancer, we look at the rates because we do 
it for illness and income tax and stuff so we look and we have a lot 
of the stuff coming out from all sorts of different people so I thought 
well you know, my odds haven’t got any worse but all I thought is 
mainly my daughter because I know it’s all to do with your breasts 
and whatever’ (R5). 
 
‘I have sort of, x (wife) doesn’t like hearing it, but I have come 
to the conclusion that if it’s going to happen it’s going to 
happen and there is not a lot I can do about it’. You know in 
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20 years’ time there might be something around or they might 
be able to eradicate it so there is a bit of a positive there’ (R1). 
 
Unlike the probands, they were in no hurry to be proactive about a positive 
mutation, regardless of age.  They took the view that there was treatment 
available if cancer did ever occur. Their focus being on prostate cancer, but 
not cancer of the breast. Unlike the women who focused on prevention and 
urgency, the men took the view that if cancer occurred, it would be slower 
growing and responsive to treatment.  Relative three explained why he had 
accepted it and took a more passive approach: 
‘There’s not a great deal that I would be able to do, (risk of 
prostate cancer) I would go with the same process that an old 
school friend has recently finished a course of chemotherapy, 
a cousin on my mother’s side, similar age to me, yeah I’ve just 
got to accept that blokes of my age have these issues and 
why shouldn’t I be one of them. Yeah, my perception of 
cancers is that the older you are the slower the cancer takes’ 
(R3). 
 
As such, in terms of their own risk, the men carried on with their normal life 
which for some, was far more complicated.  One relative, for example, was 
going through a divorce and this took priority for him: 
‘Since I had the result and I had the letter, I don’t know where 
the letter is, it’s filed away and I’ve just got on with other things 
that have been probably been taking a precedence because 
it’s been a tough couple of years and it’s just, I suppose I 
haven’t got time to think about it really’ (R5). 
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6.2.3 The Price - Having a Test and Being BRCA Positive 
As more information was obtained and understood, the majority of relatives 
recalled how fearful they were of the probands having the test, the timing of 
the test, having the mutation and the decision to elect RRM.  Why was this the 
case?  After all, this would be ensuring their survival? There was a price to this 
survival, however, making a difficult decision to be tested that had major 
implications.  Relatives were concerned about what they were taking on at 
such a young age. One relative was devastated for example when her 
daughter wanted to be tested because she knew the implications and the 
decisions she would ultimately make, lose her breasts: 
‘And then she came to me and she said I want to be tested 
and once she said it, it hit me like a brick. No that’s something 
I don’t want to know now, although I’ve done all the 
preparation for it, for when they were older, when she comes 
to me, it’s not that I didn’t want her to, it’s I didn’t want her to 
so soon. Young girl, that frightened me big time and I know 
she’s headstrong as well in a totally opposite way to my other 
daughter’ (R2). 
 
Despite having always encouraged her girls to be on the alert for signs of 
cancer because she had been diagnosed with breast cancer and deep down 
believing they would be carrying a gene; the reality of being told was still very 
frightening, because she knew what the whole process  would involve and that 
her daughter would begin the process that would lead to RRM: 
‘I think that’s why I was so frightened, I didn’t want to hear the 
fact that she would be carrying the gene but I guessed she 
would, do you know what I mean, hearing it and thinking about 
it, and you know, knowing the facts and not are two different 
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things aren’t they in one respect.  But yes, I suppose I was 
just frightened for the whole situation really’ (R2). 
 
6.2.3 The Price - Losing the Breast 
All relatives, like probands and husbands, were frightened of cancer and of not 
surviving.  They believed that probands did not have any choice other than to 
remove their breasts because it would lead to the best survival outcome and 
was, therefore, the right decision that probands were making. However, their 
initial thought of losing the breasts was one of ‘horror’.  Why did losing the 
breasts fill them with horror?  They all thought RRM was a huge decision for 
any woman to have to make, with serious consequences to their body and 
thus their life. Relative three explained: 
‘Well finding out that she has inherited it, that’s, yeah and 
subsequently then her decision to have the bilateral 
mastectomy, Yes, yeah this is your little girl and a pretty 
serious operation. Initially, the thought of it was one of horror, 
but, when you begin to look at the probabilities, the survival 
rate, the probability, as my sister had it three times, the 
recurrence and then eventually you begin to realise that this 
is the only decision you can make. So from that point of view, 
we’ve come to accept it, it’s, we would recommend it’ (R3). 
 
As with the probands and the husbands, all relatives were reliant upon surgery 
to not only prevent cancer but prevent death and guarantee survival. They saw 
RRM as lifesaving.  The price to pay for this survival, however, was 
risk-reducing mastectomy, but this was easier to accept than losing the 
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probands.  Relative one shared his despair at the thought of losing his 
daughter, explaining why it had to be surgery: 
‘If anything did happen to her or she did end up having cancer 
before all this, it would kill me. If it prolongs her life, if it stops 
the chance of her getting breast cancer, she’s got to go for it’ 
(R1). 
 
Although the thought of surgery frightened the relatives, having to cope with a 
diagnosis of breast cancer and treatment such as chemotherapy, equally 
frightened them.  Therefore, all relatives  believed that unlike family members 
who had died or who were undergoing treatment, probands had an opportunity 
to be proactive and prevent cancer and that they should take the opportunity. 
Relative three explained why surgery was the right decision for his daughter: 
‘Yes, absolutely, I would not want to see her go through that 
(breast cancer treatment). She had the opportunity that my 
niece did not, because she had to have the mastectomy at a 
time when she was also having chemotherapy, so my 
daughter is in a much better position to recover, to bounce 
back’ (R3). 
 
6.3 The Price - A Separation from Themselves 
Why was the whole process and surgery so frightening for relatives, even 
those who had been treated for cancer or done so much preparation for cancer 
occurring one day?  They were frightened about the consequences of breast 
loss for the probands, leading to a different body and a different person.  One 
relative who had personal experiences of the consequences of breast loss and 
the whole experience based her fear upon her own difficult experience.  She 
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was deeply traumatised for example when she had her breasts removed, she 
found it very difficult it to accept the way her body looked and who she had 
become, especially sexually. She would hide away her body from her 
husband. She had the same concerns for her daughter: 
‘I wouldn’t show my body to my husband or anything, it just 
broke my heart really, just seeing myself you know, coming 
out of the shower looking like that and I just, being so young, 
you know, I felt young, I didn’t feel, I don’t know, you’re not old 
at thirty-one, thirty-two, are you? And I thought I’m still a young 
woman and I, I’m still sexually active and you know, and I just 
couldn’t, I was just hiding away and I just’ (R2). 
 
Indeed, the timing of the decision to have RRM was also a concern for the 
relatives. They worried about the loss of the breasts and the effect it could 
have on their marriage.  Many relatives wanted the probands to wait until they 
were older, believing they would be more able to deal with it. Relative two 
wanted her daughter to take it in stages and not rush into it so that she was 
more mature to deal with it: 
‘So, I said look, as long as you are only thinking of having the 
gene, the testing done and you’re not going to take it any 
further now at your age. I said wait at least until you’re late 
twenties, I said you’re young, newly married, you know, x is 
so young. I mean my husband was older, he was thirty-five 
my husband so he was older and more mature to handle the 
situation’ (R2). 
 
To deal with what?  Like many of the relatives, she wanted her daughter to 
wait until she was older and based on the family pattern of cancer, felt time 
was on her side. This wait, she believed would enable her and her husband to 
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deal with the implications of breast loss, such as a radically altered body and 
a change in the way she would feel about herself.  Relatives were filled with 
sadness as well as fear at the thought of the probands having to lose their 
breasts so young.  They were concerned about how the drastic  body changes 
would affect the probands’ husbands or potential partner.  Why were they so 
concerned about the husbands?  Many relatives had also seen the 
photographs of the surgery because they had attended clinic with the 
probands.  Thus, after attending clinic with their daughters and seeing the 
photographs, they were was so shocked at the images of RRM, that they were 
immediately concerned about their son in laws.  They were fearful that they 
would also be very shocked and avoid physical contact. Two relatives share 
their fears: 
‘I am conscious of my scar so, with (pauses) so from I think 
the photographs, if she has a swimsuit on or a bra on you are 
not going to see any difference so you know, but I think she 
and I am worried about what x is going to be like with her. I 
think (pauses) I think he will sort of umm, I hope I’m wrong, 
but I think he will stand back a bit at first and she might feel it 
then. And I think you know, I don’t mean in a sexual way, but 
you know like just a cuddle or something like that, you know 
and its, I think that’s when she is going to feel it the most’ (R1). 
 
‘Scared the life out of me, broke my heart, I really didn’t want 
her to go ahead with it there and then. I really wanted her to 
wait until she was at least about twenty-eight. I say twenty-
eight, not thirty-one because the generations have got 
younger. My mother was thirty-six, I was thirty-one, so I knew 
sort of in my mind that she had to do it a little bit sooner but I 
just wanted her to sort of more or less get her twenties out of 
the way you know’ (R2). 
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6.3.1 The Price - Separation from The Marriage 
The concern about the impact on the husbands’ was a constant focus 
throughout the relative’s stories. Indeed, the majority of relatives expressed 
concern that relationships could end because the husbands may not be able 
to deal with it.  Relative two was concerned about her young son in law staying 
in the marriage: 
‘And her relationship and everything, young children, I didn’t 
want, I mean x is as good as gold and I didn’t doubt him 
supporting her in any way but there’s always that percentage 
that it could have gone wrong, it could have broken up, 
because a lot of men can’t handle it’ (R2). 
 
Why did she feel he may not handle it, handle what?  She was concerned that 
he was too young and immature to handle the changes to the body and the 
sexual difficulties that they would encounter.  She relayed a conversation that 
she had with her daughter when she first learned of the surgery:  
‘I said you’re young, newly married, you know, x is so young. 
I mean my husband was older he was thirty-five my husband 
so he was older and more mature to handle the situation’ (R2). 
 
The degree of concern that relatives had about the marriage surviving also 
depended upon how the probands would feel about their altered bodies and   
the changes to self.  Relatives worried if they would be able to cope with the 
changes.  As with the experiences of the husbands, all relatives believed that 
image was important to all of the probands and knowing what the results would 
look like, they were concerned about the psychological affect it would have on 
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probands and ultimately their marriages. The long-term psychological effect of 
RRM for the probands and their relationships was, therefore, a major concern 
for all relatives.  Two relatives share the reasons why they were concerned: 
‘Yeah because I know it’s alright for me to turn round and say 
well this is why she should be ok you know she hasn’t 
changed really, it’s still her inside, but she is so obsessed with 
her flat stomach and how she looks. That’s what’s worrying I 
think, it will be one of the major worries as well, and how will 
she cope afterwards’ (R1). 
 
‘she says she will be alright but, she seems to be ok handling 
it, but I think she is a bit you know, reading between the lines 
and I think she is a bit concerned and I think psychologically, 
I don’t know how she’s going to cope with it later if I’m honest’ 
(R3). 
 
6.3.2 The Price - Feeling the Guilt 
In addition to sadness and fear, all relatives experienced guilt, not just in 
relation to passing on the mutation but because of the need to elect to have 
RRM and the implications on the probands bodies and relationships.  The 
degree of this guilt was demonstrated by relative one who remembers the day 
he was told the result by his daughter.  He could not apologise to her enough: 
‘So, when we first got told, I was on the list for a transplant, I 
didn’t connect anything to do with me and it wasn’t until you 
know a couple of minutes after she told us, because 
obviously, we got very upset straight away, that I realised that 
I must have passed the gene onto her and the first emotion I 
had was guilt’ (R1). 
 
‘The initial feeling was guilt, guilt and sorry for her, sadness 
for x. It was a mixture of, as I said earlier, guilt, sort of feeling 
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sorry for her and apologetic to her.  And I’ve spoken to her 
and said oh I’m so sorry for passing it on and she said well it’s 
not your fault’ (R1). 
 
This guilt was even more salient if probands were not dealing with their 
experience of RRM and had changed as a person.  Relative five for example 
who also had a mutation and who was very close to his sister, felt very guilty 
about what his sister was going  through especially because she was not the 
one who had started the whole process: 
‘You think well I’d rather be worse off than her, you know, 
that’s what you think, you think, there’s a bit of guilt there as 
well and I’m not sure about my other sister because she was 
the one who started the whole ball rolling and she was 
negative and doesn’t seem to get involved that much’ (R5). 
 
Why did he feel guilty about her? He missed his relationship with his sister 
which had changed drastically because she had changed as a person 
following the RRM.  Everything was the same for him despite having a 
mutation but the result of RRM on his sister's body had been devastating for 
her and it was difficult to watch the psychological effect it was having on her: 
‘I don’t think it’s a physical thing, all the stuff she’s had done 
or maybe the future risks, it’s probably what she’s going 
through more than anything else after the surgery, Yeah and 
psychologically as well, you know it is affecting her, you know 
she’s conscious of her clothes, it’s not nice to see, she’s quite 
a bubbly confident person and that’s taken it off her, she 
doesn’t like admitting it, she doesn’t like talking and I think she 
buries herself in her work a bit, to get over that fact. She’s so 
different now’ (R5). 
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Other relatives also felt guilty because the probands had to deal with the whole 
process from testing through to surgery and some were concerned that they 
would not be able to do it.   Relative four, for example, who tested negative 
and who also felt guilty for not having the mutation, was concerned about her 
sister who had a history of depression.  Although relieved to be able to keep 
her own breasts as these defined who she was, she felt very guilty because 
her sister was also very conscious of her image and liked her breasts. Relative 
four explained why she was so worried about her sister coping with everything 
and why she felt so guilty:  
‘I’m worried about her dealing with it because it’s her, it’s, so 
my first thought was she’s never going to deal with it. I kind of 
kept saying to her don’t be surprised if they don’t test you 
because of your mental state, you know her kind of very fragile 
state at that time. Basically, how the hell is she going to cope 
with it, but I mean obviously she got tested in the end, I was 
negative and she was positive’ (R4). 
 
‘whilst I’m negative I do have that guilty feeling because it’s 
oh god, I also believe I have nice breasts and I rarely if ever 
wear a bra, I sometimes have to wear one for work, other than 
that I don’t wear one and you know then seeing her, I  feel 
guilty because I’m going in there full of health’ (R4). 
 
6.4 The Altered Child’s Trajectory 
As with the probands and the husbands, relatives were focussed on the risk 
and implications for children in the family.  Guilt, fear, sadness and shock were 
feelings that many of the relatives experienced after realising the inheritance 
pattern because of the wider implications for their own children and future 
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generations.  For one relative, the devastation and guilt of passing the gene to 
his children and potential grandchildren was vivid:  
‘Umm we stood in the kitchen and x said oh I’ve had a test and I 
have BRCA1 gene, so I said, what!  She said well x  is clear, I got 
it.  So I said what you mean BRCA1 gene.  She said it’s a gene that 
causes breast cancers and ovarian cancers.  I said what, how you 
got that.  The first thing I said was how you got that, being a bit 
naïve’. ‘But it was (thinks) how can I put it, it was when she 
came across and told us she had the gene and then told us 
the implications, its it is quite a kick in the stomach, it’s very 
you know, it’s the feeling of guilt and you know’ (R1). 
 
Why did they feel such guilt and responsibility? They felt responsible as 
parents for passing the gene on especially if there was more than one child 
that could be affected and because grandchildren were involved.  They felt 
guilty because of the decisions and the altered life trajectory that their children 
and future generations were now faced with.  Relative one had two out of three 
children who were positive which increased his guilt because there were, even 
more, children to consider: 
‘He came back as positive and I thought oh no, not another 
one you know but as you say, by then I had sort of, obviously, 
as I said earlier when she told us, there was the feeling of guilt 
that I passed it on to her and then more guilt’ (R1). 
 
Passing on a mutation to future generations meant that the consequences of 
this had to be considered by the probands.  Relatives felt they had burdened 
their children with extra worries and dilemmas about their own life trajectory 
and their potential offspring. Relative three, for example, believed he had 
introduced extra problems for his daughter and future family: 
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‘She’s now got that 50/50 chance and so as hers came closer, 
again a repeat of those guilty feelings and it sort of, everything 
goes a bit quiet when she gets the result that she’s got it too 
because you know then, that she’s got all the decisions to be 
made. My daughter is in a different position in that if she 
should choose to have children, she actually knows.  My 
father and I and how many generations we didn’t know, had 
no inkling, so it’s uncomfortable, it does put quite a burden on 
her and x that we didn’t have’ (R3). 
 
Although the relatives realised that they had no control over whether or not 
their children (including the probands) had a mutation, their main concerns 
were for their children and future generations.  They did not want the normal 
childhood trajectory to be affected by introducing constant fear in their lives nor 
their future grandchildren getting cancer.  However, the experience of a 
mutation in the family and the subsequent risk for children had in many ways 
altered their life trajectory.  For example, despite still being very young or even 
babies, they were already anxious about them having a mutation.  Two 
relatives share their anxieties: 
‘I’ve got my son and I don’t, he doesn’t want to know, which 
it’s no, I’m a boy, I said but you know it can affect you, you 
can carry the gene and you have got a little girl. He’s like mum, 
maybe in the future, I do not want to think of, at the time she 
was only like a baby, well she’s only three now. I don’t want 
to think for the next twenty odd years that my daughter, I could 
have passed a gene onto my daughter that could give her 
breast cancer.  I can’t worry about that for the next twenty odd 
years, well when it comes that she is older…’ (R2). 
 
‘I didn’t have any thoughts about it apart from oh no, the kids 
have got a 50/50 chance and that was about it. I didn’t think 
anything personally about myself or the implications, all it was, 
well I hope the kids haven’t in years to come type of thing’ 
(R5). 
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6.4.1 Preserving the Normal Child Trajectory 
All the relatives were, therefore, trying to protect their children and 
grandchildren by ensuring life was as near to normal as possible.  Like all the 
family, relatives did not want to burden the children or spoil their childhood with 
the worry. Relative two, for example, explained how although she had 
prepared herself and her daughters that breast cancer would occur one day, 
she had particularly tried to protect her children from having an altered 
childhood, interrupted by constant worry or disruption.  This was achieved by 
not telling them the whole story of her breast cancer when they were younger: 
‘But I’ve prepared myself my whole life for it and I think the 
girls have as well, you see, because they’ve all, I’ve never 
rammed it down their throats and when they were children 
always protected them, never give them a full awareness of 
the whole situation, you know’ (R2). 
 
Indeed, it was precisely for this reason that the wife of one of the relatives did 
not want him to be tested because it would introduce risk and fear into their 
children's lives, including awareness of their own risk.  He explains: 
‘my wife didn’t want me to have it done because of the kids 
and that’s about as much as I knew, to be honest until and 
then x said she was going, and x was negative and x was 
positive’ (R5). 
 
Relatives also had a fear that their children and grandchildren would get 
cancer because of a mutation and that they may lose them. This would also 
mean an altered life trajectory for their grandchildren, witnessing the 
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devastation of cancer treatment and death.  Relative one tried to imagine what 
would happen if that were the case: 
‘god what’s going to happen with the kids, will she see them, 
you know, will she be there to see the kids and see them 
married and will she become a grandmother and obviously 
thinking about that type of thing umm’ (R1). 
 
Passing the gene mutation onto future generations was, therefore, a concern 
for all relatives, especially for the females who would have the difficult decision 
of losing their breasts. This concern from the relatives was influenced by 
having witnessed the experiences of the probands. Relative five, for example, 
was concerned for his own young daughter and electing RRM based on seeing 
the impact on his sister: 
‘So I wasn’t so much concerned about x which is weird 
because they’re both my children, it was more x because she 
was a female and that’s probably because of the impact on 
my sister. That’s probably why subconsciously I’m thinking 
well me and x are just going to live through it but you know, 
prostate or whatever, but the thing is it’s more impacting on a 
woman isn’t it’ (R5). 
 
The relief of not having a positive gene and not having to worry about passing 
it on to future generations was also evident. Relative four, for example, who 
tested negative, was so delighted her daughter's lives would not be turned 
upside down:  
‘I mean I was obviously extremely happy about it, simply 
because of my daughters, I’m not giving something horrible or 
there’s not a chance that I’m giving this something horrible to 
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my daughters.  They’ve just got other things that they have to 
deal with sort of thing’ (R4). 
 
6.5 Summary of Experiences  
For the majority of relatives, a positive BRCA mutation in the family was 
devastating and they were mainly concerned with their children’s (including 
probands) and grandchildren’s risk and survival. Importantly, they felt 
responsible and guilty especially the parents in the sample, for the need of 
their daughters and future grandchildren to elect to have RRM in order to 
survive, which was a result of them passing on a mutation. They were 
especially concerned about the real and potential problems caused from a 
drastic change to the body and relationships as a result of RRM. This fact 
being the main reason for their continued guilt and sadness.  Literature had 
identified that family members feel guilty in passing on a gene mutation 
(d’Agincourt-Canning, 2006b; Hallowell et al., 2006; Stromsvik, 2010., Shiloh 
et al., 2013) but the above reasons for this guilt, offers a new contribution to 
knowledge.  
 
Relatives feared for current and future generations in terms of the timing of the 
test, the test result and the effect on their normal childhood trajectory, including 
their potential decision to elect RRM, believing that all these factors had now 
altered their life trajectory. They all feared for these children’s relationships 
and the effects of breast loss on their body, their confidence, their marriage 
and their self -identity.  At the same time, they also feared a diagnosis of breast 
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cancer for any family member and the effect this would have on the children’s 
normal life trajectory.  
 
Despite testing positive for the mutation, themselves and being at risk of both 
breast and prostate cancer, the concern for their own risk was secondary to 
their children. They believed that some form of cancer was inevitable and that 
the older it was contracted, the better the outcome.  
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CHAPTER SEVEN – Discussion and the Expanded Horizon of 
Understanding 
The three horizons of understanding that unite the probands, husbands and 
the relatives resulted from the interpretation of the most salient aspects of the 
experiences.  Each horizon developed from the data by viewing the parts in 
terms of the whole (Gadamer, 2004). The new fused expanded horizon of 
understanding, ’disembodiment’, the experience of living with a different body, 
disconnected physically, emotionally and socially from the original body, offers 
an explanation of why women undergoing RRM experience such negative 
impact on femininity, sexuality and identity. This new contribution to knowledge 
resulted from the interpretation of the experience of RRM for the probands 
primarily, but also draws on the husbands and relatives experiences of the 
consequences of RRM for the probands and their relationships; - a separation 
of themselves, leading to ‘disembodiment’.  
 
This is the first longitudinal qualitative study, to my knowledge, that explores 
the experiences of BRCA positive women, electing to have RRM, their 
husbands and their relatives. Utilising the hermeneutic circle of understanding, 
forty-three interviews were interpreted, they revealed a text that connected the 
experiences of the women, their husbands and relatives, providing a new 
fused horizon of understanding of their experience. In this discussion, the 
united interpretations and the three horizons of understanding including the 
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expanded horizon, ‘that of disembodiment’, will be explored by revisiting the 
research questions.  
 
7.1 Research Question Revisited 
My overall question was, 'What are the experiences of living with the BRCA 
gene mutation and electing bilateral risk-reducing mastectomy for the woman, 
her partner and her family’. In particular, ‘what does it mean to be a BRCA 
mutation carrier and what is it like living with someone who is a carrier?’  ‘How 
do women and their families make sense of the BRCA mutation, come to the 
decision of surgery and what are their experiences?’  ‘What is the experience 
of undergoing surgery and living beyond surgery?’ ‘Why is sexuality, femininity 
and identity so adversely affected?’  Finally, ‘what are the needs of both the 
women and their families in terms of information, assessment and nursing 
care?’. 
 
It would be impossible within the remit of this Ph.D. to discuss all the horizons 
found within the data but as Gadamer advises, in order to understand 
experience, it is necessary ‘to seek out those elements that we have found in 
our analysis of experience that are general’ (Gadamer, 2004; pg. 352).  Three 
main horizons, therefore, united the experiences of the probands, husbands 
and family and underpinned the new fused horizon. The price of survival, the 
altered child’s trajectory and a separation from self-leading to the new 
expanded fused horizon of understanding ‘disembodiment’. 
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The three horizons will now be discussed alongside the research questions. 
New Fused Horizon of Understanding 
Being a woman or a family member living with the BRCA gene can mean 
living a life of constant worry and fear of not surviving and this is not just 
individual, but is a complex family affair. Taking all available steps to 
survive fulfils a moral obligation as a wife and mother to act responsibly 
to this risk information and is not just for the sake of self, but is also part 
of a wider responsibility to their family.  Doing so however, means making 
the difficult decision to elect to have bilateral risk-reducing mastectomy. 
The results of this surgery  for probands in this study was both socially 
and culturally undesirable and had far-reaching consequences for the 
whole self because of the importance of the breast for identity, sexuality 
and gender. Thus, proceeding with bilateral mastectomy, despite 
reconstruction was associated with a separation of the whole self and 
disembodiment, an experience of living with a different body, separated 
from who one was and who one is perceived by others. This new state of 
being affects the woman and her wider family. There is a need for 
preparation, assessment, information and importantly, ongoing support. 
for this group of women and their family.     
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7.2 The Price of Survival 
 What does it mean to be a BRCA mutation carrier and what is it like living 
with someone who is a carrier? 
 
Preventing cancer when given a diagnosis of a BRCA mutation has already 
been identified as a priority in the literature (Howard et al., 2009; Lostumbo et 
al., 2010; Brandberg, et al., 2012; Jeffers et al., 2014).  Fear of cancer and an 
uncertain future drives the decision to seek testing and elect RRM (Lodder et 
al., 2002; Van Dijk et al., 2003; Watson et al., 2004; Antill et al., 2006; Graves 
et al., 2012). This was also found in the current study but extends the existing 
knowledge by highlighting that it is not just a matter of prevention, but one of 
survival.  All participants in this study believed that being BRCA positive had 
more serious consequences and therefore without surgery, they would not 
survive.  Having a BRCA mutation meant ‘being BRCA’.  This meant having 
both the current risk and the future risk, of which they perceived breast cancer 
and death as inevitable if they did not act upon the information. Being BRCA 
positive without surgery signified cancer and death. There was never a 
question of if participants got cancer, for them, it was a matter of when. 
 
Probands, husbands and relatives believed that RRM in particular was life-
saving and that they had no other choice. This finding challenged some of the 
existing pre-understandings, the focus being  on preventing cancer, preventing 
the need to undergo  surgery and chemotherapy in the future (Hoskins and 
Greene, 2012) or where other options such as surveillance are taken (Howard 
  
312 
 
et al., 2011). In this current study, there was a sense of not trusting their bodies 
to stay healthy or fight cancer should it occur and surveillance was therefore 
out of the question. 
 
Importantly, this current study demonstrates that there is a ‘price to this 
survival’ for probands and their family. By seeking a genetic test, they 
experience an unexpected long difficult journey that leads to the identification 
of a positive mutation and the complexities of the experience unfold as the 
journey continues.  Conflict within the family, the unexpected impact of results, 
difficult life changing decisions which affect probands, husbands, children and 
the wider family, electing to have RRM and living with the consequences of 
surgery, are just part of this price. 
 
In this study, more than half of the probands had witnessed the death of their 
mother, therefore, the fear of cancer and of not surviving was even more 
salient.  Findings that support other studies which show that a perceived high 
risk influences uptake of both testing and surgery (Hallowell et al., 2001; Antill 
et al., 2006; van Dijk et al., 2008) and that the death of a mother, in particular, 
has greater significance, leading to definitive risk-reducing action (Hamilton et 
al., 2009; Werner–Lin, 2012).  For the family members in this study, there was 
also a constant fear of the probands and future generations dying of cancer. 
The majority of the husbands and relatives were totally preoccupied with the 
fear of a BRCA mutation, but interestingly, the male relatives, who also carried 
a BRCA mutation, were not concerned about their own cancer risk or survival. 
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This is in contrast to the findings of Shiloh et al., (2013) who found that 74% 
of participants in their study increased their surveillance for cancer and were 
still significantly distressed four years after testing, compared to BRCA 
negative men. 
 
Probands with (7) and without (1) children were heavily influenced to have the 
test and elect surgery for their children’s sake, a concern that persisted 
because they described their responsibility for their children’s lives.  Findings 
consistent with other studies (d’Agincourt-Canning et al., 2001, 2006a; 
Hallowell, 2003; McEwan, 2011).  Probands also felt a moral obligation to their 
own and any future children in maintaining the ability to care for them by doing 
the 'right thing’ as responsible parents, findings supported by  Crabb and Le 
Couteur’s, (2006) discursive analysis of  how one woman’s decision to elect 
RRM and remove healthy breasts was portrayed as morally responsible and 
self-sacrificing. These findings are also consistent with other studies where 
women privileged motherhood and the maternal representation of their breasts 
(Hallowell, 1999, Bury, 2008, McEwan, 2011).  In these studies, women 
described a strong moral obligation to their kin to do the ‘right thing’, in doing 
so, however, they relinquished their right not to know, forcing them to act upon 
the information.  Due to the complex family dynamics and initial secrecy 
concerning who should and should not know and when they should know, in 
this current study, some probands were also forced to act upon the genetic 
test results of others which meant they were presented by other family 
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members with a moral obligation to seek testing for their children’s sake, and 
this caused divisions within the family.  
 
In other cases within this study, where probands wanted to pursue testing and 
elect to have surgery, surprisingly, some family members could be obstructive, 
unwilling to provide a sample of blood for testing and relationships were 
complex.  This raises many ethical considerations as identified by Dupras and 
Ravitsky (2013). On the one hand there is the right of the patient to privacy 
and confidentiality but on the other hand, there is the right of family members 
to receive clinical information if it affects and involves them personally. 
Furthermore, Hallowell makes the point that having a genetic mutation is not 
about individuals, it involves biological relationships and it is a family affair with 
far reaching ethical and moral implications such as who to tell, how and when 
(Hallowell, 2006). Moreover, participants in Hallowell’s (1999) study with 
women at ‘high risk’ of breast and ovarian cancer but who were not BRCA 
positive, demonstrated that in doing the right thing, women felt an obligation 
to put the needs of others before their own.  
  
This was even more salient for the women within this study who were not just 
categorised as ‘high risk’ but had a BRCA mutation, which meant that the 
probands and family once given a mutation result, felt they had done 
everything they could for their kin by electing to have RRM.  Probands strongly 
considered and acted upon their obligation to their children, their husbands 
and their family members, putting their own needs second. This supports but 
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also extends knowledge specifically for BRCA women, because it also 
demonstrates how family responsibility, including gender responsibilities such 
as motherhood and social obligations, strongly influence decisions around 
testing, preventing cancer and importantly electing  to have RRM. 
 
At the time of disclosure of the mutation result, surviving cancer and the moral 
obligation to children was therefore at the forefront of all decisions.  The effects 
of RRM on the body was not as significant. One explanation for this is that the 
breasts were initially seen as ‘dangerous objects’ that needed to be removed, 
findings consistent with Hallowell’s (2000) study. Probands and family 
members in this study unlike many other women with a BRCA mutation who 
choose surveillance, did not trust that mammograms would detect cancer. This 
extends knowledge and was the experience for five of the probands. 
  
The majority of participants in this study reported the need for more information 
and support. Although Some of the previous literature had suggested that 
more information surrounding RRM and the psychological effects on wellbeing 
was required, research limitations had resulted in conflicting conclusions, 
making it difficult for women to be well informed (Lloyd et al.,  2000; Payne et 
al., 2000; Josephson et al., 2000; Hatcher et al., 2001; Bresser et al., 2006; 
Rolnick et al., 2007; Isern et al., 2008; Spear et al., 2008; Gahm et al., 2010; 
Wasteson et al., 2011, McEwan, 2011). Glassey et al (2016), identified that for 
younger women, in particular, electing to have RRM has unique information 
needs, yet there has been little focus on their experiences. This current study, 
  
316 
 
therefore, adds a new contribution to knowledge by identifying when and why 
younger women, in particular, need more information and support.  They 
needed information and support specifically before testing to understand the 
implications of a positive test result, whilst trying to accept their result, whilst 
making difficult decisions about surgery and whilst dealing with concerns about 
their children. Post –surgery counselling was especially required when they 
were dealing with sexual and sensitive issues as a result of the drastic 
changes to their bodies. There was also a desire to meet other women with a 
BRCA mutation to see real life images of the expected surgical outcome and 
to discuss personal feelings. Both findings offering a new contribution to 
knowledge with important implications for practice. Future Counselling was 
specifically recommended by participants to prepare other BRCA women and 
their husbands for the drastic changes to the body and support to deal with 
the negative changes to sexual relationships.  
 
 How do women and their families make sense of the BRCA mutation, come 
to the decision of surgery and what are the experiences of risk-reducing 
mastectomy? 
 
Despite genetic counselling, making sense of the BRCA mutation varied 
amongst the participants especially the younger probands and family 
members because of their limited knowledge of inheritance, genetics and 
because a specific BRCA gene mutation was unknown to them. The link 
between breast and ovarian cancer risk was a shock for many of the 
  
317 
 
participants as was the link between risk-reducing breast and ovarian surgery, 
they were not aware that this latter procedure had also decreased their risk of 
breast cancer by 50%.  For all participants, having a BRCA mutation was a life 
changing experience.  They had breasts and ovaries to worry about but the 
decision to elect to have RRM was by far the most difficult.  Losing their ovaries 
did not have the same impact and many of the women following their results 
decided to have their ovaries removed first because they perceived this as the 
easier option, less visible and less threatening to body integrity.  Findings 
supported in the study by Hallowell and Lawton (2002) and Howard et al., 
(2011). Why was losing the ovaries an easier decision? 
 
In addition to being aware of the lifestyle and environmental risks for breast 
cancer, the probands, experienced a corporeal risk as described by Kavanagh 
and Broom (1998) and Hallowell (2000).  In Kavanagh and Broom’s study of 
abnormal pap smears, they identified a Cartesian splitting of body and self in 
their participant’s, where the body was objectified and the self was not seen of 
as ‘at risk’.  This enabled the objectifying of their ‘risky’ body parts (cervix) and 
thus their disposal (removal of the cervix), as not having any implications for 
‘self’. It is proposed that the probands in this study were also able to objectify 
their ovaries. However, with regards to their breasts, this was far more difficult. 
The probands in this study viewed their breasts not just as ‘risky’, but as 
dangerous and life threatening and in order to make and justify their decision 
to undergo RRM, and control their ‘dangerous’ body parts (their breasts), it is 
proposed that initially, they also experienced a Cartesian splitting of body and 
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self, where the risk was seen of as residing in the ‘body’ but not as of the ‘self’.  
Many of the women viewed their breasts as ‘ticking time bombs’ that they 
‘wanted gone’ and thought it would be easy to dissociate from because of the 
physical risk.  However, it was not as simple as this and after seeing images 
of surgery, it soon became evident that RRM and the loss of the nipple 
especially, as potentially threatening other aspects of self, their self-identity as 
a woman and their emotional self. 
 
On one level all participants felt a great need to preserve their physical health 
and stave off the risk of death because they perceived they would not survive 
and they had to act upon the information they had been given. They believed 
that electing to have RRM was the only way of managing and preserving their 
physical health.  This reflects a finding in the study by Howard et al., (2011), 
who reminds us of the four dimensions of self; physical health, self-identity, 
relationships with others and the emotional self. Preserving self, could be 
understood in various ways in relation to the four aspects identified by Howard.  
Women elect to have RRM in order to preserve the physical health aspect of 
self as opposed to those women who choose other risk management 
strategies such as surveillance, these women are attempting to preserve their 
self-identity and also their emotional self (Howard et al., 2011). Instead of 
choosing surveillance which the majority of women did in the study by Howard 
et al., (2011), the women and families in this study, with their focus on survival, 
privileged their physical health, by electing to have surgery. 
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This choice was made, however, without realising the full extent of the effect  
that RRM would have on their other aspects of self, namely self-identity, 
relationship with others and their emotional self. It is argued that the reason 
for this was that they anticipated breast reconstruction would restore the 
aspect of self-identity and preserve their emotional self and the relationship 
with others.  
 
Without realising it, decision-making, therefore, went beyond preserving their 
physical health because of the implication of the other three elements of self 
as identified by Howard et al., (2011), that of self-identity as a woman, 
relationships with others and the emotional self.  The probands and family, for 
example, showed concern about aspects of the decision to elect surgery, how 
family and friends would perceive them without breasts and how they would 
appear physically, emotionally and socially.  Probands, relatives and 
husbands in addition to wanting to preserve the physical health (their survival), 
soon became concerned about the emotional self and the effects of surgery 
on their self-identity. Thus, although they did not see any alternative to surgery 
in maximising survival, pre-surgery, they had reservations about physical 
appearance post-surgery and how femininity and sexuality would be affected.  
 
The importance of identity and how the body is experienced socially, has also 
be highlighted by Fox (2012) and many other scholars with an interest in 
embodiment. Bartky (1990), Merleau-Ponty (2002), Butler (2004) and van 
Manen (2014) who remind us that gender plays a critical role in the way that 
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embodiment is experienced. More importantly, how society and culture 
construct gendered bodies, thus having breasts means ‘being’ a woman. 
There was a huge price to their survival therefore, for the women in this study– 
losing the breasts with all the social and cultural meanings attached to the 
breast, such as womanhood, femininity, identity and sexuality. Fox (2012) 
argues that we need to understand human bodies and ‘selves’, not so much 
as entities in their own right, but as connected to and always in relationship 
with both their physical and social environment. 
 
Thus, for women with a BRCA mutation seeking RRM, it is the type of risk, the 
perceived danger, the location of the breasts and the social and cultural 
meaning of breasts, which present the fear and dilemma for women and their 
families and which is the price they pay for survival. 
 
7.3 The Altered Child’s Trajectory 
The family risk and fears continued onto the next generation and 
consequently, there was ongoing concern about all the children within the 
family, even though many were still very young. This was consistent amongst 
all participants and supports some of the pre-understandings (Lodder et al., 
2001; Metcalfe et al., 2004a; Kenen et al., 2006; Mireskandari et al., 2007). 
However, this study extends knowledge by highlighting the focus of these 
concerns and fears. Fathers, in particular, were totally preoccupied by their 
children’s risk of inheriting a BRCA mutation, especially their daughters and 
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were extremely anxious about how and when to tell them. Moreover, they were 
already beginning to worry about the next generation and their 
granddaughters.  
 
My continual questioning of the text led to me ask why they were worried when 
their children were so young. Why were they already assuming that future 
generations would test positive when there was a 50% chance that they would 
not have the mutation? Instead of being able to enjoy their children and 
grandchildren, the present was clouded by what they perceived as ‘problems 
that lay ahead of them’. Their biggest fears were that their children would not 
not survive cancer but also, they feared their children having to elect to have 
RRM with all its implications for their future relationships. Thus, they viewed 
their children and future children’s life trajectory in a different light, believing 
that others would also view them differently if they had a BRCA mutation. They 
believed that the children now been given a burden to live with and extra 
issues to consider on top of the challenges of puberty, adolescence and 
adulthood.  
 
Some of the men in this study, therefore, found it difficult to share the results 
with their children, findings consistent with other studies (Daley et al., 2003; 
Hallowell et al., 2005) but increases knowledge by highlighting the reasons 
why. Parents, in particular, assumed that their daughters would have a 
mutation and were mindful of not disrupting the key transition periods in their 
lives (Hamilton et al., 2009). They particularly feared the thought of their 
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daughters losing their breast and the effect this would have on their marriage, 
based upon the experience of the probands. For this reason, some of the 
children had not been informed and the men in the family took on the 
responsibility for the decision of whether or not to tell and when to tell.  
 
This is in contrast to other studies where women have taken on the main role 
of disclosure (d’Agincourt-Canning 2001; Forrest et al., 2003).  The probands 
and family were less concerned however about their sons because they did 
not have to lose their breasts.  For their daughters, they feared for their future 
husbands, marriage and their self-image.  This led all participants to feel a 
huge amount of guilt and responsibility which was evident in all of the 
experiences.  
 
Most of the relatives in this study, as well as feeling an obligation to be tested, 
felt a huge amount of guilt in having passed on or the potential to pass on, a 
mutation to their daughters (three of the probands), findings consistent with 
other studies (Liede et al., 2000; Lodder et al., 2001; Stromsvik et al., 2009). 
However, this study reveals that the guilt was because their daughters and 
granddaughters would have to lose their breasts, the implications for their 
body, their future, their relationships and opportunities for marriage. 
Furthermore, unlike previous studies (Mc Allister et al., 1998; Liede et al., 
2000) where men deliberately avoided talking about RRM with the family, 
when asked the question ‘tell me about the BRCA gene’, loss of the breasts, 
was the key focus and concern for all the men in this study. Siblings in this 
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study also experienced guilt, whether they did (1) or did not (1) have the 
mutation. This guilt was again because of the implications of breast loss for  
the women. Unlike findings in other studies (Leide 2000; Daley et al., 2003) 
where constant measures for surveillance were sought, relatives rationalised 
that they could do nothing about their own risk of cancer and appeared to have 
taken a fatalistic approach, accepting the fact.  In this study, all their concerns 
focused on the probands and their future kin. 
 
7.4 A Separation from Self - ‘Disembodied’ 
 What is the experience of undergoing surgery and living beyond surgery? 
 ‘Why is sexuality, femininity and identity so adversely affected?’   
 What are the needs of both the women and their families in terms of 
information and care delivery? 
 
Although RRM was a priority for the majority of participants, it was still an 
experience that caused great anxiety both pre and post-operatively. 
Pre-surgery the fear of breast cancer, but importantly, the fear of not surviving 
without electing RRM, dominated their experience, findings that add new 
knowledge. Post-surgery, participants experienced a separation from the fear, 
the fear of cancer had resolved for the majority, findings supported by other 
studies (Frost et al., 2000; van Oostrum, 2003; Dowdy et al., 2004; Brandberg 
at al., 2008; Hamilton et al., 2009; Miller et al., 2010; Hallowell, 2012), only to 
be replaced by pre-occupation with the body and their children. These findings 
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offer a new contribution to knowledge. Indeed, for some, there was complete 
resolution of fear regarding the probands’ risk which continued long-term. 
However, the fear had shifted to the fear for their children, mainly daughters 
and concerned the issue of breast loss. 
 
Post-surgery, the effect that RRM had on their bodies became the main focus 
and preoccupation for all participants because their expectations of the results 
of surgery were very different to the actual results. For the majority, they were 
expecting more of a cosmetically acceptable procedure despite seeing images 
of the surgery. All probands and their husbands hoped that their result would 
be better than the images had portrayed. The reality, however, was that for the 
majority, they were not. The breast without a nipple made a significant 
difference to the way probands and husbands perceived their post-surgical 
body.  It signified a difference in looking normal and the meaning of being 
feminine and of being a woman.  Despite believing it was the safest decision, 
the loss of the nipple had a major unexpected impact on how probands felt 
about their bodies. A nipple reconstruction later in their journey made some 
difference to increasing their confidence. 
 
The anxiety about the effects of surgery on self-image, femininity and sexuality 
as found in many of the pre-understandings (Hopwood et al., 2000; Payne et 
al., 2000; Hatcher et al., 2001; Bresser et al., 2006) was very evident in this 
study especially from the experiences of the husbands and the family. 
Although electing to have RRM is regarded as a way of preventing cancer and 
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avoiding the devastating effects of treatments like chemotherapy, especially in 
younger BRCA positive patients (Hoskins and Greene, 2012), it also has its 
own devastating consequences on the body.  For this reason, initially, all of 
the participants believed that breast reconstruction would be the answer and 
would prevent the emotional impact of losing the natural breast.  In reality 
however and after seeing the likely cosmetic result without nipples, this was 
challenged.In support of Harcourt et al’s, (2003) findings, post-surgery, the 
over reliance on breast reconstruction to restore the effects of the loss of 
femininity and self-image was evident and the majority of probands were 
dissatisfied.  Furthermore, as found in some  studies, although the majority of 
probands did not regret having the surgery (Metcalfe et al., 2004a; Brandberg 
et al., 2012; Gopie et al., 2013) and felt that they had done everything possible 
to survive, they all experienced a loss of their natural breasts (Crompvoets, 
2003; Hamilton et al., 2009), especially nipple loss.  Husbands and relatives 
were distressed and concerned about the effects that RRM had physically and 
emotionally on the probands, believing that they now looked very different, had 
changed in personality and for one husband ‘destroyed his wife’.  Similar to 
the women in Piot-Zeiglers et al’s (2010) study where mastectomy with 
reconstruction, provoked a painful experience of body deconstruction, the 
probands in this study endured a similar experience but one of 
‘disembodiment’.  Like the participants in Piot-Zeigler's study whose aim was 
to examine the consequences of mastectomy on identity, probands 
experienced dissonance when comparing their former intact body with their 
now challenged, compromised body.  Although women in Piot-Zeigler's study 
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had breast cancer, it is argued that the experience of feeling mutilated 
following mastectomy, was similarly experienced in this study. Furthermore, 
because probands in this study did not have cancer and were separated from 
their healthy breasts as opposed to diseased breasts, it is again argued that it 
was even more difficult to accept and integrate their new corporality.  
 
Unlike the ovaries or cervix which are invisible and easier to dissociate from 
(Hallowell and Lawton 2003; Howards et al., 2011), the dissociation from the  
potentially cancerous breasts was far more difficult because of their overt 
visible presence, the social, cultural meaning attached to them and their 
connection to femininity and identity, and as such, probands and husbands 
grieved the loss.  Relatives also highlighted the negative effects on the 
probands and how probands were suffering from the loss.  This loss was a 
result of their breasts feeling different, they looked different and consequently, 
they felt differently about their bodies, especially sexually. Findings consistent 
with Hallowell et al’s (2012) study.  Most probands and some husbands talked 
of the negative effect on their sexual relationship and how the emotional 
connection was absent.  It is argued therefore that the drastic changes to the 
body and the effect on femininity, identity and sexuality caused by electing 
RRM, resulted from women feeling that they had been unexpectedly, and 
permanently separated from their bodies.  This separation leading to 
‘disembodiment’.  It offers a new contribution to knowledge by demonstrating 
why women have such altered body image and report problems with 
femininity, their sexual relationships and identity, as highlighted in previous 
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studies (Hatcher and Fallowfield, 2003; Altschuler et al., 2008; Brandberg et 
al., 2008; McEwan, 2011).  Their body image, sexuality and identity had been 
negatively altered because their breasts did not feel a part of who they now 
were, separated from their body and their ‘selves’ as women. 
 
Many of the findings in this study also resonate with some of the 
pre-understandings and in particular, the findings of Hallowell et al., (2012) 
where women were found to experience a lack of sensation in the 
reconstructed breasts, yet feelings of hardness in the implant reconstruction.  
Many negative changes in their bodies were experienced which probands and 
husbands felt unprepared for. The reconstructed breasts even if they were 
‘looking like breasts’ did not feel like breasts and were not seen as part of their 
body. Therefore, the majority of probands were inhibited sexually because of 
the lack of sensation, affecting their relationships.  Maloney and Kirkman 
(2005) remind us that sexuality encompasses the whole self, including 
thoughts, desires, sensations, emotions and identities.  In the study by 
Werner-Lin, (2008) similar findings were reported where women with a BRCA 
mutation were found to be sexually inhibited because the reconstructed 
breasts became triggers for the distress that they had encountered and the 
sacrifices they had to make to accommodate the risk.  Moreover, the breasts 
were regarded as fake and the single women described themselves as 
damaged goods and imperfect. The probands in this study, despite 
reconstruction, reported feeling less feminine, ‘masculine’, even ‘boy like’.  
They hid away and covered their bodies up feeling intimidated in the presence 
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of other women.  I would argue, therefore, that many of the probands in this 
study also felt imperfect and that their breasts were experienced as fake.  They 
also experienced a different gender, not recognising themselves as female or 
feminine, which did not fit it with what is culturally acceptable or what it means 
to be a woman as suggested by De Franscisco and Palzowescki, (2007).  
 
One explanation for these reactions is offered by Butler (2004). In order to 
produce a gendered subjectivity, Butler contends that femininity and 
masculinity are bodily styles that we incorporate and are ones in which we act 
out, not just ourselves but in relation to others and which others act out in 
relation to us. Pelters (2014) supports this view in her study where women 
were found to have both a normative view of femininity in line with gender 
functionality and an alternative self-determined femininity. Bartky (1990) also 
reminds us of the ideal and properly feminine body, a body with two breasts 
and how this is socially constructed.   She argues that the properly feminine 
body is maintained and produced as a result of disciplinary practices such as 
dieting, exercise, makeup and plastic surgery. This is evidenced by how many 
women in society constantly pursue the ideal body image, seeking approval 
through behaviours such as breast enhancement or cosmetic surgery.  Many 
of the probands in this study believed their surgery would be more cosmetically 
acceptable despite seeing photographs, this adds a contribution to knowledge 
and has important implications for practice in preparing women and setting 
realistic expectations. 
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As a result of this discipline described by Bartky (1990), the feminine body 
looks a particular shape and moves in a certain way providing individuals with 
a sense of identity, that of being and looking ‘natural’ like a woman should. 
Bodies in this way are disciplined to represent and comply with a social ideal 
and women discipline their bodies to derive pleasure and avoid social 
punishment (Bartky,1990). Thus, a body that is undisciplined and appears a 
different shape (as the women in this study describe) is seen as deficient, non-
feminine and at odds with social normalisation. Furthermore, it is proposed 
that this management and maintenance of the feminine body also entails 
managing the whole self, which is an integral part of the body. 
 
It may be therefore, that when making the decision to remove their natural 
looking breasts, women in this study were temporarily able to objectify their 
breasts and experienced an initial intentional Cartesian splitting of body and 
self. They did this in order to preserve their physical self from their dangerous 
(potentially cancerous) breasts believing that it would have little or no effect on 
the other aspects of self as identified by (Howard et al., 2011) self-identity, 
relationships with others and the emotional self. The reality, however, is that it 
did have a significant impact on all aspects of the self because probands could 
not easily part with their breasts because they are integral to the whole self. 
As a result of their loss therefore, probands felt ‘disembodied,’ with family 
members also witnessing this substantial negative change in the way 
probands felt about themselves and lived their lives  post -surgery.  
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Thus unlike the ovaries, it makes it impossible to objectify the breasts or 
dispose of them without major implications for all aspects of the whole self; 
body and self are intrinsically one.  Although it is possible that the women in 
this study who underwent oophorectomy may have felt unfeminine and 
masculine because of the effects of their oophorectomy, they did not report 
this as so.  On the contrary, it is argued, they were more able to objectify their 
internal (dangerous parts) less visible body parts as described by Kavanagh 
and Broom, successfully separating the ovaries from self, especially for 
probands who had completed their family. 
 
 
In this study, a feminine looking body, as well as a feminine feeling body (which 
normal women possess), was the initial expectation following reconstruction, 
by all participants, in order to balance the dilemma of disposing of their ‘ticking 
time bombs’ and maintaining a feminine body, which they perceived as the 
ideal. Like the women in Hallowell’s, (2000) and (2012) studies, women in this 
study experienced a lack of breast sensitivity, a lack of movement and a 
change in texture of the reconstructed breasts as compromising their 
femininity and as having profound consequences on their sex life, even if their 
appearance looked acceptable. For although women in this current study may 
have had breasts which looked normal to the gaze of the outside world, they 
did not feel or experience their body as feminine or natural. 
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Furthermore, like the women in Hallowell’s studies and in congruence with 
Bartkys’ analysis, pre-surgery the probands were more concerned initially 
about survival and less concerned with the materiality of the body, how their 
breasts would feel and function. They were more concerned with having a 
body that looked or appeared feminine. However post-surgery, probands and 
their family were concerned with both the materiality of their breasts as well as 
how they looked. This sits in contrast to some of the pre-understandings that 
focus on the importance of looking feminine (McGaughey, 2006; Spear et al., 
2008). 
 
Moreover, in the current study, the probands’ reconstructed breasts may or 
may not have looked like breasts, but they did not perceive them as real 
breasts, even for the proband who preserved her nipples. In support of 
Hallowell’s (2000) study and the participants in McEwan’s, (2011) and Pelter’s  
(2014) studies ,it follows that femininity is not only dependent on how a body 
complies with the normalised looking feminine body, but involves a particular 
type of material embodiment (how feminine the body feels). If this material 
body is in some way changed or reconfigured, as in the case of breast removal 
and reconstruction for the eight women in this study, then it is reasonable to 
suggest that it had major repercussions for gender identity and was therefore 
responsible for the disembodiment that they experienced.  
 
Furthermore, when individuals experience a disturbance between their body 
and their world, as is the case with all the participants in this study, their whole 
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existence is profoundly shaken (Merleau-Ponty, 2002). The probands, 
husbands and relatives, initially hoped that breast reconstruction would enable 
the probands to look both natural and feel natural, to themselves and to others. 
They hoped this would restore their self -identity as women. 
However, many probands experienced problems with healing and had multiple 
operations which affected the way the reconstruction eventually looked and 
felt, having considerable consequences on identity and sexual relationships. 
Indeed, some probands felt unprepared for these difficulties and wanted to be 
able to discuss their sexual difficulties.  As a consequence, all the participants 
requested support and help in this regard. These findings support Hallowell’s 
(2012) latest study in which few of the women felt entirely prepared for the 
reality of the procedure. In adding to the body of knowledge, women in this 
study reported that despite seeing photographs of surgery, it did not 
completely prepare them for how the new breasts would feel and more 
importantly how they would experience the disruption to self. In agreeing with 
Hallowell’s (2012) study and others (den Heijer, et al., 2012, Gopie, et al., 
2013) it is recommended that women and their family with a BRCA gene 
mutation should not only be provided with information gleaned from this and 
other studies that enable them to decide on the best options, but that they 
should have access to psychosocial care both pre and post-surgery if required. 
 
As time has elapsed and with more women seeking risk-reducing surgery 
nationally, the inclusion of a clinical psychologist in the multidisciplinary team 
is now becoming routine practice, highlighting the problems experienced. 
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Furthermore, women with a BRCA gene mutation need to be assessed and 
cared for in the context of the wider family who also need support because 
these decisions are a family affair. Breast care nurse specialists are ideally 
placed to provide care that includes support from genetic counselling through 
decision making, surgery and beyond and many are also trained in 
psychological therapies. However, in a time of austerity, there has to be strong 
evidence that this is necessary and it is proposed that the fused expanded 
horizon of understanding ‘disembodiment’ found in this study adds new 
knowledge, contributing to that evidence. Further research in this area is also 
recommended as it is acknowledged that this study involved a small sample 
and may not be typical of all BRCA women electing to have RRM, resulting in 
some further gaps in knowledge and limitations to this discussion. 
 
It may also be that with the newer techniques of reconstruction, more women 
preserving the NAC and increased access to plastic surgeons in a combined 
multidisciplinary team, that women may report more favourable experiences. 
However, it is also proposed that in concurring with Harcourt and colleagues 
(2003), there may be an over reliance on the role that breast reconstruction 
offers in the restoration of a woman’s femininity and sense of self especially 
following RRM which women and families need to be prepared for.  Finally, 
with more units across the country providing assessment of and intervention 
for potential psycho-social problems pre and post risk-reducing surgery, more 
women and  their families will be spared some of the negative, life changing 
consequences of electing to have risk-reducing mastectomy.   
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7.5 Strengths and limitations of this Study 
The strength of this study lies in its prospective qualitative design and the focus 
on understanding the experiences of eight women who all have a BRCA 
mutation and who elected to have a risk-reducing mastectomy with implant 
reconstruction.  In contrast, the majority of literature (pre-understandings) has 
focused on pre-determined outcome measurements using quantitative 
designs that have included women with different categories of high risk, 
including those with breast and ovarian cancer, in addition to BRCA positive 
women. 
 
Its other major strength is that it offers a new contribution to the body of 
knowledge at a significant time when breast clinics, Nationally and 
Internationally, are experiencing a threefold increase in referrals for testing 
and those electing to have RRM, both with the BRCA gene alone and women 
with an additional diagnosis of breast cancer. These findings have important 
implications for clinical practice and the way in which women and their families 
are cared for. 
 
The study’s final major strength is that it includes the experiences of the family 
corpus, that of the husbands and a sample of different family relatives 
including mothers, fathers and siblings who are an integral part of the 
experience.  There are no other qualitative studies, to my knowledge, that have 
included all three groups of the same family, in the same study.  
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As a result of this study, the new fused expanded horizon of understanding 
can be shared with others and has already had a major impact on service 
delivery within the author’s clinical setting. For example, women and their 
family members are now offered at least three meetings with the surgeon, the 
consultant nurse and a plastic surgeon prior to surgery. There is now a 
dedicated joint clinic, which runs each month, that incorporates the geneticist, 
the surgeons (including a plastic surgeon), the consultant nurse and new 
aspiring specialist nurses. 
 
Women now have the option of all the surgical reconstruction techniques, for 
example, implant techniques using both internal or external skin to support the 
implant (dermal sling and strattice), muscle flaps including using the abdomen, 
buttock and inner thigh fat and preservation of the nipple areolar complex 
(NAC). More importantly, and in, line with the recommendations from this 
study, the potential for body image, gender identity, and sexual issues are at 
the core of the discussions and assessment that take place (Bonadies et al., 
2011). 
 
In reflecting on the limitations of the study, this was a small group of women, 
in one area of Wales, who offered to take part in the study.  All the probands 
in this study had implant only surgery.  Different reconstructive techniques may 
have found different experiences and thus different horizons.  
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Furthermore, not all of the husbands of the eight probands took part. It could 
also be argued that these women and their families are not representative of 
the whole of the BRCA population due to geographical differences. A different 
group of BRCA women and their family at a different time may yield different 
experiences. Furthermore, it is accepted that a different researcher may find 
different horizons that connect and unite the women and their family. However, 
it was not the intention of this study or to qualitative inquiry, to generalise these 
findings to all women and their family with the BRCA mutation, in all areas. 
This study does, however, offer a new horizon of understanding that 
contributes to the body of existing knowledge, helping members of the 
multidisciplinary team to learn from those who experience living with a BRCA 
mutation and who elect to have risk-reducing mastectomy and reconstruction. 
 
7.6 Concluding Statement 
Staying true to Gadamerian philosophy (Gadamer, 2004) in offering an 
‘understanding’ of ‘being’ a BRCA women who elects to have RRM in the 
context of her family, this thesis expounds the experience of living with the 
consequences of bilateral risk-reducing mastectomy and the effects on gender 
identity, body image and sexuality for the woman and her family.  In having a 
moral obligation to survive for the sake of self and others, women make a 
difficult, brave and selfless decision to elect to have risk-reducing mastectomy, 
but in doing so, this leads to ‘disembodiment’, having consequences for the 
whole family.  
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7.7 Recommendations and Implications for Practice 
Future research conducted in this area is proposed with women and their 
families who are BRCA positive but who decide against surgery and choose 
surveillance.  Future studies could also focus on the children of those who 
elect to have RRM.  A longitudinal study with husbands and female partners 
of those women with a BRCA mutation would also add a valuable contribution 
to knowledge in the future.  With more patients attending cancer genetic clinics 
in the future, there may also be a need to capture the experiences of a cohort 
of men with a BRCA mutation. 
 
1. It is recommended that women with the BRCA mutation and their families 
electing to have risk-reducing surgery have appropriate information and 
support both verbal and written pre and post-surgery, from a suitably 
trained team of clinicians and nurses as part of a multidisciplinary team.  
 
2. Patients are given time and access to the multidisciplinary team in order 
to make appropriate informed decisions about risk-reducing mastectomy 
and reconstruction with an allocated key worker. 
 
3. Body image, gender identity and sexuality should be discussed openly 
pre and post-surgery including the assessment or appropriate referral for 
psychosocial intervention if necessary.  
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4. Women with the BRCA mutation should have access to onco-plastic 
reconstruction and be given the opportunity to meet patient volunteers to 
discuss and observe the cosmetic surgical outcome. Preserving the 
nipple areolar should be at the forefront of the discussion. 
 
5. Patients and their families should be signposted to support groups if 
required and their information needs should be individually assessed and 
met. 
 
6.  Future research is required exploring the experiences of women and their 
families who elect to have RRM using different types of flap 
reconstructions. 
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APPENDIX ONE - A Short Autobiography 
This study is about women and their family with the Breast Cancer 
Susceptibility gene (BRCA1/2). They do not yet have cancer but are at a very 
high risk. My personal experience of risk and family life as well as my 
professional life as a nurse, have therefore in some part contributed to the 
motivation to conduct and continue with this study.  As you begin to read this 
short autobiography therefore, my hope is that you get a feeling of the many 
factors that influenced my decision to conduct the study and why it was this 
particular group of participants. 
 
Even as a small child I knew, I wanted to be a nurse. I am the eldest of five 
children and always took charge of them when growing up.  My real father 
disappeared soon after I was born and I had the luxury of having my mother 
all to myself until the age of two. In the 1960’s it was frowned upon to have a 
child whilst not being married and so my mother met my new father when I 
was two.  After they married, they went on to have four more children so I have 
one brother and three sisters. I have always regarded them and referred to 
them as my siblings, not half-sister or brother. The importance of family life 
and normality therefore have always been a high priority in my life in 
maintaining a strong family unit.  Even now, my family turn to me for advice 
and support because we lost our mother at the age of fifty-three and my father 
was an alcoholic, times were very tough. I cared for and nurtured my siblings 
alongside my mother until I started my nurse training in 1982. 
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Nursing is therefore a career I have embraced, adored and have never 
regretted. I have worked my way up the career ladder from staff nurse to ward 
sister, clinical nurse specialist and lecturer and I am very proud and privileged 
to be the only Consultant Nurse in Breast Care in Wales. Until October 2014 
and during the time of my study, I was proud to claim an exemplary sick record 
with no sick time at all!  However, during this study, I had major abdominal 
surgery where I underwent total abdominal hysterectomy, bilateral 
oophorectomy with removal of my omentum.I had to take three months off, 
and it was at this time that the PhD went on hold because the future was 
uncertain. The surgery was necessary as I had a large tumour in my womb 
which was indeterminate and with a strong family history of cancer, prevention 
was better than cure. At the same time as my surgery, I was told that I had 
possible liver secondaries.  This was a terrible time in my life and my only 
concern was for my ten-year-old daughter. Sadly, there was no information or 
psychological care offered to my immediate family or myself because the 
surgery was seen as preventative.  
 
Thankfully and eventually, after many weeks of deliberation and extreme 
anxiety, the histology and the results confirmed that it was a large benign 
tumour and that the liver lesions must be ‘something else’. They apologised. 
However, I now have yearly MRI scans to monitor the lesions. The uncertainty 
and the constant worry, I have learnt to manage. The liver is rather a large 
organ to remove and so this was never a viable option for me!  My counselling 
  
386 
 
background has no doubt helped me accept and deal with the ongoing 
uncertainty. 
 
Along this journey of conducting my study, I have lost a few relatives and many 
young friends with a diagnosis of cancer.  In my role as Consultant Nurse and 
conducting my own nurse led clinics, I am constantly breaking bad news to 
individuals whether it be early breast cancer or metastatic (non-curable) 
disease. An opportunity to study a different group of individuals was both 
refreshing and exciting because there existed a group of patients who I felt 
were marginalised and as they did not have cancer and there was no nursing 
care pathway. Important factors that motivated me to conduct this study. 
  
The biggest loss in my life however has been my dear mum who was a fit, 
energetic, motivated and extremely resilient woman who sadly in 2000, 
developed both ovarian cancer and a separate bowel cancer and died at the 
age of 56.  Alongside my siblings, I nursed her until her death eighteen months 
after her diagnosis.  
 
Thus, many other motivations led to my decision to conduct this study. My 
experience as a specialist nurse in breast disease, my own personal 
experience of surgery, losing my mum at such a young age to cancer and 
constantly breaking bad news to individuals with cancer were just a few. The 
importance and complexities of family life and valuing a stable unit, in addition 
to wanting to set up a service for BRCA positive women and their family, were 
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also vital factors that contributed to my desire to conduct this study.  I 
witnessed for myself the deep loss of a family member to cancer and the 
experience of undergoing major surgery to prevent getting cancer and dying 
of the disease. The importance of a solid family network and meeting the 
needs of the whole family was ever apparent and sadly lacking. In addition, 
having the bilateral salpingo-oophorectomy has been no easy journey 
especially whilst trying to write a PhD thesis and thus many of the findings in 
my study, I can personally relate to. Writing this short autobiography also fulfils 
aspects of the ‘expressions of rigour’ as identified by de Witt and Ploeg (2006), 
openness, concreteness and resonance. 
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APPENDIX TWO - NICE (2013) Guidelines  
NICE (2013) Guidelines for referral to cancer genetics and secondary 
care 
Referral from primary care 
1.3.3 People without a personal history of breast cancer who meet the following 
criteria should be offered referral to secondary care: 
 one first-degree female relative diagnosed with breast cancer at younger than 
age 40 years or 
 one first-degree male relative diagnosed with breast cancer at any age or 
 one first-degree relative with bilateral breast cancer where the first primary 
was diagnosed at younger than age 50 years or 
 two first-degree relatives, or one first-degree and one second-degree relative, 
diagnosed with breast cancer at any age or 
 one first-degree or second-degree relative diagnosed with breast cancer at 
any age and one first-degree or second-degree relative diagnosed with 
ovarian cancer at any age (one of these should be a first-degree relative) or 
 three first-degree or second-degree relatives diagnosed with breast cancer at 
any age. [2004] 
1.3.4 Advice should be sought from the designated secondary care contact if any of 
the following are present in the family history in addition to breast cancers in relatives 
not fulfilling the above criteria:  
 bilateral breast cancer  
 male breast cancer  
 ovarian cancer  
 Jewish ancestry  
 sarcoma in a relative younger than age 45 years  
 glioma or childhood adrenal cortical carcinomas 
 complicated patterns of multiple cancers at a young age  
 paternal history of breast cancer (two or more relatives on the father's side of 
the family). [2004] 
1.3.5 Discussion with the designated secondary care contact should take place if the 
primary care health professional is uncertain about the appropriateness of referral 
because the family history presented is unusual or difficult to make clear decisions 
about, or where the person is not sufficiently reassured by the standard information 
provided. [2004] 
1.3.6 Direct referral to a specialist genetics service should take place where a high-
risk predisposing gene mutation has been identified (for example, BRCA1, BRCA2 or 
TP53). [2004] 
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Patient education and information 
Referral to a specialist genetic clinic 
1.4.4 People who meet the following referral criteria should be offered a referral to a 
specialist genetic clinic. 
 At least the following female breast cancers only in the family: 
o two first-degree or second-degree relatives diagnosed with breast 
cancer at younger than an average age of 50 years (at least one must 
be a first-degree relative) [2004] or 
o three first-degree or second-degree relatives diagnosed with breast 
cancer at younger than an average age of 60 years (at least one must 
be a first-degree relative) [2004] or 
o four relatives diagnosed with breast cancer at any age (at least one 
must be a first-degree relative). [2004] or 
 Families containing one relative with ovarian cancer at any age and, on the 
same side of the family: 
o one first-degree relative (including the relative with ovarian cancer) or 
second-degree relative diagnosed with breast cancer at younger than 
age 50 years [2004] or 
o two first-degree or second-degree relatives diagnosed with breast 
cancer at younger than an average age of 60 years [2004] or 
o another ovarian cancer at any age. [2004] or 
 Families affected by bilateral cancer (each breast cancer has the same count 
value as one relative): 
o one first-degree relative with cancer diagnosed in both breasts at 
younger than an average age 50 years [2004] or 
o one first-degree or second-degree relative diagnosed with bilateral 
cancer and one first or second degree relative diagnosed with breast 
cancer at younger than an average age of 60 years. [2004] or 
 Families containing male breast cancer at any age and, on the same side of 
the family, at least: 
o one first-degree or second-degree relative diagnosed with breast 
cancer at younger than age 50 years [2004] or 
o two first-degree or second-degree relatives diagnosed with breast 
cancer at younger than an average age of 60 years. [2004] or 
 A formal risk assessment has given risk estimates of: 
o a 10% or greater chance of a gene mutation being harboured in the 
family (see recommendations 1.5.8–1.5.13) [new 2013] or  
o a greater than 8% risk of developing breast cancer in the next 10 years 
[2004] or 
o a 30% or greater lifetime risk of developing breast cancer. [2004] 
1.4.5 Clinicians should seek further advice from a specialist genetics service for 
families containing any of the following, in addition to breast cancers: 
 triple negative breast cancer under the age of 40 years [new 2013] 
 Jewish ancestry [2004] 
 sarcoma in a relative younger than age 45 years [2004] 
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 glioma or childhood adrenal cortical carcinomas [2004] 
 complicated patterns of multiple cancers at a young age [2004] 
 very strong paternal history (four relatives diagnosed at younger than 60 years 
of age on the father's side of the family). [2004] 
1.4.6 The management of high-risk people may take place in secondary care if they 
do not want genetic testing or risk-reducing surgery and do not wish to be referred to 
a specialist genetics service. [2004] 
1.4.7 Following initial consultation in secondary care, written information should be 
provided to reflect the outcomes of the consultation. [2004] 
Genetic counselling for people with no personal history of breast cancer 
1.4.9 Women with no personal history of breast cancer meeting criteria for referral to 
a specialist genetic clinic should be offered a referral for genetic counselling regarding 
their risks and options. [2004] 
1.4.10 Women attending genetic counselling should receive standardised information 
beforehand describing the process of genetic counselling, information to obtain prior 
to the counselling session, the range of topics to be covered and brief educational 
material about hereditary breast cancer and genetic testing. [2004] 
1.4.11 Predictive genetic testing should not be offered without adequate genetic 
counselling. [2004] 
1.5 Genetic testing 
1.5.1 All eligible people should have access to information on genetic tests aimed at 
mutation finding. [2004] 
1.5.2 Pre-test counselling (preferably two sessions) should be undertaken. [2004] 
1.5.3 Discussion of genetic testing (predictive and mutation finding) should be 
undertaken by a healthcare professional with appropriate training. [2004] 
1.5.4 Eligible people and their affected relatives should be informed about the likely 
informativeness of the test (the meaning of a positive and a negative test) and the 
likely timescale of being given the results. [2004] 
Mutation tests 
1.5.5 Tests aimed at mutation finding should first be carried out on an affected family 
member where possible. [2004] 
1.5.6 If possible, the development of a genetic test for a family should usually start 
with the testing of an affected individual (mutation searching/screening) to try to 
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identify a mutation in the appropriate gene (such as BRCA1, BRCA2 or TP53) (see 
recommendations 1.5.8–1.5.13). [2004] 
1.5.7 A search/screen for a mutation in a gene (such as BRCA1, BRCA2 or TP53) 
should aim for as close to 100% sensitivity as possible for detecting coding alterations 
and the whole gene(s) should be searched. [2004] 
Carrier probability at which genetic testing should be offered 
1.5.8 Discuss the potential risk and benefits of genetic testing. Include in the 
discussion the probability of finding a mutation, the implications for the individual and 
the family, and the implications of either a variant of uncertain significance or a null 
result (no mutation found). [new 2013] 
1.5.9 Inform families with no clear genetic diagnosis that they can request review in 
the specialist genetic clinic at a future date. [new 2013] 
1.5.10 Clinical genetics laboratories should record gene variants of uncertain 
significance and known pathogenic mutations in a searchable electronic database. 
[new 2013] 
Genetic testing for a person with no personal history of breast cancer but with 
an available affected relative 
1.5.11 Offer genetic testing in specialist genetic clinics to a relative with a personal 
history of breast and/or ovarian cancer if that relative has a combined BRCA1 and 
BRCA2 mutation carrier probability of 10% or more. [new 2013] 
Genetic testing for a person with no personal history of breast cancer and no 
available affected relative to test 
1.5.12 Offer genetic testing in specialist genetic clinics to a person with no personal 
history of breast or ovarian cancer if their combined BRCA1 and BRCA2 mutation 
carrier probability is 10% or more and an affected relative is unavailable for testing. 
[new 2013] 
Genetic testing for a person with breast or ovarian cancer 
1.5.13 Offer genetic testing in specialist genetic clinics to a person with breast or 
ovarian cancer if their combined BRCA1 and BRCA2 mutation carrier probability is 
10% or more. [new 2013] 
Genetic testing for BRCA1, BRCA2 and TP53 mutations within 4 weeks of 
diagnosis of breast cancer 
1.5.14 Offer people eligible for referral to a specialist genetic clinic a choice of 
accessing genetic testing during initial management or at any time thereafter. [new 
2013] 
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1.5.15 Offer fast-track genetic testing (within 4 weeks of a diagnosis of breast cancer) 
only as part of a clinical trial. [new 2013] 
1.5.16 Discuss the individual needs of the person with the specialist genetics team 
as part of the multidisciplinary approach to care. [new 2013] 
1.5.17 Offer detailed consultation with a clinical geneticist or genetics counsellor to 
all those with breast cancer who are offered genetic testing, regardless of the 
timeframe for testing. [new 2013] 
Surveillance for women with no personal history of breast cancer but with a 
high risk or BRCA gene 
 
Mammographic surveillance 
1.6.3 Offer annual mammographic surveillance to women:  
 aged 40–49 years at moderate risk of breast cancer 
 aged 40–59 years at high risk of breast cancer but with a 30% or lower 
probability of being a BRCA or TP53 carrier 
 aged 40–59 years who have not had genetic testing but have a greater than 
30% probability of being a BRCA carrier 
 aged 40–69 years with a known BRCA1 or BRCA2 mutation. [new 2013] 
1.6.4 Offer mammographic surveillance as part of the population screening 
programme to women:  
 aged 50 years and over who have not had genetic testing but have a greater 
than 30% probability of being a TP53 carrier 
 aged 60 years and over at high risk of breast cancer but with a 30% or lower 
probability of being a BRCA or TP53 carrier 
 aged 60 years and over at moderate risk of breast cancer 
 aged 60 years and over who have not had genetic testing but have a greater 
than 30% probability of being a BRCA carrier 
 aged 70 years and over with a known BRCA1 or BRCA2 mutation. [new 2013] 
1.6.5 Consider annual mammographic surveillance for women: 
 aged 30–39 years at high risk of breast cancer but with a 30% or lower 
probability of being a BRCA or TP53 carrier 
 aged 30–39 years who have not had genetic testing but have a greater than 
30% probability of being a BRCA carrier 
 aged 30–39 years with a known BRCA1 or BRCA2 mutation 
 aged 50–59 years at moderate risk of breast cancer. [new 2013] 
1.6.6 Do not offer mammographic surveillance to women:  
 aged 29 years and under  
 aged 30–39 years at moderate risk of breast cancer 
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 aged 30–49 years who have not had genetic testing but have a greater than 
30% probability of being a TP53 carrier 
 of any age with a known TP53 mutation. [new 2013] 
MRI surveillance 
1.6.7 Offer annual MRI surveillance to women: 
 aged 30–49 years who have not had genetic testing but have a greater than 
30% probability of being a BRCA carrier 
 aged 30–49 years with a known BRCA1 or BRCA2 mutation 
 aged 20–49 years who have not had genetic testing but have a greater than 
30% probability of being a TP53 carrier 
 aged 20–49 years with a known TP53 mutation. [new 2013] 
1.6.8 Consider annual MRI surveillance for women aged 50–69 years with a known 
TP53 mutation. [new 2013] 
1.6.9 Do not offer MRI to women: 
 of any age at moderate risk of breast cancer 
 of any age at high risk of breast cancer but with a 30% or lower probability of 
being a BRCA or TP53 carrier 
 aged 20–29 years who have not had genetic testing but have a greater than 
30% probability of being a BRCA carrier 
 aged 20–29 years with a known BRCA1 or BRCA2 mutation 
 aged 50–69 years who have not had genetic testing but have a greater than 
30% probability of being a BRCA or a TP53 carrier, unless mammography has 
shown a dense breast pattern 
 aged 50–69 years with a known BRCA1 or BRCA2 mutation, unless 
mammography has shown a dense breast pattern. [new 2013] 
MRI surveillance 
1.6.13 Offer annual MRI surveillance to all women aged 30–49 years with a personal 
history of breast cancer who remain at high risk of breast cancer, including those who 
have a BRCA1 or BRCA2 mutation. [new 2013] 
1.6.14 Do not offer MRI surveillance to any women aged 50 years and over without a 
TP53 mutation unless mammography has shown a dense breast pattern. [new 2013] 
1.6.15 Consider annual MRI surveillance for women aged 20–69 years with a known 
TP53 mutation or who have not had a genetic test but have a greater than 30% 
probability of being a TP53 carrier. [new 2013] 
 
Surveillance for women who remain at moderate risk of breast cancer 
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1.6.16 Ensure that surveillance for people with a personal history of breast cancer 
who remain at moderate risk of breast cancer is in line with Early and locally advanced 
breast cancer (NICE clinical guideline 80). [new 2013] 
Recommendations for all women having surveillance 
1.6.17 Offer support (for example, risk counselling, psychological counselling and risk 
management advice) to women who have ongoing concerns but are not eligible for 
surveillance additional to that offered by the national breast screening programmes[5]. 
[2004, amended 2013] 
1.6.18 Before decisions on surveillance are made, discuss and give written 
information on the benefits and risks of surveillance, including: 
 the possibility that mammography might miss a cancer in women with dense 
breasts and the increased likelihood of further investigations [new 2013] 
 possible over diagnosis 
 the risk associated with exposure to radiation 
 the possible psychological impact of a recall visit. [2004, amended 2013] 
Risk-reducing mastectomy 
1.7.56 Discuss the risks and benefits of risk-reducing mastectomy with women with a 
known or suspected BRCA1, BRCA2 or TP53 mutation. [new 2013] 
1.7.57 For a woman considering risk-reducing mastectomy, include in the discussion 
of risks and benefits: 
 the likely prognosis of their breast cancer, including their risk of developing a 
distal recurrence of their previous breast cancer 
 a clear quantification of the risk of developing breast cancer in the other breast 
 the potential negative impact of mastectomy on body image and sexuality 
 the very different appearance and feel of the breasts after reconstructive 
surgery 
 the potential benefits of reducing the risk in the other breast and relieving the 
anxiety about developing breast cancer. [new 2013] 
1.7.58 Give all women considering a risk-reducing mastectomy the opportunity to 
discuss their options for breast reconstruction (immediate and delayed) with a 
member of a surgical team with specialist skills in oncoplastic surgery or breast 
reconstruction. [new 2013] 
1.7.59 Ensure that risk-reducing mastectomy and breast reconstruction are carried 
out by a surgical team with specialist skills in oncoplastic surgery and breast 
reconstruction. [new 2013] 
1.7.60 Offer women who have BRCA1, BRCA2 or TP53 mutations but who decide 
against risk-reducing mastectomy, surveillance according to their level of risk. [new 
2013] 
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Risk-reducing bilateral salpingo-oophorectomy 
1.7.61 Discuss the risks and benefits of risk-reducing bilateral salpingo-oophorectomy 
with women with a known or suspected BRCA1, BRCA2 or TP53 mutation. Include in 
the discussion the positive effects of reducing the risk of breast and ovarian cancer 
and the negative effects of a surgically induced menopause. [new 2013] 
1.7.62 Defer risk-reducing bilateral salpingo-oophorectomy until women have 
completed their family. [new 2013] 
Risk-reducing mastectomy for women with no personal history of breast 
cancer 
1.7.30Bilateral risk-reducing mastectomy is appropriate only for a 
small proportion of women who are from high-risk families and should 
be managed by a multidisciplinary team. [2004] 
1.7.31Bilateral mastectomy should be raised as a risk-reducing 
strategy option with all women at high risk. [2004] 
1.7.32Women considering bilateral risk-reducing mastectomy should 
have genetic counselling in a specialist cancer genetic clinic before 
a decision is made. [2004] 
1.7.33Discussion of individual breast cancer risk and its potential 
reduction by surgery should take place and take into account 
individual risk factors, including the woman's current age (especially 
at extremes of age ranges). [2004] 
1.7.34Family history should be verified where no mutation has been 
identified before bilateral risk-reducing mastectomy. [2004] 
1.7.35Where no family history verification is possible, agreement by 
a multidisciplinary team should be sought before proceeding with 
bilateral risk-reducing mastectomy. [2004] 
1.7.36Pre-operative counselling about psychosocial and sexual 
consequences of bilateral risk-reducing mastectomy should be 
undertaken. [2004] 
1.7.37The possibility of breast cancer being diagnosed histologically 
following a risk-reducing mastectomy should be discussed pre-
operatively. [2004] 
1.7.38All women considering bilateral risk-reducing mastectomy 
should be able to discuss their breast reconstruction options 
(immediate and delayed) with a member of a surgical team with 
specialist oncoplastic or breast reconstructive skills. [2004] 
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1.7.39A surgical team with specialist oncoplastic/breast 
reconstructive skills should carry out risk-reducing mastectomy 
and/or reconstruction. [2004] 
1.7.40Women considering bilateral risk-reducing mastectomy should 
be offered access to support groups and/or women who have 
undergone the procedure. [2004] 
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APPENDIX THREE - Literature Review Search Strategy 
 
Terms Used for Search Strategy 
 
BRCA1  
and 2 
Mastectomy Risk 
Reduction 
Relatives Experience 
  Risk adj3 
reduct* 
Spouses Phenomonol* 
 Prophylactic 
mastectomy 
Risk 
Reduction 
Behaviour 
Family 
relations 
Qualitative 
Research 
   Husband  
   Partner  
   Family  
   Proband  
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TABLE OF INCLUDED STUDIES 
 
Author Topic Method / 
Sample 
Main Findings 
Altschuler et 
al (2008) 
American 
Study 
Long term 
Psychosocial 
outcomes of 
bilateral or 
contralateral 
prophylactic 
mastectomy 
Retrospective 
Qualitative open 
ended  
Mailed Survey 3-
22 years 
post-surgery 
967 Sample (195 
RRM) (772 
contra-lateral 
mx) No BRCA 
positive women. 
Negative impact on 
body image, 
sexuality and 
dissatisfaction with 
surgery in women 
having RRM. 
Brandberg et 
al (2008) 
Swedish study 
Evaluate Body 
image, 
sexuality and 
emotional 
reactions after 
RRM 
Quantitative 
Prospective 
Questionnaire 
Sample 90 
women 
Negative impact on 
body image and 
sexuality for BRCA 
positive women(50) 
Brandberg et 
al (2012) 
Swedish 
Study 
Cosmetic 
results and 
expectations 
post RRM and 
reconstruction 
in BRCA 
positive 
women 
Quantitative 
retrospective 
questionnaire 
Sample 91 (49 
BRCA Positive) 
Higher expectations 
in BRCA women not 
met post-surgery. 
Satisfaction with 
overall cosmetic 
result varied 
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Bresser et al 
(2006) The 
Netherlands 
Satisfaction 
with 
Prophylactic 
mastectomy 
and 
reconstruction 
in genetically 
predisposed 
women 
Retrospective 
questionnaire 
design with 114 
women 3 years 
post surgery.63 
BRCA positive.  
Adverse effects in 
sexual relationships 
and altered feelings 
of femininity found 
Included women with 
breast cancer 
electing prophylactic 
mastectomy 
Den Heijer et 
al (2012) 
The 
Netherlands 
Body image 
and 
psychological 
distress after 
prophylactic 
Mastectomy 
and 
reconstruction 
in genetically 
pre-disposed 
women 
Prospective 
quantitative long 
term  study using 
Questionnaires 
Sample 36 
women (27 
BRCA positive) 
Psychological 
distress about cancer 
reduced. Body image 
problems evident 
long term( 9 years) 
Frost et al 
(2000) 
American 
Study 
Long term 
quality of life 
and 
satisfaction 
following 
bilateral 
prophylactic 
mastectomy 
Quantitative  
Retrospective 
study 14 years 
post-surgery 
Sample 572 
women (None 
BRCA) 
Reduced concern 
about cancer. Most 
women were 
satisfied with 
surgery. However, 
18% would not 
choose surgery 
again. Problems 
found with sexuality, 
body image and 
self-esteem.  
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Geiger et al 
(2007) 
American 
Study 
Long-term 
Quality of life 
following 
prophylactic 
mastectomy 
Retrospective 
Quantitative 
Questionnaire 
with a sample of 
312 Women.195 
had procedure, 
117 did not 
(none BRCA) 23 
years 
post-surgery. 
Bilateral prophylactic 
mastectomy neither 
positively nor 
negatively impacts 
long-term 
psychosocial 
outcomes. 
Dissatisfaction with 
quality of life was 
associated with pre-
surgery sex life. 
Gopie et al 
(2013) 
The 
Netherlands 
Body image 
issues 
following 
prophylactic 
mastectomy 
and 
reconstruction  
Prospective 
Quantitative 
study with 
questionnaires 
Sample size 48 
(44 BRCA) 
Cancer related 
distress lower. Body 
image scores 
decreased with 
continuing problems.  
Hatcher and 
Fallowfield 
(2003) 
United 
Kingdom 
Psychosocial 
implications of 
bilateral 
prophylactic 
mastectomy 
Qualitative 
prospective 
study with in 
depth interviews. 
Sample 80 
Women (60 
surgery) 20 
(declined) (8 
BRCA positive) 
Pain, anxiety and 
mixed satisfaction 
with cosmetic results 
and sexuality 
post-surgery. 
Hatcher et al 
(2001) 
United 
Kingdom 
Psychological 
and sexually 
morbidity 
Prospective 
Quantitative 
study using 
questionnaires. 
High levels of anxiety 
persisted in non -
surgical group. 
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Sample 143 
women(79 
surgery) (64 
declined) 
No significant change 
in sexual pleasure 
post-surgery  
Hallowell et al 
(2012) 
Australia 
Women’s 
reactions to 
risk-reducing 
and ovarian 
surgery 
Qualitative 
retrospective 
study with a 
sample of 40 
women. 
Risk and relief of 
cancer reduced. 
Positive and negative 
changes to body. 
More preparation and 
psychosocial input 
required 
Hopwood et al 
(2000) 
United 
Kingdom 
Body image 
and Clinical 
follow up after 
prophylactic 
mastectomy 
Retrospective 
Quantitative 
study using 
questionnaires. 
Sample 76 
women (6 
BRCA) 
Contradictory 
findings. No 
significant body 
image problems. 
Reduced feelings of 
sexual 
attractiveness, 
problems with self-
consciousness and 
feeling less feminine. 
Minority had serious 
body image and 
psychological 
problems  
Lloyd et al 
(2000) 
United 
Kingdom 
Understanding 
the experience 
of Prophylactic 
bilateral 
mastectomy 
Qualitative 
Grounded 
Theory 
retrospective 
study. Sample 10 
women(2 BRCA 
Findings 
demonstrated a core 
category of ‘Suffering 
and countering 
multiple 
loss’.Including family 
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positive) and 8 
men. 
member losses and 
loss of 
‘womanliness.’Sexual 
and image problems. 
McEwan 
(2011) 
Experiences of 
New Zealand 
Women living 
with increased 
risk of breast 
and Ovarian 
cancer 
Qualitative study 
interviews with 
32 women, 6 had 
breast cancer.14 
BRCA-4 RRM. 
Women at increased 
risk are prepared to 
undergo 
risk-reducing surgery 
to ‘get on with it’ for 
the sake of 
children.RRM 
affected femininity 
and loss 
experienced.Adverse 
reactions from 
friends re RRM 
Mauer et al 
(2015) 
American 
Study 
Exploration of 
male attitudes 
of partnerships 
and sexuality 
with BRCA 
Women 
Retrospective 
online survey. 
Sample 25 men 
Intimacy and 
communication 
problems after 
disclosure and 
surgery 
Mireskandari 
et al (2006) 
 
Evaluation of 
needs of 
partners of 
high risk 
women 
Qualitative 
retrospective 
study. Sample 15 
men telephone 
interviews  (7of 
their partners 
BRCA positive)1 
had RRM  
Main findings, 
partners of BRCA 
women more 
distressed. Concerns 
about the decision to 
have RRM and 
children were most 
challenging. 
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Metcalfe et al 
(2005) 
Canada 
Predictors of 
quality of life in 
women 
following 
bilateral 
prophylactic 
mastectomy 
Retrospective 
Quantitative 
questionnaire. 
Sample 60 
women (13 
BRCA)  
Predictors of QOL 
related to 
psychological 
distress and 
vulnerability for body 
image problems   
Metcalfe et al 
(2004a) 
Canada 
Psychosocial 
functioning in 
women 
following 
prophylactic 
mastectomy 
Retrospective 
Quantitative 
Questionnaire. 
Sample 75 
women (60 
returned (13 
BRCA) 
Most women were 
happy with their 
decision of surgery 
(with reconstruction) 
although younger 
women less so. No 
significant body 
image or sexual 
problems. Cancer 
related distress still 
high post-surgery for 
BRCA women. 
Payne et al 
(2000) 
American 
Study 
Regret 
following 
bilateral 
prophylactic 
mastectomy 
Retrospective 
Quantitative 
questionnaire 
with 21 women 
(none BRCA 
Positive) 
Physical and 
Psychological trauma 
of surgery and lack of 
support reasons for 
regret. Surgery 
initiated by physician 
and not the women. 
van Oostrum 
et al (2003) 
The 
Netherlands 
Long term 
psychological 
impact of 
carrying the 
mutation and 
Mixed method 
using 
questionnaires 
and interviews. 
Sample 65 
Reduced fear in 
getting cancer. 
BRCA Women had 
less favourable body 
image and sexuality 
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having 
surgery. 
women.23 BRCA 
positive and 21 
had surgery. 
scores. 70% reported 
sexual difficulties 
Wasteson et 
al (2011) 
Swedish 
Study 
Long term 
satisfaction 
following  
bilateral 
prophylactic 
mastectomy 
Retrospective 
Qualitative study 
using interviews. 
Sample 13 
women (1 BRCA 
positive)  
High Satisfaction with 
decision to have 
surgery and overall 
satisfied with 
cosmetic result. 
Some family 
problems identified. 
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APPENDIX FOUR - Publication and Dissemination Plan 
 
When undertaking a PhD, it is imperative that the knowledge gained from the 
findings are disseminated and accessible for professionals both academic and 
clinical. I have been involved in strategic level work and service development 
for over twenty years and I have made close links with colleagues at a national 
and international level. I am also a nurse advisor for The National Institute of 
Health and Care Excellence (NICE). I have consistently been invited to speak 
at conferences nationally and internationally, meeting inspirational nurses 
from all over the world. One example of my collaborative work is that I am 
Principal Investigator on a multicentre national study involving women newly 
diagnosed with breast cancer seeking breast reconstruction and a scientific 
committee member for the European Breast Cancer Conference in Barcelona.  
 
It is my intention to publish my research in relevant, targeted journals that will 
reach clinicians and members of the multidisciplinary team nationally and 
internationally, an example of one of my publications  
 
West, N. (2014) New approaches to managing risk of familial breast cancer, 
Primary Care Women’s Health Journal. May 2014. 
 
Suggested Articles and Target Journals 
 Article 1 - The experiences of BRCA women electing to have risk-
reducing mastectomy. An Interpretive Phenomenological study. 
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 Target Journal - The Breast Journal/Journal of Advanced 
Nursing/Psych-oncology/ Journal of surgical Oncology. 
 Article 2 - The experiences of partners whose wives elect to have 
risk-reducing mastectomy due to the BRCA gene. 
 Target Journal - International Journal of Social Research/Journal of 
Advanced Nursing/The Breast/Journal of Surgical Oncology. 
 Article 3 - The experiences of relatives living with the BRCA Gene 
mutation. 
 Target Journal - International Journal of Social Research/ Journal of 
Advanced Nursing 
 Article 4 - The trials and tribulations of doing a PhD part time. 
 Target Journal  - Journal of Advanced Nursing 
 Article 5 - Gadamerian Philosophy and its contribution to qualitative 
nursing research 
 Target Journal - Qualitative research/International Journal of Social 
Research 
 
Further Dissemination 
All the participants in the study will be given an overview of the findings 
personally.  Information will be disseminated at the following local meetings: 
 
1. The All Wales Breast Cancer Conference and Network. 
2. The Florence Nightingale Foundation. 
3. The Cardiff and Vale University Health Board Research Conference. 
  
408 
 
4. Cardiff University. 
5. Breast Cancer Care Network. 
6. Internationally - 11th International Breast Cancer Conference, 
Barcelona (2018). 
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APPENDIX FIVE - National and International Presentations 
                                                   
Paris, 2013  4TH International Breast Cancer Conference  
 
Antwerp, 2014  5th International Breast Cancer Conference 
                                                  
London, 2014  Florence Nightingale Foundation Conference 
 Poster Presentation    
                                            
Lisbon, 2014 Advanced Breast Cancer meeting 
 
Istanbul, 2014  Turkey Breast Cancer Conference 
 
Helsinki, 2014  International Council of Nursing Conference 
 
Bournemouth, 2015            British Association of Surgical Oncologists 
 (BASO) Meeting 
 
Cardiff, 2015                       Cardiff and Vale University Health Board 
 Research Conference 
                            
Amsterdam, 2015                10th European Breast Cancer Conference     
Manchester, 2016              British Association of Surgical Oncologists 
 (BASO) Meeting 
 
Barcelona, 2018                   11th European Breast Cancer conference   
                                            
Awards Received 
 Leadership Award at the Welsh Chief Nursing officer Conference, 2012 
 
 Royal College of Nursing Welsh Specialist Nurse of the Year, 2012 
 
 Runner up for Oncology Nurse of the Year, 2013. British Journal of 
Nursing Award.  
 
 Florence Nightingale Research Scholarship, 2013 (The Band Trust) 
£1995 
 
 Florence Nightingale Research Scholarship, 2014 (The Garfield Weston 
Foundation) £1914 
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 Florence Nightingale Research Scholarship, 2015 (The Stephanie 
Thompson Memorial Trust) £1500 
                                                   
 
Research 2016  
 
PI (PEGASUS STUDY) Patients’ Expectations & Goals: Assisting Shared 
Understanding of Surgery 
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APPENDIX SIX – Reflections and Diary 
 
Reflection One – April, 2014 
There were a few challenges reflected upon during this study. Being conscious 
of some of the pre-understandings and being involved with the whole family, I 
was mindful not to lead the participants during the interviews or pay particular 
attention to certain issues for example, body image. As a novice interviewer, 
it was very tempting to lapse into role of counsellor or consultant nurse and try 
to fix everything. As the interviews continued, I became more confident and 
said very little, my listening skills intensified allowing all participants to have 
their ‘voice’. I was genuinely interested and open to whatever they wanted to 
tell me.  
 
My reflective journal was therefore an aid demonstrating how my behaviour 
had changed over time. The pre-understandings became less conscious and 
less important as understanding developed. The biggest challenge was the 
analysis and seemed to take me a lifetime. The challenge has been ‘letting go’ 
of the data.I was so immersed in the data and inspired by what they were 
telling me, despite so many years in practice, that it was extremely difficult to 
prioritise what was important. To me, it was all very important. However, 
staying true to Gadamerian philosophy, engaging in the hermeneutic circle 
and considering the parts that made up the whole, gave me direction to identify 
the experience that united the three groups and which generated new 
knowledge. Using the mind maps to organise my data was invaluable  
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The participants in this study all described how they valued the chance to help 
me understand their experience, not just for the benefit of themselves but for 
the benefit of others after them. They were particularly vocal and helpful about 
how professionals could help in the transition of their altered self by receiving 
more preparation and ongoing support. There were many points in the 
interviews when the participants were upset and particularly with the family, I 
had to stop the recorder and after a short break, recommence the interview, 
at their request. I felt very privileged that they wanted to talk to me and very 
grateful. I also noted the trust that they had put in me and the ease at which 
they discussed very intimate sensitive information.  
 
Extract from Diary July, 2011 
Completing forms, protocol, ethical approval. Really slow on the computer. 
Need to attend as many study days as possible to catch up with other PhD 
students. Attending qualitative MSc module social sciences.Amanda Coffey 
and Paul Atkinson excellent speakers.Met with Amanda Coffey to discuss 
narrative analysis and methodology as a result of one of the inspiring 
lectures.Endnote training day 11.11.11. Want to include the husband’s and 
family in the study. 
 
Extract from Diary January, 2012 
Ethical approval granted quickly after a panel meeting in which I was 
present. Quite daunting before the meeting but very excited to know that I 
can  start the study.GP on the panel concerned about how I will recruit 
partners and what I would do if they separated from the women. Feel proud 
to have answered all questions. Coffee with Aimee at Costa to celebrate. 
Hope there will be enough BRCA women referred. Hope partners will want to 
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take part. Really keen to know about their experiences. Panel really pleased 
that partner’s and relative’s experiences included. 
 
Extract from diary March, 2012 
Started interviews. Proband’s so honest and forthcoming. Many women 
wanting to take part. Partners and relatives wanting to take part, so really 
excited. Emotional interviews. Started to type up interview transcripts, looking 
at the transcripts and beginning to look for what the experience is all about. 
So difficult to transcribe. Booked in for numerous study days including working 
with long documents, rapid reading, NVIVO training. Feel like the oldest 
student in the class. More interviews booked. 
 
Extract from Diary August, 2013 
Really confusing trying to understand the difference between Ontology and 
epistemology. So many articles to read and difference of opinion. Reading too 
much, have to stop reading and get writing. Supervision session booked to 
clarify. Had a long conversation and debate with PhD colleague and it’s like 
the blind leading the blind. Useful articles from Jane Harden that really helped 
to clarify the confusion. So much to learn and read. Ontology is the study of 
being. I strongly believe that there is not one reality and that reality is 
subjective but experiences can be shared. So excited to be doing a qualitative 
study. Gadamer’s philosophy and his book ‘Truth and method’ fits more closely 
with my methodology and fits with a constructivist approach, although I 
recognise that it has not been utilised as much in nursing as Husserl’s 
phemonenology. I have come to the conclusion that epistemology is the study 
of knowledge and asks the question, what is the nature of the relationship 
between the knower and what can be known. Is knowledge objective and 
measureable or is it subjective and interpretive. A bond or link exists between 
the participant’s and myself as a nurse because of my experience in breast 
care and my place as a woman in society.  
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Extract from Diary January, 2014 
Analysis really difficult, so much that is important, need help with the 
transcribing. Paying professionally for transcribing. Seeing links between the 
whole and the parts. The issue of breast loss dominating all the interviews. No 
drop out from the participants and the interviews continue. Need to start 
writing. Practice taking over, no study time. Meeting regular with supervisors. 
Realise the body image scale that I intended to use will not add to the findings 
and the experience. Feel uncomfortable using it as it implies I am looking for 
body image changes and so I have decided not to include it. Does not fit with 
my methodology. 
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APPENDIX SEVEN - MINDMAPS 
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APPENDIX EIGHT – NHS R&D Approval 
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APPENDIX TEN – REC Provisional Approval 
 
 
 
 
 
 
 
 
South East Wales Research Ethics Committee 
Panel D 
Sixth Floor, Churchill House 
17 Churchill Way 
Cardiff  CF10 2TW 
 
Telephone : 029 2037 6823      
E-mail : 
debbie.burch@wales.nhs.uk 
 
Website : www.nres.nhs.uk     
 
 
12 January 2012 
 
Mrs Nicola West 
Consultant Nurse Breast Care/Lecturer 
Cardiff and Vale University Health Board 
Llandough Hospital Penlan Road Penarth 
Cardiff 
CF64 2XX 
 
Dear Mrs West 
 
Study Title: The long term experience of BRCA1/2(gene mutation carriers) 
Women undergoing  bilateral risk-reducing mastectomy. 
REC reference: 12/WA/0003 
Protocol number: spon 1027-11 
 
The South East Wales Research Ethics Committee - Panel D reviewed the above application 
at their meeting held on the 12th January 2012. 
 
Thank you for attending to discuss the study, the clarification that you provided was most 
helpful. 
 
Documents reviewed 
 
The documents reviewed at the meeting were: 
  
Document    Version    Date      
Investigator CV  N West       
  
439 
 
Investigator CV  K Featherstone       
Letter from Sponsor  Cardiff University  10 October 2011    
Participant Consent Form  1  01 December 2011    
Participant Information Sheet: Patient 
Information Sheet inc Initial Contact Consent  
3  01 December 2011    
Protocol  1.0  02 September 2011    
REC application  IRAS 3.3  09 December 2011    
 
Provisional opinion 
 
The Committee noted that this was a single site study with the main objective being to explore 
the long term experiences of women who have inherited the breast cancer gene and who 
decide to undergo bilateral risk-reducing mastectomy with or without breast reconstruction. 
 
The Committee noted that the study was being carried out for an educational qualification.    
 
The Committee noted that potential participants would initially be identified and approached 
by healthcare professionals involved in their care. 
 
The Committee noted that potential participants will be provided with written information about 
the purpose of the study, why they have been invited to participate, who is conducting the 
research, how the data would be used and what participation will require of them. They will 
also be given the opportunity to ask any questions about the study. Written consent will be 
obtained prior to participation in the study. It will be made clear throughout the study that 
participation is entirely voluntary and that they can withdraw at any point for any reason. 
 
The Committee also noted that once participants have consented they will be given 
information to pass on to their partners/others to consider taking part. 
 
The Committee noted that no intervention or procedure, which would normally be considered 
a part of routine care, would be withheld from participants.  
 
The Committee noted that the Cardiff University would be acting as sponsor for the above 
study in accordance with the Research Governance Framework. 
 
The Committee noted that the sponsor had signed the declaration in the application form to 
confirm that an appropriate process of scientific critique had demonstrated that the research 
proposal is worthwhile and of high scientific quality and that the necessary insurance or 
indemnity arrangements will be in place prior to commencement of the research.  
 
The Committee noted from Q (A43) of the application form that study data would be stored for 
over 3 years after the end of the study.   The Committee asked that you ensure that all data 
is stored and destroyed in line with the Data Protection Act (1998). 
 
The Committee noted your reassurance that some data would be stored on laptop computers 
and that all data would be stored in line with University policy on such matters and that a 
suitable encryption programme would be used to ensure the security and confidentiality of the 
data. 
 
The Committee noted that the start date on the application was incorrect and asked that the 
study does not commence until all the relevant approvals are in place. 
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The Committee agreed that they would be content to give a favourable ethical opinion of the 
research, subject to receiving a complete response to the request for further information 
set out below. 
 
The Committee delegated authority to confirm its final opinion on the application to the Chair. 
 
Further information or clarification required 
 
1. The patient information sheet should explain that you will be approaching the patient’s 
partner, with the patient’s knowledge and consent, to participate in the research.    
 
2. The information sheet section: ‘What are the possible benefits of taking part?’  The 
Committee agreed that it was important not to exaggerate the possible benefits to the 
particular patient during the course of the study.  Where there is no intended clinical 
benefit to the patient from taking part in the study this should be stated clearly. 
 
3. The information sheet; ‘How and where will the research be undertaken?’   The Committee 
asked that the third sentence be revised to read ‘They will be take place either in your own 
home, or if you prefer at a location of your choice at your convenience’. 
 
4. The Committee noted that you intended to contact the patient’s partner in order to recruit 
them into the study.  The Committee were of the view that it is important that the patient 
has knowledge of this and has given permission for you to contact their partner/relative.  
The Committee were of the view that the most pragmatic method of doing this would be 
to provide the patient with a letter explaining the nature of the study and providing your 
contact details, which could be passed by the patient to their partner if they wish to do so.  
The partner can then contact you if they wish to participate. 
 
5. The Committee noted that the information sheet referred in places to ‘I’ and other places 
to ‘we’ this should be consistent. 
 
6. The Committee noted that information sheet stated that ‘The tapes will be locked in a 
secure cabinet within the University’.  You should state for how long and explain when 
they will be destroyed. 
 
7. The Committee noted that the page layout of the information sheet was random and asked 
that you look at this.   
 
8. The Committee made reference to the consent form ‘point 4’ and asked that you explain 
in the consent form who the ‘involved organisations’ are. 
 
9. The Committee asked that you provide a topic guide or interview schedule for the patients 
and their partners. 
 
10. The Committee asked that a separate partner information sheet and consent form be 
provided. 
 
11. The Committee noted that your CVs were not dated as required by the Standard Operating 
Procedures for Research Ethics Committees . The CVs must therefore be revised and 
resubmitted. 
 
If you would find it helpful to discuss any of the matters raised above or seek further 
clarification from a member of the Committee, you are welcome to contact Mrs J Sidhu, 
Co-ordinator on 02920 376822. 
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When submitting your response to the Committee, please send revised documentation where 
appropriate underlining or otherwise highlighting the changes you have made and giving 
revised version numbers and dates.   
 
If the committee has asked for clarification or changes to any answers given in the application 
form, please do not submit a revised copy of the application form; these can be addressed in 
a covering letter to the REC. 
The Committee will confirm the final ethical opinion within a maximum of 60 days from the 
date of initial receipt of the application, excluding the time taken by you to respond fully to the 
above points.  A response should be submitted by no later than 11 May 2012. 
 
Membership of the Committee 
 
The members of the Committee who were present at the meeting are listed on the attached 
sheet. 
 
Statement of compliance  
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK.  
 
12/WA/0003   Please quote this number on all correspondence 
 
Yours sincerely 
 
 
 
 
Dr K J Craig 
Chair 
 
Email: jagit.sidhu@bsc.wales.nhs.uk 
 
Enclosures: List of names and professions of members who were present at the meeting 
and those who submitted written comments. 
 
 
Copy to: Professor Jonathan Bisson, Cardiff and Vale UHB 
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APPENDIX ELEVEN – Potential Interview Topics 
Potential Topics / Information to be discussed in one to one interviews. 
 
Questions and areas discussed pre-surgery with patients will cover: 
 What has it been like living with the Risk and BRCA1/2 status? 
 What if any, were the disclosure problems to friends and family 
members? 
 What are your fears and expectations? 
 What is your past medical history of physical and psychological 
problems? Body image/ Sexuality problems 
 How do you cope with stressful situations, what are your Coping 
strategies? 
 
Information needs - were they met and how can they be improved. 
 
Areas discussed with the patient post-surgery will cover: 
 Recovery. 
 Satisfaction, regret? 
 Body image and sexuality. 
 Anxiety and fear. 
 Problems experienced. 
 Effects on the family. 
 The impact of the experience. 
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 Coping. 
 The need for psychological help? 
 Areas of questions for the partners/ relatives. 
 How has the results of the gene testing affected you? 
 What are your fears /expectations? 
 What are your information and psychological needs? 
 How can the breast care team help you? 
 What has the whole experience of the results and what your relative 
has been through been like for you? 
 Are there any specific problems that you think we could help with? 
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APPENDIX TWELVE - Patient Consent Form Version 2 
                                                 
Consent Form Version 2, January 2012 
 
Study Title: The long term experience of BRCA1/2(gene mutation 
carriers) women undergoing bilateral risk-reducing mastectomy 
 
Please initial box 
1. I confirm that I have read the information sheet for the                 
above study. I have had the opportunity to consider the 
information, ask questions and have had these answered 
satisfactorily. 
 
2. I understand that my participation is voluntary and that I               
am free to withdraw at any time without giving any reason, 
without my medical care or legal rights being affected. 
 
3. I understand that my interview will be recorded on a digital           
recording device. I give permission for this. 
 
4. I understand that data collected may be looked at by                     
responsible representatives from  Cardiff University and 
Cardiff and Vale Health Board for the purposes of monitoring 
and auditing the conduct of the research. I give permission 
for this. 
 
5. I understand that data collected will not be transferred to               
any commercial organisation. 
 
6. I understand that if I lose the capacity to consent, that I                  
will be withdrawn from the study. I understand that any 
information collected from interviews/observations before 
the loss of consent will still be included in the study. 
 
7. I agree to take part in the above study. 
 
□ 
□ 
□ 
□ 
□ 
□ 
 Name of Person taking consent 
Date 
Signature 
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APPENDIX THIRTEEN - Patient Information Sheet 
 
 
Patient Participant Information Sheet (Relative) 
Version 4 January 2012 
 
Information about the Research 
Study title: The long term experience of BRCA1/2(gene mutation 
carriers) women undergoing bilateral risk-reducing mastectomy. 
You are invited to take part in the above research study because your 
relative is planning to undergo bilateral risk-reducing mastectomy in order to 
prevent breast cancer. Before you decide if you would like to take part in this 
research, please read the following information and feel free to discuss it with 
others. My name is Nicola West, I am a Consultant Nurse working within the 
Cardiff breast centre and this research is my PhD. For this research, I am 
based at the school of nursing and midwifery, Cardiff University. I am 
exploring the long term experiences and impacts of this surgery on women 
who carry the BRCA1/2 gene and their partners and family. This is important 
as this research will inform local services, so that they can be tailored to 
meet both women’s physical needs and the  emotional needs of the family.   
 
What is the research about? 
The research is about developing an understanding of the long term 
experiences of women who carry the gene and decide to undergo bilateral 
mastectomy with or without breast reconstruction. The research will also look 
at the wider impact on partners and family, which has been rarely examined.  
 
Why is the research being undertaken? 
At present, NHS services focus on patients with breast cancer, thus here is 
limited service provision (follow up and ongoing care) supporting women at 
high risk of breast cancer who undergo risk-reducing surgery. There is little 
evidence of the long term physical and psychological impacts of such 
surgery or the effects on partners and significant others. The findings from 
this research will inform the development of appropriate care pathways so 
that women and their families can receive the support and help they require. 
 
How and where will the research be undertaken? 
If you agree, you will be asked to take part in a number of interviews with me. 
There will be three interviews, which will be conducted at different time points 
such as pre-surgery, 6 months after the surgery and 12-18 months later. 
  
446 
 
They will take place either in your own home, or a location at your 
convenience or choice. Interviews will be audio recorded and will usually 
take 1-1.5 hours. All information is completely confidential and you will not be 
recognised as taking part in the study unless you want to. 
 
Do I have to take part? 
You do not have to take part in the study, and your care will not be affected 
in any way. 
  
What are the potential benefits of the research? 
You will be able to talk openly and honestly about your experiences and this 
will provide you with an opportunity to contribute to future services. It will also 
mean that there is a contact for you. This may be the first time you have 
been able to express your feelings and experiences. In addition, it will 
provide health professionals involved with women and families with a high 
risk of breast cancer with a much better understanding of the longer term 
effects of such surgery on the family and be able to offer appropriate support 
and care. 
 
Is there any risk of harm from the research? 
There is no predicted harm from participating in this study, although it is 
possible that discussing some aspects of undertaking your treatment and its 
effect on your life and family may cause some distress. If this happens, the 
researcher is a qualified counsellor and is able to offer support. 
 
Will my taking part in the study be kept confidential? 
Yes. I will follow ethical and legal practice and all information about you will 
be handled in confidence. You will not be identified by name and all 
procedures for handling storage and destruction of the data match the 
Caldecott principles. I will collect the data from the interviews which I will do 
by taping the interviews and the information will be stored on my computer 
within the university with an encrypted password. After 5 years of keeping 
the data, Cardiff University will archive and then destroy the information. The 
recordings will be locked in a secure cabinet within the University until 
transcribed and verified and then destroyed. 
 
What do I do now? 
If you are interested in taking part, please complete the attached form and 
return it in the pre-paid envelope .I will then contact you to organise a time 
convenient to meet with you. 
 
Who to contact? 
If you have any questions or queries, please feel free to contact me: 
 
Nicola West. Room 702A.School of Nursing and Midwifery Studies, Cardiff 
University East Gate House .35 – 43 Newport Road.CF24 0AB 
On 07811959583O or westn@cf.ac.uk 
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Lynne Rollins Secretary on 02920716823 
Dr Katie Featherstone at featherstonek@cf.ac.uk 
 
Alternatively you could contact Dr Mark Rogers or Dr Alexandra Murray at 
The All Wales Cancer Genetics Service on 02920744058.  
 
Additional Information about the Research 
 
Study title: The long term experience of BRCA1/2 (gene mutation 
carriers) women undergoing bilateral risk-reducing mastectomy 
All the information collected will be treated confidentially, your name and 
address will not be attached in any way. All data will be safely stored. The 
tapes used to record the interviews will be safely stored, and the tapes will 
be destroyed when the interviews have been transcribed. The data collected 
will only be shared with my supervisors, but may be reviewed by Cardiff and 
Vale University Health Board to monitor the conduct of the research. 
 
What will happen with the results of the research? 
The findings of the study will be discussed with the healthcare team at the 
University Hospital of Wales and Breast care team in Cardiff. The findings 
will also be submitted for publication in various Journals for healthcare 
professionals. The results will be disseminated across Wales so that all 
patients at high risk have access to appropriate care. 
 
Who is funding the study? 
I work as a Consultant nurse within the Breast Centre at Llandough hospital 
and also as a lecturer at Cardiff University. Cardiff University and The Health 
Board are funding my study. 
 
Who has approved the study? 
The study has been approved by the Research Ethics Committee for South 
East Wales, and has undergone scientific review by the Joint University 
Health Board and Cardiff University review service (Cardiff Research Review 
Service). Research and Development approval has been issued following 
this review by the Cardiff and Vale University Health Board Research and 
Development office.  
 
What if something goes wrong? 
I do not expect any harm to come to you from taking part in this study. 
However, if you are not happy about any aspect of the study, please feel free 
to contact me on the details above. Alternatively, you can contact any 
member of the team at the Cardiff Breast unit on 02920715722 or the All 
Wales Cancer Genetics Team about any aspect of the research. If you wish 
to make a more formal complaint, the Cardiff and Vale University Health 
Board has a complaints service, and they can be contacted on 029 2074 
2202. 
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Other considerations 
If you lost capacity to consent during the study you would be excluded and 
no new information would be collected from you. However, previous 
information collected during interviews would still be used – the researcher 
will explain this in full if you decide to take part in the study. 
 
Patient Initial Contact Consent 
 
Consent for Initial Contact. 
 
 
Nicola West 
School of Nursing and Midwifery 
Cardiff University 
Room 702 Eastgate House 
Newport Road, Cardiff CF24 0AB 
Mobile 07811959583       
                                                      
I confirm that I have read the information leaflet about your research project 
and I am happy for you to contact me to arrange a meeting. 
 
I understand that my participation is entirely voluntarily and that I am free to 
withdraw at any time without giving a reason. 
 
Name. 
 
Address. 
 
Signature. 
 
Telephone Number. 
 
Preferred method of contact. 
 
Relationship to Patient 
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APPENDIX FOURTEEN - Patient Information Sheet Final 
 
 
Patient Participant Information Sheet 
Version 4 January 2012 
Information about the Research 
Study title: The long term experience of BRCA1/2(gene mutation 
carriers) women undergoing bilateral risk-reducing mastectomy. 
You are invited to take part in the above research study because you are 
planning to undergo bilateral risk-reducing mastectomy in order to prevent 
breast cancer. With your consent, your partner will also be approached to take 
part in the study. Before you decide if you would like to take part in this 
research, please read the following information and feel free to discuss it with 
others. My name is Nicola West, I am a Consultant Nurse working within the 
Cardiff breast centre and this research is my PhD. For this research, I am 
based at the school of nursing and midwifery, Cardiff University. I am exploring 
the long term experiences and impacts of this surgery on women who carry 
the BRCA1/2 gene and their partners and family. This is important as this 
research will inform local services, so that they can be tailored to meet 
women’s physical and emotional needs.   
 
What is the research about? 
The research is about developing an understanding of the long term 
experiences of women who carry the gene and decide to undergo bilateral 
mastectomy with or without breast reconstruction. The research will also look 
at the wider impact on partners and family, which has been rarely examined.  
 
Why is the research being undertaken? 
At present, NHS services focus on patients with breast cancer, thus here is 
limited service provision (follow up and ongoing care) supporting women at 
high risk of breast cancer who undergo risk-reducing surgery. There is little 
evidence of the long term physical and psychological impacts of such surgery 
or the effects on partners and significant others. The findings from this 
research will inform the development of appropriate care pathways so that 
women and their families can receive the support and help they require. 
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How and where will the research be undertaken? 
If you agree, you will be asked to take part in a number of interviews with me. 
There will be three interviews, which will be conducted at different time points 
such as while you are waiting for the surgery, 6 months after the surgery and 
12-18 months later. They will take place either in your own home, or if you 
prefer at a location at your convenience or choice. Interviews will be audio 
recorded and will usually take 1-1.5 hours. In addition, you will be asked to 
complete a simple self-assessment scale to assess body image. All 
information is completely confidential and you will not be recognised as taking 
part in the study unless you want to. 
 
Do I have to take part? 
You do not have to take part in the study, and your care will not be affected in 
any way. 
  
What are the potential benefits of the research? 
You will be able to talk openly and honestly about your experiences and this 
will provide you with an opportunity to contribute to future services. It will also 
mean that there is a contact for you. Partners and other family members will 
benefit because it may be the first time they have been able to express their 
feelings and experiences. In addition, from a clinical perspective, it will provide 
health professionals involved with women with a high risk of breast cancer with 
a much better understanding of the longer term effects of such surgery and be 
able to offer appropriate support and care. 
 
Is there any risk of harm from the research? 
There is no predicted harm from participating in this study, although it is 
possible that discussing some aspects of undertaking your treatment and its 
effect on your life and family may cause some distress. If this happens, the 
researcher is a qualified counsellor and is able to offer support. 
 
Will my taking part in the study be kept confidential? 
Yes. I will follow ethical and legal practice and all information about you will be 
handled in confidence. You will not be identified by name and all procedures 
for handling storage and destruction of the data match the Caldecott principles. 
I will collect the data from the interviews which I will do by taping the interviews 
and the information will be stored on my computer within the university with an 
encrypted password. After 5 years of keeping the data, Cardiff University will 
archive and then destroy the information. The recordings will be locked in a 
secure cabinet within the University until transcribed and verified and then 
destroyed. 
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What do I do now? 
If you are interested in taking part, please complete the attached form and 
return it in the pre-paid envelope .I will then contact you to organise a time 
convenient to meet with you. Could you please also pass on my details to your 
partner if you are happy for them to be approached? 
 
Who to contact? 
If you have any questions or queries, please feel free to contact me: 
Nicola West. Room 702A.School of Nursing and Midwifery Studies, Cardiff 
University East Gate House .35 – 43 Newport Road.CF24 0AB 
On 07811959583O or westn@cf.ac.uk 
Lynne Rollins Secretary on 02920716823 
Dr Katie Featherstone at featherstonek@cf.ac.uk 
 
Alternatively you could contact Dr Mark Rogers or Dr Alexandra Murray at The 
Al l Wales Cancer Genetics Service on 02920744058.  
 
Additional Information about the Research 
 
Study title: The long term experience of BRCA1/2 (gene mutation 
carriers) women undergoing bilateral risk-reducing mastectomy 
All the information collected will be treated confidentially, your name and 
address will not be attached in any way. All data will be safely stored. The 
tapes used to record the interviews will be safely stored, and the tapes will be 
destroyed when the interviews have been transcribed. The data collected will 
only be shared with my supervisors, but may be reviewed by Cardiff and Vale 
University Health Board to monitor the conduct of the research. 
 
What will happen with the results of the research? 
The findings of the study will be discussed with the healthcare team at the 
University Hospital of Wales and Breast care team in Cardiff. The findings will 
also be submitted for publication in various Journals for healthcare 
professionals. The results will be disseminated across Wales so that all 
patients at high risk have access to appropriate care 
 
Who is funding the study? 
I work as a Consultant nurse within the Breast Centre at Llandough hospital 
and also as a lecturer at Cardiff University. Cardiff University and The Health 
Board are funding my study. 
 
Who has approved the study? 
The study has been approved by the Research Ethics Committee for South 
East Wales, and has undergone scientific review by the Joint University Health 
Board and Cardiff University review service (Cardiff Research Review 
Service). Research and Development approval has been issued following this 
review by the Cardiff and Vale University Health Board Research and 
Development office.  
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What if something goes wrong? 
I do not expect any harm to come to you from taking part in this study. 
However, if you are not happy about any aspect of the study, please feel free 
to contact me on the details above. Alternatively, you can contact any member 
of the team at the Cardiff Breast unit on 02920715722 or the All Wales Cancer 
Genetics Team about any aspect of the research. If you wish to make a more 
formal complaint, the Cardiff and Vale University Health Board has a 
complaints service, and they can be contacted on 029 2074 2202. 
 
Other considerations 
If you lost capacity to consent during the study you would be excluded and no 
new information would be collected from you. However, previous information 
collected during interviews would still be used – the researcher will explain this 
in full if you decide to take part in the study. 
 
Patient Initial Contact Consent 
 
Consent for Initial Contact. 
 
Nicola West 
School of Nursing and Midwifery 
Cardiff University 
Room 702 Eastgate House 
Newport Road 
Cardiff 
CF24 OAB 
Mobile 07811959583  
 
I confirm that I have read the information leaflet about your research project 
and I am happy for you to contact me to arrange a meeting. 
 
I understand that my participation is entirely voluntarily and that I am free to 
withdraw at any time without giving a reason. 
 
Name. 
 
 
Address. 
 
 
Signature. 
 
 
Telephone Number. 
 
 
Preferred method of contact. 
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APPENDIX FIVETEEN – Partner Consent Form Version 2 
                                                 
Consent Form Version 2, January 2012 (Partner/Relative) 
Study Title: The long term experience of BRCA1/2 (gene mutation 
carriers) women undergoing bilateral risk-reducing mastectomy 
 
Please initial box 
1. I confirm that I have read the information sheet for the                 
above study. I have had the opportunity to consider the 
information, ask questions and have had these answered 
satisfactorily. 
 
2. I understand that my participation is voluntary and that I               
am free to withdraw at any time without giving any reason, 
without my medical care or legal rights being affected. 
 
3. I understand that my interview will be recorded on a digital           
recording device. I give permission for this. 
 
4. I understand that data collected may be looked at by                     
responsible representatives from  Cardiff University and 
Cardiff and Vale Health Board for the purposes of monitoring 
and auditing the conduct of the research. I give permission 
for this. 
 
5. I understand that data collected will not be transferred to               
any commercial organisation. 
 
6. I understand that if I lose the capacity to consent, that I                  
will be withdrawn from the study. I understand that any 
information collected from interviews/observations before 
the loss of consent will still be included in the study. 
 
7. I agree to take part in the above study. 
□ 
□ 
□ 
□ 
□ 
□ 
□ 
Name of Participant  
Date  
Signature 
 
Name of Person taking consent 
Date 
Signature 
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APPENDIX SIXTEEN – FN Award Letter  
  The Florence Nightingale 
Foundation  
34 Grosvenor Gardens, First Floor Front, London SW1W 0DH  
Tel: 020 7730 3030  
Fax: 020 7730 6262  
  Email: admin@florence-nightingale-foundation.org.uk www.florence-nightingale-
foundation.org.uk  
     
14 July 2014  
 
Mrs Nicola West  
Roslyn  
167c Marshfield Road  
Marshfield  
Cardiff   
Email: agentors@btinternet.com   
Nicola.west@wales.nhs.uk  
Dear Nicola  
The Selection Panel were delighted to have the opportunity to meet you at your recent 
skype interview. 
  
Through the generosity of The Stephanie Thompson Memorial Trust we are pleased 
to offer you an award of £1,500.00 to assist you in undertaking the 4th year of your 
PhD in Nursing September 2014 to April 2015. The title of your study is: What 
are the experiences of BRCA1/2 woman, their partners and relatives following 
diagnosis and up to 18 months post bilateral riskreducing mastectomy?   I am aware 
that this is less than you requested but we believe should still enable you to achieve 
your stated objectives. This money will be paid either to the University where you are 
undertaking your course or directly to you, as required. In either case, we would need 
to have sight of an invoice or receipt as appropriate.  
 
Royal Patron: HRH Princess Alexandra, the Hon. Lady Ogilvy, KG GCVO  
President: the Baroness Emerton, DBE DL Chairman: Mr Bryan Sanderson, CBE Chief Executive: Professor 
Elizabeth Robb Administrator: Stephanie Dawes  
A company limited by guarantee Registration No. 518623 Registered in England and Wales  
Charity Registration No. 229229 and in Scotland Charity Registration No. SC044341  
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Would you thank Mr Jeff Thompson, on behalf of The Stephanie Thompson 
Memorial Trust at the email below.  
jct_jct@yahoo.com 
The terms and conditions of acceptance of this scholarship are:  
  
• The Foundation require a short six month review report by the end of 
April 2015 to update us on your progress.  This needs to be a brief 
update of no more than 500 words which can be sent to the administrator 
at admin@florence-nightingale-foundation.org.uk as an attachment in a 
word document.  
  
• I attach some notes for guidance on report writing plus a front cover for 
your report.  A full report on your research (two hard copies and one on 
CD or stick) should reach The Foundation on completion of your studies 
covered by this award. Your report should include an acknowledgement 
of your sponsor and The Florence Nightingale Foundation, and be 
presented in a clear plastic cover.    
  
• You should also send a copy of your report to your sponsor at the end 
of your scholarship.  
  
• Your final report should be submitted within 3 months of 
completion of your year of study but no later than 18 December 
2015.   
  
• Your sponsor may also ask you to give a formal presentation on 
the outcome of your studies at a future meeting; we will liaise with 
you on this nearer the time.  
  
• If asked, you should be willing to present your work at a 
Foundation conference.  
  
• We also ask you publish something as a result of your scholarship.  
By accepting this award you agree to the Foundation sharing 
intellectual property rights generated as a result of this 
scholarship.  
  
• By accepting this award we also hope that you will be happy to 
become an Alumni of the Foundation to help support future 
scholars within your area of expertise.  Unless you inform us 
otherwise we will keep your electronic personal date on file and 
contact you with relevant information and opportunities to 
collaborate with The Foundation.   
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• If your home address or employment details change before you 
have submitted your report, you are required to keep the 
Foundation up-to-date with your contact details at all times.  
  
• If you have a significant period of sickness or any event that may 
impact on the completion and/or submission of your final report, 
you are required to inform the Foundation as soon as possible to 
negotiate a new submission date if required.  
  
• In the event that you do not undertake the study and produce an 
acceptable report for which this award is being made, you will 
return to The Foundation the money you have received, in order 
that it may be used to fund another Scholar.  
  
If you accept the award in accordance with the conditions set out above 
in this letter, please sign one copy and return it to me as soon as 
possible, but by 24/7/14 at the latest  keeping the second copy for 
future reference.  
  
If you require any further information, please do not hesitate to contact 
this office.  
  
With best wishes and congratulations on this award.  
  
Yours sincerely  
  
Professor Elizabeth Robb  
Chief Executive  
I accept this award on the conditions set out above and undertake to refund 
the money if circumstances outlined above apply.  
........................................................   ……………………………………. 
Name      Date  
Royal Patron: HRH Princess Alexandra, the Hon. Lady Ogilvy, KG GCVO 
President: the Baroness Emerton, DBE DL Chairman: Mr Bryan Sanderson, 
CBE Chief Executive: Professor Elizabeth Robb  
Administrator: Stephanie Dawes 
A company limited by guarantee Registration No. 518623 Registered in England and Wales 
Charity Registration No. 229229 and in Scotland Charity Registration No. SC044341  
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APPENDIX SEVENTEEN – FN Award Letter 2013/14 
   The Florence Nightingale Foundation 
 
34 Grosvenor Gardens, First Floor Front, London SW1W 0DH 
Tel: 020 7730 3030 
Fax: 020 7730 6262 
Email: admin@florence-nightingale-foundation.org.uk 
www.florence-nightingale-foundation.org.uk 
5 July 2013 
 
Nicola West 
Roslyn 
167c Marshfield Road 
Cardiff CF3 2TU 
Email: WestN@cardiff.ac.uk   argentors@btinternet.com 
 
 
Dear Nicola 
 
THE FLORENCE NIGHTINGALE FOUNDATION RESEARCH SCHOLARSHIPS 
2013-2014: GARFIELD WESTON FOUNDATION RESEARCH SCHOLARSHIP  
 
The Selection Panel were delighted to have the opportunity to meet you at your 
recent Skype interview. 
 
Through the generosity of Garfield Weston Foundation we are pleased to offer you 
an 
award  of £1,914.00 to assist you in undertaking the 3rd year of her PhD in Nursing. 
The title of her study is: What are the experiences of BRCA1/2 woman, their 
partners 
and relatives following diagnosis and up to 18 months post bilateral risk-reducing 
mastectomy? This money will be paid either to the University where you are 
undertaking your course or directly to you, as required.  In either case, we would 
need to have sight of an invoice or receipt as appropriate. 
                                                                  
Would you thank Clare Wilkinson, on behalf of Garfield Weston Foundation. 
Her contact details are: 
  Clare Wilkinson 
  Grants Manager 
  Garfield Weston Foundation 
  Weston Centre 
  10 Grosvenor Street 
  London W1K 4QY 
      
Patron: HRH Princess Alexandra. The Hon. Lady Ogilvy, KG GCVO 
President: the Baroness Emerton, DBE DL Chairman: Mr Bryan Sanderson, CBE Chief Executive: 
Professor Elizabeth Robb 
Administrator: Stephanie Dawes 
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The terms and conditions of acceptance of this scholarship are: 
 
 The Foundation require a short six month review report by the end of March 
2014 to update us on your progress. 
 
 I attach some notes for guidance on report writing plus front covers for your 
report. A full report on your research (two hard copies and one on CD or 
stick) should reach The Foundation on completion of your studies covered 
by this award. Your report should include an acknowledgement of the 
Garfield Weston Foundation and The Florence Nightingale Foundation, and 
be presented in a clear plastic cover.   
 
 You should also send a copy of the report to your sponsor at the end of your 
scholarship. 
 
 Your final report should be submitted within 3 months of completion of your 
year of study i.e. no later than 29 November 2014. 
 
 Your sponsor may also ask you to give a formal presentation on the 
outcome of your studies at a future meeting; we will liaise with you on this 
nearer the time. 
 
 If asked, you should be willing to present your work at a Foundation 
conference. 
 
 We also ask you publish something as a result of your scholarship.  By 
accepting this award you agree to the Foundation sharing intellectual 
property rights generated as a result of this scholarship. 
 
 By accepting this award we also hope that you will be happy to become an 
Alumni of 
The Foundation to help support future scholars within your area of expertise.  
Unless you inform us otherwise we will keep your electronic personal date on 
file and contact you with relevant information and opportunities to collaborate 
with The Foundation.  
 
 If your home address or employment details change before you have 
submitted your report, you are required to keep the Foundation up-to-date with 
your contact details at all times. 
 
 In the event that you do not undertake the study and produce an acceptable 
report for which this award is being made, you will return to The Foundation 
the money you have received, in order that it may be used to fund another 
Scholar. 
 
If you accept the award in accordance with the conditions set out above in this 
letter, please sign one copy and return it to me as soon as possible, but 
by 23/7/13 at the latest keeping the second copy for future reference. 
 
If you require any further information, please do not hesitate to contact this office. 
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With best wishes and congratulations on this award. 
 
Yours sincerely 
 
 
Professor Elizabeth Robb 
Chief Executive 
 
 
 
I accept this award on the conditions set out above and undertake to refund 
the money if circumstances outlined above apply. 
 
..................................................       
........................................................ 
Name Date 
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